‘ĺă‘ĺŠwˆăŠw•””畆‰ČŠw‹łŽşŠw‰ď”­•\‹ĆŃWi‚P‚X‚V‚W`‚Q‚O‚O‚R”Nj

F‘fŤŠŁ”çÇ

Ž›“c@˜aŽq@@‘˝“c@łŒ›@@ź‰Ş@@´@@ź–{@ˆŰ–ž iZ—F@Œ`ŹŠO‰Čj
‘ć233‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1978.10.28
‘ĺăÔ\Žš•a‰@
@
Subcorneal pustular dermatosis iSneddon-Wilkinsonj ‚Ě‚P—á
‚ˆŔ@@i
‘ć36‰ń“ú”ç‰ď‘ĺ•Ş’n•ű‰ď
1978.10.28
•Ę•{
@
“Ş•”C Šç–Ę‚Ě morphea ‚Ě‚P—á
‹Ę’u@OŒő iă‘厨•@‰Čj @@’JŠ_@••F
‘ć40‰ńŽ¨•@ˆôA—Տ°ˆă‰ď
1978.10.29
Šň•Œ
@
Eosinophilic spongiosis
‹v•Ű@rŽq@@‹´–{@Œö“ń@@ź‰Ş@@´
‘ć42‰ń“Œ“ú–{˜A‡’n•ű‰ď
1978.10.7
“Œ‹ž
@
‰ťĎ•i—pƒAƒ]F‘f‚Ě”˝‰žŒđłŤ‚ĚŒŸ“˘
“Ą–{@Œ\ˆę iZ—Fj @@’†‘ş@—R”ü i“Żj @@‹´–{@˝ˆę i“Żj @@Ź’ˁ@—Y–Ż@@@“c‘ă@@ŽŔ@@’†“ě@@Œł iă‘ĺ@—@’†ěŒ¤j @
‘ć42‰ń“Œ“ú–{˜A‡’n•ű‰ď
1978.10.7
“Œ‹ž
@
ƒAƒŒƒ‹ƒM[ŤÚG”畆‰Š‚̍l‚Ś•ű
ź‰Ş@@´
Maibach ‹łŽöu‰‰‰ď
1978.11
‘ĺă
@
Œ{ăó”畆”­ś‰ß’ö‚É‚¨‚Ż‚郀ƒR‘˝“œƒRƒ‰[ƒQƒ“‡Ź
’†‘ş@rF@@‰iˆä@—T i“Œ‹žˆăŽ•‘ĺ“ďŒ¤ˆŮí‘ăŽÓj
‘ć51‰ń“ú–{ś‰ťŠw‰ď
1978.11.27
‹ž“s
@
Œ{ăóüˆŰ‰č×–E‚É‚¨‚Ż‚éŽ_Ťƒ€ƒR‘˝“œ‚̐ś‡Ź
“ń‹{@‘P•ś@@’†‘ş@rF@@‰iˆä@@—T i“Œ‹žˆăŽ•‘ĺ“ďŒ¤ˆŮí‘ăŽÓj
‘ć51‰ń“ú–{ś‰ťŠw‰ď
1978.11.27
‹ž“s
@
ŠˆŤ‰ťƒŠƒ“ƒpß×–E‚ć‚čŽYś‚ł‚ę‚錌ŠÇVśˆöŽq
ź‰Ş@@´@@•ĐŽR@ˆę˜N
‘ć‚W‰ń“ú–{–ƉuŠw‰ď
1978.11.27-29
‹ž“s
@
ÚGƒAƒŒƒ‹ƒM[‚É‚¨‚Ż‚éR‘Ě‚Ě–đŠ„EŠ´ěŒŒ´‚É‚ć‚éÚ‰đƒAƒŒƒ‹ƒM[‚Ě—}§‚Ć CBH ‚Ě”­Œť
•ĐŽR@ˆę˜N@@ź‰Ş@@´
‘ć‚W‰ń“ú–{–ƉuŠw‰ď
1978.11.27-29
‹ž“s
@
‰ťĎ•i—pƒAƒ]F‘f‚Ě”˝‰žŒđłŤ‚ĚŒŸ“˘
“Ą–{@Œ\ˆę iZ—Fj @@’†‘ş@—R”ü i“Żj @@‹´–{@˝ˆę i“Żj @@Ź’ˁ@—Y–Ż@@@“c‘ă@@ŽŔ@@’†“ě@@Œł iă‘ĺ@—@’†ěŒ¤j @
‘ć‚R‰ń’†•”ƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç—á‰ď
1978.12.17
‘ĺă
@
‰ťĎ•iF‘f‚̐¸ť‚Ć•sƒ•¨‚Ě•ŞÍ
“Ą–{@Œ\ˆę iZ—Fj @@’†‘ş@—R”ü i“Żj @@‹´–{@˝ˆę i“Żj @@Ź’ˁ@—Y–Ż@@“c‘ă@@ŽŔ@@’†“ě@@Œł iă‘ĺ@—@’†ěŒ¤j
‘ć‚R‰ń’†•”ƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç—á‰ď
1978.12.17
‘ĺă
@
Žs”̐F‘f‚Ě–â‘č“_|‹UĚ•i‚Ě‘śÝ‚ɂ‚˘‚Ä
“Ą–{@Œ\ˆę iZ—Fj @@’†‘ş@—R”ü i“Żj @@‹´–{@˝ˆę i“Żj @@Ź’ˁ@—Y–Ż@@“c‘ă@@ŽŔ@@’†“ě@@Œł iă‘ĺ@—@’†ěŒ¤j
‘ć‚R‰ń’†•”ƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç—á‰ď
1978.12.17
‘ĺă
@
ŽîᇍזE‚Ěƒwƒ‹ƒp[”\‚đŒŸő‚ľ‚˝ T cell lymphoma ‚Ě‚P—á
”ÂŒŠ@@’q@@‹´–{@Œö“ń
‘ć234‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1978.12.9
˜a‰ĚŽRˆă‘ĺ
@
”|—{üˆŰ‰č×–E‚É‚ć‚鐍ƒzƒ‹ƒ‚ƒ“Žó—e‘Ě‚ĚŒŸő
‚ˆŔ@@i@@ź–{@Œ\Žj iă‘ĺŠŕŒ¤j
ŒúśČ“Á’莞Šłƒzƒ‹ƒ‚ƒ“Žó—e‘ĚˆŮíÇ’˛¸Œ¤‹†”Á‘‰ď
1978.2.12
‹ž“s
@
‘gDŠwăƒWƒ…[ƒŠƒ“ƒOáv]ó”畆‰Š‚đŽv‚í‚š‚˝—Ţ“Vávጂ̂P—á
‹v•Ű@rŽq@@“n•Ó@~Žq@@‹´–{@Œö“ń@@ź‰Ş@@´
‘ć230‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1978.2.25
ă‘ĺ
@
Pityriasis rubra pilaris ‚Ě‚P—á
“n•Ó@~Žq@@ź‰Ş@@´
‘ć230‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1978.2.25
ă‘ĺ
@
Actinic reticuloid ‚Ě‚P—á
•ĐŽR@ˆę˜N@@ź‰Ş@@´
‘ć230‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1978.2.25
ă‘ĺ
@
”ń’čŒ^RŽ_‹Ű“÷‰čŽî‚Ě‚Q—á
ŽO‰Y@~Žq@@‚ˆŔ@@i@@ŽR–{@łŸ@@Ô–؁@łŽu i”Ş”öŽs–Żj ´…@—mŽq iă‘ĺ’†ŒŸj@@
‘ć231‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1978.4.22
_ŒË’†‰›Žs–Ż•a‰@
@
‚ IgE ŒŒÇ‚𔺂Á‚˝‘Ű᝗l”畆‰Š‚Ě‚P—á
“n•Ó@~Žq@@ź‰Ş@@´
‘ć231‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1978.4.22
_ŒË’†‰›Žs–Ż•a‰@
@
ƒPƒƒCƒh‚É‚¨‚Ż‚錋‡DŹ•Ş‚Ě•ŞŽq‚̐Ťó
‹gŠÔ@‰p—Y@@VŠC@@Ÿą@@˛–ě@žÄt
‘ć77‰ń“ú”ç‰ď‘‰ď
1978.5.19-21
ĺ‘ä
@
ŠŁáŤŠÖßÇ‚É‚¨‚Ż‚é HLA RŒ´‚ɂ‚˘‚Ä
‹´–{@Œö“ń@@’Ň–{@ł‹L iă‘后ŠOj @@’†“c@¸ŽO iă‘ĺ1ŠOj @@źŽR@łŒo i“Żj @@X@@@—˛ i“Żj
‘ć77‰ń“ú”ç‰ď‘‰ď
1978.5.19-21
ĺ‘ä
@
F‘fŤŠŁ”çÇ‚̐V‚ľ‚˘Œ^
rŁ@˝ŽĄ i“ż“‡‘ĺj @@••”@@Œ[ i‹ž“s‘ĺj @@Ź’ˁ@—Y–Ż
‘ć77‰ń“ú”ç‰ď‘‰ď
1978.5.19-21
ĺ‘ä
@
COPP —Ă–@‚É‚ć‚芰‰đ‚ľ‚˝‹Űó‘§“÷Ç‚Ě‚P—á
“c’ĂŒ´ŒjŽq@@“c‘ă@@ŽŔ
‘ć77‰ń“ú”ç‰ď‘‰ď
1978.5.19-21
ĺ‘ä
@
…“—‚¨‚ć‚Ń‘Ńóáv]‚ĚŒŒ´Šw“IŠĎŽ@
”¨@´ˆę˜Y
‘ć70‰ń“ú”ç‰ďŽl‘’n•ű‰ď
1978.6.17
ˆ¤•Q
@
f’f—á
‹gŠÔ@‰p—Y
‘ć71‰ń‹ß‹E”畆‰ČW’k‰ď
1978.6.25
‹ž“s
@
5|FU ‹Ç’‚Ş‘tŒř‚ľ‚˝Šî’ę×–Eă”çŽî
”¨@´ˆę˜Y
‘ć71‰ń‹ß‹E”畆‰ČW’k‰ď
1978.6.25
‹ž“s
@
l”畆üˆŰ‰č×–E‚đ—p‚˘‚˝ androgen receptor ‚Ě‘Ş’č
‚ˆŔ@@i@@˜e–{@@”Ž iă‘ĺŠŕŒ¤j @@…’JC‘ž˜Y iă‘ĺ”ĺ”AŠí‰Čj @Â–ě@•q”Ž i“ŻŽY•wl‰Čj @@ź–{@Œ\Žj i“ŻŠŕŒ¤j @@
‘ć51‰ń“ú–{“ŕ•Ş”ĺŠw‰ď‘‰ď
1978.6.3-5
“Œ‹ž
@
ƒVƒ“ƒ|ƒWƒEƒ€ u‰ťĎ•i”畆áŠQ‚ɂ‚˘‚Ä‚Ě–â‘č“_v ƒ^[ƒ‹ŒnF‘f
Ź’ˁ@—Y–Ż
“ú–{Ď•i‰ČŠw‰ď‘ć‚R‰ńŠwp‘ĺ‰ď
1978.6.5
“Œ‹ž
@
_ŒoüˆŰŽî‚ĚŒ‹‡‘gDŹ•Ş‚ą‚Ć‚ÉƒRƒ‰[ƒQƒ“‚̐Ťó
VŠC@@Ÿą@@ź—с@Žü–M@@‹gŠÔ@‰p—Y@@’†‘ş@rF@@˛–ě@žÄt
“ú–{Œ‹‡DŠw‰ď‘ć10‰ń‘ĺ‰ď
1978.7.14
‹ŕ‘ň
@
b”ç—l•ę”Á‚É”­ś‚ľ‚˝ˆŤŤ•FŽî
é@@—ÇŽq@@‹v•Ű@rŽq@@ŽN@ç’ĂŽq@@ź‰Ş@@´
‘ć232‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1978.7.22
ŠÖźˆă‘ĺ
@
ƒ~ƒmƒTƒCƒNƒŠƒ“‚Ş’˜Œř‚đŽŚ‚ľ‚˝F‘fŤáy]‚Ě‚Q—á
“c‘ă@@ŽŔ
‘ć232‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1978.7.22
ŠÖźˆă‘ĺ
@
Clinical biochemical and genetic studies on Japanese families of hypercholesterolemia with or without xanthomatosis
Yamamoto, A, Endo, A., Kitano, Y., Ichihara, K., Sudo, H.,and Yamamura, T.
10th International Congress of Gerontology
1978.8.20-25
“Œ‹ž
@
ƒAƒhƒŠƒAƒ}ƒCƒVƒ“‚Ě“Ž–Ź“ŕ“Š—^‚É‚ć‚čŘœ‰Â”\‚Ć‚Č‚Á‚˝—ź”x“]ˆÚ‚𔺂¤‹‘ĺ‚ȉE‘ĺ‘ÚˆŤŤŠÔ—tŽî‚ĚŒoŒą—á
‘˝“c@Ol iă‘ĺ‚PŠOj @@’ˇ’Jě‡‹g i“Żj @@Ź’ˁ@—Y–Ż
‘ć16‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď
1978.9
–źŒĂ‰Ž
@
ƒRƒPƒCƒ“Ç×–E‚Ě DNA C•œ
’r‰i@–žś iă‘ĺˆă•úŠîj @@úá“c@—˛”Ž i“ŻŹŽ™‰Čj @@Ź’ˁ@—Y–Ż
“ú–{•úŽËü‰e‹żŠw‰ď‘ć21‰ń‘ĺ‰ď
1978.9.15-17
ŽD–y
@
l”玉‘B‚Ě testosterone 5ƒż-reductase ŠˆŤ
‚ˆŔ@@i@@˜e–{@@”Ž iă‘ĺŠŕŒ¤j @@”ÂŒŠ@@’q
‘ć‚R‰ń”畆‰ČŒ¤‹†“ŻD‰ď
1978.9.22
‹ŕ‘ň
@
”畆Žîᇂɔş‚¤‘ą”­Ť”畆ƒAƒ~ƒƒCƒhÇ
‰Ş“c@“Ţ’ĂŽq@@Šě‘˝–쐪•v
‘ć29‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1978.9.23-24
‹ŕ‘ň
@
ƒRƒ‰ƒQƒ“‚Ě‘ăŽÓ‚Ć—Ő°
˛–ě@žÄt
‘ć29‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1978.9.23-24
‹ŕ‘ň
@
‰ťĎ•iF‘f‚̐¸ť‚Ć•sƒ•¨‚Ě•ŞÍ
Ź’ˁ@—Y–Ż@@“c‘ă@@ŽŔ@@“Ą–{@Œ\ˆę@@’†‘ş@—R”ü@@‹´–{@˝ˆę iZ—Fj@@’†“ě@@Œł iă‘ĺ—@’†ěŒ¤j
‘ć29‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1978.9.23-24
‹ŕ‘ň
@
Acrodermatitis enteropathica
•ĐŽR@ˆę˜N@@˛–ě@žÄt
‘ć29‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1978.9.23-24
‹ŕ‘ň
@
‘˝–т𔺂Á‚˝‘˝”X–E—‘‘ƒÇ—á‚Ě–Ń”X‚É‚¨‚Ż‚é testosterone 5ƒż-reductase ŠˆŤ
‹{č@ł•q@@Â–ě@•q”Ž@@‘q’q@Œhˆę@@‚ˆŔ@@i@@ź–{@Œ\Žj
‘ć26‰ń“ú–{“ŕ•Ş”ĺŠw‰ďź•”Žx•”‘‰ď
1978.9.28-29
L“‡
@
ŠOŤŠí‚̏—Ť‰ť‚đ’ć‚ľ‚˝ XY gonadal dysgenesis Ç—á‚Ě“ŕ•Ş”ĺŠw“IŒŸ“˘
’ç@@”Ž‹v@@Â–ě@•q”Ž@@ŽR–{”ü‘ăŽq@@ˆßŠ}@—˛•ś@@“ěě~”V—S@@ě‘ş@‘׍O@@‘q’q@Œhˆę@@‚ˆŔ@@i@@ź–{@Œ\Žj
‘ć26‰ń“ú–{“ŕ•Ş”ĺŠw‰ďź•”Žx•”‘‰ď
1978.9.28-29
L“‡
@
Formation of basement membrane in cell culture
Kitano Y.
6th Pacific Skin Research Club
1978.9.30-10.1
ˇ‰Ş
@
f’f—á
’†‘ş@rF@@•ĐŽR@ˆę˜N@@˛–ě@žÄt
“ú”ç‰ď’†•”˜A‡’n•ű‰ď
1979
‘ĺă
@
Mycobacterium marinum Š´őÇ‚Ě‚P—á
‰ĄŒŠ@ˆçŽq@@”¨@´ˆę˜Y@@´…@—mŽq
‘ć238‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1979.10.6
‘ĺă
@
Ą‰ÄW’c”­ś‚ľ‚˝ŠC…—”畆‰Š‚ɂ‚˘‚Ä
’JŠ_@••F@@˛“Ą@Œ’“ń@@‰““Ą˛•ŰŽq iŽs—§’r“cj @@•Ÿ“c@Œ[Žq i“‡‘ĺ‹ł—{•”j
‘ć238‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1979.10.6
‘ĺă
@
Šż•ű–ň‚É‚ć‚Á‚Ä—U”­‚ł‚ę‚˝”^ávŤŠŁá
ź‰Ş@@´@@“c’ĂŒ´ŒjŽq@@˛–ě@žÄt
‹ž“s”畆‰ČW’k‰ď
1979.10.7
‹ž“s
@
“Ž•¨ƒRƒ‰ƒQƒi[ƒ[‚É‚ć‚é‡TC ‡UC ‚¨‚ć‚чVŒ^ƒRƒ‰[ƒQƒ“•Ş‰đ‘Ź“x‚Ě”äŠr
’†‘ş@rF@@—с@@˜a•F@@–x@@‹vŽ}@@‰iˆä@@—T i“ŒˆăŽ•‘ĺ“ďŒ¤j
‘ć51‰ń“ú–{ś‰ťŠwŠw‰ď
1979.10.8
“Œ‹ž
@
ƒVƒ“ƒ|ƒWƒEƒ€ uÚG”畆‰Šv ÚG”畆‰Š‚Ě”­ś‹@˜|–Ɖu’S“–×–E‚𒆐S‚É‚ľ‚Ä
ź‰Ş@@´
“ú”ç‰ďŽR‰A’n•ű‰ď
1979.11.2
o‰_
@
‰Ć‘°Ť‚É”­ś‚š‚éáΊېŤ—Ť‰ťÇ iTFSj ‚Ě“ŕ•Ş”ĺŠw“IŒŸ“˘
˛X–ؔɑž@@Â–ě@•q”Ž@@‚“c@@–ž@@‘q’q@Œhˆę@@‚ˆŔ@@i@@ź–{@Œ\Žj
‘ć61‰ń‹ß‹EŽY‰Č•wl‰ČŠw‰ď‘‰ď
1979.11.25
_ŒË
@
F‘fŤŠŁ”çÇ‚É‚¨‚Ż‚é”M•sˆŔ’čy‘f
‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v
‘ć12‰ńŠî‘b”畆‰Č§˜b‰ď
1979.12.1
“Œ‹ž
@
Rƒnƒvƒeƒ“R‘Ě‚É‚ć‚éÚGƒAƒŒƒ‹ƒM[‚Ě—}§‹@\
•ĐŽR@ˆę˜N@@ź‰Ş@@´
‘ć‚X‰ń“ú–{–ƉuŠw‰ď
1979.12.3-5
“Œ‹ž
@
ƒKƒXƒNƒƒ}ƒgƒOƒ‰ƒtƒB[‚É‚ć‚é Sudan I ‚Ě’č—Ę
ŽsŒ´@ă`Žq@@“c‘ă@@ŽŔ@@Ź’ˁ@—Y–Ż@@’†‘ş@—R”ü@@’†“ě@@Œł
‘ć239‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1979.12.8
‘ĺăŽs‘ĺ
@
von Recklinghausen •a‚ɍ‡•š‚ľ‚˝ juvenile xanthogranuloma ‚Ě‚P—á
ˆäă@‰ŔŽq@@‚ˆŔ@@i@@­“c@˜a—m iă‘后ŠOj
‘ć235‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1979.2.24
ă‘ĺ
@
Pilar tumor of the scalp
ŽO‰Y@~Žq@@Šě‘˝–쐪•v
‘ć235‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1979.2.24
ă‘ĺ
@
Cross-sensitivity within azo dyes synthesized from 2-naphthol
Kozuka, T.
IV International Symposium on Contact Dermatitis
1979.3.29-31
ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR
@
Brilliant Lake Red R as a cause of pigmented contact dermatitis
Kozuka, T.
IV International Symposium on Contact Dermatitis
1979.3.29-31
ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR
@
ƒAƒ]F‘f‚É‚ć‚éE‹ĆŤÚG”畆‰Š‚Ě‚P—á
“Ą–{@Œ\ˆę@@‹´–{@˝ˆę@@’†‘ş@—R”ü@@Ź’ˁ@—Y–Ż@@“c‘ă@@ŽŔ@@’†“ě@@Œł
‘ć78‰ń“ú”ç‰ď‘‰ď
1979.4.11-13
“Œ‹ž
@
ÚGƒAƒŒƒ‹ƒM[‚É‚¨‚Ż‚é cutaneous basophil hypersensitivity —U“ąˆöŽq
•ĐŽR@ˆę˜N@@ź‰Ş@@´
‘ć78‰ń“ú”ç‰ď‘‰ď
1979.4.11-13
“Œ‹ž
@
T cell lymphoma ‚Ě‚P—á
•ĐŽR@~Žq@@ź‰Ş@@´
‘ć236‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1979.4.21
ă‘ĺ
@
l•\”ç×–E‚Ě‘ĚŠO”|—{‚É‚¨‚Ż‚é•Ş‰ť
Šě‘˝–쐪•v
“ú–{‘gD”|—{Šw‰ď‘ć47‰ńŒ¤‹†‰ď
1979.5.1-2
_ŒË
@
ƒ‰ƒmƒŠƒ“‚É‚ć‚éÚG”畆‰Š
Ź’ˁ@—Y–Ż
‘ć‚T‰ń“ú–{ŽY‹Ć”畆‰qś‹Ś‰ďŒ¤‹†”­•\‰ď
1979.5.11
‹ž“s
@
áy]—l”ç]‚𔺂Á‚˝‚ IgE ŒŒÇ‚Ě‚P—á
‘Dˆä@—´•F@@‚ˆŔ@@i
‘ć72‰ń‹ß‹E”畆‰ČW’k‰ď
1979.5.13
‘ĺ’Ă
@
Are procollagen peptidases I and ‡U different endopeptid clases?
Shinkai, H., Rycher, C.D., Nersugens, B., Coblet, Y., Lappire C.M.
Joint Meeting
1979.6.11-12
ƒAƒ€ƒXƒeƒ‹ƒ_ƒ€
@
ƒVƒ“ƒ|ƒWƒEƒ€ uDermal toxicologyv Ď•iŹ•Ş‚̏ƒ“x‚Ɣ畆ŽhŒƒ‚¨‚ć‚ѐڐGƒAƒŒƒ‹ƒM[
Ź’ˁ@—Y–Ż
“ú–{Ď•i‰ČŠw‰ď
1979.6.7-8
“Œ‹ž
@
ƒqƒgŽq‹{“ŕ–Œ—R—ˆ‚Ě”|—{üˆŰ‰č×–E‚ĚƒAƒ“ƒhƒƒQƒ“ƒŒƒZƒvƒ^[
˜e–{@@”Ž iă‘ĺŠŕŒ¤j @@‚ˆŔ@@i@@ź–{@Œ\Žj iă‘ĺŠŕŒ¤j
‘ć52‰ń“ú–{“ŕ•Ş”ĺŠw‰ď‘‰ď
1979.6.7-9
‹ž“s
@
áĺ‘f‚É‚ć‚éƒ{[ƒGƒ“•a‚Ě‚P—á
’JŠ_@••F@@˛“Ą@Œ’“ń
‘ć237‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1979.7.21
‰H‰g–ě•a‰@
@
Sweet •a‚Ě‚P—á
”ÂŒŠ@@’q@@ź‰Ş@@´
‘ć237‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1979.7.21
‰H‰g–ě•a‰@
@
Sudan I ‚É‚ć‚é pigmented contact dermatitis
Ź’ˁ@—Y–Ż
‘ć‚X‰ńRŒ´Œ¤‹†‰ď i’Pƒ‰ťŠw•¨Žż‚É‚ć‚é”畆áŠQŒ¤‹†‰ďj
1979.7.27
“Œ‹ž
@
Keratinization of human keratinocytes in cell culture. Effect of cyclic AMP
Kitano Y., Okada, N.
Japan-US Seminor "Biochemistry of Normal and Abnormal Differentiation"
1979.7.29-8.2
ƒ~ƒVƒKƒ“
@
ƒwƒ‹ƒp[ T ‹@”\‚đ—L‚ľ‚˝‹Űó‘§“÷Ç‚Ě‚P—á
Ź—с@äoŽs@@”ÂŒŠ@@’q@@‹´–{@Œö“ń@@’JŒű@M”Ž i‚Q“ŕj
‘ć43‰ń“ú”ç‰ď“Œ“ú–{˜A‡’n•ű‰ď
1979.8.25-26
ŽD–y
@
Undersurface of keratinocytes in cell culture
Kitano, Y.
Gordon Conference "Epidermal Differentiation and Keratinization"
1979.8.6-10
ƒjƒ…[ƒnƒ“ƒvƒVƒƒ[
@
Pigmented contact dermatitis from azo dyes. ‚ƒlinical and animal studies
Kozuka, T.
International Conference of Swiss Society of Cosmetic Chemists
1979.9.17
ƒo[ƒ[ƒ‹
@
F‘fŤŠŁ”çÇ×–E‚Ě”M•sˆŔ’čy‘f‚ɂ‚˘‚Ä
‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v
‘ć30‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1979.9.23-24
‘ĺă
@
ƒVƒ“ƒ{ƒWƒEƒ€ uŒŒŠÇ‰Šv –Ɖu•Ą‡‘Ě‚É‚ć‚éŽŔŒą“IŒŒŠÇ‰ŠěŹ‚ĚŽŽ‚Ý
ŽN@ç’ĂŽq@@ź‰Ş@@´
‘ć30‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1979.9.23-24
‘ĺă
@
ś‰ş‘Ú‘O–Ę‚É”­ś‚ľ‚˝ˆŤŤŽîá‡
é@@—ÇŽq@@‹´–{@Œö“ń@@Šě‘˝–쐪•v
‘ć30‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1979.9.23-24
‘ĺă
@
ƒVƒ“ƒ{ƒWƒEƒ€ uŒŒŠÇ‰Šv ”畆ŒŒŠÇ‰Š‚É‚¨‚Ż‚錌‰t”Sâf“x‚ĚˆÓ‹`
ź‰Ş@@´@@ŽN@ç’ĂŽq
‘ć30‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1979.9.23-24
‘ĺă
@
ƒEƒCƒ‹ƒXRŒ´‚É‚ć‚é‘яóáv]ŠłŽŇƒŠƒ“ƒp‹…—cŽá‰ťŒťŰ
”¨@´ˆę˜Y
‘ć30‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1979.9.23-24
‘ĺă
@
ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“ u–ňÜƒAƒŒƒ‹ƒM[v ÚGƒAƒŒƒ‹ƒM[‚É‚¨‚Ż‚é×–E“ŕ•Ş‰ć‚ĚˆÓ‹`
ź‰Ş@@´
‘ć29‰ń“ú–{ƒAƒŒƒ‹ƒM[Šw‰ď‘‰ď
1979.9.26-28
“Œ‹ž
@
l”畆‚Ě testosterone 5ƒż-reductase ŠˆŤ
‚ˆŔ@@i@@˜e–{@@”Ž iŠŕŒ¤j @@”ÂŒŠ@@’q
‘ć31‰ńź•”Žx•”‘‰ď
1979.9.29-30
‰F•”
@
Ž‡ŠOü‚ɍ‚Š´ŽóŤ‚đŽŚ‚ˇV‚ľ‚˘ƒ^ƒCƒv‚Ěƒqƒgˆâ“`•a‚ɂ‚˘‚Ä
’r‰i@–žś@@’JŠ_@••F
‘ć23‰ń“ú–{•úŽËü‰e‹żŠw‰ď
1980.10.
@
@
Darier •a
‰Á“Ą@ƒŽq@@Šě‘˝–쐪•v
‘ć243‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1980.10.11
äŽs–Ż•a‰@
@
Eccrime poroma ‚Ě‚P—á
“ŕ“Ą@”üŽq@@ˆäă@‰ŔŽq@@ŽN@ç’ĂŽq@@’JŠ_@••F
‘ć243‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1980.10.11
äŽs–Ż•a‰@
@
ƒ^[ƒ‹F‘f‚É‚ć‚鏗ŽqŠç–ʍ•”çÇ
Ź’ˁ@—Y–Ż
‘Ű‰ď‹c u”畆‚ƉťĎ•i‰ČŠwv
1980.10.11-12
“Œ‹ž
@
Normal human melanocytes in culture
Kitano, Y.
X1th International Pigment Cell Conference
1980.10.14-17
ĺ‘ä
@
ƒqƒg”畆Šp‰ť×–E‚đ—p‚˘‚˝‰ťŠw”­Šŕ‚ĚŒ¤‹† i‚Rj ƒRƒŒƒ‰“Ĺ‘fC EGF ‚¨‚ć‚Ń TPA ‚ĚŠp‰ť×–E‚Ě‘B‚Ö‚ĚŒř‰Ę
•–Ř“oŽu•v i“Œ‘ĺˆă‰ČŒ¤j @@Šě‘˝–쐪•v
‘ć39‰ń“ú–{ŠŕŠw‰ď‘‰ď
1980.11.5-7
“Œ‹ž
@
ƒqƒg”畆Šp‰ť×–E‚đ—p‚˘‚˝‰ťŠw”­Šŕ‚ĚŒ¤‹† i‚Pj Šp‰ť×–E‚¨‚ć‚ѐüˆŰ‰č×–E‚Ěƒxƒ“ƒcƒsƒŒƒ“‘ăŽÓ”\
•–Ř“oŽu•v i“Œ‘ĺˆă‰ČŒ¤j @@Ş–{@M—Y i‘—§‚Ş‚ńƒZƒ“ƒ^[j @@Šě‘˝–쐪•v
‘ć39‰ń“ú–{ŠŕŠw‰ď‘‰ď
1980.11.5-7
“Œ‹ž
@
ánćҏó•\”ç”­ˆçˆŮíŽžŠłŽŇ—R—ˆ×–E‚ĚŽ‡ŠOüŠ´ŽóŤ
’r‰i@–žś@@’JŠ_@••F
‘ć39‰ń“ú–{ŠŕŠw‰ď‘‰ď
1980.11.5-7
“Œ‹ž
@
ƒqƒg”畆Šp‰ť×–E‚đ—p‚˘‚˝‰ťŠw”­Šŕ‚ĚŒ¤‹† i‚Qj ƒxƒ“ƒcƒsƒŒƒ“‘ăŽÓ‚Ć‚ť‚Ě•ř‡‘ĚŒ`Ź
”–{@M—Y i‘—§‚Ş‚ńƒZƒ“ƒ^[j @@Šě‘˝–쐪•v@@•–Ř“oŽu•v i“Œ‘ĺˆă‰ČŒ¤j
‘ć39‰ń“ú–{ŠŕŠw‰ď‘‰ď
1980.11.5-7
“Œ‹ž
@
”|—{•\”ç×–E‚Ě˜V‰ť
‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v
‘ć31‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1980.11.8-9
Šň•Œ
@
ƒqƒgüˆŰ‰č×–E‚ɑ΂ˇ‚郊ƒ“ƒzƒJƒCƒ“‚̍ě—p
Ź—с@äoŽs@@ź‰Ş@@´@@˛–ě@‰ht
‘ć31‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1980.11.8-9
Šň•Œ
@
áĺ‘fŤŠp‰ťÇ‚Ě‚P—áFƒ{[ƒGƒ“Šŕ‹y‚Ń‚ť‚Ě‘Sg“]ˆÚ‚đ”F‚ß‚˝Ç—á
“y‹•q–ž@@•ĐŽRˆę˜N@@ź“cŒ’Ž÷@@ź‰Ş@´
‘ć31‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1980.11.8-9
Šň•Œ
@
ˆŤŤŒŒŠÇ“ŕ”çŽî‚Ě–UŒŸ—á
ź‰i@‰xŽĄ
‘ć244‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1980.12.
@
@
ć“VŤ‹›—Řᝂ̂Q—á
źˆä”ü‘ăŽq@@Šě‘˝–쐪•v
‘ć294‰ń‹žŽ ”畆‰ČW’k‰ď
1980.12.20
‹ž“s
@
ƒ^[ƒ‹F‘f‚Ěƒpƒbƒ`ƒeƒXƒgŹŃ
Ź’ˁ@—Y–Ż
’†•”ƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç55”N“x—á‰ď
1980.12.7
‹ž“s
@
Sudan I ’č—Ę–@‚ĚŒŸ“˘
Ź’ˁ@—Y–Ż@@“c‘ă@@ŽŔ@@’†‘ş@—R”ü
’†•”ƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç55”N“x—á‰ď
1980.12.7
‹ž“s
@
—Lž™×–EŠŕ‚Ě‚Q—á
”¨@´ˆę˜Y@@’†”ö@—ʕہ@@ˆÉ“Ą@Žő‹L@@ˆÉ“Ą@••F
‘ć240‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1980.2.16
ă‘ĺ
@
ŹŽ™‚Ěƒwƒ‹ƒyƒXŠ´őÇ
”¨@´ˆę˜Y
ŹŽ™”畆‰ČŠwƒZƒ~ƒi[ k‡Vl
1980.2.23
“Œ‹ž
@
”畆Žîᇂɔş‚¤‘ą”­ŤƒAƒ~ƒƒCƒhÇ‚ɂ‚˘‚Ä
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq@@˛–ě@žÄt
•ś•”Č‰ČŒ¤‘‡Œ¤‹† iAj ƒAƒ~ƒƒCƒh[ƒVƒXş˜a54”N“x”ljď‹c
1980.2.23
‹ŕ‘ň
@
”|—{•\”ç×–E‚Ě˜V‰ť|“Á‚É”M•sˆŔ’萍y‘f‚ɂ‚˘‚ā|
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq
•ś•”Č‰ČŒ¤‘‡Œ¤‹† iAj ˜V‰ť‚Ě•\”ç•Ş‰ť‚É‹y‚Ú‚ˇ‰e‹ż‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒ¤‹†ş˜a54”N“x”ljď‹c
1980.2.29
“Œ‹ž
@
—ź‘¤Ťbó‘Bœ‘—lŠŕ‚É”ş‚Á‚˝ multiple mucosal neuroma
ˆäă@‰ŔŽq@@”¨@´ˆę˜Y@@X–{@–ΐl@@ŒFŒ´@—Yˆę@@‚ˆä@Vˆę˜Y
‘ć79‰ń“ú”ç‰ď‘‰ď
1980.4.4-6
L“‡
@
Ageing of human keratinocytes in culture
Okada, N, Kitano Y.
4lst annual meeting of the Society for Investigative Dermatology
1980.5.12-15
Washington, D.C.
@
Heat-labile glucose-6-phosphate dehydrogenase in cultured fibroblasts from subjects with De Sanctis-Cacchiome syndrome
Okada, N., Kitano Y.
8th Annual Meeting of Pacific Skin Research Club
1980.5.19
Palo Alto
@
1980”N‘ă‚̔畆‚đl‚Ś‚é
Ź’ˁ@—Y–Ż@@‘ź
‘ć‚U‰ń“ú–{ŽY‹Ć”畆‰qś‹Ś‰ďŒ¤‹†”­•\‰ď
1980.5.20
‹ž“s
@
‰ťĎ•i•›ě—pƒ‚ƒjƒ^[‚Ə—ŽqŠç–ʍ•”çÇ
Ź’ˁ@—Y–Ż
‘ć‚W‰ń SCCJ Œ¤‹†“˘˜_‰ď
1980.6.13
‘ĺă
@
Beh$5002et •a‚É Sweet •a‚đ‡•š‚ľ‚˝‚P—á
Ź—с@äoŽs@@’|“c@“ń@@Šě‘˝–쐪•v
‘ć73‰ń‹ß‹E”畆‰ČW’k‰ď
1980.6.22
˜a‰ĚŽR
@
ŠÂó”z—ń‚đŽŚ‚ľ‚˝—Ţ“VáváŒ
“y‹@•q–ž@@•ĐŽR@ˆę˜N@@ŽN@ç’ĂŽq
‘ć242‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1980.7.12
•şŒÉˆă‘ĺ
@
Suppression of contact sensitivity by IgGl anti hapten antibody
Nishioka, K., Katayama, I.
4th International Congress of Immunology
1980.7.26
Paris
@
”|—{ƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě benzo kal pyrene ‘ăŽÓ
Šě‘˝–쐪•v@@•–Ř“oŽu•v i“Œ‘ĺˆă‰ČŒ¤j
‘ć‚T‰ń”畆‰ČŒ¤‹†“ŻD‰ď
1980.7.5-6
‰ŞŽR
@
–Ń•ďŽîá‡
Ź—с@äoŽs@@ź‰i@‰xŽĄ@@‚ˆŔ@@i i‘ĺ•Şˆă‘ĺj
‘ć32‰ń“ú”ç‰ďź•”Žx•”‘‰ď
1980.9.28
’ˇč
@
Paraben ‚É‚ć‚éÚG”畆‰Š
Ź’ˁ@—Y–Ż@@“c‘ă@@ŽŔ@@ŽsŒ´@ă`Žq@@“Ą–{@Œ\ˆę@@’†‘ş@—R”ü@@‹´–{@˝ˆę@@
‘ć10‰ńRŒ´Œ¤‹†‰ď i’Pƒ‰ťŠw•¨Žż‚É‚ć‚é”畆áŠQŒ¤‹†‰ďj
1980.9.29
‰_ĺ
@
l•\”ç×–E‚Ě”|—{Œo‰ß‚ɑ΂ˇ‚éƒRƒŒƒ‰ƒgƒLƒVƒ“|ƒTƒCƒNƒŠƒbƒN AMP ‚̉e‹ż
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq
‰ČŒ¤‘‡Œ¤‹† iAj ˜V‰ť‚Ě•\”ç•Ş‰ť‚É‹y‚Ú‚ˇ‰e‹ż‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒ¤‹†
1981.1.10
ĺ‘ä
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚Ě”ç]‚Š‚ç•Şˆç‚ł‚ę‚˝ƒqƒgƒCƒ{ƒEƒCƒ‹ƒX‚ɂ‚˘‚Ä
“’’Ę“°–žŽő’j@@’ÐX@Fś@@‰H‘q@@–ž@@’JŠ_@••F@@“n•ÓMˆę˜Y
‘ć40‰ń“ú–{ŠŕŠw‰ď‘‰ď
1981.10.
@
@
Eccrine duct carcinoma ‚Ě‚P—á
‘ž“c@ƒŽq@@‰Ş“c“Ţ’ĂŽq@@˛“Ą@Œ’“ń@@Šě‘˝–쐪•v
‘ć32‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1981.10.17
_ŒË
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚ĚŽo’í—á
’JŠ_@••F@@“c‘ă@@ŽŔ@@˛“Ą@Œ’“ń@@“n•ÓMˆę˜Y@@źŽR@ł—˛@@’r‰i@–žś@@ź–{@˜a—Y
‘ć32‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1981.10.17
_ŒË
@
ƒqƒgüˆŰ‰č×–E‚ɑ΂ˇ‚郊ƒ“ƒzƒJƒCƒ“‚̍ě—p
Ź—с@äoŽs@@ź‰Ş@@´@@˛–ě@žÄt
‘ć32‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1981.10.17-18
_ŒË
@
ÚG‰ß•qÇ”­Œť‚É‚¨‚Ż‚é•\”ç×–E‚Ě–đŠ„
‘Dˆä@—´•F@@‰ĄŠÖ@”Ž—Y@@ź‰Ş@@´
‘ć31‰ń“ú–{ƒAƒŒƒ‹ƒM[Šw‰ď‘‰ď
1981.10.21-23
“Œ‹ž
@
‘ĺ–Ô”ç•Ů‚É‚ć‚é‹š•ÇÄŒš
“Ąě@š˜a@@–{‘˝@•üm@@‚“c@ÍD@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć37‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1981.11.21
ˆ¤•Q
@
ƒZƒUƒŠ[ÇŒóŒQ‚ ‚邢‚͈ęŽí‚Ě“÷‰čŽîÇ
‘Ť—§@@€@@Šě‘˝–쐪•v
‘ć33‰ń“ú”ç‰ďź“ú–{Šwp‘ĺ‰ď
1981.11.8
źŽR
@
ƒ_ƒŠƒG•a‚ɍ‡•š‚ľ‚˝ƒJƒ|ƒW[…“——l”­]Ç‚Ě‚P—á
”¨@´ˆę˜Y@@’†‘ş@‹`˜N@@’JŠ_@••F@@’ҁ@@˜a’j
‘ć250‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1981.12.12
‘ĺă
@
ƒAƒ~ƒƒCƒh’ž’…‚𔺂Ś‚éˆâ“`Ť”Ä”­ŤF‘fˆŮíÇ
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq
‰ČŒ¤‘‡Œ¤‹† iAj ƒAƒ~ƒƒCƒh[ƒVƒX‚Ě•a‘ԍ‡“ŻŒ¤‹†”­•\‰ď
1981.2.21
‹ŕ‘ň
@
Effects of cholera toxin on proliferation of cultured human keratinocytes in relation to intracellular cyclic AMP levels
Okada, N., Kitano Y., and Ichihara, K.
42nd annual meeting of the Society for Investigative Dermatology
1981.4.27-29
San Francisco
@
”|—{•\”ç×–E‚Ě˜V‰ť
‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v
‘ć80‰ń“ú”ç‰ď‘‰ď
1981.4.3-5
–źŒĂ‰Ž
@
‘ĚŠO”|—{‚É‚¨‚Ż‚é•\”çE^”ç‘ŠŒÝě—p
Šě‘˝–쐪•v
‘ć80‰ń“ú”ç‰ď‘‰ď
1981.4.3-5
–źŒĂ‰Ž
@
‘ĚŠO”|—{‚É‚¨‚Ż‚éƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě×–EŽüŠú
Šě‘˝–쐪•v@@‹ŕ‘ň@CŽq@@‰Ş“c“Ţ’ĂŽq
‘ć80‰ń“ú”ç‰ď‘‰ď
1981.4.3-5
–źŒĂ‰Ž
@
“ÁˆŮ‚Ȕ畆Çó‚đŽŚ‚ľ‚˝ MCTD
Ź—с@äoŽs@@ź‰i@‰xŽĄ@@ź‰Ş@@´@@˛–ě@žÄt
‘ć80‰ń“ú”ç‰ď‘‰ď
1981.4.3-5
–źŒĂ‰Ž
@
Žź]”˝‰ž‚̖ƉuŠw“I”wŒi
ź‰Ş@@´
‘ć80‰ń“ú”ç‰ď‘‰ď
1981.4.3-5
–źŒĂ‰Ž
@
‹}‘Ź‚ɐS”X‰Š‚ć‚čtƒNƒŠ[ƒ[‚ɐis‚ľ‚˝‘SgŤisŤ‹­”çÇ iPSSj ‚Ě‚P—á
‘Dˆä@—´•F@@‹´–{@Œö“ń@@˛–ě@žÄt
‘ć80‰ń“ú”ç‰ď‘‰ď
1981.4.3-5
–źŒĂ‰Ž
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚̖Ɖu i‘ć‚P•ńj
’JŠ_@••F@@“n•ÓMˆę˜Y@@źŽR@łŒo
‘ć80‰ń“ú”ç‰ď‘‰ď
1981.4.3-5
–źŒĂ‰Ž
@
ÚGƒAƒŒƒ‹ƒM[‚Ě CBH ˆöŽq‚É‚ć‚éD‰–Šî‹…‚Ě chemotaxis
“y‹@•q–ž@@•ĐŽR@ˆę˜N@@ź‰Ş@@´
‘ć80‰ń“ú”ç‰ď‘‰ď
1981.4.3-5
–źŒĂ‰Ž
@
”­]‚đŽŚ‚ˇƒEƒCƒ‹ƒXÇ‚É‚¨‚Ż‚é—Տ°ŒŸ¸
”¨@´ˆę˜Y
‘ć80‰ń“ú”ç‰ď‘‰ď
1981.4.3-5
–źŒĂ‰Ž
@
‘яóáv] i–Ɖu‚ĆŽĄ—Áj
”¨@´ˆę˜Y
‘ć80‰ń“ú”ç‰ď‘‰ď
1981.4.3-5
–źŒĂ‰Ž
@
“ű–[ŠO Paget's •aŽčp‚Ě‚R—á
ź‘ş@‰ëŽŚ@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1981.6.20
‹ž“s
@
čň•”‹‘ĺŽîᎂđ’ć‚ľ‚˝ƒTƒ‹ƒRƒCƒh[ƒVƒX
“y‹@•q–ž@@ź‰Ş@@´@@˛–ě@žÄt@@“c‘ş@MŽi iă‘ĺ‚Q“ŕj
‘ć247‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1981.6.27
‘ĺăÔ\Žš•a‰@
@
$5003ŒŒ—Ă–@‚É‚ć‚čŒy‰ő‚ľ‚˝ porphyrla cutanea tarda ‚Ě‚P—á
“ŕ“Ą@”üŽq@@Ź’ˁ@—Y–Ż@@Šě‘˝–쐪•v@@‹vŽu–{@“Œ@@Â–؁@•q”V
‘ć74‰ń‹ß‹E”畆‰ČW’k‰ď
1981.6.7
‘ĺă
@
ƒEƒCƒ‹ƒXŤ”­]Ç‚ÉŠÖ‚ˇ‚éĹ‹ß‚Ě˜b‘č@‚QD —Տ°f’f‚Ěƒ|ƒCƒ“ƒg
”¨@´ˆę˜Y
@
1981.7.11
@
@
Angiogenic factor in immune reaction
Nishioka, K.
Tokyo International Symposium on Microcirculation
1981.7.26
“Œ‹ž
@
ƒPƒ‹ƒYƒX“Ăጂ̂P—á
­“c@‰ŔŽq@@“Œ@@âZ•F@@‘Dˆä@—´•F
‘ć248‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1981.8.1
‘ĺă
@
Žá”NŤƒqƒAƒŠƒ“üˆŰŽîÇ‚Ě‚ť‚ĚŒă
Šě‘˝–쐪•v@@”˘•ű@—tŽq
ŠÖźˆă‘ĺ”畆‰ČŠw‹łŽş‹L”OŠw‰ď
1981.9.5
‘ĺă
@
”畆ƒAƒ~ƒƒCƒhÇ‚ĚƒAƒ~ƒƒCƒh•¨Žż‚Ě•\”ç‹NŒš‚ÉŠÖ‚ˇ‚élŽ@
Šě‘˝–쐪•v
•ś•”Č‰ČŒ¤‘‡Œ¤‹† iAj ƒAƒ~ƒƒCƒh[ƒVƒX‚Ć‚­‚ɔ畆ƒAƒ~ƒƒCƒh[ƒVƒX‚Ě•aˆö•a‘Ô‚¨‚ć‚ŃŽĄ—Ă‚ÉŠÖ‚ˇ‚錤‹†ş˜a56”N”ljď‹c
1982.1.30-31
Šň•Œ
@
ˆŤŤŽîá‡‚đ‡•š‚ľ‚˝ánćҏó•\”ç”­ˆçˆŮíÇC ”畆ˆŤŤ•Ď‰ť‚Ö‚Ě•a—”­ś‹@\
’JŠ_@••F@@‘O“c@@‹@@“Ąě@š˜a@@ă’n@@‹M@@‰H‘q@@–ž@@‹Ę’u@OŒő
‘ć33‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1982.10.2-3
@
@
’PƒŤáv]ŒŒ´‰uŠw“I’˛¸|10”N‚Ě”äŠr|
”¨@´ˆę˜Y
‘ć33‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1982.10.2-3
@
@
Reflectance spectrometry ‚É‚ć‚é”畆ŒŒ—Ź“Ž‘Ô‚Ě‘Ş’č–@
‘O“c@@‹@@ź–{@ˆŰ–ž@@ź‰Ş@@´@@˛“Ą@MăE iă‘ĺ‚P“ŕj
‘ć46‰ń“ú”ç‰ď“Œ“ú–{Šwp‘ĺ‰ď
1982.10.23
“Œ‹ž
@
ƒqƒgüˆŰ‰č×–E‘B‘ŁiˆöŽq‚ɑ΂ˇ‚é PSS —R—ˆüˆŰ‰č×–E‚Ě”˝‰žŤ
Ź—с@äoŽs@@ź‰Ş@@´@@˛–ě@žÄt
‘ć32‰ń“ú–{ƒAƒŒƒ‹ƒM[Šw‰ď‘‰ď
1982.10.7-9
‰ŞŽR
@
Basal cell epithelioma ‚Ě‚S—á
ˆäă@—TŽj@@‹vŽu–{@“Œ i‘ĺăŒxŽ@•a‰@j @@ź–{@ˆŰ–ž
‘ć254‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.11.13
‘ĺă˜JĐ•a‰@
@
ˆâ“`Ť‘Α¤ŤF‘fˆŮíÇ i‰“ŽRj ‚Ě‚P—á
‰ĄŒŠ@ˆçŽq@@”¨@´ˆę˜Y@@‰““Ą@G•F i•şŒÉˆă‘ĺj
‘ć254‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.11.13
‘ĺă˜JĐ•a‰@
@
–ԏ󎈒[F‘f’ž’…Ç i–k‘şj ‚Ě‚P—á
ŽN@ç’ĂŽq@@˛“Ą@‰ht
‘ć254‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.11.13
‘ĺă˜JĐ•a‰@
@
ƒqƒrƒeƒ“Á“Ĺ‚É‚ć‚čƒAƒiƒtƒBƒLƒ‰ƒV[‚đ‹N‚ą‚ľ‚˝‚Q—á
–ě‘ş@­•v@@‰Ş–ě@šŽ÷@@‰Ş“c“Ţ’ĂŽq@@˛“Ą@Œ’“ń@@“c‘ă@@ŽŔ@@ŒËč@—mŽq iă‘ĺ–ƒŒj @@•l@@˜Z˜Y iă“ě’†‰›•a‰@j
‘ć254‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.11.13
‘ĺă˜JĐ•a‰@
@
ÚGƒAƒŒƒ‹ƒM[‚É‚¨‚Ż‚é cutaneous basophil hypersensitivity —U“ąˆöŽq‡U. basophil chemotaxis ‚É‚¨‚ć‚Ú‚ˇ‰e‹ż
•ĐŽR@ˆę˜N@@“y‹@•q–ž@@ź‰Ş@@´
‘ć12‰ń“ú–{–ƉuŠw‰ď
1982.11.17-19
ĺ‘ä
@
‚—îŽŇ‚É‚¨‚Ż‚é free flap ‚ĚŒoŒą
ă’n@@‹M@@‚“c@ÍD@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć39‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1982.11.6
‘ĺă
@
•@”wŽü•ÓŽîᇐ؏œŒă‚ĚÄŒš—á
­“c@‰ŔŽq@@–{‘˝@•üm@@‚“c@ÍD@@“Ąě@š˜a@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć39‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1982.11.6
‘ĺă
@
Œo”ç“I”畆ŒŒ—Źó‘Ô‚Ě‘Ş’č–@ iReflectance spectrometry ‚É‚ć‚éj
‘O“c@@‹@@–{‘˝@•üm@@“Ąě@š˜a@@ź–{@ˆŰ–ž
‘ć39‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1982.11.6
‘ĺă
@
łíƒqƒg•\”ç×–E‚Ě‘B‚ĆƒqƒXƒ^ƒ~ƒ“
“y‹@•q–ž@@•ĐŽR@ˆę˜N@@ź‰Ş@@´@@‘O“c@@‹@@‘OŽR@ˆę—˛ iă‘ĺ“ń–ňj
‘ć255‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.12.18
ŠÖźˆă‘ĺ
@
ă‘ĺ‚ĹŒo‰ßŠĎŽ@’†‚̐F‘fŤŠŁ”çÇŠłŽŇ‚Ěˆâ“`“I‘Š•âŤŒQ‚ɂ‚˘‚Ä
˛“Ą@Œ’“ń@@’r‰i@–žś@@˛–ě@žÄt
‘ć14‰ńŠî‘b”畆‰Č§˜b‰ď
1982.12.4
‘ĺă˜JĐ•a‰@
@
Dyschromatosis universalis hereditaria ‚Ě‚R—á
–q–ě@‹žŽq@@Šě‘˝–쐪•v
‘ć14‰ńŠî‘b”畆‰Č§˜b‰ď
1982.12.4
‘ĺă˜JĐ•a‰@
@
’ˇŠú‚ĚŒo‰ß‚đ‚˝‚Ç‚č”äŠr“I—ǐŤ‚Ě‘gD‘œ‚đ’ć‚ľ‚˝—Lž™×–EŠŕ
‰Ş–ě@šŽ÷@@‘O“c@@‹@@‰Ş“c“Ţ’ĂŽq@@ź–{@ˆŰ–ž@@Šě‘˝–쐪•v@@˛–ě@žÄt
‘ć251‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.2.13
‘ĺăŽs‘ĺ
@
Cat-scratch disease ‚Ě‚P—á
ŽO‰Y@~Žq iŽs—§’r“cj @@“c‘ă@@ŽŔ
‘ć251‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.2.13
‘ĺăŽs‘ĺ
@
ˆÝŠŕŽĄ–üŘœŒă‚É”­Ç‚ľ‚˝ acanthosis nigricans ‚Ě‚P—á
X–{@iŒb@@ź‰Ş@@´
‘ć251‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.2.13
‘ĺăŽs‘ĺ
@
SjoNgren ÇŒóŒQ‚đ‡•š‚ľ‚˝isŤ‘SgŤd‰ťÇ‚Ě‚P—á
’†‘ş@‹`˜N@@‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v
‘ć251‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.2.13
‘ĺăŽs‘ĺ
@
l•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě‹Ÿ—^ŽŇ‚Ě”N—ß‚Ć”|—{‚É‚¨‚Ż‚鑝B—lŽŽE×–EŽüŠú‚Ć‚ĚŠÖ˜A@|Œ°”÷‰f‰ć‚É‚ć‚é•ŞÍ|
Šě‘˝–쐪•v@@‰Ş–ě@šŽ÷
•ś•”Č‰ČŒ¤‘‡Œ¤‹† iAj ˜V‰ť‚Ě•\”ç•Ş‰ť‚É‹y‚Ú‚ˇ‰e‹ż‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒ¤‹†ş˜a56”N“x”ljď‹c
1982.2.26
“Œ‹ž
@
‹Ç–ʏó—ŢŠŁá‚Š‚ç‚ĚˆÚs‚đŠĎŽ@‚ľ‚˝‹Űó‘§“÷Ç
ˆäă@—TŽj@@ŽR‘ş@’íˆę@@Šě‘˝–쐪•v@@‚ˆŔ@@i i‘ĺ•Şˆă‘ĺj
‘ć240‰ń“ú”ç‰ď•Ÿ‰Ş’n•ű‰ď
1982.3.14
•Ÿ‰Ş
@
y‘fˆ—‚É‚ć‚éƒGƒbƒNƒŠƒ“Šž‘B‚Ě•Ş—Ł
‰Ş“c“Ţ’ĂŽq@@‰Á—ˆ@iŒb@@Šě‘˝–쐪•v
‘ć81‰ń“ú”ç‰ď‘‰ď
1982.4.2-4
“Œ‹ž
@
”|—{•\”ç×–E‚̐Ťó‚ƍ‚‘Ź‰t‘ĚƒNƒƒ}ƒgƒOƒ‰ƒtƒB[‚É‚ć‚郌ƒ`ƒmƒCƒh‘ăŽÓ”\‚ÉŠÖ‚ˇ‚錤‹† iƒVƒ“ƒ|ƒWƒEƒ€C •\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě‘ĚŠO”|—{‚Ć‚ť‚Ě—Ő°Œ¤‹†‚ւ̉ž—pj
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq@@‰Ş–ě@šŽ÷@@’ˇŁ@CŽq
‘ć81‰ń“ú”ç‰ď‘‰ď
1982.4.2-4
“Œ‹ž
@
üˆŰ‰č×–E‚ɍě—p‚ˇ‚郊ƒ“ƒzƒJƒCƒ“
Ź—с@äoŽs@@ź‰Ş@@´@@˛–ě@žÄt
‘ć81‰ń“ú”ç‰ď‘‰ď
1982.4.2-4
“Œ‹ž
@
‰ß‹Ž10”NŠÔ‚É‚¨‚Ż‚é“–‰Č‚Ĺˆľ‚Á‚˝ˆŤŤŽîᇂ̓Œv“IŠĎŽ@|‘ć‚P•ń|
‘O“c@@‹@@–{‘˝@•üm@@“Ąě@š˜a@@ŽN@ç’ĂŽq@@ź–{@ˆŰ–ž@@˛–ě@žÄt
‘ć81‰ń“ú”ç‰ď‘‰ď
1982.4.2-4
“Œ‹ž
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚Ě”ç]‚Š‚ç•Ş—Ł‚ł‚ę‚˝ƒqƒgƒCƒ{ƒEƒCƒ‹ƒX‚ĚƒNƒ[ƒjƒ“ƒO‚ɂ‚˘‚Ä
’JŠ_@••F@@“’’Ę“°–žŽő’j@@’ÐX@Fś@@‰H‘q@@–ž@@“n•ÓMˆę˜Y
‘ć81‰ń“ú”ç‰ď‘‰ď
1982.4.2-4
“Œ‹ž
@
…“—C ‘яóáv]ƒEƒCƒ‹ƒXRŒ´‚É‚ć‚é‘яóáv]ŠłŽŇƒŠƒ“ƒp‹…—cŽá‰ť
”¨@´ˆę˜Y
‘ć81‰ń“ú”ç‰ď‘‰ď
1982.4.2-4
“Œ‹ž
@
ć“VŤ•\”琅ávÇ iÚ‡•”…ávŒ`ŹŒ^j ‚Ě‚PÇ—á
‰ĄŠÖ@”Ž—Y@@’†‘ş@‹`˜N@@‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v iă‘ĺj @@ÎŒ´@d•F@@“cK@@m@@Źě@@›‰ i“ŻŹŽ™‰Čj@
‘ć81‰ń“ú”ç‰ď‘‰ď
1982.4.2-4
“Œ‹ž
@
“÷‰čŽî—l•a•Ď‚ć‚萜‚ś‚˝”畆 T ×–EƒŠƒ“ƒpŽî‚Ě‚P—á
‘Ť—§@@€@@“c‘ă@@ŽŔ@@‘Dˆä@—´•F@@‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v iă‘ĺj @@“ŕ“Ą@”üŽq i‘ĺă’üMj
‘ć81‰ń“ú”ç‰ď‘‰ď
1982.4.2-4
“Œ‹ž
@
‰ťŠw—Ă–@‚Ş‘tŒř‚ľ‚˝ Letterer- Siwe •a‚Ě‚P—á
“y‹•q–ž@@ˆäă—TŽj@@ź“cŒ’Ž÷@@ź‰Ş@´ iă‘ĺj @@’r“c‹Pś i“ŻŹŽ™‰Čj @@‹gěÍ•F iˆď–ŘŽsj
‘ć81‰ń“ú”ç‰ď‘‰ď
1982.4.2-4
“Œ‹ž
@
‡WŒ^ƒAƒŒƒ‹ƒM[”˝‰ž‚đ‰î‚ˇ‚é”畆•a•Ď
ź‰Ş@@´
‘ć81‰ń“ú”ç‰ď‘‰ďƒOƒ‹[ƒvƒfƒBƒXƒJƒbƒVƒ‡ƒ“
1982.4.2-4
“Œ‹ž
@
ÚG‰ß•qÇ”­Œť‚É‚¨‚Ż‚é•\”ç×–E‚Ě–đŠ„
‘Dˆä@—´•F@@‰ĄŠÖ@”Ž—Y@@ź‰Ş@@´
‘ć81‰ń“ú”ç‰ď‘‰ďƒOƒ‹[ƒvƒfƒBƒXƒJƒbƒVƒ‡ƒ“
1982.4.2-4
“Œ‹ž
@
Groin flap ‚đ—˜—p‚ľ‚˝ŠO‰A•”‚ĚÄŒš
‘O“c@@‹@@–{‘˝@•üm@@“Ąě@š˜a@@‚“c@ÍD@@ź–{@ˆŰ–ž
‘ć25‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1982.5.13-15
Îě
@
Growth inhibition of B16 mouse melanoma cells by an aromatic retinoid Ro10-9359 and its metabolism
Adachi, J.C Okada, N.C and Kitano, Y.
‘ć10‰ń‘ž•˝—m”畆Œ¤‹†‰ď
1982.5.20
” Ş
@
Cell-mediated immunity to varicella-zoster virus demonstrated by lymphocyte transformation in herpes zoster
Hata S.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Suppression of contact sensitivity by IgGl antihapten antibody iin symposium "Recent advances in contact dermatitis"
Katayama, I.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Suppression of contact sensitivity by IgGl antihapten antibody iin Workshop "Advances in the pathogenesis of contact dermatitis"j
Katayama, I.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Property of basophil chemotactic factor in contact sensitivity iin Workshop Chemotaxisj
Katayama, I.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Kinetics of keratinocytes in cultune
Kitano, Y.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Diminished reactivity of fibroblast proliferation factor in PSS
Kobayashi, Y., Nishioka, K., Sano, S.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
A syndrome with pernio, periostosis and lipodystrophy
Matsunaga, E., Kaku, T., Okada, N., and Kitano, Y.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Lymphokines iin Symposium "Dermatopharmacology"j
Nishioka, K.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Specific prophylaxis of contact dermatitis iin Symposium "Recent advances in contact dermatitis"j
Nishioka, K.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Endothelial cell interactions in immunology iin Workshop "Microcirculation and lymphatics"j
Nishioka, K.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Contact dermatitis: Cell interaction and humoral factors iin Course Immunodermatologyj
Nishioka, K.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Isolation of a viable eccrime sweat gland by enzymatic digestion
Okada, N.C Kitano, Y.C and Kaku, T.
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
”^”琍ŠŁá‚Ć‚¤‚ÁŒŒŤS‹ŘÇ‚𔺂Á‚˝ć“VŤŠžŤŠOăó—tŒ`Ź•s‘S‚Ě‚P—á
‘Dˆä@—´•F@@ź‰Ş@@´@@’JŠ_@••F
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚Ě”ç]‚Š‚ç•Ş—Ł‚ł‚ę‚˝ƒqƒgƒCƒ{ƒEƒCƒ‹ƒX‚ɂ‚˘‚Ä
’JŠ_@••F@@“’’Ę“°–žŽő’j@@‰H‘q@@–ž@@“n•ÓMˆę˜Y
XV1 International Congress of Dermatology
1982.5.23-28
“Œ‹ž
@
Pseudohypoparathyroidism ‚Ě‚P—á
ˆäă@—TŽj@@“Ąě@š˜a@@‘O“c@@‹@@‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v@@
X–{@–ΐl iă‘ĺ‚S“ŕj @@‘吟@—˜•v i“Żj
1982.6.
‘ć75‰ń‹ß‹E”畆‰ČW’k‰ď
@
Free dorsalis pedis flap ‚É‚ć‚éŠç–ĘÄŒš
‚“c@ÍD@@–{‘˝@•üm@@“Ąě@š˜a@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć38‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1982.6.19
_ŒË
@
•úŽËü’×ᇂ̏C•œ—á
–{‘˝@•üm@@“Ąě@š˜a@@­“c@‰ŔŽq@@‚“c@ÍD@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć38‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1982.6.19
_ŒË
@
ŹŽ™‚ĚˆŤŤƒŠƒ“ƒpŽî
‰ĄŠÖ@”Ž—Y@@ŽR‘ş@’íˆę@@Šě‘˝–쐪•v@@ź‰Ş@@´
‘ć252‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.6.5
ă‘ĺ
@
”畆•a•Ď‚đŽĺ‘i‚Ć‚ľ‚Ä—ˆ‰@‚ľ‚˝‘˝”­Ťœ‘Žî
ŽO‰Y@~Žq iŽs—§’r“cj @@•Ÿ–{@‘×–ž i“Ż“ŕ‰Čj @@“c‘ă@@ŽŔ
‘ć252‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.6.5
ă‘ĺ
@
Pyoderma chronica glutealis
’†‘ş@‹`˜N@@‰Ş“c“Ţ’ĂŽq@@–xˆä@@–ž@@“‡–ě@‚Žu i“Ż“ńŠOj
‘ć252‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.6.5
ă‘ĺ
@
‘ĺăŽs“ŕ‚Ě‚P“űŽ™‰@‚É‚¨‚Ż‚é“`őŤg”Á‚Ě—Źs
”¨@´ˆę˜Y@@”nę@Gˆę iă‘召Ž™j @@’Ă“c@’źŽ÷ i“Żj @@ŽR“c@@–ž i“Żj
‘ć‚U‰ńŹŽ™”畆‰ČŠw‰ď
1982.7.10-11
@
@
ŠŚ—âĺ@–ƒ]‚É‚¨‚Ż‚錌’†ƒqƒXƒ^ƒ~ƒ“’č—Ę‚ĚŽŽ‚Ý iH1‚¨‚ć‚ŃH2 antagonist ‚̉e‹żj
“y‹@•q–ž@@•ĐŽR@ˆę˜N@@ź‰Ş@@´@@‘OŽR@ˆę—˛@@‘ĺ˜a’J@Œú iă‘ĺ“ń–ňj
‘ć‚P‰ńĺ@–ƒ]ƒVƒ“ƒ|ƒWƒEƒ€
1982.7.17
‘ĺă
@
Pseudoxanthoma elasticum ‚É‚¨‚Ż‚é thready material-PAP –@‚É‚ć‚éŒőŒ°“IE“dŒ°“IŠĎŽ@|
ŽR‘ş@’íˆę@@˛–ě@žÄt
‘ć14‰ń“ú–{Œ‹‡‘gDŠw‰ď
1982.7.22-23
ŽD–y
@
“€áŒ—l”ç]‚𔺂¤”ě‘名œœ–ŒÇ i‰źĚj ‚Ě‚P—á
X–{@iŒb@@‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v@@ź‰i@‰xŽĄ i‘ĺ•Ş‘ĺj
‘ć253‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1982.7.31
‘ĺă’üM•a‰@
@
–F‘°ƒŒƒ`ƒmƒCƒh Ro 10-9359‚É‚ć‚鑝B—}§‚Ć×–E‚ĚƒŒƒ`ƒmƒCƒh‘ăŽÓ”\
‘Ť—§@@€@@Šě‘˝–쐪•v
‘ć‚V‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1982.9.19
‹ž“s
@
ánćҏó•\”ç”­ˆçˆŮíÇŠłŽŇ‚ć‚č•Ş—Ł‚ł‚ę‚˝ƒpƒsƒ[ƒ}ƒEƒCƒ‹ƒX
“’’Ę“°–žŽő’j@@’†–ě@–F˜N@@’JŠ_@••F@@‰H‘q@@–ž
‘ć31‰ń“ú–{ƒEƒCƒ‹ƒXŠw‰ď
1983.10.
‘ĺă
@
‰“SŤ”z—ń‚đ‚Ć‚ég”ÁŤŒ‹ß—á|Subacute nodular migratory panniculitis ?
˛–ě@žÄt@@‰ĄŠÖ@”Ž—Y@@‘ęK@’żd
‘ć259‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.10.1
“Ţ—Çˆă‘ĺ
@
“ú–{‚ɉ—‚Ż‚éánćҏó•\”ç”­ˆçˆŮíÇ iEpidermodysplasia verruciformis, L-L., 1922j ‚̉uŠw
’JŠ_@••F@@˛“Ą@Œ’“ń@@Œ‡“c@—ÇŽ™@@˛–ě@žÄt
‘ć259‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.10.1
“Ţ—Çˆă‘ĺ
@
Clinical and cellular characteristics of some xeroderma pigmentosum patients in Taiwan and Japan
Ikenaga, M., Watatani, M, Ohtani, H., Sato, K.
‘ć42‰ń“ú–{ŠŕŠw‰ď‘‰ď
1983.10.25-27
–źŒĂ‰Ž
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚̉uŠw
’JŠ_@••F@@˛“Ą@Œ’“ń@@Œ‡“c@—ÇŽ™@@‰H‘q@@–ž@@“’’Ę“°–žŽő’j@@’r‰i@–žś@@“n•Ó@Mˆę˜Y
‘ć42‰ń“ú–{ŠŕŠw‰ď‘‰ď
1983.10.25-27
–źŒĂ‰Ž
@
”畆ˆŤŤƒŠƒ“ƒpŽî‚Ě—Ő°“IE•a—Šw“IŒ¤‹†
ŽR‘ş@’íˆę@@˛–ě@žÄt@@Âů@Ž”V iă‘ĺ•a—•a‘ԁj @@ˆäă@–ž•ś i“Żj @ź–{@Œ\Žj i“Żj@
‘ć42‰ń“ú–{ŠŕŠw‰ď‘‰ď
1983.10.25-27
–źŒĂ‰Ž
@
Ä”­Ťáv]ŤŽź]
”¨@´ˆę˜Y
‘ć35‰ń“ú”ç‰ďź•”Žx•”‘‰ď
1983.11.19-20
‘q•~
@
Acantholytic dermatosis ‚Ě‚P—á
–ě‘ş@­•v@@ŽN@ç’ĂŽq@@Šě‘˝–쐪•v
‘ć35‰ń“ú”ç‰ďź•”Žx•”‘‰ď
1983.11.19-20
‘q•~
@
Induction of differentiation-specific keratins by 5-azacytidine treatment of SV40-infected human epidermal keratinocytes
Steinberg, M.L., Okada, N., Defendi V.
23rd Annual meeting of the American Society for Cell Biology
1983.11.29-12.4
San Antonio
@
•F‚đ’悡‚éŽîᇂ̓Œv“IŠĎŽ@ iş˜a43-57j
‰Ş–ě@šŽ÷@@Šě‘˝–쐪•v
‘ć34‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1983.11.5-6
ˆ¤’m
@
—Տ°•a—ƒJƒ“ƒtƒ@ƒŒƒ“ƒX Lymphomatoid papulosis ‚Ě‚P—á
‹ŕ@@˜aŽq@@“c‘ă@@ŽŔ@@‰œ‘ş@–rŽq i–Ľ–ĘŽs—§j
‘ć34‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1983.11.5-6
ˆ¤’m
@
—Lž™×–EŠŕ‚đ•š”­‚ľ‚˝‰h—{áŠQŒ^ć“VŤ•\”琅ávÇ
‘ęK@’żd@@˛–ě@‰h‹I@@­“c@‰ŔŽq@@‹´–{@Œö“ń@@’JŠ_@••F@@ź‰Ş@@´@@Šě‘˝–쐪•v@@˛–ě@žÄt
‘ć34‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1983.11.5-6
ˆ¤’m
@
”|—{•\”ç×–E‚Ě plasminogen activator ŠˆŤ‚ɑ΂ˇ‚é Thrombin ‚Ě—}§ě—p
‹´–{@Œö“ń@@“y‹@•q–ž@@ź‰Ş@@´
‘ć260‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.12.17
•şŒÉˆă‘ĺ
@
‹­”çÇŠłŽŇ•a•Ď•”üˆŰ‰č×–E‚̐üˆŰ‰č×–E‘BˆöŽq‚ɑ΂ˇ‚é”˝‰žŤ
ź‰Ş@@´@@Ź—с@äoŽs@@˛–ě@žÄt
‘ć260‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.12.17
•şŒÉˆă‘ĺ
@
Nevoid basal cell carcinoma syndrome ‚Ě‚P—á
ˆäă@—TŽj@@‹vŽu–{@“Œ@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć41‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1983.12.3
@
@
Linear verrucous nevus ‚Ě‚R—á
ˆäă@—TŽj@@‹vŽu–{@“Œ
‘ć256‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.2.19
‘ĺăˆă‘ĺ
@
ƒGƒ“ƒhƒƒgƒŠƒI[ƒVƒX‚Ě‚P—á
Š@@^‹|@@‘O“c@@‹@@Šě‘˝–쐪•v@@˛–ě@žÄt
‘ć256‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.2.19
‘ĺăˆă‘ĺ
@
f’f—á
ŽO‰Y@~Žq@@–Č’J@^—@@‘ĺˆä@@Žç i’r“cŽs–Ż’†ŒŸj
‘ć256‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.2.19
‘ĺăˆă‘ĺ
@
”S–Œ]‚Ĺ”­Ç‚ľ‚˝…ávŤ—Ţ“Vávጂ̂P—á
‘ęK@’żd@@ŽN@ç’ĂŽq@@‹´–{@Œö“ń
‘ć256‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.2.19
‘ĺăˆă‘ĺ
@
De Sanctis-Cacchione ÇŒóŒQŠłŽŇ‚̐üˆŰ‰č×–E‚Ě”M•sˆŔ’čy‘f‚ɂ‚˘‚Ä
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq
ŒúśČ“Á’莞Šł_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”Ǐş˜a57”N“x‘‰ď
1983.2.24
“Œ‹ž
@
Reflectance spectrophotometry ‚É‚ć‚é”畆ŒŒ—Ź“Ž‘Ô‚Ě‘Ş’č
ź‰Ş@@´@@‘O“c@@‹@@˛–ě@žÄt@@˛“Ą@Mh@@Š™“c@•M
‘ć22‰ń“ú–{MEŠw‰ď
1983.4.11-13
‘ĺă
@
Stability and metabolism of retinoids in culture
Kitano, Y., Adachi, J.
SID-ESDR Joint International Meeting
1983.4.27-5.1
Washington, D.C.
@
‘gDŠw“I‚É malignant lymphoma ‚Ɛf’f‚ł‚ę‚Č‚Ş‚çŽŠ‘RÁĺň‚ľ‚˝‚P—á
ˆäă@—TŽj@@‹vŽu–{@“Œ@@ź‰Ş@@´@@‹gě@Í•F iˆď–ŘŽsj
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
PUVA —Ă–@‚Ş’˜Œř‚đŽŚ‚ľ‚˝‹Űó‘§“÷Ç‚Ě‚Q—á
Š@@^‹|@@ˆäă@—TŽj@@‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
l•\”ç×–E‚̏‰‘ă”|—{‚É‚¨‚Ż‚é×–E‚Ě‘B—lŽŽ‚Ɛ˘‘㎞ŠÔ
Šě‘˝–쐪•v@@’ˇŁ@CŽq@@‰Ş“c“Ţ’ĂŽq@@‰Ş–ě@šŽ÷
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
ƒVƒ“ƒ|ƒWƒEƒ€ u”…áv‚ĚŒ`Ź‰ß’öv ’ljÁ”­Œž@“Vávጂɂ¨‚Ż‚鐅ávŒ`Ź‚ĚƒƒJƒjƒYƒ€
‹´–{@Œö“ń
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
F‘fŤŠŁ”çÇŠłŽŇ‚Ɛłíl‚Ě“úŒő‰ß•qŤ‚ɂ‚˘‚Ä‚Ě’č—Ę“I”äŠr
˛“Ą@Œ’“ń@@Ź’ˁ@—Y–Ż@@˛–ě@žÄt@@’r‰i@–žś iă‘ĺ•úŠîj @–xŒĂ@–Żś i‰H‰g–ěj @@‹vŽu–{@“Œ i“Żj @@H–{@—˛“š i“Żj @@“Ą“c@‰vŽq i“Żj @Â–؁@•q”V i“Żj @@
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
”畆‚ĚŠÔŽż‚ɂ‚˘‚Ä iƒvƒƒWƒfƒ“ƒVƒƒƒ‹ƒAƒhƒŒƒXj
˛–ě@žÄt
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
‘ĺă‘ĺŠw‹y‚ŃŠÖ˜A•a‰@‚ɉ—‚Ż‚é”畆ˆŤŤƒŠƒ“ƒpŽî‚Ě—Ő°“IE‘gDŠw“IŒŸ“˘
ŽR‘ş@’íˆę@@˛–ě@žÄt@@Âů@Ž”V iă‘ĺ•a—ó‘ԁj
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
”畆‰Č‚É‚¨‚Ż‚éŒ`ŹŠO‰Č“I’mŽŻ
ź–{@ˆŰ–ž
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
ÚG‰ß•qÇ‚É‚¨‚Ż‚é•\”ç×–E‚Ě–đŠ„
‘Dˆä@—´•F@@‰ĄŠÖ@”Ž—Y@@ź‰Ş@@´
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
Basedow •a‚đ‡•š‚ľ‚˝ PSS ‚Ě‚P—á
‘Š”n@Ć‘ă@@“c‘ă@ ŽŔ@@‰Ş“c“Ţ’ĂŽq@@•ĐŽR@ˆę˜N@@‹´–{@Œö“ń@@…“c@mŽm@@‹{’n@@Œ‰ iă‘ĺ’†ŒŸj
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
ƒqƒgƒCƒ{ƒEƒCƒ‹ƒX3C 5Œ^‚Ş•Ş—Ł‚ł‚ę‚˝ánćҏó•\”ç”­ˆçˆŮíÇ
’JŠ_@••F@@“’’Ę“°–žŽő’j@@’ÐX@Fś@@‰H‘q@@–ž
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
‘Šú‚Ě Woringer-Kolopp •a
“ŕ“Ą@”üŽq@@X–{@iŒb i‘ĺă’üMj @@‘ž“c@ƒŽq i“Żj @@ě’Á@’qĽ i“Żj@@ŽR‘ş@’íˆę @@
‘ć82‰ń“ú”ç‰ď‘‰ď
1983.4.3-5
‘ĺă
@
”畆ˆŤŤƒŠƒ“ƒpŽî‚Ě—Ő°•a—Šw“IŒ¤‹†
ŽR‘ş@’íˆę@@˛–ě@žÄt@@Âů@Ž”V iă‘ĺ•a—•a‘ԁj @@ˆäă@–ž•ś i“Żj@@ź–{@Œ\Žj i“Żj @@
‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď
1983.4.3-5
‘ĺă
@
“Vávጂ̎Ą—Á|“Á‚ɃXƒeƒƒCƒh—Ł’E‚ɂ‚˘‚Ä
ź‰Ş@@´@@ŽN@ç’ĂŽq@@‹´–{@Œö“ń
‘ć‚T‰ń…ávÇŒ¤‹†‰ď
1983.5.14
O‘O
@
ƒeƒOƒŒƒg[ƒ‹‚É‚ć‚é–ň]‚đ•š”­‚ľ‚˝ Erthema papulatum centrifugum
‹ŕ@@˜aŽq@@ź‰Ş@@´
‘ć257‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.5.21
_ŒË’†‰›Žs–Ż•a‰@
@
Piebaldism ‚Ě‚P‰ĆŒn
‚“c@ÍD@@‘O“c@@‹@@ź‰Ş@@´@@˛–ě@žÄt
‘ć257‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.5.21
_ŒË’†‰›Žs–Ż•a‰@
@
Properties of basophil chemotactic factor involved in cutaneous basophil hypersensitivity iCBHj
Katayama, I., Doi, T., Nishioka K.
5th International Congress of Immunology
1983.5.21-27
‹ž“s
@
Induction of lymphird cell proliferation by liposomes carrying molecules from haptenated epidermal cells
Nishioka, K., Funai, T., Yokozeki, H., Katayama, I.
5th International Congress of Immunology
1983.5.21-27
‹ž“s
@
•F‚đ’悡‚éŽîᇂ̓Œv“IŠĎŽ@ iş˜a56E57”N“xj
‰Ş–ě@šŽ÷@@Šě‘˝–쐪•v
‘ć76‰ń‹ß‹E”畆‰ČW’k‰ď
1983.6.5
äŽs–Ż‰ďŠŮ
@
Mycosis fungoides ‚Ě‚P—á
‹vŽu–{@“Œ@@ˆäă@—TŽj@@‘Š”n@Ć‘ă
‘ć76‰ń‹ß‹E”畆‰ČW’k‰ď
1983.6.5
äŽs–Ż‰ďŠŮ
@
ƒJƒ“ƒWƒ_Ť“÷‰čŽî‚Ě‚P—á
”¨@´ˆę˜Y
‘ć76‰ń‹ß‹E”畆‰ČW’k‰ď
1983.6.5
äŽs–Ż‰ďŠŮ
@
‹š•Ç‚Ě‹‘ĺŒ‡‘š‚đC•œ‚ľ‚˝‚P—á
ˆäă@—TŽj@@‹vŽu–{@“Œ@@ă’n@@‹M@@“Ąě@š˜a@@–{‘˝@•üm@@‚“c@ÍD@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć40‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1983.7.2
_ŒË
@
Reflectance spectrometry ‚É‚ć‚é”畆‚Ěƒ‚ƒjƒ^ƒŠƒ“ƒO
‘O“c@ ‹@@–{‘˝@•üm@@‚“c@ÍD@@ź–{@ˆŰ–ž
‘ć40‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1983.7.2
_ŒË
@
ŽĄ—Ă‚É“ďa‚ľ‚˝‹š•”H“šÄŒš—á
–{‘˝@•üm@@ă’n@@‹M@@“Ąě@š˜a@@­“c@‰ŔŽq@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć40‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1983.7.2
_ŒË
@
ŹlŒ^ T ×–EƒŠƒ“ƒpŽî‚Ě‚P—á
Œ‡“c@—ÇŽ™@@ŽR‘ş@’íˆę@@‹´–{@Œö“ń@@Šě‘˝–쐪•v@@˛–ě@žÄt
‘ć258‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.7.30
‰H‰g–ě•a‰@
@
“€áŒ—l”ç]‚𔺂¤”ě‘名œœ–ŒÇ i‰źĚj ‚Ě‚P—á
X–{@iŒb@@‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v@@ź‰i@‰xŽĄ i‘ĺ•Ş‘ĺj
‘ć258‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.7.30
‰H‰g–ě•a‰@
@
Žîᇎ€‚ľ‚˝F‘fŤŠŁ”çÇ‚Ě‚P—á
–ě‘ş@­•v@@˛“Ą@Œ’“ń@@Šě‘˝–쐪•v
‘ć258‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1983.7.30
‰H‰g–ě•a‰@
@
Effect of 5-Azacytidine on the differentiation of SV40-infected human epidermal keratinocytes
Osada, N., Steinberg, M.L., Defendi, V.
Gordon Research Conference
1983.8.
New Hampshire
@
“Á•Ęu‰‰ uÚG”畆‰Š‚ ‚ę‚ą‚ęv
ź‰Ş@@´
RŒ´Œ¤‹†‰ď
1983.8.6
•Ÿ‰Ş
@
ˆŤŤŒŒŠÇ“ŕ”ç×–EŽî‚Ě‚P—á
–ě‘ş@­•v@@‰i–؁@Œö”ü@@’JŠ_@••F@@‘ĺé@@–Đ iă‘ĺ“ńŠOj
‘ć44‰ń‘ĺăŒŒŠÇŠO‰Č“ŻD‰ď
1983.9.24
‘ĺă
@
Xanthogranuloma iadult typej ‚Ě‚P—á
Ź—с@äoŽs@@ź‰Ş@@´@@˛–ě@žÄt
‘ć74‰ńŽRŒű’n•ű‰ď
1984.1.29
‰F•”
@
ƒ‚ƒ‹ƒ‚ƒbƒg”畆‚É‚ć‚éƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“ D2‚ĚŽYś
Ź’ˁ@—Y–Ż@@Francis, D.M., Barr, R.M., Greaves, M.W.
‘ć15‰ńŠî‘b”畆‰Č§˜b‰ď
1984.1.7
L“‡
@
Neurofibroma ‚ĚˆŤŤ‰ť‚đ‚Ý‚˝ von-Recklinghausen ‚Ě‚P—á
ă“c@´—˛@@•ĐŽR@ˆę˜N@@–ě‘ş@­•v@@‹´–{@Œö“ń@@Šě‘˝–쐪•v
‘ć265‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.10.6
˜a‰ĚŽR‘ĺ
@
Myopathy ‚đ‡•š‚ľ‚˝ scleromyxedma
‘ě@˜aŽq@@“y‹@•q–ž@@ŽR‘ş@’íˆę@@‹´–{@Œö“ń@@ź‰Ş@@´@@–ěč@‰€Žq iă‘ĺ2“ŕj @@‚‹´@Œő—Y@
‘ć265‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.10.6
˜a‰ĚŽR‘ĺ
@
ˆÝŠŕ“Eo‚É‚ć‚č”ç]‚̉ü‘P‚đ‚Ý‚˝”畆‹Ř‰Š‚Ě‚P—á
‹ŕ@@˜aŽq@@‰Ş“c“Ţ’ĂŽq@@“Ą–{@N—T iă‘ĺ2ŠOj @@“cŞ@@‰b i“Żj@@Źě@“š—Y i“Żj @@
‘ć265‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.10.6
˜a‰ĚŽR‘ĺ
@
“–‰Č‚É‚¨‚Ż‚鏬Ž¨Ç‚ĚŽčpŒoŒą
ˆäă@—TŽj@@­“c@‰ŔŽq@@‹vŽu–{@“Œ@@ź–{@ˆŰ–ž
‘ć43‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1984.11.17
‘ĺă
@
A humoral factor which affect basophils in contact sensitivty
Katayama, I., Nishioka, K.
Ist International sky club symposinm on the biological role of proneinase and their inhibitors in skin
1984.11.3-4
“Œ‹ž
@
‹­”çÇŠłŽŇŒŒ´‚Ěƒ‚ƒ‹ƒ‚ƒbƒgŒŒŠÇ“ŕ”ç×–E‚ɑ΂ˇ‚鑝B—}§ě—p‚ĚŒŸ“˘
Ź—с@—^Žs@@ź‰Ş@@´@@˛–ě@žÄt
‘ć266‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.12.15
‹ß‘ĺ
@
DNP ƒAƒ~ƒmŽ_‚É‚ć‚éƒ}ƒEƒXÚGƒAƒŒƒ‹ƒM[‚Ě—}§
•ĐŽR@ˆę˜N@@ź‰Ş@@´
‘ć266‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.12.15
‹ß‘ĺ
@
‘ą”­Ť”畆ƒAƒ~ƒƒCƒhÇ‚Ě“Œv“IŠĎŽ@
–ě‘ş@­•v@@‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v
‘ć266‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.12.15
‹ß‘ĺ
@
“œ”A•aŤ’×ᇂɑ΂ˇ‚éƒvƒƒXƒ^ƒOƒ‰ƒ“ƒfƒBƒ“ E1‚ĚŽg—pŒoŒą
‹vŽu–{@“Œ@@ˆäă@—TŽj
‘ć‚V‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘Žl‘’n•ű‰ď
1984.2.11
@
@
•a‘ƒŠ´ő‚É‚ć‚é‚ĆŽv‚í‚ę‚é‘˝Ę‚Č”ç]‚đ’ć‚ľ‚˝‚P—á
‰i–؁@Œö”ü@@ŽR‘ş@’íˆę@@‹´–{@Œö“ń@@˛–ě@žÄt
‘ć261‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.2.18
ă‘ĺ
@
Arning Œ^F‘fŤĺ@–ƒ]‚Ě‚PÇ—á
˛–ě@‰h‹I@@“y‹@•q–ž@@˛–ě@žÄt
‘ć261‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.2.18
ă‘ĺ
@
–Ť‰ŠÇ‹y‚Ń“÷‰čŽîŽžŠł‚É‚¨‚Ż‚éƒAƒ~ƒƒCƒh’ž’…
–ě‘ş@­•v@@Šě‘˝–쐪•v
•ś•”Č‰ČŒ¤‘‡Œ¤‹† iAj u”畆ƒAƒ~ƒƒCƒh[ƒVƒX‚Ě•aˆö•a‘Ô‚Ć‘SgŤƒAƒ~ƒƒCƒh[ƒVƒX‚Ć‚ĚŠÖ˜A‚ÉŠÖ‚ˇ‚錤‹†v ”ljď‹c
1984.3.10-11
–źŒĂ‰Ž
@
‘ć‚P‘ć‚Qéҋ|ÇŒóŒQ‚Ě‚P—á
ˆäă@—TŽj@@‹vŽu–{@“Œ@@ź–{@ˆŰ–ž
‘ć27‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1984.4.5-7
‰Ą•l
@
”˝ŽËƒXƒyƒNƒgƒ‹‰đÍ–@‚É‚ć‚é”ç•Ů‚Ěƒ‚ƒjƒ^ƒŠƒ“ƒO
‘O“c@@‹@@ź–{@ˆŰ–ž@@ź‰Ş@@´@@˛“Ą@Mh iă‘ĺˆę“ŕj
‘ć27‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1984.4.5-7
‰Ą•l
@
‹‘ĺëŒ\ƒRƒ“ƒWƒ[ƒ€‚đŽv‚í‚š‚˝ŠO‰A•” Paget Šŕ‚Ě‚P—á
‘Ž}”ü•äŽq@@™“c@ˆę”V@@‘O“c@@‹@@ź‰Ş@@´
‘ć262‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.4.7
‘ĺă‰ńś•a‰@
@
ˆŤŤŒŒŠÇ“ŕ”ç×–EŽî‚Ě‚T—á
–ě‘ş@­•v@@’JŠ_@••F@@‘O“c@@‹@@Ź—с@äoŽs@@Ź’ˁ@—Y–Ż@@”¨@´ˆę˜Y
‘ć262‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.4.7
‘ĺă‰ńś•a‰@
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚Ě”ç]Œ`‘Ô‚Ćƒqƒgƒpƒsƒ[ƒ}ƒEƒCƒ‹ƒX‚Ěƒ^ƒCƒv
Œ‡“c@—ÇŽ™@@’JŠ_@••F@@˛“Ą@Œ’“ń@@Šě‘˝–쐪•v@@“’’Ę“°–žŽő’j@@X“c@GŽ÷
‘ć77‰ń‹ß‹E”畆‰ČW’k‰ď
1984.5.13
“V—
@
In vitro anaphylactic release of prostaglandin D2 by guinea pig skin
Kozuka, T., Fraucis, D.M., Barr, R.M., Mallet, A.I., Greaves, M.W.
45th Annual Meeting of the Society for Investigative Dermatology
1984.5.7-9
Washington, D.C.
@
Release of prostaglandin D2 during in vitro anaphylaxis in guinea pig skin
Kozuka, T.
‡W the International Washington Spring Symposium : Prostaglandin & Leukotriens '84 Their Biochemistry, Mechanism of Action & Clinical Applications
1984.5.8-11
Washington,D.C.
@
ÚGƒAƒŒƒ‹ƒM[”­Œť‰ß’ö‚É‚¨‚Ż‚éD‰–Šî‹…‚Ě–đŠ„
•ĐŽR@ˆę˜N
‘ć‚P‰ń–ƉuƒAƒŒƒ‹ƒM[‚Ě•ŕ‚Ý
1984.6.2
‘ĺă
@
Lymphscrotum ‚Ě‚P—á
‘ĺŠp@ˆęĆ@@ˆäă@—TŽj@@ă’n@@‹M@@—с@@ßŠw@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć42‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1984.6.30
‘ĺă
@
’ሟ‰”ŒŒÇ‚𔺂í‚Č‚˘’°ŤŽˆ’[”畆‰Š‚Ě‚P—á
‰˘@@–ž“N@@“c‘ă@@ŽŔ@@–q@@ˆę˜Y iă‘召Ž™‰Čj @@Œ´“c@“ż‘  i“Żj
‘ć83‰ń“ú”ç‰ď‘‰ď
1984.6.8-10
ŽD–y
@
ƒŠƒ|ƒ][ƒ€‚đ—p‚˘‚˝ÚG‰ß•qÇ‚Ě—U“ą
‘ęK@’żd@@‰ĄŠÖ@”Ž—Y@@•ĐŽR@ˆę˜N@@ź‰Ş@@´
‘ć83‰ń“ú”ç‰ď‘‰ď
1984.6.8-10
ŽD–y
@
ánćҕ\”ç”­ˆçˆŮíÇ iepidermodysplasia verruciformisGLewandowsky-Lutz, 1922j ‚Ěˆę–UŒŸ—á
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Aź@–M•v i•şŒÉˆă‘ĺ•a—j @@‰““Ą@G•F i•şŒÉˆă‘ĺE”çj @“’’Ę“°–žŽő’j iă‘ĺ”÷Œ¤j
‘ć83‰ń“ú”ç‰ď‘‰ď
1984.6.8-10
ŽD–y
@
Adie ÇŒóŒQ‚ƐF‘f”Á‚𔺂Á‚˝–łŠžÇ‚Ě‚P—á
“c’ĂŒ´ŒjŽq iŽs—§’r“cj @@“c‘ă@@ŽŔ
‘ć83‰ń“ú”ç‰ď‘‰ď
1984.6.8-10
ŽD–y
@
ƒRƒNƒVƒWƒIƒCƒfƒXÇ
”¨@´ˆę˜Y@@´…@—mŽq i’†ŒŸj @@Sugar, A.M.@@Stevens, D.A. iStanford Univj
‘ć83‰ń“ú”ç‰ď‘‰ď
1984.6.8-10
ŽD–y
@
Autoimmune progesterone depmatis ‚Ě‚P—á
•ĐŽR@ˆę˜N@@ź‰Ş@@´
‘ć83‰ń“ú”ç‰ď‘‰ď
1984.6.8-10
ŽD–y
@
Basophil chemotaxis in contact sensitivity
Katayama, I., Nishioka, K.
‘ć‚X‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1984.7.19-20
‰Ą•l
@
Tissue culture of keratinocyte
Šě‘˝–쐪•v
‘ć‚X‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1984.7.19-20
‰Ą•l
@
‘яóáv]‚ĚŽŠ‘RŒo‰ßƒVƒ“ƒ|ƒWƒEƒ€g‘яóáv]‚ĚŽĄ—Ă‚đl‚Ś‚éh
”¨@´ˆę˜Y
‘ć18‰ńƒyƒCƒ“ƒNƒŠƒjƒbƒNŒ¤‹†‰ď
1984.7.28
@
@
X-linked ichthyosis ‚Ěˆę‰ĆŒn
‰Ş–ě@šŽ÷@@Šě‘˝–쐪•v
‘ć264‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.7.28
_ŒË‘ĺ
@
ƒƒ`ƒ‹ƒvƒŒƒhƒjƒ]ƒƒ“‘ĺ—Ę—Ă–@‚Ş‘tŒř‚ľ‚˝”xüˆŰÇ‚𔺂Á‚˝”畆‹Ř‰Š
“y‹@•q–ž@@‘ęK@’żd@@ź‰Ş@@´
‘ć264‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1984.7.28
_ŒË‘ĺ
@
”|—{•\”ç×–E‚É‚ć‚é•›t”玿ƒzƒ‹ƒ‚ƒ“‚Ě‘ăŽÓ
Šě‘˝–쐪•v
‘ć83‰ń“ú”ç‰ď‘‰ď
1984.7.8-10
ŽD–y
@
‘˝”­‹Ř‰Š‚𔺂ȂÁ‚˝ malignant histiocytosis ‚Ě‚P—á
‘Ž}”ü•äŽq@@–ě‘ş@­•v@@‰Ş–ě@šŽ÷@@Œ‡“c@—ÇŽ™@@ŽR‘ş@’íˆę@@‹´–{@Œö“ń@@˛–ě@žÄt
‘ć35‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1984.9.22-23
‘ĺă
@
Ô”’ŒŒ•a‚É‚¨‚Ż‚é“Ş•””畆Z—á
…‰z@’źŽq@@˛“Ą@Œ’“ń@@˛–ě@žÄt
‘ć35‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1984.9.22-23
‘ĺă
@
‘~”j‚É‚ć‚錌’†ƒqƒXƒ^ƒ~ƒ“‚Ě•Ď“Ž
“y‹@•q–ž@@•ĐŽR@ˆę˜N@@ź‰Ş@@´
‘ć35‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1984.9.22-23
‘ĺă
@
Multicentric reticulohistiocytosis ‚Ě‚P—á
“ŒŽR@^—@@ŽR‘ş@’íˆę@@‹´–{@Œö“ń@@˛–ě@žÄt
‘ć35‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1984.9.22-23
‘ĺă
@
Propyleneglycol monostearate ‚ÉŠÜ‚Ü‚ę‚Ä‚˘‚é•sƒ•¨‚É‚ć‚é pigmented contact dermatitis
“Ą–{@Œ\ˆę@@‹´–{@˝ˆę iZ—F•a‰@j @@Ź’ˁ@—Y–Ż@@“c‘ă@@ŽŔ
‘ć35‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1984.9.22-23
‘ĺă
@
Žá”NŹl‚É‚¨‚Ż‚éƒiƒCƒƒ“•z”畆Ç’˛¸
”¨@´ˆę˜Y@@’JŠ_@••F@@ŽOč@Ÿ”V@@’†“c@ˆę—m i‘S“ú‹óf—ÏŠj@@‰Ş“c@@Í iŠŰgf—ÏŠj @@
‘ć35‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1984.9.22-23
‘ĺă
@
ˆŤŤŽîᇂ𔺂Á‚˝ánćҏó•\”ç”­ˆçˆŮíÇ
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@˛“Ą@Œ’“ń@@“’’Ę“°–žŽő•v@@‰H‘q@@–ž@@’r‰i@–žś
‘ć44‰ń“ú–{ŠŕŠw‰ď‘‰ď
1985.10.
‘ĺ’Ă
@
S–[”S‰tŽî‚̔牺“]ˆÚ—á
‰Ş“c“Ţ’ĂŽq@@ŽR‘ş@’íˆę@@Šě‘˝–쐪•v@@ź‘ň@—SŽŸ i“ń“ŕj
‘ć36‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1985.10.12-13
‘ĺ’Ă
@
”畆‹Ř‰Š22—á‚Ě“Œv“IŠĎŽ@
Œ‡“c@—ÇŽ™@@’JŠ_@••F@@Šě‘˝–쐪•v
‘ć36‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1985.10.12-13
‘ĺ’Ă
@
d•ĄŠŕ‚Ě‚P—á
ŽsŒ´@ă`Žq@@“Œ@@rŽq@@ˆüŽR@—şŽs i‘ĺă˜JĐj @@‘O“c@@‹ iă‘ĺj
‘ć36‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1985.10.12-13
‘ĺ’Ă
@
‚­‚č‚Ę‚Ť–D‡–@‚ĚŒŸ“˘
ˆäă@—TŽj@@ź’J@–ÎŽ÷@@—с@@ŕŠw@@‚–؁@@ł@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć45‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1985.11.16
‘ĺă
@
—ź‘¤O—ô‚ŕiN—֏njóŒQ‚đ‡•š‚ľ‚˝‚P—á
ź’J@–ÎŽ÷
‘ć45‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1985.11.16
‘ĺă
@
ƒ|ƒŠƒGƒ`ƒŒƒ“ƒOƒŠƒR[ƒ‹–„–vŽx’Œ‚ĆƒtƒBƒuƒŠƒ“ŒĐ‚đ—p‚˘‚˝”÷ŹŒŒŠÇ•Ť‡‚ĚŽŽ‚Ý
ă’n@@‹M@@ˆäă@—TŽj@@‘O“c@@‹@@ź–{@ˆŰ–ž iă‘ĺj @@ź‰Ş@@´ i“Ż”畆j
‘ć12‰ńƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ďŒ¤‹†‰ď
1985.11.22
Îě
@
”şŤ‹›—ŘᝂĚ22—á
‰Ş–ě@šŽ÷@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć255‰ń“ú”ç‰ď•Ÿ‰Ş’n•ű‰ď
1985.11.23
•Ÿ‰Ş
@
ƒrƒ^ƒ~ƒ“‚c‚É‚ć‚éŠŁá‚ĚŽĄ—Ă
‹gě@–M•F@@Ź’ˁ@—Y–Ż@@Šě‘˝–쐪•v@@”¨@´ˆę˜Y iă‘ĺj @@X–{@–ΐl@@Ą’†@rŽ˘@@“’ě@Žl˜Y@@‘吟@—˜•v@@ŒFŒ´@—Yˆę i“Ż‚S“ŕj
‘ć10‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď ‘ć‚P‰ń Clinically Oriented Research Symposium
1985.11.29-30
“Œ‹ž
@
”­Šŕ‚Ě“ń’iŠKŕ iCore speakerj
Šě‘˝–쐪•v
‘ć271‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.11.3
_ŒË
@
ƒGƒNƒŠƒ“ŠžŠíŠŻŤŽîᇂ̂R—á
ŽsŒ´@ă`Žq@@ˆüŽR@—şŽs i‘ĺă˜JĐj @@‘O“c@@‹ iă‘ĺj
‘ć271‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.11.3
_ŒË
@
ƒCƒ“ƒ^[ƒtƒFƒƒ“‚̍RŽîᇍě—p iCore speakerj
ź‰Ş@@´
‘ć271‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.11.3
_ŒË
@
‚X”NŒă‚É“]ˆÚ‚đ—ˆ‚˝‚ľ‚˝ Acral lentiginous melanoma
‘ęK@’żd@@Ź’ˁ@—Y–Ż@@’JŠ_@••F@@‘O“c @‹@@Šě‘˝–쐪•v@@‹gě@–M•F@@
‘ć271‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.11.3
_ŒË
@
”畆‹Ř‰Š‚đ‡•š‚ľ‚˝“]ˆÚÇŠĚŠŕ‚Ě‚PŽĄ—Ă—á
’†–ě@”ŽŽj@@”¨ŽR@_‹B@@‹ŕˆä@r—Y@@ś‹ß@ŒŤl@@–ĺ“c@Žçl@@“cŞ@@‰b@@Źě@‰Ă—_@@‰Ş‘ş@@ƒ@@X@@•’ĺ iă‘ĺ“ńŠOj @@‰Ş“c“Ţ’ĂŽq iă‘ĺj
‘ć38‰ń‹ß‹EŠO‰ČŠw‰ď
1985.11.30
‘ĺă
@
•\”ç×–E‚Ě‘B‚Ć•Ş‰ť
Šě‘˝–쐪•v
ƒqƒg×–EŒ¤‹†‰ďƒVƒ“ƒ|ƒWƒEƒ€F‘B‚Ć•Ş‰ť|ƒqƒg×–E‚𒆐S‚Ć‚ľ‚ā|
1985.12.6
“Œ‹ž
@
ƒqƒ}ƒV–ű‚É‚ć‚éÚG”畆‰Š‚Ěˆę—á
‹gě@–M•F@@Ź’ˁ@—Y–Ż@@“y‹@•q–ž@@•Đ‰Ş@—tŽq iă‘ĺj @@“Ą–{@Œ\ˆę@@‹´–{@˝ˆę iZ—Fj
‘ć10‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1985.12.7-8
_ŒË
@
Calcifying epithelioma
‹vŽu–{@“Œ@@™“c@ˆę”V@@­“c@‰ŔŽq@@‘Š”n@Ć‘ă@@“ŒŽR@^—˘ i‘ĺăŒxŽ@Œ`Źj
‘ć‚V‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1985.2.10
L“‡
@
”w•”ˆŤŤŽîᇂ̂Q—á
™“c@ˆę”V@@‹vŽu–{@“Œ@@­“c@‰ŔŽq@@‘Š”n@Ć‘ă@@“ŒŽR@^—˘ i‘ĺăŒxŽ@Œ`Źj
‘ć‚X‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1985.2.10
L“‡
@
ŠáÇó‚𔺂Á‚˝ Incontinentia pigmenti iBloch-Sulzbergerj ‚Ě‚PÇ—á
ó“c@G•v@@‹´–{@Œö“ń iă‘ĺj @@“c–ě@•Ű—Y@@‰Ş–{@–ÎŽ÷ i“ŻŠá‰Čj
‘ć267‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.2.16
‘ĺă
@
Cutaneous B cell lymphoma ‚Ě‚P—á
’r–ě@@G@@ŽR‘ş@’íˆę@@‹´–{@Œö“ń
‘ć267‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.2.16
‘ĺă
@
DŽ_‹…Ť‹Ř–Œ‰Š‚Ě‚TÇ—á‚ɂ‚˘‚Ä
–ź”¨@@F@@“c‘ă@@ŽŔ@@Šě‘˝–쐪•v
‘ć267‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.2.16
‘ĺă
@
Muco-epidermoid carcinoma ‚Ě‚P—á‚Ĺ–j•”“î•”‘gDŒ‡‘š‚đ DP-flap ‚ɂďCŽ‚ľ‚˝‚P—á
“ŒŽR@^—˘@@‘Š”n@Ć‘ă@@­“c@‰ŔŽq@@™“c@ˆę”V@@‹vŽu–{@“Œ i‘ĺăŒxŽ@j @ˆäă@—TŽj@@ź–{@ˆŰ–ž iă‘ĺj @@‚“c@ÍD i•şŒÉŒ§—§‚ą‚Ç‚ŕ•a‰@j
‘ć267‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.2.16
‘ĺă
@
”畆‚Ě˜V‰ť‚ĆƒAƒ~ƒƒCƒh’ž’…
–ě‘ş@­•v@@Šě‘˝–쐪•v iă‘ĺj
ş˜a59”N“x”畆ƒAƒ~ƒƒCƒh[ƒVƒX‚Ě•aˆöC •a‘Ô‚Ć‘SgŤƒAƒ~ƒƒCƒh[ƒVƒX‚ĚŠÖ˜A‚ÉŠÖ‚ˇ‚錤‹†”ljď‹c
1985.2.9-10
Šň•Œ
@
“–‰Č‚É‚¨‚Ż‚éˆŤŤ•FŽî‚ĚŽĄ—ĂŒoŒą
‹gě@–M•F@@‘O“c@@‹@@ŽO–с@‹I•v
‹žŽ ”畆‰ČW’k‰ď
1985.3.
‹ž“s
@
“Vávጂɂ¨‚Ż‚éƒpƒ‹ƒX—Ă–@‚ĚŽŽ‚݁E‚R—á‚̉đÍ
ŒĂě”ü‹IŽq@@‹´–{@Œö“ń@@ź‰Ş@@´@@‹gě@–M•F
‘ć268‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.3.23
‘ĺăÔ\Žš•a‰@
@
ŹŽ™ Sweet •a‚Ě‚Q—á
ă“c@´—˛@@ź‰Ş@@´
‘ć268‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.3.23
‘ĺăÔ\Žš•a‰@
@
ŽĄ—Ă‚ŞŒř‚đ‘t‚ľ‚˝‚ƍl‚Ś‚ç‚ę‚éánć҂̐”—á
’JŠ_@••F@@Œ‡“c@—ÇŽ™ iă‘ĺj @@‹´–{@˝ˆę iZ—Fj @@˛–ě@žÄt i‘—§‘ĺăj
‘ć268‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.3.23
‘ĺăÔ\Žš•a‰@
@
ˆŤŤŽîᇂđ‚ŕ‚Á‚˝ánćҏó•\”ç”­ˆçˆŮíÇ
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Šě‘˝–쐪•v@@‹gě@–M•F@@‰H‘q@@–ž@@“’’Ę“°–žŽő•v@@‹´–{@˝ˆę
‘ć‚P‰ńl“ű“ŞŽîƒEƒCƒ‹ƒXŒ¤‹†‰ď
1985.4.12
@
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚ĚŒZ’í”­Ç—á
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Šě‘˝–쐪•v@@‹gě@–M•F@@‰H‘q@@–ž@@“’’Ę“°–žŽő•v@@‹´–{@˝ˆę
‘ć‚P‰ńl“ű“ŞŽîƒEƒCƒ‹ƒXŒ¤‹†‰ď
1985.4.12
@
@
”|—{ƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚é—Ţ“VávግRŒ´‚Ě”­Œť
‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v iă‘ĺj @@‹{ě@KŽq@@â–{@–MŽ÷ i“Ţ—Çˆă‘ĺj
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
”şŤˆâ“`Ť‹›—Ř᝕ۈöŽŇ‚Ě steroid sulfatase ŠˆŤ’l
‰Ş–ě@šŽ÷@@Ź’ˁ@—Y–Ż@@Šě‘˝–쐪•v
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
ă”琍Žîᇂɑ΂ˇ‚éƒAƒƒ}ƒ`ƒbƒNƒŒƒ`ƒmƒCƒh‚ĚŒř‰Ę
‹gě@–M•F iă‘ĺj @@‰Ą“c”ü’mŽq@@‘O“c@’ź“ż i–źŽs‘ĺj
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
–ňÜ—U”­“VáváŒ
‹´–{@Œö“ń
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
’PƒNƒ[ƒ“ŤRŠjR‘Ě‚ĚěŹ‚ĆŽŠŒČ–ƉuŠłŽŇ‰đÍ‚ւ̉ž—p
‹ŕ“c@^— iă‘ĺj @@÷ˆä@@—˛@@“ŕ“c@@邁@@‰Ş“c@‘P—Y i×–EHŠwƒZƒ“ƒ^[j
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
’PFŒőĆŽË‚ōě—p”g’ˇ‚đ–ž‚ç‚Š‚É‚ľ“ž‚˝Ží“——l…ávÇ‚Ě‚P—á
‘Ž}”üŽ}Žq@@˛“Ą@Œ’“ń@@‘ě@˜aŽq@@Šě‘˝–쐪•v
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
ƒiƒCƒƒ“ťƒ^ƒIƒ‹–€ŽC”畆Ç‚̉uŠw
’JŠ_@••F@@”¨@´ˆę˜Y@@Šě‘˝–쐪•v@@–ě‘ş@­•v@@˛“Ą@Œ’“ń@@Œ‡“c@—ÇŽ™@@˛–ě@žÄt
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
ÔŒŒ‹…ŽŠŒČŠ´ěÇŒóŒQ‚đ‚¨‚ŕ‚í‚š‚˝ŽŠŤ”畆Ç
“ŒŽR@^—@@Šě‘˝–쐪•v iă‘ĺj @@˛“Ą@˜aŠ° i“Ż¸_‰Čj@@ăź@š›G i‘—§‘ĺă¸_‰Čj @@
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
lƒƒ‰ƒm[ƒ}×–EŠ”‚Ć‚ť‚Ě“ÁŤ
Šě‘˝–쐪•v@@–ě‘ş@­•v@@‹ŕ@@˜aŽq@@‰Ş“c“Ţ’ĂŽq iă‘ĺj@@ŒĂŽR@‡ˆę i•şŒÉˆă‘ĺˆâ“`j @@
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
ánćҏó•\”ç”­ˆçˆŮíÇ iLewandowsky-Lutz 1992j ‚Ě”ç]‚Ş”­ś‚ľ‚˝ SLE ‚Ě‚P—á
Œ‡“c@—ÇŽ™@@’JŠ_@••F@@˛“Ą@Œ’“ń@@Šě‘˝–쐪•v iă‘ĺj @@“’’Ę“°–žŽő’j@@‰H‘q@@–ž i“Ż”÷Œ¤j
‘ć84‰ń“ú”ç‰ď‘‰ď @
1985.4.12-14
‰ŞŽR
@
ŠŽ‘S—ź‘¤O—ôŒűŠW—ô‚Ć“_“Ş‚Ä‚ń‚Š‚ń‚đ‡•š‚ľ‚˝‰h—{áŠQŒ^ć“VŤ•\”琅ávÇ‚Ě‚P—á
™“c@ˆę”V@@‘Š”n@Ć‘ă@@­“c@‰ŔŽq@@‹vŽu–{@“Œ i‘ĺăŒxŽ@j@ź–{@ˆŰ–ž iă‘ĺj @@
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
’˜–ž‚ȐS•a•Ď‚𔺂Á‚˝ PSS ‚Ě‚P—á
‘ęK@’żd@@˛–ě@‰h‹I@@ó“c@G•v@@‹´–{@Œö“ń@@ź‰Ş@@´ iă‘ĺj@@–x@@ł“ń i“Żˆę“ŕj @@
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
‘яóáv]‚Š‚ç‚Ě VĽZ ƒEƒCƒ‹ƒX•Ş—Ł
”¨@´ˆę˜Y iă‘ĺj @@”nę@Gˆę i“ŻŹŽ™‰Čj @@–ƒś@ŒÜŒŽ@@{ŠL@“N˜Y i‘ĺă‰ńśj@@ź“ˆ@Žq@@’Š“c@N•v iŠÖźˆă‘ĺj @@@@@‹`˜Y@@“yˆä@@Œ° i_ŒË’†‰›Žs–Żj
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
‘gDŠw“I‚ɈŤŤƒŠƒ“ƒpŽî‚đ‹^‚í‚š‚˝ Iymphoadenosis benigna cutis
–xŒĂ@–Żś@@‘Dˆä@—´•F@@Â–؁@•q”V i•{—§‰H‰g–ěj @@“c‘ă@@ŽŔ@@ŽR‘ş@’íˆę iă‘ĺj@
‘ć84‰ń“ú”ç‰ď‘‰ď
1985.4.12-14
‰ŞŽR
@
Ž„‚˝‚ż‚ĚŽ¨‰îŒ`Źp
ź–{@ˆŰ–ž@@ˆäă@—TŽj@@‹vŽu–{@“Œ
‘ć28‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1985.4.4-5
‰ŞŽR
@
‘gD”˝ŽËƒXƒyƒNƒgƒ‹‰đÍ–@‚É‚ć‚éfree flap‚Ěƒ‚ƒjƒ^ƒŠƒ“ƒO i‘ć‚Q•ńj
‘O“c@@‹@@“Ąě@š˜a@@ź–{@ˆŰ–ž@@–{‘˝@•üm
‘ć28‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1985.4.5
‰ŞŽR
@
ˆŤŤŒŒŠÇ“ŕ”ç×–EŽî‚Ě‚U—á
ˆäă@—TŽj@@ă’n@@‹M@@“Ąě@š˜a@@–{‘˝@•üm@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć28‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1985.4.6
‰ŞŽR
@
ˆŸ‰”ŠÜ—Lƒe[ƒv‚đ—p‚˘‚˝”ěŒúŤá­‚¨‚ć‚ŃƒPƒƒCƒh‚ĚŽĄ—ĂŒoŒą
ă’n@@‹M@@ˆäă@—TŽj@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć28‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1985.4.6
‰ŞŽR
@
Distribution of caldesmon ia calmodulin and actin-binding proteinj in cultured keratinocytes
Adachi, J., Kitano, Y., Okada, N., Sobue, K. and Kakiuchi, S.
Joint Meeting of the Society for Investigative Dermatology and Japanese Society for Investigative Dermatology
1985.5.1-5
Washington DC
@
Lymphocytes products induce production of epidermal cell proliferating factorisj from bone marrow cells.
Katayama, I., Hashimoto, K. and Nishioka, K.
Joint Meeting of the Society for Investigative Dermatology and Japanese Society for Investigative Dermatology
1985.5.1-5
Washington DC
@
Induction and suppression of contact sensitivity by liposomes bearing hapten-conjugated molecules from epidermal cells.
Nishioka, K., Yokozeki, H., Katayama, I. and Hashimoto, K.
Joint Meeting of the Society for Investigative Dermatology and Japanese Society for Investigative Dermatology
1985.5.1-5
Washington DC
@
Expression of pemphigoid antigen by SV40-transformed human keratinocytes
Okada, N., Kitano, Y., Miyagawa, S., Sakamoto, K. and Steinberg, M. L
Joint Meeting of the Society for Investigative Dermatology and Japanese Society for Investigative Dermatology
1985.5.1-5
Washington DC
@
Detection of heterozygotes of X-linked ichthyosis by measuring steroid sulphatase activity of lymphocytes. Mode of inheritance in three families.
Okano, M., Okada, N. and Kitano, Y.
Joint Meeting of the Society for Investigative Dermatology and Japanese Society for Investigative Dermatology
1985.5.1-5
Washington DC
@
ˆŤŤ•FŽî‚ɑ΂ˇ‚é ƒż-ƒCƒ“ƒ^[ƒtƒFƒƒ“‚É‚ć‚鎥—Ă
ŽO–с@‹I•v@@‘O“c@@‹@@Ź—с@äoŽs@@ŽR‘ş@’íˆę@@‹´–{@Œö“ń@@ź‰Ş@@´@@‹gě@–M•F
‘ć269‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.5.11
‘ĺă
@
‰AŒsŠŕ‚Ě‚P—á
ă“c@´—˛@@‰Yě@W–ç@@‘O“c@@‹@@”¨@´ˆę˜Y
‘ć269‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.5.11
‘ĺă
@
ć“VŤ•\”琅ávÇ‚Ěˆę—á
‘O“c@@‹@@ă’n@@@‹M@@ź–{@ˆŰ–ž iă‘ĺj @@–{‘˝@•üm i‘ĺ•Şˆă‘ĺ”畆j
‘ć28‰ń“ú–{Žč‚ĚŠO‰ČŠw‰ď‘‰ď
1985.5.9
_ŒË
@
ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[‚É‚¨‚Ż‚郂ƒjƒ^ƒŠƒ“ƒO
‘O“c@@‹@@ă’n@@‹M@@“Ąě@š˜a@@ź–{@ˆŰ–ž
‘ć28‰ń“ú–{Žč‚ĚŠO‰ČŠw‰ď‘‰ď
1985.5.9
_ŒË
@
—n‰đŤŽx’Œ‚đ—p‚˘‚˝ƒtƒBƒuƒŠƒ“ŒĐ‚É‚ć‚é”÷ŹŒŒŠÇ•Ť‡–@
ă’n@@‹M
‘ć44‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1985.6.22
‘ĺă
@
‹C”]Ç‚Ě‚P—á
‰Yě@W–ç@@ă’n@@‹M@@—с@@ŕŠw@@ˆäă@—TŽj@@‘O“c@@‹@@ź–{@ˆŰ–ž iă‘ĺj @@ś‰–@ŒłŒh i“Ż”]ŠOj
‘ć44‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1985.6.22
‘ĺă
@
ƒŒƒ`ƒmƒCƒh i“Á•Ęu‰‰j
‹gě@–M•F
‘ć@‰ń“ú”ç‰ď•Ÿ‰Ş’n•ű‰ď
1985.6.30
‹v—Ż•Ä
@
Thiopronine induced Lupus like syndrome.
•ĐŽR@ˆę˜N@@‹´–{@•‘Ľ i‘—§‘ĺăj @@ź‰Ş@@´ iă‘ĺj
‘ć270‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.7.20
‘ĺă
@
qíŤŠŁá‚ɑ΂ˇ‚銈ŤŒ^ƒrƒ^ƒ~ƒ“D‚ĚŒř‰Ę E PILOT STUDY
Ź’ˁ@—Y–Ż@@Šě‘˝–쐪•v@@‹gě@–M•F iă‘ĺj @@X–{@–ΐl@@‘吟@—˜•v@@‚–؁@Ÿ”V@@Ą’†@rŽ˘@@“’ě@Žj˜N@@ŒFŒ´@—Yˆę iŽl“ŕj
‘ć270‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.7.20
‘ĺă
@
Dysplastic nevus syndrome
’r–{@—tŽq@@Šě‘˝–쐪•v@@‹gě@–M•F@@‘O“c@@‹@@‘ĺŠp@ˆęĆ iă‘ĺj @@‰œ‘ş@—YŽi i‘ĺăŽsj
‘ć270‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1985.7.20
‘ĺă
@
Cytoskeleton of cultured human keratinocytes :Immunofluorescence study of keratin and actin and alteration by oncogenic virus and Ca++
Kitano, Y., Okada, N., Adachi, J., Sobue, K., Tazawa, T. and Ito, M.
4th US-Japan Seminar "Process in Cutaneous Epidermal Differentiation"
1985.7.24-28
Ann Arbor
@
Šá•”‘яóáv]Œă‚ĚŽ‘ąŤ_Œo’É‚É‚˝‚˘‚ˇ‚éV‚ľ‚˘ŽĄ—Ă–@|ƒCƒIƒ“ƒgƒtƒHƒŒ[ƒ[|
Ź‘ň@FD@@‰ş‘ş@‰Ăˆę@@â–{@Mˆę@@•l–ě@@F@@‘ĺ‹´@—Sˆę@@^“ç@—çŽO iă‘ĺŠá‰Čj @@”¨@´ˆę˜Y@@ź‰Ş@@´@
‘ć227‰ń‘ĺăŠá‰ČW’k‰ď
1985.9.28
‘ĺă
@
Malignant histiocytosis ‚Ě‚Q—á
ŽR‘ş@’íˆę@@ó“c@G•v@@ŽO–с@‹I•v@@‹gě@–M•F iă‘ĺj @@Âů@Ž”V i“Ż•a—j
‘ć43‰ń“ú”ç‰ď‘ĺ•Ş’n•ű‰ď
1985.9.7
‘ĺ•Ş
@
bó‘BŠŕ‚ŞŒŠ‚ç‚ę‚˝ Werner ÇŒóŒQ
˜a“cŒb’ĂŽq@@•Đ‰Ş@—tŽq@@‰Ş“c“Ţ’ĂŽq@@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj @–Ô–ě@Ms i“Ż’†ŒŸj@@
‘ć43‰ń“ú”ç‰ď‘ĺ•Ş’n•ű‰ď
1985.9.7
‘ĺ•Ş
@
ƒ}ƒ‹ƒNƒXEƒKƒ“ŒťÇ‚ɑ΂ˇ‚éŽčpŒoŒą
ˆäă@—TŽj@@—с@@ŕŠw@@‚–؁@@ł@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć10‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1985.9.8
‘q•~
@
Œűo“ŕŽîᇂɑ΂ˇ‚éForearm flap‚ĚŒoŒą
‚–؁@@ł@@‘O“c@@‹@@ˆäă@—TŽj@@ź–{@ˆŰ–ž
‘ć10‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1985.9.8
‘q•~
@
‘“ŕŠe’n‚Ĺ•Ş—Ł‚ł‚ę‚˝’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‡UŒ^ƒQƒmƒ€\‘˘‚Ě”äŠr‰đÍ
â‰Ş@@”Ž i–k‘厕×‹Űj @@ˆäŒ´@@˝ i‘ĺă•{Œö‰qŒ¤j @@”¨@´ˆę˜Y iă‘ĺj
‘ć34‰ń“ú–{ƒEƒCƒ‹ƒXŠw‰ď
1986.10.13-15
•Ÿ‰Ş
@
_ŒoüˆŰŽî×–E‚Ě”|—{-S100’`”’—zŤ×–E‚ɂ‚˘‚Ä
Šě‘˝–쐪•v@@‰Ş–ě@šŽ÷@@‰Ş“c“Ţ’ĂŽq@@’JŠ_@••F
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ǁ@ş˜a61”N“x‘ć‚P‰ń‘‰ď
1986.10.23
“Œ‹ž
@
œ‘Žî‚đ‡•š‚ľ‚˝ŠÖßÇŤŠŁá
źˆä@–F•v@@‹gě@–M•F
‘ć‚P‰ń“ú–{ŠŁáƒVƒ“ƒ|ƒWƒEƒ€
1986.10.29-30
•Ę•{
@
ŠŁá‚Ćƒrƒ^ƒ~ƒ“D
X–{@–ΐl@@L’†@—˛Žj iă‘ĺ‚S“ŕj @@‹gě@–M•F@@Ź’ˁ@—Y–Ż@@Šě‘˝–쐪•v i“Ż”畆‰Čj@@
‘ć‚P‰ń“ú–{ŠŁáƒVƒ“ƒ|ƒWƒEƒ€
1986.10.29-30
•Ę•{
@
Ä”­‚đ‚­‚č‚Š‚Ś‚ľ’ˇŠú‚ĚŒo‰ß‚đ‚Ć‚Á‚˝‘˝Œ^ŸřoŤg”Á ‚Ě‚P—á
˛–ě@žÄt@@“c‘ă@@ŽŔ@@•Đ‰Ş@—tŽq
‘ć277‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.11.15
‘ĺă
@
Pigmented fungiform papillae of the tongue ‚Ě‚P—á
a’J@‹žŽq@@‹gě@–M•F
‘ć277‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.11.15
‘ĺă
@
”畆Œ´”­ŤƒNƒŠƒvƒgƒRƒbƒNƒXÇ
‹gě@„Ži@@Ź’ˁ@—Y–Ż@@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj @@–kŽR@@“™@@‹vŽR@@ƒ@@‹ŕŽR@—Ç’j@@•Ä‘ň@@‹B i“Ż“ń“ŕj @@ŽR“c“O‘ž˜Y iŽs—§–L’†j@@
‘ć277‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.11.15
‘ĺă
@
”畆•t‘ŽŠíŽîᇂ̂P—á
ŽsŒ´@ă`Žq@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@‘O“c@@‹ iă‘ĺj
‘ć63‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1986.11.20
‘ĺă
@
Mast cell numbers in diffuse scleroderma.
Katayama, I. and Nishioka, K.
‘ć12‰ń’†‰Ř–Ż‘”畆‰Č‘‰ď
1986.11.21-23
Taipei
@
ƒnƒvƒeƒ“Œ‹‡ƒPƒ‰ƒ`ƒmƒTƒCƒg—R—ˆ•ŞŽq‚đ‘g‚ݍž‚ń‚žƒŠƒ|ƒ\[ƒ€‚É‚ć‚éÚG‰ß•qÇ‚̉đÍ
ź‰Ş@@´@@•ĐŽR@ˆę˜N@@źŽR@–Εv i–k—˘‘ĺj @@‘ęK@’żd@@Ź—с@äoŽs iă‘ĺj
‘ć16‰ń“ú–{–ƉuŠw‰ď‘‰ď
1986.12.15-17
“Œ‹ž
@
ŠŁáŠłŽŇ‚É‚¨‚Ż‚é Ca, Pi ‚Ě‘ăŽÓ
‹gě@–M•F@@Ź’ˁ@—Y–Ż@@Šě‘˝–쐪•v iă‘ĺj @@X–{@–ΐl@@‘吟@—˜•v@@L’†@—˛Žu@@ŒFŒ´@—Yˆę i“ŻŽl“ŕj
‘ć278‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.12.20
‘ĺă
@
p-Phenylene diamine ‚É‚ć‚éÚG”畆‰Š
‹gě@–M•F@@Ź’ˁ@—Y–Ż@@Îˆä@‘fŽq@@“y‹@•q–ž@@‹î‘ş@Œö”ü
‘ć11‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1986.12.6-7
‘ĺă
@
ÚGƒAƒŒƒ‹ƒQƒ“‚Ěƒf[ƒ^ƒx[ƒX
Ź’Ë—Y–Ż@@Îˆä‘fŽq@@ź“cŒ’Ž÷@@“y‹•q–ž@@‹î‘şŒö”ü@@‹gě–M•F@
‘ć11‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1986.12.6-7
‘ĺă
@
Indomethcin ‚É‚ć‚éÚG”畆‰Š
Îˆä@‘fŽq@@Ź’ˁ@—Y–Ż@@“y‹@•q–ž@@‹î‘ş@Œö”ü@@‹gě@–M•F
‘ć11‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1986.12.6-7
‘ĺă
@
ƒAƒŒƒ‹ƒM[ŤŒűO‰Š‚Ě‚S—á
“Ą–{@Œ\ˆę@@‹´–{@˝ˆę iZ—Fj @@Ź’ˁ@—Y–Ż@@‹gě@–M•F iă‘ĺj
‘ć11‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1986.12.6-7
‘ĺă
@
üˆŰ‰č×–E‚É‚ć‚éƒRƒ‰ƒQƒi[ƒ[ŽYś‚É‚¨‚Ć‚Ú‚ˇ•¨—“IŽhŒƒ‚̉e‹ż
Ź—с@äoŽs@@ź‰Ş@@´@@‘ęK@’żd@@‹gě@–M•F
ŒúśČ‹H­“ŤŽžŠł’˛¸Œ¤‹†”Ç ş˜a60”N“x‘ć‚Q‰ń‰ď‹c
1986.2.1
‹v—Ż•Ä
@
Angiosarcoma ‚Ě‚P—á
źˆä@–F•v@@’r–ě@@G@@‘q“c‘s‘ž˜Y@@‘O“c@@‹@@“c‘ă@@ŽŔ@@Ź’ˁ@—Y–Ż@@ŽR‘ş@’íˆę@@‹gě@–M•F@@
‘ć273‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.2.15
‘ĺă
@
Scleromyxoedema ‚Ě‚P—á
“ěŒű@—mŽq@@źˆä@–F•v@@Ź’ˁ@—Y–Ż@@ŽR‘ş@’íˆę@@‹gě@–M•F
‘ć273‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.2.15
‘ĺă
@
ƒTƒ‹ƒRƒCƒh•a•Ď‚đ”F‚ß‚˝ƒVƒF[ƒOƒŒƒ“ÇŒňŒQ‚Ě‚P—á
•ĐŽR@ˆę˜N@@ŒĂě”ü‹IŽq@@ŽR‰ş@‹IŽq@@ůˆä@ŒhŽq@@‹´–{@•‘Ľ i‘—§‘ĺăj@@˛–ě@žÄt iă‘ĺj
‘ć273‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.2.15
‘ĺă
@
ˆŤŤ_ŒoüˆŰŽî‚Ě‚Q—á
Œ‡“c@—ÇŽ™@@ă“c@´—˛@@Šě‘˝–쐪•v iă‘ĺj @@“ŕ“Ą@”üŽq@@ě’Á@’qĽ i‘ĺă’üM•a‰@j@
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ǁ@ş˜a60”N“x‘ć‚Q‰ń‘‰ď
1986.2.27
“Œ‹ž
@
R–ŃƒPƒ‰ƒ`ƒ“Eƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě HKN-6‚̔畆ƒAƒ~ƒƒCƒh•¨Žż‚ɑ΂ˇ‚é”˝‰ž
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq iă‘ĺj @@“c‘ň@•q’j@@ˆÉ“Ą@‰ëÍ
•ś•”Č‰ČŠwŒ¤‹†”Ç iAj ”畆ƒAƒ~ƒƒCƒh[ƒVƒX‚Ě•aˆöC •a‘Ô‚Ć‘SgŤƒAƒ~ƒƒCƒh[ƒVƒX‚Ć‚ĚŠÖ˜A‚ÉŠÖ‚ˇ‚錤‹†@ş˜a60”N“x”ljď‹c
1986.2.8-9
–źŒĂ‰Ž
@
ŠO‰A•”Paget•a‚ĚŽĄ—ĂŒoŒą
‰Yě@W–ç@@ă’n@@‹M@@ˆäă@—TŽj@@ź’J@–ÎŽ÷@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć27‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď–k—¤’n•ű‰ď
1986.3.2
‹ŕ‘ň
@
A case of pigmented contact dermatitis from impurities in commercial propyrene glycol monostearate.
Fujimoto, K., Kozuka, T., Yoshikawa, K., and Hashimoto, S.
8th International Symposium on Contact Dermatitis.
1986.3.20-22
Cambridge
@
A case of allergic contact dermatitis to ricinoleic acid in caster oil.
Kozuka, T., Doi, T., Kataoka, Y. and Yoshikawa, K.
8th International Symposium on Contact Dermatitis.
1986.3.20-22
Cambridge
@
Human papilloma virus iHPVj 38Œ^‚Ş•Ş—Ł‚ł‚ę‚˝ánćҏó•\”ç”­ˆçˆŮíÇ iEVj ‚Ě‚P—á
Œ‡“c@—ÇŽ™@@’JŠ_@••F@@Šě‘˝–쐪•v iă‘ĺj @@“’’Ę“°–žŽő’j@@‰H‘q@@–ž i”÷Œ¤j
‘ć274‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.3.22
‘ĺă
@
Sjogren ÇŒňŒQ‚𔺂Á‚˝’jŽq SLE Ç—á‚Ě‚P—á
•ĐŽR@ˆę˜N@@ă“c”ü‹IŽq@@ŽR‰ş@‹IŽq@@ůˆä@ŒhŽq@@‹´–{@•‘Ľ i‘—§‘ĺăj@ ˛–ě@žÄt iă‘ĺj
‘ć274‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.3.22
‘ĺă
@
Giant cell tumor of tendon sheath ‚Ě‚Q—á
˜a“cŒb’ĂŽq@@‘O“c@@‹@@ź‰Ş@@´ iă‘ĺj @@‹gě@Í•F iˆď–ŘŽsj @X@@Šě‹I i_|j@@
‘ć274‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.3.22
‘ĺă
@
Forearm Flap‚É‚ć‚éă‘S“EŒăC ÄŒš‚Ěˆę—á
ă’n@@‹M@@‘q“c‘‘‘ž˜Y@@ˆäă@—TŽj@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć46‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1986.3.22
ź]
@
O—ô—ô‰‚Ě‘gDŠw“IŒŸ“˘
‘q“c‘‘‘ž˜Y@@ź–{@ˆŰ–ž@@‘O“c@@‹@@ˆäă@—TŽj@@ă’n@@‹M@@ź’J@–ÎŽ÷ iă‘ĺj @@‘ĺŒ´@‹`—Y@@™“c@ˆę”V@@‘ĺŠp@ˆęĆ i•şŒÉŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć46‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1986.3.22
ź]
@
”|—{•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚éƒrƒ^ƒ~ƒ“AŒ‹‡’`”’
‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć‚P‰ń•\”ç×–EŒ¤‹†‰ď
1986.4.12-13
” Ş
@
Cutaneous B cell lymphoma ‚Ě‚P—á
“y‹•q–ž@@‘S@–ž@@ź“cŒ’Ž÷@@ŽR‘ş’íˆę@@Ź’Ë—Y–Ż@@‹gě–M•F
‘ć79‰ń‹ß‹EW’k‰ď
1986.4.20
‘ĺă
@
œ‘‘BŤŽžŠł‚ɍ‡•š‚ľ‚˝áy]—l‹u]‚Ě‚P—á
˜a“cŒb’ĂŽq@@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj @@•Đ‹Ë@Cˆę i“Ż“ń“ŕj
‘ć79‰ń‹ß‹EW’k‰ď
1986.4.20
‘ĺă
@
‰AŒsánć҂̗Տ°‘œ
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Šě‘˝–쐪•v@@‹gě@–M•F@@‰H‘q@@–ž@@“’’Ę“°–žŽő•v@@‹´–{@˝ˆę
‘ć‚Q‰ńl“ű“ŞŽîƒEƒCƒ‹ƒXŒ¤‹†‰ď
1986.5.15
@
@
ánćҏó•\”ç”­ˆçˆŮíÇ iEVj ‚̉uŠw
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Šě‘˝–쐪•v@@‹gě@–M•F@@‰H‘q@@–ž@@“’’Ę“°–žŽő•v@@‹´–{@˝ˆę
‘ć‚Q‰ńl“ű“ŞŽîƒEƒCƒ‹ƒXŒ¤‹†‰ď
1986.5.15
@
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚Ě”ç]Œ`‘Ô‚Ćƒqƒgƒpƒsƒ[ƒ}ƒEƒCƒ‹ƒX‚Ěƒ^ƒCƒv
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Šě‘˝–쐪•v@@‹gě@–M•F@@‰H‘q@@–ž@@“’’Ę“°–žŽő•v@@
‘ć‚Q‰ńl“ű“ŞŽîƒEƒCƒ‹ƒXŒ¤‹†‰ď
1986.5.15
@
@
”|—{•\”ç×–E‚É‚¨‚Ż‚éƒrƒ^ƒ~ƒ“AŒ‹‡’`”’
‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć85‰ń“ú”ç‰ď‘‰ď
1986.5.16-18
‹ž“s
@
ƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚éƒAƒNƒ`ƒ“×üˆŰ‚Ě“Ž‘Ô
Šě‘˝–쐪•v@@‘Ť—§@@€@@‰Ş“c“Ţ’ĂŽq
‘ć85‰ń“ú”ç‰ď‘‰ď
1986.5.16-18
‹ž“s
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚Ě“Ż–E—á iƒEƒCƒ‹ƒXŠw“IŒ¤‹†j
Œ‡“c@—ÇŽ™@@’JŠ_@••F@@Šě‘˝–쐪•v@@‹gě@–M•F iă‘ĺj @@“’‰ß“°–žŽő’j@@‰H‘q@@–ž i”÷Œ¤j@
‘ć85‰ń“ú”ç‰ď‘‰ď
1986.5.16-18
‹ž“s
@
‹­”çÇŠłŽŇŒŒ´’†‚̐üˆŰ‰č×–EŠˆŤ‰ťˆöŽq‚ĚŒŸ“˘
Ź—с@äoŽs@@ź‰Ş@@´
‘ć85‰ń“ú”ç‰ď‘‰ď
1986.5.16-18
‹ž“s
@
”Ä”­Ť‹­”çÇ‚É‚¨‚Ż‚é”ě–ž×–E‚Ě“Ž‘Ô
‘ęK@’żd@@ź‰Ş@@´@@Ź—с@äoŽs@@•ĐŽR@ˆę˜N
‘ć85‰ń“ú”ç‰ď‘‰ď
1986.5.16-18
‹ž“s
@
”­Ç58“úŒă‚ɃEƒCƒ‹ƒX‚đ•Ş—Ł‚ľ“ž‚˝Ä”­Ť”Ä”­Ť‘яóáv]
”¨@´ˆę˜Y iă‘ĺj @@‹Ę’u@r’u i“ń“ŕj
‘ć85‰ń“ú”ç‰ď‘‰ď
1986.5.16-18
‹ž“s
@
ƒfƒXƒ‚ƒ][ƒ€‚¨‚ć‚ŃƒPƒ‰ƒ`ƒ“‚Ě Ca++|ƒJƒ‹ƒ‚ƒWƒ…ƒŠƒ“ˆË‘śŤƒŠƒ“Ž_‰ť
‹gě@–M•F@@–ě‘ş@­•v iă‘ĺj @@‘c•ƒ]Œ›ŽĄ i“Żś‰ťj
‘ć33‰ń“ú–{ś‰ťŠw‰ď‹ß‹EŽx•”—á‰ď
1986.5.30
‹ž“s
@
ƒtƒBƒuƒŠƒ“ŒĐ‚ĆPEG4000‚đ—p‚˘‚˝”÷ŹŒŒŠÇ•Ť‡‚ĚŽŽ‚Ý
ă’n@@‹M@@ˆäă@—TŽj@@‘O“c@@‹@@ź–{@ˆŰ–ž@@ź‰Ş@@´
‘ć29‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1986.6.14
ŽD–y
@
“ŞŒz•”—ĚˆćÄŒš‚É‚¨‚Ż‚é—LŒs‹Ř”ç•Ů‚Ć—V—Ł”ç•ŮE‹Ř”ç•Ů‚Ě”äŠr
‘O“c@@‹@@ź’J@–ÎŽ÷@@ă’n@@‹M@@—с@@ŕŠw@@‰Yě@W–ç@@ź–{@ˆŰ–ž iă‘ĺj @@‹g“c@~ˆę@@˛X–Ř—Ç“ń i“ŻŽ¨•@‰Čj
‘ć29‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1986.6.14
ŽD–y
@
Plasminogen activator synthesis by P815 mastocytoma cells.
Katayama, I., Nishioka, K., Hashimoto, K. and Yokozeki, H.
5th Joint Meeting of the European Society for Dermatological Research and the Society for Investigative Dermatology
1986.6.22-25
Geneva
@
Fibroblast activating factors in scleroderma sera.
Kobayashi, Y., Katayama, I. and Nishioka, K.
5th Joint Meeting of the European Society for Dermatological Research and the Society for Investigative Dermatology
1986.6.22-25
Geneva
@
Lymphocyte stimulation by liposomes with molecules from haptenated PAM cells.
Nishioka, K., Katayama, I., Kobayashi, Y. and Takijiri, C.
5th Joint Meeting of the European Society for Dermatological Research and the Society for Investigative Dermatology
1986.6.22-25
Geneva
@
Cellular retinoic-acid-binding proteins in cultured human epidermal keratinocytes
Okada, N., Kitano, Y. and Yoshikawa, K.
5th Joint Meeting of the European Society for Dermatological Research and the Society for Investigative Dermatology
1986.6.22-25
Geneva
@
Fiberglass dermatitis
Ź’ˁ@—Y–Ż
‘ć275‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.7.12
•şŒÉˆă‘ĺ
@
œ‘Žî‚đ•š”­‚ľ‚˝ŠÖßÇŤŠŁá‚Ě‚P—á
źˆä@–F•v@@˜a“cŒb’ĂŽq@@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj @@“n•Ó@L–ž@@‚Î@Œ’Ži@@‹vŽR@@ƒ@@•Đ‹Ë@Cˆę i“Ż“ń“ŕj@
‘ć275‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.7.12
•şŒÉˆă‘ĺ
@
Treatment of psoriasis with vitamin D.
Yoshikawa, K., Kozuka, T., Kitano, Y., Morimoto, S., Ohnishi, T. and Kumahara, Y.
4th International Symposium on Psoriasis
1986.7.6-11
Stanford
@
Epidemiologic aspects of epidermodysplasia verruciformis iL-L, 1922j in Japan : Clinical observation, virological studies in eleven patients with epidermodysplasia verruciformis.
Tanigaki, T., Kanda, R., Yoshikawa, K., Kitano, Y., Yutsudo, M. and Hakura, A.
5th International Workshop of Papilloma Viruses
1986.9.
Cold Spring
@
Epidermodysplasia verruciformis in Japan : Characterization of the lesions and risk of widespread conversion in relation to the types of human papilloma virus involved.
Tanigaki, T., Kanda, R., Yoshikawa, K., Kitano, Y., Yutsudo, M. and Hakura, A.
5th International Workshop of Papilloma Viruses
1986.9.
Cold Spring
@
ƒAƒŒƒ‹ƒM[ŽžŠł‚̐f’fC ŽĄ—Â̐i•ŕFƒAƒŒƒ‹ƒM[ŤÚG”畆‰Š‚Ě—Ő° iľ‘ҍu‰‰j
‹gě@–M•F
“ú–{ŽY‹Ć‰qśŠw‰ďE‹ĆŤƒAƒŒƒ‹ƒM[Œ¤‹†‰ď
1986.9.13
–źŒĂ‰Ž
@
“űŽ™S‘ŸŽčpŒă‚Ě‹š•ÇŒ‡‘š‚ɑ΂ˇ‚é• ’ź‹Ř•Ů‚ĚŒoŒą
–k‹g@@Œő@@‰H”’@@˝@@ź’J@–ÎŽ÷@@ă’n@@‹M@@‘O“c@@‹@@ź–{@ˆŰ–ž iă‘ĺj @@ź“c@@ô@@•“ŕ@KN i“Ż‚PŠOj
‘ć47‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1986.9.20
“Ţ—Ç
@
“Ş•”ƒGƒbƒNƒŠƒ“Šž‘BŠŕ‚Ě‚P—á
Š_•Ł@ł’j@@âˆä@–ő•v@@‰Yě@W–ç@@ă’n@@‹M@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć47‰ń“ú–{ŹŒ`ŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1986.9.20
“Ţ—Ç
@
Toxic epidermal necrolysis ‚Ě‚Q—á
‰Ş–ě@šŽ÷@@Šě‘˝–쐪•v
‘ć37‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1986.9.27-28
•xŽR
@
ƒqƒXƒ^ƒ~ƒ“‚¨‚ć‚Ń‚ť‚Ě‘ăŽÓ•¨‚Ě’č—Ę i‘ć‚P•ńj |GC-MS ‚É‚ć‚é”A’†ƒCƒ~ƒ_ƒ][ƒ‹|Ž_‚Ě’č—Ę–@|
“y‹@•q–ž@@Ź’ˁ@—Y–Ż@@Îˆä@‘fŽq@@‹gě@–M•F
‘ć37‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1986.9.27-28
•xŽR
@
ATLL ‚Ě‚P—á
Šp@—˛”V@@ŽR“c@ł”V@@‰Ş“c“Ţ’ĂŽq@@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj@@•Đ‹Ë@Cˆę i“Ż“ń“ŕj @@
‘ć37‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1986.9.27-28
•xŽR
@
‰EŽ¨‰î‚É’P”­‚ľ‚˝ Iymphoma ‚Ě‚P—á
‰Ş–ě@šŽ÷@@‰Ş“c“Ţ’ĂŽq@@ŽR‘ş@’íˆę@@Šě‘˝–쐪•v
‘ć276‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.9.6
‘ĺă
@
‰Šú‚É MCTD ‚Ě•a‘œ‚đ’ć‚ľ‚˝ SLE ‚Ě‚P—á
“Ą’J@—TŽq@@źˆä@–F•v@@ˆäă@—TŽj@@Šě‘˝–쐪•v
‘ć276‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1986.9.6
‘ĺă
@
ƒqƒgƒpƒsƒ[ƒ}ƒEƒCƒ‹ƒX‚ĆŠŕ
‰H‘q@@–ž@@“’’Ę“°–žŽő•v@@’JŠ_@••F
‘ć22‰ń“ú–{ˆăŠw‰ď‘‰ďƒVƒ“ƒ|ƒWƒEƒ€
1987
@
@
_ŒoüˆŰŽî×–E‚Ě”|—{‚É‚¨‚Ż‚é S-100’`”’—zŤ×–E‚Ě“Ž‘ԁ|NGF ‚ĚŒř‰Ę‚ɂ‚˘‚ā|
Šě‘˝–쐪•v@@Žç‰Ž@–MŽq
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ǁ@ş˜a62”N“x‘ć‚P‰ń‘‰ď
1987.10.22
“Œ‹ž
@
Psoriasis and active forms of vitamin D.
Morimoto, S., Yoshikawa, K., Hironaka, T., Shiraishi, T., Itoh, K., Kozuka, T., Fukuo, K., Imanaka, S., Ohnishi, T. and Kumahara, Y.
5th Asian Congress of Nutrition
1987.10.26-29
Osaka
@
‘BŤ“Vávጂ̂P—á
‰““Ą@@ŒO@@ě“ŕ @•×@@’JŠ_@••F@@‹gě@–M•F
‘ć38‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1987.10.31-11.1
˜a‰ĚŽR
@
•\”ç×–E‚Ě×–EŽüŠú‚ɑ΂ˇ‚éƒrƒ^ƒ~ƒ“D‚̉e‹ż
’r“c@‹I˜a@@Šě‘˝–쐪•v
‘ć38‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1987.10.31-11.1
˜a‰ĚŽR
@
ƒTƒŠƒ`ƒ‹ƒAƒ~ƒh‚É‚ć‚éŒĹ’č–ň]‚Ě‚P—á
“y‹@•q–ž@@Ź’ˁ@—Y–Ż@@‹gě@–M•F
‘ć38‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1987.10.31-11.1
˜a‰ĚŽR
@
L”ÍˆÍ‚É”ç‰şÎŠD’ž’…‚đ”F‚ß‚˝ SLE ‚Ě‚P—á
“Ą’J@—TŽq@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj @@‰Ş“c@‘SŽi i“ŻŽO“ŕj
‘ć38‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1987.10.31-11.1
˜a‰ĚŽR
@
Proliferating trichilemmal tumor‚Ě‚Q—á
‹vŽu–{@“Œ@@‚“c@ÍD@@’r–ě@@G@@“cŠ@äŽk i‘ĺăŒxŽ@Œ`Źj
‘ć49‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1987.11.14
‰ŞŽR
@
—V—Ł• ’ź‹Ř”ç•Ů‚É‚ć‚é“ŞŒz•”Šŕ‚ĚÄŒš
ŠC˜VŒ´–­Žq@@‘O“c@@‹@@“Ąě@š˜a@@Š_•Ł@ł’j
‘ć49‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1987.11.14
‰ŞŽR
@
“–‰Č‚É‚¨‚Ż‚é‰ß‹Ž10”NŠÔ‚ĚˆŤŤ•FŽî‚Ě“Œv“IŠĎŽ@
“cŒ´@—RŽq@@ź–{@ˆŰ–ž@@ź’J@–ÎŽ÷@@ź‰ş@“N–ç
‘ć49‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1987.11.14
‰ŞŽR
@
Medial Plantar flap‚̉ž—p
“Ąě@š˜a@@ź–{@ˆŰ–ž@@‘O“c@@‹@@–k‹g@@Œő
‘ć49‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1987.11.14
‰ŞŽR
@
Malignant Melanoma
“cŠ@äŽk@@‹vŽu–{@“Œ@@‚“c@ÍD@@’r–ě@@G i‘ĺăŒxŽ@Œ`Źj
‘ć70‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1987.11.26
‘ĺă
@
ƒ}ƒEƒX”畆‚É‚¨‚Ż‚é”ě–ž×–E‘O‹ě×–E
‰€“c@‘•c iă‘ĺj @@–k‘ş@K•F iŠŕŒ¤j
‘ć284‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.12.12
“Ţ—Ç
@
”|—{•\”ç×–E‚É‚ć‚é Proezyme Œ^ Urokinase ‚ĚŽYś
‹´–{@Œö“ń
‘ć284‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.12.12
“Ţ—Ç
@
ƒ`ƒbƒN‚É‚ć‚éÚG”畆‰Š‚Ě‚Q—á
‹î‘ş@Œö”ü@@Ź’ˁ@—Y–Ż@@Îˆä@‘fŽq@@‹gě@–M•F@@
‘ć12‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1987.12.5-6
‘ĺă
@
ƒWƒCƒ\ƒvƒƒpƒm[ƒ‹ƒAƒ~ƒ“‚É‚ć‚éÚG”畆‰Š
“Ą–{@Œ\ˆę@@‹´–{@˝ˆę iZ—Fj @@Ź’ˁ@—Y–Ż@@‹gě@–M•F iă‘ĺj
‘ć12‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1987.12.5-6
‘ĺă
@
“Ş’¸•”‚É”­ś‚ľ‚˝ŠďŒ`Žî‚Ě‚P—á
ź‰ş@“N–ç@@‹vŽu–{@“Œ@@‚“c@ÍD@@’r–ě@@G i‘ĺăŒxŽ@Œ`Źj
‘ć13‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1987.2.1
‚ź
@
‹}‘Ź‚ČŽî’Ł‚đ‚Ť‚˝‚ľ‚˝śăŠááَîᎂ̂P—á
—с@@ŕŠw@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć13‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1987.2.1
‚ź
@
“Ş•”‹‘ĺŽîᎁECellular blue nevus ‚Ě‚P—á
âˆä@–ő•v@@‘O“c@@‹@@ă’n@@‹M@@ź–{@ˆŰ–ž@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć279‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.2.14
‘ĺă
@
DŽ_‹…‚đŹ‚ś‚˝‘˝”­Ť–Ń”X‰Š‚Ě‚P—á
‘ęK@’żd@@‘Ť—§@@€@@Ź“ˆ@‰vŽq@@Â–؁@•q”V i•{—§‰H‰g–ěj@@‰Ş“c“Ţ’ĂŽq iă‘ĺj @@
‘ć279‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.2.14
‘ĺă
@
“Ş•”‹‘ĺŽîᎁ|Cellular blue nevus‚Ě‚P—á
âˆä@–ő•v@@‘O“c@@‹@@ă’n@@‹M@@ź–{@ˆŰ–ž iă‘ĺj@@Šě‘˝–쐪•v@@‹gě@–M•F i“Ż”畆j
‘ć279“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1987.2.14
‘ĺă
@
F‘fŤŠŁ”çÇ‚É‚¨‚Ż‚é_ŒoÇó‚ɂ‚˘‚Ä
ŽO–q@FŽŠ iă‘召Ž™j @@Šě‘˝–쐪•v iă‘ĺj
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ǁ@ş˜a61”N“x‘ć‚Q‰ń‘‰ď
1987.2.26
“Œ‹ž
@
The method of reconstruction in microtia, focosed on chonchal creation
MatsumotoC K.
IX International congress for plastic and reconstructive surgery
1987.3
New Deli
@
CTCL ‚Ě‚PÇ—á
ě“ŕ@@•×@@‰Ş“c“Ţ’ĂŽq@@Ź—с@äoŽs@@Œ‡“c@—ÇŽ™@@‹gě@–M•F
‘ć280‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.3.14
‘ĺă
@
”ěŒúŤá­‚ĚŽĄ—Á|ˆŸ‰”ŠÜ—Lƒe[ƒv‚Ě—LŒřŤ|
‰Yě@W–ç@@Š_•Ł@ł’j@@ź’J@–ÎŽ÷@@ă’n@@‹M@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć29‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď–k—¤’n•ű‰ď
1987.3.14
‹ŕ‘ň
@
‘O˜r”ç•Ů40—á‚ĚŒoŒą
–k‹g@@Œő@@âˆä@–ő•v@@‰Yě@W–ç@@ă’n@@‹M@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć29‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď–k—¤’n•ű‰ď
1987.3.14
‹ŕ‘ň
@
ˆŤŤ‰ť‚đ‹^‚Á‚˝F‘fŤ•ę”Á‚Ě‚R—á
ŽsŒ´@ă`Žq@@”¨@´ˆę˜Y@@ˆüŽR@—şŽs i‘ĺă˜JĐj @@‘O“c@@‹ iă‘ĺj
‘ć66‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1987.3.26
‘ĺă
@
SLE ŠłŽŇ‚É”­ś‚ľ‚˝ calcifying brusitis ‚Ě‚P—á
‰H”’@@˝@@‘O“c@@‹@@Ź—с@äoŽs@@‹gě@–M•F
‘ć86‰ń“ú”ç‰ď‘‰ď
1987.4.10-12
‰Ą•l
@
ƒrƒ^ƒ~ƒ“A—މ‰ť‡•¨@E-5166‚Ě”|—{•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě•Ş‰ť‚É‹y‚Ú‚ˇ‰e‹ż
‰Ş“c“Ţ’ĂŽq@@’r“c@‹I˜a@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć86‰ń“ú”ç‰ď‘‰ď
1987.4.10-12
‰Ą•l
@
True Histiocytic lymphoma ‚É‚¨‚Ż‚錌´’†–Ɖu—}§’`”’ iIAPj ‚ĚŒŸoˆÓ‹`
ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj @@’Ň‘ş”ü•äŽq i‘ĺŽč‘Oj @@Âů@Ž”V iă‘ĺ•a—j
‘ć86‰ń“ú”ç‰ď‘‰ď
1987.4.10-12
‰Ą•l
@
DŽ_‹…ŤŠC–ȏó‘Ԃ𔺂Á‚˝…ávÇ‚Ě‚P—á
Žç‰Ž@–MŽq@@‘ęK@’żd@@Ź—с@äoŽs@@Šě‘˝–쐪•v
‘ć86‰ń“ú”ç‰ď‘‰ď
1987.4.10-12
‰Ą•l
@
ŠO‰A•” paget •a‚ĚŽĄ—ĂŒoŒą
‘O“c@@‹@@‰H”’@@˝@@Ź—с@äoŽs@@‹gě@–M•F
‘ć86‰ń“ú”ç‰ď‘‰ď
1987.4.10-12
‰Ą•l
@
––Šú‚É‹}ŤœŤ”’ŒŒ•a‚đ‡•š‚ľ‚˝ Histiocytic Panniculitis ‚Ě‚P—á
“ĄŒ´@ě•˝@@”ÂŒŠ@@’q@@•“c@^b@@ź‰i@‰xŽĄ@@VŠC@@Ÿą@@‚ˆŔ@@i i‘ĺ•Şˆă‘ĺj @@×ě@—˛•ś@@HŒŽ^ˆę˜Y@@ŽR‘ş@’íˆę iă‘ĺj@@X@@–ΘY@
‘ć86‰ń“ú”ç‰ď‘‰ď
1987.4.10-12
‰Ą•l
@
Œ´”­Ť”畆ƒNƒŠƒvƒgƒRƒbƒNƒXÇ
‹gě@„Ži@@Ź’ˁ@—Y–Ż@@Ź—с@äoŽs@@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj@@–kŽR@@“™@@‹vŽR@@ƒ@@‹ŕŽR@—Ç’j@@•Ä‘ň@@‹B@@‚ˆä´ˆę˜N i“Ż“ń“ŕj@@ŽR“c“O‘ž˜Y iŽs—§–L’†j @@
‘ć86‰ń“ú”ç‰ď‘‰ď @@
1987.4.10-12
‰Ą•l
@
ánćҏó•\”ç”­ˆçˆŮíÇ12—á‚Ě—Ő°‘œ‚Ć human papillomavirus ‚Ć‚ĚŠÖŒW
Œ‡“c@—ÇŽ™@@’JŠ_@••F@@Šě‘˝–쐪•v@@‹gě@–M•F iă‘ĺj @@“’’Ę“°–žŽő’j@@‰H‘q@@–ž i“Ż”÷Œ¤j@@
‘ć86‰ń“ú”ç‰ď‘‰ď
1987.4.10-12
‰Ą•l
@
Œ‹ßŤg”Á—l”ç]‚ސś‚ś‚˝ˆŤŤƒŠƒ“ƒpŽî
‘ž“c@ƒŽq@@‹ŕ@@˜aŽq@@‚–؁@Œ\ˆę@@ě’Á@’qĽ i‘ĺă’üMj @™“c‚Š‚¨‚é i“Ż“ŕ‰Čj @@ŽR‘ş@’íˆę iă‘ĺj@@
‘ć86‰ń“ú”ç‰ď‘‰ď
1987.4.10-12
‰Ą•l
@
“Ťánć҂ɂ‚˘‚Ä
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Šě‘˝–쐪•v@@‹gě@–M•F@@”¨@´ˆę˜Y@@‰H‘q@@–ž@@“’’Ę“°@–žŽő•v@@‹´–{@˝ˆę
‘ć‚R‰ńl“ű“ŞŽîƒEƒCƒ‹ƒXŒ¤‹†‰ď
1987.4.12
@
@
ánć҂Ɣ­Šŕ
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Šě‘˝–쐪•v@@‹gě@–M•F@@”¨@´ˆę˜Y@@‰H‘q@@–ž@@“’’Ę“°–žŽő•v@@‹´–{@˝ˆę
‘ć‚R‰ńl“ű“ŞŽîƒEƒCƒ‹ƒXŒ¤‹†‰ď
1987.4.12
@
@
ánćҏó•\”ç”­ˆçˆŮíÇ iEVj ‚̐f’f
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Šě‘˝–쐪•v@@‹gě@–M•F@@”¨@´ˆę˜Y@@‰H‘q@@–ž@@“’’Ę“°–žŽő•v@@‹´–{@˝ˆę
‘ć‚R‰ńl“ű“ŞŽîƒEƒCƒ‹ƒXŒ¤‹†‰ď
1987.4.12
@
@
Ž¨‰îŠO‚̏C•œŒoŒą
‚“c@ÍD@@‹vŽu–{@“Œ@@’r–ě@@G@@ź‰ş@“N–ç i‘ĺăŒxŽ@Œ`Źj
‘ć30‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1987.4.16
“Œ‹ž
@
Šá—Ö‹Ř”ç•Ů‚̏ŹŒoŒą
ă’n@@‹M@@‰Yě@W–ç@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć30‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1987.4.17
“Œ‹ž
@
Beckwith WiedemannÇŒóŒQ‚Ě‚R—á
ˆäă@—TŽj@@—с@@ŕŠw@@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć30‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1987.4.18
“Œ‹ž
@
”|—{üˆŰ‰č×–E‚ĚƒRƒ‰ƒQƒi[ƒ[ŽYś‚ɑ΂ˇ‚鈟‰””Z“x‚̉e‹ż
ă’n@@‹M@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć30‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1987.4.18
“Œ‹ž
@
”畆ŠÇ‚É‚ć‚é‹š•”H“š‚ĚÄŒš
‘O“c@@‹@@ă’n@@‹M@@ź–{@ˆŰ–ž iă‘ĺj@@’J@@–ő•F i‘—§—Ă—{Šˆ¤•Q•a‰@ŠO‰Čj
‘ć30‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1987.4.18
“Œ‹ž
@
Eosinophilic spongiosis ‚ĚŒŠ‚ç‚ę‚˝…ávÇ‚Ě‚P—á
”ö‰Ô@rě@@“y‹@•q–ž@@Ź’ˁ@—Y–Ż@@Â–؁@–M•v@@Šě‘˝–쐪•v@@‹gě@–M•F@
‘ć281‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.5.16
˜a‰ĚŽRˆă‘ĺ
@
Successful treatment of cutaneous B-cell lymmphoma with local injection of interferon-gamma and hyperthermia.
Doi, T., Yamamura, T., Kozuka, T. and Yoshikawa, K.
17th World Congress of Dermatology
1987.5.24-29
W.Berlin
@
Effects of 1,25-dihydroxyvitamin D3 and dexamethasone on cell proliferation of psoriatic fibroblasts.
Hironaka, T., Morimoto, S., Yoshikawa, K., Shiraishi, T. and Kumahara, Y.
17th World Congress of Dermatology
1987.5.24-29
W.Berlin
@
Growth of human keratinocytes in defined medium supplemented with growth factor of serum.
Kitano, Y., Okada, N., Okano, M. and Sasai, S.
17th World Congress of Dermatology
1987.5.24-29
W.Berlin
@
Psoriasis responded to 1-alpha-OH-vitamin D3 treatment.
Kozuka, T., Yoshikawa, K. and Morimoto, S.
17th World Congress of Dermatology
1987.5.24-29
W.Berlin
@
Inverse relation between severity of psoriasis and serum 1,25-dihydroxyvitamin D level. iBest Clinical Reserch Poster Award ŽóÜj
Morimoto, S., Yoshikawa, K., Kozuka, T., Hironaka, T. and Kumahara, Y.
17th World Congress of Dermatology
1987.5.24-29
W.Berlin
@
Ca++-calmodulin dependent phosphorylation of desmosome and keratin
Nomura, M., Yoshikawa, K. and Sobue, K.
17th World Congress of Dermatology
1987.5.24-29
W.Berlin
@
Toxic epidermal necrolysis due to cephem antibiotic.
Okano, M., Kitano, Y. and Ohzono, K.
17th World Congress of Dermatology
1987.5.24-29
W.Berlin
@
Comparison of clinical features of X-linked ichthyosis and ichthyosis vulgaris by measuring steroid sulphatase activity.
Okano, M., Okada, N. and Kitano, Y.
17th World Congress of Dermatology
1987.5.24-29
W.Berlin
@
A case with atypical angioendothelial hyperplasia.
Yoshikawa, K., Minamiguchi, Y. and Yamamura, T.
17th World Congress of Dermatology
1987.5.24-29
W.Berlin
@
SSA/Ro antigen expression in SV40-transformed keratinocytes
Miyagawa, S., Okada, N., Kitano, Y., Sakamoto, K., Steinberg, M.L.
49th Annual Meeting of the Society for Investigative Dermatology
1987.5.3-6
San Diego
@
Unusual cases with cutaneous lymphoma.
Okano, M.
International Congress of Malignant Lymphoma
1987.6.
Lugano
@
—V—Ł‘O˜r”ç•Ů‚É‚ć‚鉺ˆô“ށEH“š‚ĚÄŒš
âˆä@–ő•v@@‰Yě@W–ç@@“Ąě@š˜a@@‘O“c@@‹
‘ć48‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1987.6.13
‘ĺă
@
‹tsŤŒăœŠÔ”ç•Ů‚ĚŒoŒą
“Ąě@š˜a@@‘O“c@@‹ iă‘ĺj @@ŠÖŒű@‡•ă@@Ź—ѐ˝ˆę˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć48‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1987.6.13
‘ĺă
@
BCC‚ĚŽĄ—ĂŒoŒą i‰ß‹Ž10”NŠÔj
–k‹g@@Œő@@Š_•Ł@ł’j@@ź’J@–ÎŽ÷@@ź–{@ˆŰ–ž
‘ć48‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1987.6.13
‘ĺă
@
Two cases of epidermodysplasia verruciformisiLew-Lutz,1922j with skin cancer: Carcinogenetic process.
Tanigaki, T., Kanda, R., Yoshikawa, K., Yutsudo, M and Hakura, A.
6th International Workshop of Papilloma Viruses
1987.6.14-18
Washington DC
@
Sweet •a‚Ě‚Q—á
‹gě@„Ži@@’JŠ_@••F iă‘ĺj @@“Ą–{@Œ\ˆę@@‹´–{@˝ˆę iZ—Fj
‘ć80‰ń‹ß‹EW’k‰ď
1987.6.21
‘ĺă
@
”畆Œ´”­ŤˆŤŤŽîᇂ̓Œv‚ĆÄ”­—á‚RÇ—á
ŽsŒ´@ă`Žq@@ˆüŽR@—şŽs@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@‘O“c@@‹@@‰Yě@W–ç iă‘ĺj@
‘ć80‰ń‹ß‹EW’k‰ď
1987.6.21
‘ĺă
@
Cutaneous B cell Lymphoma ‚Ěˆę—á
ŽR‘ş@’íˆę@@“y‹@•q–ž@@Œ‡“c@—ÇŽ™@@‹gě@–M•F@
‘ć‚U‰ń”畆ƒŠƒ“ƒz[ƒ}Œ¤‹†‰ď
1987.7.11-12
‹{č
@
ˆŤŤ‰~’ŒŽî‚Ě‚P—á
Š_•Ł@ł’j@@‘O“c@@‹@@ŽR‘ş@’íˆę@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć282‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.7.18
_ŒË
@
—ź‘¤“űŠŕpŒă‚É—źŽčŽw‚É‘˝”­‚ľ‚˝”S‰t”XŽî‚Ě‚P—á
Š_•Ł@ł’j@@“Ąě@š˜a@@‘O“c@@‹@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć282‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.7.18
_ŒË
@
A case of pustular psoriasis with hypocalcemia and with low circulating 1,25-dihydroxyvitamin D iƒ[ƒNƒVƒ‡ƒbƒv‚SFŠŁáj.
Morimoto, S., Yoshikawa, K., Kozuka, T., Kitano, Y., Ohnishi, T. and Kumahara, Y.
‘ć12‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1987.8.6-7
ŽD–y
@
Negative correlation between severity of skin disease and serum cholesterol in patients with psoriasis vulgaris.
Morimoto, S., Yoshikawa, K., Kozuka, T., Shiraishi, T., Hironaka, T., Ohnishi, T. and Kumahara, Y.
‘ć12‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1987.8.6-7
ŽD–y
@
ƒGƒgƒŒƒ`ƒl[ƒg’ˇŠú•ž—pŠłŽŇ‚ĚŒŒ’†”Z“x‚̉đÍ
‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć12‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1987.8.6-7
ŽD–y
@
ƒqƒg•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě”|—{–@‚̉ü—ǁ|ŒŒ´’`”’‚Ě55-70“—°ˆŔ•Ş‰ć‚ĚŽg—p|
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq
‘ć12‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1987.8.6-7
ŽD–y
@
Two-dimensional gel electrophoresis of membrane proteins from normal and psoriatic epidermis.
Matsumoto-Aoki, Ku., Higashiyama, M., Park, K.C. and Yoshikawa, K.
‘ć‚Q‰ń•\”ç×–EŒ¤‹†‰ď
1987.8.8-9
ƒjƒZƒR
@
‰A•”‚É”­ś‚ľ‚˝ánć҂̗Տ°‘œ‚Ćƒqƒgƒpƒsƒ[ƒ}ƒEƒCƒ‹ƒX‚Ěƒ^ƒCƒv‚ɂ‚˘‚Ä
Œ‡“c@—ÇŽ™@@”ö‰Ô@rě@@’JŠ_@••F@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć283‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.9.12
‘ĺă
@
śçGŠp‰ťÇ‚Ě‚Q—á
Žç‰Ž@–MŽq@@Šě‘˝–쐪•v
‘ć283‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.9.12
‘ĺă
@
Primary Sjo*gren ÇŒóŒQ‚Ě’jŤ—á
ă“c”ü‹IŽq iă‘ĺj @@‹´–{@•‘Ľ i‘—§‘ĺăj @
‘ć283‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1987.9.12
‘ĺă
@
‘ŤçG”ç•Ů‚É‚ć‚čÄŒš‚ľ‚˝ćů•”ˆŤŤŽîᇂ̂Q—á
“cŠ@äŽk@@‹vŽu–{@“Œ@@’r–ě@@G@@‚“c@ÍD i‘ĺăŒxŽ@Œ`Źj@@“Ąě@š˜a@@ź‰ş@“N–ç iă‘ĺj
‘ć14‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1987.9.6
ŹŒS
@
‰AŒs–Dü”Xáv‚Ě‚Q—á
ź‰ş@“N–ç@@“cŒ´@—RŽq@@“Ąě@š˜a@@‘O“c@@‹@@ź–{@ˆŰ–ž
“ú–{Œ`ŹŠO‰ČŠw‰ď‘ć14‰ń’†‘EŽl‘’n•ű‰ď—á‰ď
1987.9.6
ŹŒS
@
ፍ­‚đ•ę’n‚Ć‚ˇ‚é—Lž™×–EŠŕ
ź’J@–ÎŽ÷@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a@@ŠC˜VŒ´–­Žq
“ú–{Œ`ŹŠO‰ČŠw‰ď‘ć14‰ń’†‘EŽl‘’n•ű‰ď—á‰ď
1987.9.6
ŹŒS
@
ŽčE‘O˜r‚ĚˆŤŤŽîᇂĚ50—á‚ĚŒŸ“˘
‰Yě@W–ç@@ă’n@@‹M@@‘O“c@@‹@@ź–{@ˆŰ–ž
‘ć28‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď–k—¤’n•ű‰ď
1987.9.7
‹ŕ‘ň
@
ƒqƒrƒeƒ“$5001Á“Ĺ‚É‚ć‚čƒAƒiƒtƒBƒ‰ƒLƒV[—lÇó‚đ’ć‚ľ‚˝‚S—á
‰Ş–ě@šŽ÷@@–ě‘ş@­•v@@‰Ş“c“Ţ’ĂŽq@@˛“Ą@Œ’“ń@@“c‘ă@@ŽŔ@@•l@@˜Z˜Y
‘ĺă•{•›ě—pˆĎˆő‰ď
1988
‘ĺă
@
_ŒoÇó‚Ě‹É‚­Œy‚˘ A ŒQF‘fŤŠŁ”çÇ
˛“Ą@Œ’“ń@@–Č’J@łO@@’r‰i@–žś
•úśŒ¤ƒ[ƒNƒVƒ‡ƒbƒv
1988
‹ž“s
@
ƒxƒ“ƒ`Žî‚Ě‚P—á
“cŠ@äŽk@@‹vŽu–{@“Œ i‘ĺăŒxŽ@Œ`Źj
‘ć72‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1988.1.28
‘ĺă
@
‘BŒXŒü‚đŽŚ‚ľ‚˝—Ţ“Vávጂ̂P—á
‹v•Ä@şœA@@‹´–{@Œö“ń@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć289‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.10.22
‘ĺă
@
ŕ͍g”M—l”­]‚đ’ć‚ľ‚˝ phenytoin ‚É‚ć‚é–ň]‚Ě‚P—á
Žç‰Ž@–MŽq@@‰““Ą@@ŒO@@Œ‡“c@—ÇŽ™@@’JŠ_@••F@@‹gě@–M•F
‘ć289‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.10.22
‘ĺă
@
‚—î”­ś‚ĚƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ě‚P—á
ě“ŕ@@•×@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć289‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.10.22
‘ĺă
@
ŠˆŤŒ^ƒOƒ‹ƒRƒRƒ‹ƒ`ƒRƒCƒh•Ą‡‘Ě‚Ć core histone •ŞŽqŽí‚Ć‚ĚŒ‹‡
ă“c@´—˛@@‹gě@–M•F iă‘ĺj @@ˆé‹´@•śG@@‰Ş–{@ˆę‹N@@‘•{@ˆç‰›@@â–{@KĆ@
‘ć61‰ń“ú–{“ŕ•Ş”ĺŠw‰ďHŠú‘ĺ‰ď
1988.11.4-5
‘ĺă
@
ŹlÇ‚đ‡•š‚ľ‚˝ć“VŤ•\”琅ávÇ‚Ě‚P—á@—źÇ‚É‚¨‚Ż‚鐏’ˇƒzƒ‹ƒ‚ƒ“‚Ě•aˆö˜_“I–đŠ„
Šy–؁@GŽŔ@@’†‘ş@•śş@@•Ÿ”ö@Œb‰î@@’†ŠŰ@Œőş@@^™@•ś‹I@@‘吟@—˜•v@@”‹Œ´@r’j iă‘ĺŽl“ŕj @@‹´–{@Œö“ń@@Ź’ˁ@—Y–Ż@@‹gě@–M•F i“Ż”畆‰Čj@
‘ć61‰ń“ú–{“ŕ•Ş”ĺŠw‰ďHŠú‘ĺ‰ď
1988.11.4-5
‘ĺă
@
Žîᎌ^䕏󌌊ǎî‚̏Á‘Ţ‚ÉŠÖ‚ˇ‚錟“˘
âˆä@–ő•v@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj@@“cŒ´@—RŽq iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć51‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1988.11.5
‘ĺă
@
ćäŠÔŒ`Źp‚É‚¨‚Ż‚鏬ŽOŠp•Ů‚Ě—˜—p|‡ćäÇ‚¨‚ć‚Ń‘˝‡ćäÇ‚ɂ‚˘‚ā|
“cŠ@äŽk@@ź–{@ˆŰ–ž@@“Ąě@š˜a@@–k‹g@@Œő@@ó“c@—TŽi
‘ć51‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1988.11.5
‘ĺă
@
Tissue expander‚đ—p‚˘‚˝“ű–[Œ`Źp
“Ąě@š˜a@@ź–{@ˆŰ–ž@@‘O“c@@‹ iă‘ĺj @@‚“c@ÍD i‘ĺăŒxŽ@Œ`Źj
‘ć51‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1988.11.5
‘ĺă
@
—V—Ł‹ó’°ˆÚA‚ĚŒoŒą
Œ´Œł@@’ށ@@‘O“c@@‹@@“Ąě@š˜a@@Š_•Ł@ł’j@@ź‰ş@“N–ç
‘ć51‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1988.11.5
‘ĺă
@
ƒGƒŠƒeƒ}ƒg[ƒfƒX—l”ç]‚Ĺ”­Ç‚ľ‚˝”畆Œ`Žż×–E‘‘˝Ç‚Ě‚P—á
Œ‡“c@—ÇŽ™@@’JŠ_@••F@@‹gě@–M•F iă‘ĺj @@’†”ö@_‹v i“Ż“ń“ŕj
‘ć39‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1988.11.5-6
–źŒĂ‰Ž
@
Necrotizing Fasciitis ‚Ě‚P—á
“c‘ş@‰ŔM@@ŠC˜VŒ´–­Žq@@Ź—с@äoŽs@@‘O“c@@‹@@‹gě@–M•F
‘ć39‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1988.11.5-6
–źŒĂ‰Ž
@
łí‚¨‚ć‚ŃŠŁá•\”ç‘gD‚É‚¨‚Ż‚é TGF-ƒż iTransforming Growth Factor Type-ƒżj ‚ĚˆÓ‹`‚ɂ‚˘‚Ä
“ŒŽR@^—˘@@‹´–{@Œö“ń@@Šâ˛@^l@@ă“c@´—˛@@ź–{@–M•v@@Ź—с@äoŽs@@‹gě@–M•F@
‘ć39‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1988.11.5-6
–źŒĂ‰Ž
@
”|—{•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚é EBA RŒ´‚Ě”­Œť
‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v@@‹gě@–M•F iă‘ĺj @@‹{ě@KŽq@@ă–{@–MŽ÷ iă‘ĺj@ –xŒű@—TŽĄ i‹ž‘ĺj
‘ć39‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1988.11.5-6
–źŒĂ‰Ž
@
’e—͐üˆŰ‚Ě”÷×\‘˘‚ĚˆŮí‚đ”F‚ß‚˝’oŠÉŤ”畆‚Ě‚P—á
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq@@ź“cŒ’Ž÷ iă‘ĺj @@ŽO–qlŽŠ@@ĺM“ŕ•SŽĄ i“ŻŹŽ™‰Čj@@
‘ć39‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1988.11.5-6
–źŒĂ‰Ž
@
”|—{•\”ç×–E plasminogen activator iPAj ŠˆŤ‰ť‚ɑ΂ˇ‚é dexamethasone ‚̉e‹ż‚ɂ‚˘‚Ä
Šâ˛@^l@@‹´–{@Œö“ń@@ź–{@–M•v@@‰H”’@@˝@@ă“c@´—˛@@ź“c@‚ä‚č@@“c‹˝@GŽq@@“ŒŽR@^—˘@@‹gě@–M•F@
‘ć290‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.12.17
‘ĺă
@
TGF-ƒŔ‚̐łíƒqƒg”|—{•\”ç×–E‚Ě plasminogen activetor ŠˆŤ‚¨‚ć‚Ń plasminogen activator inhibitor ‚ɑ΂ˇ‚é‰e‹ż‚ɂ‚˘‚Ä
‹´–{@Œö“ń@@ź–{@–M•v@@“ŒŽR@^—˘@@Šâ˛@^l@@‰H”’@@˝@@‹ŕ@@˜aŽq@@“c‹˝@GŽq@@ź“c@‚ä‚č@@‹gě@–M•F@
‘ć290‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.12.17
‘ĺă
@
ƒqƒg”|—{ƒPƒ‰ƒ`ƒmƒTƒCƒg‚ɑ΂ˇ‚éƒrƒ^ƒ~ƒ“‚c3‚Ě‘B‘jŠQě—p
ź–{@–M•v@@“ŒŽR@^—˘@@ź“c@‚ä‚č@@‰H”’@@˝@@Šâ˛@^l@@ă“c@´—˛@@“c‹˝@GŽq@@‹ŕ@@˜aŽq@@‹´–{@Œö“ń@@‹gě@–M•F@
‘ć290‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.12.17
‘ĺă
@
TGF-ƒŔ iTransforming Growth Factor, Type ƒŔj ‚̝G•˝ă”ç×–E—R—ˆ‚Ě cell line ‚ɑ΂ˇ‚é‰e‹ż‚ɂ‚˘‚Ä i‘ć‚Q•ńj
“ŒŽR@^—˘@@ź“c@‚ä‚č@@“c‹˝@GŽq@@‰H”’@@˝@@Šâ˛@^l@@ă“c@´—˛@@‹ŕ@@˜aŽq@@ź–{@–M•v@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć290‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.12.17
‘ĺă
@
œ•t‚Ť—V—ŁŒ¨b”ç•Ů‚É‚ć‚é“Ş”çC “ŞŠWœŒ‡‘š‚ĚÄŒš
Š_•Ł@ł’j@@“Ąě@š˜a@@ź–{@ˆŰ–ž
‘ć15‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1988.12.2
ŒF–{
@
—V—Ł• ’ź‹Ř”ç•Ů‚É‚ć‚é‹š•ÇÄŒš
“Ąě@š˜a@@ź–{@ˆŰ–ž@@‘O“c@@‹@@–k‹g@@Œő@@ź‰ş@“N–ç
‘ć15‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1988.12.2
ŒF–{
@
‰ťĎ•i‚É‚ć‚éƒAƒŒƒ‹ƒM[ŤÚG”畆‰Š@ iƒVƒ“ƒ|ƒWƒEƒ€FRŒ´•¨Žż‚̉ťŠw•ŞÍj
Ź’ˁ@—Y–Ż@@Îˆä@‘fŽq@@“c‹˝@GŽq@@‹gě@–M•F
‘ć13‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1988.12.3-4
–źŒĂ‰Ž
@
ƒGƒXƒeƒ‹ƒKƒ€‚É‚ć‚éÚG”畆‰Š‚Ě‚P—á
Îˆä@‘fŽq@@Ź’ˁ@—Y–Ż@@“c‹˝@GŽq@@‹gě@–M•F iă‘ĺj @@‹´–{@•‘Ľ@@‘Dˆä@—´•F@@‘S@@@–ž@@ŒI–{@@ŠŢ@@’Šě—R‰Ŕ—˘@@’˛@@—SŽŸ i‘—§‘ĺăj@
‘ć13‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1988.12.3-4
–źŒĂ‰Ž
@
‰–Ž_ƒNƒƒRƒiƒ][ƒ‹‚É‚ć‚éÚG”畆‰Š
“Ą–{@Œ\ˆę@@‹´–{@˝ˆę iZ—Fj @@’JŠ_@••F iă‘ĺj
‘ć13‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1988.12.3-4
–źŒĂ‰Ž
@
Ž•‰Č‹ŕ‘Ž20Ží—Ţ‚É‚ć‚éƒpƒbƒ`ƒeƒXƒgŹŃ
‹î‘ş@Œö”ü iă˜aň–kj @@“Ą–{@Œ\ˆę@@‹´–{@˝ˆę iZ—Fj @@•Đ‰Ş@—tŽq@@“c‘ă@@ŽŔ i‘Dˆő•ŰŒŻj @@Ź’ˁ@—Y–Ż@@‹gě@–M•F iă‘ĺj@
‘ć13‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1988.12.3-4
–źŒĂ‰Ž
@
Indigo Carmine ‚É‚ć‚éÚG”畆‰Š‚Ě‚P—á
Ź’ˁ@—Y–Ż@@“c‹˝@GŽq@@Îˆä@‘fŽq@@‹gě@–M•F iă‘ĺj @@“y‹@•q–ž@@‘˝“c@łŒ› i‘ĺăŒxŽ@j@
‘ć13‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1988.12.3-4
–źŒĂ‰Ž
@
ƒXƒeƒƒCƒhŠîÜ‚É‚ć‚éÚG”畆‰Š
“ŒŽR@^—˘@@Ź’ˁ@—Y–Ż@@‹gě@–M•F iă‘ĺj @@‘Š”n@Ć‘ă@@‘˝“c@łŒ› i‘ĺăŒxŽ@j@@
‘ć13‰ńƒpƒbƒ`ƒeƒXƒgŒ¤‹†”Ç‘‰ď
1988.12.3-4
–źŒĂ‰Ž
@
“VávግR‘Ě‚É‚ć‚é•\”ç×–E‚É‚¨‚Ż‚é urokimase mRNA ‚Ě—U“ą
‹´–{@Œö“ń@@ź–{@–M•v@@“ŒŽR@^—˘@@Ź—с@äoŽs@@‹gě@–M•F
‘ć18‰ńŠî‘b”畆‰Č§˜b‰ď
1988.2.11
‘ĺă
@
ƒqƒgƒpƒsƒ[ƒ}ƒEƒBƒ‹ƒX‚Ěˆâ“`î•ń
Œ‡“c@—ÇŽ™@@’JŠ_@••F@@‹gě@–M•F iă‘ĺj @@“’’Ę“°–žŽő’j
‘ć18‰ńŠî‘b”畆‰Č§˜b‰ď
1988.2.11
‘ĺă
@
Šŕˆâ“`Žq“ą“ü‚É‚ć‚é•\”ç×–EŠ”‚ĚŽ÷—§‚ĚŽŽ‚Ý
ź–{@–M•v@@‹´–{@Œö“ń@@“ŒŽR@^—˘@@Ź—с@äoŽs@@‹gě@–M•F
‘ć18‰ńŠî‘b”畆‰Č§˜b‰ď
1988.2.11
‘ĺă
@
Šj‚ɑ΂ˇ‚郂ƒmƒNƒ[ƒiƒ‹R‘Ě‚đ—p‚˘‚˝ŽŠŒČ–ƉuŽžŠł‚̉đÍ
‹ŕ“c@^—@@‹gě@–M•F iă‘ĺj @@‹ŕ“c@ˆŔŽm@@“ŕ“c@@x@@‰Ş“c@‘P—Y i“Ż×–EHŠwƒZƒ“ƒ^[j@
‘ć18‰ńŠî‘b”畆‰Č§˜b‰ď
1988.2.11
‘ĺă
@
ŠŁá‚Ćƒrƒ^ƒ~ƒ“D i‹łˆçu‰‰j
‹gě@–M•F
‘ć31‰ń“ú”ç‰ďĂ‰Ş’n•ű‰ď
1988.2.14
•lź
@
’˜–ž‚Č desmoplasia ‚𔺂Á‚˝ˆÝŠŕ‚ĚŠç–ʔ畆ˆÚˆÚ“]‚Ě‚P—á
‹v•Ä@şœA@@Ź—с@äoŽs@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@ŸNˆä@Š˛ŒČ i“Ż•a—j
‘ć285‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.2.20
‘ĺă
@
Malignant hidroacanthoma simplex ‚Ě‚P—á
“cŒ´@—RŽq@@“Ąě@š˜a@@ź–{@–M•v@@Ź’ˁ@—Y–Ż@@‹gě@–M•F
‘ć285‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.2.20
‘ĺă
@
Dermoid cyst‚đ‡•š‚ľ‚˝‚Ş‚ÜŽî‚Ě‚P—á
âˆä@–ő•v@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj@@—с@@ŕŠw@@Ž›Žt@_l iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć15‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1988.2.7
źŽR
@
‰äX‚ĚŒoŒą‚ľ‚˝“Ş”çC “ŞŠWœŒ‡‘š‚ĚÄŒš‚ɂ‚˘‚Ä
Š_•Ł@ł’j@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a@@ź’J@–ÎŽ÷@@ź‰ş@“N–ç iă‘ĺj @@’Ň–{@‰ëˆę i’Ň–{•a‰@j
‘ć15‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1988.2.7
źŽR
@
Šç–Ę•‚ŽîC ŠÂóg”Á‚đ’ć‚ľ‚˝ Sjogren syndrome ‚Ě‚P—á
–Ř‘ş@‰p“ń@@Ź—с@äoŽs@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć286‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.3.26
‘ĺă
@
ˆŤŤ‘gD‹…ÇH‚Ě‚P—á
‰Ş–ě@šŽ÷@@Œ‡“c@—ÇŽ™@@’JŠ_@••F@@Ź—с@äoŽs@@ŽR‘ş@’íˆę@@‹gě@–M•F@@ŽO‘P@‰p˜a@@Žá‹ˇ@Œ¤ˆę
‘ć87‰ń“ú”ç‰ď‘‰ď
1988.4.1-3
ŒF–{
@
”畆ˆŤŤŽîᇍזE‚É‚¨‚Ż‚éƒAƒNƒ`ƒ“×üˆŰ‚Ě•Ş•z
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq@@Žç‰Ž@–MŽq@@’r“c@‹I˜a
‘ć87‰ń“ú”ç‰ď‘‰ď
1988.4.1-3
ŒF–{
@
”|—{ƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚é SSA/Ro RŒ´‚Ě”­Œť
‹{ě@KŽq@@ă–{@–MŽ÷ i“Ţ—Çˆă‘ĺj @@‰Ş“c“Ţ’ĂŽq@@Šě‘˝–쐪•v iă‘ĺj@ ˆîŠ_@ˆŔ‹I@@A–؁@G–ž iěčˆă‘ĺj@@
‘ć87‰ń“ú”ç‰ď‘‰ď
1988.4.1-3
ŒF–{
@
ánćҏó•\”ç”­ˆçˆŮíÇ‚É‚¨‚Ż‚éˆŤŤŽîᇂ̔­ś‚ɂ‚˘‚Ä
’JŠ_@••F
‘ć87‰ń“ú”ç‰ď‘‰ď
1988.4.1-3
ŒF–{
@
qíŤŠŁá‚Ć“VáváŒ‚đ‡•š‚ľ‚˝‚R—á
“ŒŽR@^—˘@@ŽR–{@’nŽq@@Ź—с@äoŽs@@‹´–{@Œö“ń@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć87‰ń“ú”ç‰ď‘‰ď
1988.4.1-3
ŒF–{
@
”x–ě‚É‹‘ĺ‚Č”XŽîŒ^“]ˆÚ‘ƒ‚Ť‚˝‚ľ‚˝ˆŤŤ•FŽî‚Ě‚P—á
“Ą’J@—TŽq@@ě“ŕ@@•×@@ŽR–{’nŽq@@Ź—с@äoŽs@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć87‰ń“ú”ç‰ď‘‰ď
1988.4.1-3
ŒF–{
@
Synthesis of epidermolysis bullosa acquisita antigen by SV40-transformed human keratinocytes
Okada, N., Miyagawa, S., Horiguchi, Y., Kitano, Y., Yoshikawa, K., Sakamoto, K. and Steinberg, M.L.
50th Anniversary Meeting of the Society for Investigative Dermatology
1988.4.27-30
Washington DC
@
HPV‚R‚Ş•Ş—Ł‚ł‚ę‚˝”Ä”­Ťánćҏǁ|EV ‚Ć”äŠrŒŸ“˘|
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć‚S‰ńl“ű“ŞŽîƒEƒCƒ‹ƒXŒ¤‹†‰ď
1988.4.3
@
@
“‚Čánć҂̐”—á|ŽĄ–ü‹@\‚ÉŠÖ‚ľ‚Ä‚QC ‚R‚̍lŽ@
’JŠ_@••F@@Œ‡“c@—ÇŽ™@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć‚S‰ńl“ű“ŞŽîƒEƒCƒ‹ƒXŒ¤‹†‰ď
1988.4.3
@
@
Ž‰–bŽî
‹vŽu–{@“Œ@@™“c@ˆę”V@@­“c@‰ŔŽq i‘ĺăŒxŽ@Œ`Źj
‘ć28‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1988.4.6
‰ŞŽR
@
Ž¨b‰îo‚đ‹­’˛‚ľ‚˝ŹŽ¨Ç‚ĚÄŒš
ź–{@ˆŰ–ž
‘ć31‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1988.4.7
“Œ‹ž
@
Forearm flap|ŒűoEˆô“Ş•”ÄŒš‚É‚¨‚Ż‚éH•v|
‘O“c@@‹@@ź–{@ˆŰ–ž@@“Ąě@š˜a@@Š_•Ł@ł’j@@“cŒ´@—RŽq@@ŠC˜VŒ´–­Žq
‘ć31‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1988.4.7
“Œ‹ž
@
“–‰Č‚É‚¨‚Ż‚é“ŞŒz•”ŠŕÄŒšŽž‚̏pŽŽ‚Ě‘I‘đ
“Ąě@š˜a@@ź–{@ˆŰ–ž@@‘O“c@@‹@@ź’J@–ÎŽ÷@@ź‰ş@“N–ç
‘ć31‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1988.4.7
“Œ‹ž
@
‹tsŤŒăœŠÔ”ç•Ů‚ĚŒoŒą
Š_•Ł@ł’j@@ź–{@ˆŰ–ž@@“Ąě@š˜a@@ź’J@–ÎŽ÷@@ź‰ş@“N–ç
‘ć31‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1988.4.9
“Œ‹ž
@
“–‰Č‚É‚¨‚Ż‚éhemifacial microsomia‚É”ş‚¤Šç–ʍœ•ĎŒ`‚ɑ΂ˇ‚鎥—ĂŒoŒą
ă’n@@‹M@@Ź—ѐ˝ˆę˜Y@@‚“c@—TŽq@@‘ĺXŠě‘ž˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć31‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1988.4.9
“Œ‹ž
@
’j—ăüLÇŠłŽŇăüâ|”畆 iƒAƒ|ƒNƒŠƒ“‘Bj ‚É‚¨‚Ż‚é’jŤƒzƒ‹ƒ‚ƒ“‚Ě‘Ş’č
‘q“c‘‘‘ž˜Y@@‹´–{@—T”V@@Ž›Žt@_l@@–{‘˝@•üm i‘ĺ•Şˆă‘ĺŒ`Źj@@‚ˆŔ@@i i“Ż”畆j
‘ć31‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1988.4.9
“Œ‹ž
@
t‰Š‚𔺂Á‚˝ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á‚Ě‚R—á
ě“ŕ@@•×@@Ź—с@äoŽs@@‹gě@–M•F
‘ć184‰ń“ú”ç‰ď‰ŞŽR’n•ű‰ď
1988.5.14
‰ŞŽR
@
•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě”|—{‚Ɣ畆‰Č—Տ°‚Ƃ̐ړ_
Šě‘˝–쐪•v
‘ć61‰ń“ú–{”|—{Šw‰ď
1988.5.19-21
‘ĺ•Ş
@
ƒ~ƒmƒ}ƒCƒVƒ““ŕ•ž‚É‚ć‚艺‘ڂɍL”ĂȐF‘f’ž’…‚𐜂ś‚˝‚PÇ—á
Žç‰Ž–MŽq@@ź“cŒ’Ž÷@@‰Ş“c“Ţ’ĂŽq@@‹gě–M•F iă‘ĺj@@Ź—Ń“N˜Y i“Ż“ńŠOj
‘ć81‰ń‹ß‹EW’k‰ď
1988.5.2
‘ĺ’Ă
@
‘O˜r”ç•ŮĚŽć•”‚Ě–â‘č“_|—V—Ł”ç•Ů70—á‚Ě—Ő°“IŒŸ“˘|
“Ąě@š˜a@@‘O“c@@‹@@ź–{@ˆŰ–ž iă‘ĺj @@‹g“c@~ˆę i‘ĺă’üM•a‰@Ž¨•@j
‘ć31‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1988.5.20
ˆ¤’m
@
‘ą”­Ť”­]Œ^‰ŠFŽî‚Ě‚P—á
ź‘ş@‰ëŽŚ@@“Œ@@âZ•F iŽs—§äj @@Šâ˛@^l@@’˛@@—TŽŸ iă‘ĺj
‘ć81‰ń‹ß‹EW’k‰ď
1988.5.29
‘ĺ’Ă
@
Œ´ˆö•s–ž‚ĚŒőü‰ß•qÇ‚Ě˜IŒő•””ç]‚É‚Ý‚ç‚ę‚˝”畆 SOD ŠˆŤ‚ɂ‚˘‚Ä
ˆéƒmăł–ž@@˛“Ą@Œ’“ń@@Ź—с@äoŽs@@Šě‘˝–쐪•v@@‹gě@–M•F iă‘ĺj@@‹{’n@—ÇŽ÷ i‹ž‘ĺj @@
‘ć81‰ń‹ß‹EW’k‰ď
1988.5.29
‘ĺ’Ă
@
ƒXƒeƒƒCƒhƒNƒŠ[ƒ€ŠîÜ‚É‚ć‚éÚG”畆‰Š
“ŒŽR@^—˘@@Ź’ˁ@—Y–Ż@@‹gě@–M•F iă‘ĺj @@‘Š”n@Ć‘ă@@‘˝“c@łŒ› i‘ĺăŒxŽ@j@
‘ć287‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.5.7
‘ĺă
@
How to repair facial linear scars
MatsumotoC K.
‘ć‚W‰ńƒAƒWƒAC ƒI[ƒXƒgƒ‰ƒŠƒA”畆‰ČŠw‰ď‹c
1988.6
ƒCƒ“ƒhƒlƒVƒA
@
ŠO—ˆŹŽčp‚É”x…Žî‚đ‚Ť‚˝‚ľ‚˝‚P—á
ˆäă@—TŽj@@‘ĺŒ´@‹`—Y@@âˆä@–ő•v iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć50‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1988.6.18
ŠŰ‹T
@
Šááٕ”“dŒ‚‚Ě‚P—á
‰Yě@W–ç@@’JŒű@@š iŠÖź˜JĐŒ`Źj @@^–ě@•x–ç@@–{‘q@^‘㠁i“ŻŠá‰Čj
‘ć50‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1988.6.18
ŠŰ‹T
@
Necrotizing Fascitis‚Ěˆę—á
ŠC˜VŒ´–­Žq@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a
‘ć50‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1988.6.18
ŠŰ‹T
@
Living Nerve Graft‚ĚŒoŒą
ź‰ş@“N–ç@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a
‘ć50‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1988.6.18
ŠŰ‹T
@
Pachydermoperiostosis‚ĆŽv‚í‚ę‚鏗Ť—á
ź’J@–ÎŽ÷@@­“c@‰ŔŽq@@‹eˆä@’mŽq@@Źů@Šě‹u@@”–@@ä•v iZ—FŒ`Źj
‘ć50‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1988.6.18
ŠŰ‹T
@
Romberg•a‚ĚŽĄ—ĂŒoŒą
“Ąě@š˜a@@ź–{@ˆŰ–ž@@‘O“c@@‹@@Š_•Ł@ł’j
‘ć50‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1988.6.18
ŠŰ‹T
@
ć“VŤŠO•@Œ‡‘š‚Ě‚P—á
âˆä@–ő•v@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj iŒ§—§‚ą‚Ç‚ŕŒ`Źj
“ú–{Œ`ŹŠO‰ČŠw‰ď‘ć50‰ńŠÖź’n•ű‰ď
1988.6.18
ŠŰ‹T
@
”şŤˆâ“`Ť‹›—ŘᝂƐqíŤ‹›—Řᝁ|Steroid sulphatase ŠˆŤ‘Ş’č‚É‚ć‚éf’fŠm’č‚Ć—Ő°“Œv“IŒŸ“˘
‰Ş–ě@šŽ÷@@‘Ť—§@@€@@Ź“ˆ@‰vŽq@@Â–؁@•q”V i‰H‰g–ěj @@Šě‘˝–쐪•v@@‹gě@–M•F iă‘ĺj @@’†‘ş@@ł i“Ż“ń“ŕj@
‘ć‚R‰ńŠp‰ťÇŒ¤‹†‰ď
1988.6.25
“Œ‹ž
@
”şŤˆâ“`Ť‹›—Řᝂ̌Œ´ƒŠƒ|’`”’‚ɂ‚˘‚Ä
’†‘ş@@ł@@ź‘ň@—CŽŸ iă‘ĺ“ń“ŕj @@‰Ş–ě@šŽ÷@@Šě‘˝–쐪•v@@‹gě@–M•F iă‘ĺj
‘ć‚R‰ńŠp‰ťÇŒ¤‹†‰ď
1988.6.25
“Œ‹ž
@
‰äX‚̍s‚Á‚Ä‚˘‚é“îŒűŠW—ôCłp
âˆä@–ő•v@@‘ĺŒ´@‹`—Y@@Ž›Žt@_l iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć12‰ń“ú–{ŒűŠW—ôŠw‰ď‘‰ď
1988.7.15
•Ÿ‰Ş
@
ƒrƒ^ƒ~ƒ“D‚Ɣ畆‚ĆŠŁá i“Á•Ęu‰‰j
‹gě@–M•F
‘ć89‰ń“ú”ç‰ďŽ­Ž™“‡’n•ű‰ď
1988.8.21
Ž­Ž™“‡
@
A case of eye shadow dermatitis.
Kozuka, T., Doi, T., Togoh, H., Ishii, M. and Yoshikawa, K.
1st Japan China Joint Meeting of Dermatol
1988.9.10-12
Beijing
@
ƒƒtƒFƒiƒ€Ž_ iƒ|ƒ“ƒ^[ƒ‹$5001j‚É‚ć‚éŒĹ’č–ň]‚Ě‚P—á
‹î‘ş@Œö”ü iă˜aň–kj @@˛“Ą@Œ’“ń@@Ź’ˁ@—Y–Ż@@‹gě@–M•F iă‘ĺj
‘ć288‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.9.17
_ŒË
@
“œ”A•a‚ɍ‡•š‚ľ‚˝ scleredema —l‚Ě”ç]‚ɂ‚˘‚Ä
Œ‡“c@—ÇŽ™@@’JŠ_@••F@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć288‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.9.17
_ŒË
@
ƒ}ƒ€ƒV™ů‚Ě‚PÇ—á
źč@@ł@@Œ‡“c@—ÇŽ™@@Ź’ˁ@—Y–Ż@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć288‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1988.9.17
_ŒË
@
łí‚¨‚ć‚ŃŠŁá•\”ç‘gD‚É‚¨‚Ż‚éTGF-ƒż‚ɂ‚˘‚Ä iƒVƒ“ƒ|ƒWƒEƒ€ ŠŁá 1988j
‹gě@–M•F@@‹´–{@Œö“ń@@“ŒŽR@^—˘@@Šâ˛@^l@@ă“c@´—˛@@ź–{@–M•v@@Ź—с@äoŽs@
‘ć‚R‰ń“ú–{ŠŁáŒ¤‹†‰ď
1988.9.2-3
ŽD–y
@
ƒrƒ^ƒ~ƒ“D’ďRŤ‚đŽŚ‚ˇŠŁá—á‚ɂ‚˘‚Ä
X–{@–ΐl@@L’†@—˛Žu@@–ź”¨@@F@@ˆÉ“Ą@˜aK@@‚@@‰h’j@@”’Î@Pl@@X“c@—´•˝@@’JŒű@˜a‹v@@‘吟@—˜•v iă‘ĺŽl“ŕj @@‹gě@–M•F i“Ż”畆‰Čj
‘ć‚R‰ń“ú–{ŠŁáŒ¤‹†‰ď
1988.9.2-3
ŽD–y
@
łí‚¨‚ć‚ŃŠŁá•\”ç‘gD‚É‚¨‚Ż‚é TGF-ƒż‚ĚˆÓ‹`‚ɂ‚˘‚Ä
“ŒŽR@^—˘@@‹´–{@Œö“ń@@Šâ˛@^l@@ă“c@´—˛@@ź–{@–M•v@@Ź—с@äoŽs@@‹gě@–M•F@
‘ć‚R‰ń“ú–{ŠŁáŒ¤‹†‰ď
1988.9.2-3
ŽD–y
@
ƒAƒCƒVƒƒƒh[”畆‰Š‚Ě‚P—á
Ź’ˁ@—Y–Ż i‘—§‘ĺăj @@“y‹@•q–ž@@‘˝“c@łŒ› i‘ĺăŒxŽ@j @@“c‹˝@GŽq@@Îˆä@‘fŽq@@‹gě@–M•F iă‘ĺj@
‘ć76‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1988.9.22
‘ĺă
@
Mixed Tumor‚Ě•a—‘gDŠw“IŒŸ“˘
ŠC˜VŒ´–­Žq@@‹vŽu–{@“Œ i‘ĺăŒxŽ@Œ`Źj @@’Ň–{@ł•F i“Ż•a—‘gD‚ ‚čj
‘ć16‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1988.9.4
‘q•~
@
‹UŤł’†O—ô‚ĚŽčp‚É‚¨‚Ż‚錟“˘
âˆä@–ő•v@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj@@“cŒ´@—RŽq iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć16‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1988.9.4
‘q•~
@
Arterial Island Flap‚É‚ć‚鍜‘‰ŠŽĄ—Ă‚ĚŒoŒą
ź’J@–ÎŽ÷@@­“c@‰ŔŽq@@”–@@ä•v iZ—FŒ`Źj @@“cŒ´@^–ç i_‘厨•@‰Čj
‘ć16‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1988.9.4
‘q•~
@
VśŽ™“Ş•”L”͔畆‰óŽ€‚Ě‚P—á
ó“c@—TŽi@@ź–{@ˆŰ–ž@@“cŠ@äŽk@@Œ´Œł@@’Ş
‘ć16‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1988.9.4
‘q•~
@
‹‘ĺ‚Ȑł’†_Œo”ě‘ĺ‚đ’ć‚ľ‚˝‚P—á
“cŒ´@—RŽq@@ˆäă@—TŽj@@‘ĺŒ´@‹`—Y@@âˆä@–ő•v iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć16‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1988.9.4
‘q•~
@
—V—ŁŒăœŠÔ”ç•Ů‚ĚŒoŒą
–k‹g@@Œő@@‘O“c@@‹@@“Ąě@š˜a@@Š_•Ł@ł’j
‘ć16‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1988.9.4
‘q•~
@
Plantar Fibromatosis‚Ě‚P—á
–ě‘ş@­•v@@“Ąě@š˜a@@‹gě@–M•F
‘ć295‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989
@
@
Organization and disorganization of actin filaments in human epidermal keratinocytes.
Kitano, Y. and Okada, N.
Joint Meeting:American Society for Biochemistry and Molecular Biology and the American Society for Cell Biology.
1989.1.29-2.2
San Francisco
@
–ŤC Ä”RŤŽžŠł‚ɉ—‚Ż‚éˆŰŽ—Ă–@‚Ć‚ľ‚Ä‚ĚƒXƒeƒƒCƒhŠO—pÜŠÔŸ[“Š—^‚Ě—LŒřŤ‚ĆˆŔ‘SŤ‚ɂ‚˘‚Ä‚ĚŒŸ“˘
‰œ‘ş@–rŽq i–Ľ–ĘŽs—§j @@‹gě@–M•F iă‘ĺj
‘ć40‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1989.10.21-22
‘ĺă
@
‰ď“ލu‰‰Fƒrƒ^ƒ~ƒ“D‚Ɣ畆
‹gě@–M•F
‘ć40‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1989.10.21-22
‘ĺă
@
THP-adriamycin ‚É‚ÄŽĄ—Ă‚ľ‚˝”畆T×–EŤƒŠƒ“ƒpŽî‚Ě‚R—á
‹v•Ä@şœA@@źč@@ł@@”Ą–ě@@“N@@‰€“c@‘•c@@‘Dˆä@—´•F@@‹´–{@Œö“ń@@‹gě@–M•F@
‘ć40‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1989.10.21-22
‘ĺă
@
ƒVƒ“ƒ|ƒWƒEƒ€F×–EŹ’ˇˆöŽqŒ¤‹†‚É‚¨‚Ż‚éŒťó
‹´–{@Œö“ń
‘ć40‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1989.10.21-22
‘ĺă
@
ƒVƒ“ƒ|ƒWƒEƒ€Fƒqƒg•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě‘BE•Ş‰ť‚Ć TGF-ƒŔ
ź–{@–M•v@@‹´–{@Œö“ń@@ź“c@‚ä‚č@@“ŒŽR@^—˘@@‰H”’@@˝@@‹gě@–M•F
‘ć40‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1989.10.21-22
‘ĺă
@
ƒTƒCƒNƒƒXƒ|ƒŠƒ“A‚ޔ畆d‰ť‚É‘tŒř‚ľ‚˝ PSS ‚Ě‚Q—á
‘Dˆä@—´•F@@‹v•Ä@şœA@@”Ą–ě@@“N@@‰€“c@‘•c@@ă“c@´—˛@@Ź—с@äoŽs@@‹gě@–M•F
‘ć40‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1989.10.21-22
‘ĺă
@
ƒVƒ“ƒ|ƒWƒEƒ€Fłíƒqƒg•\”ç‹y‚ŃŠŁá•a•Ď•”•\”ç‘gD‚É‚¨‚Ż‚é TGF-ƒż iTransforming Growth Factor Type-alphaj ‚ĚˆÓ‹`‚ɂ‚˘‚Ä
“ŒŽR@^—˘@@‹´–{@Œö“ń@@ź–{@–M•v@@‹gě@–M•F
‘ć40‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1989.10.21-22
‘ĺă
@
”şŤˆâ“`Ť‹›—ŘᝂƐqíŤ‹›—Řᝁ@|Steroid sulphatase ŠˆŤ‘Ş’č‚É‚ć‚éf’fŠm’č‚Ć—Ő°“Œv“IŒŸ“˘|
‰Ş–ě@šŽ÷ iˆ¤ő‹´j @@Šě‘˝–쐪•v@@‹gě@–M•F iă‘ĺj @@’†‘ş@@ł@@ź‘ň@—CŽŸ i“Ż“ń“ŕj@@
‘ć40‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1989.10.21-22
‘ĺă
@
—ź‘¤Ť‚ɐś‚ś‚˝‘¤“Ş“Ž–Ź‰Š
‘ž“c@ƒŽq@@‰Şč@@ł@@“c‘ş@‰ŔM@@ě’Á@’qĽ i‘ĺă’üMj@@’†‘ş@–FŽq i“ŻŠá‰Čj @@˛“Ą@Œ’“ń iă‘ĺj @@
‘ć40‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1989.10.21-22
‘ĺă
@
ˆâ“`Ť”畆ˆŤŤ•FŽîŠłŽŇ×–E‚Ĺ‚Ě4NQO ‚É‚ć‚é’vŽ€Š´ŽóŤ‚Ć‚ť‚Ě DNA ‚Ö‚ĚŒ‹‡‚Ć‚ĚŠÖŒW
˛“Ą@Œ’“ń iă‘ĺj @@Hawell@@JN@@Mahar@@VM@@McOmick@@JJ iƒ~ƒVƒKƒ“B—§‘ĺj @@Green@@MH iƒAƒŠƒ]ƒiˆăŠwƒZƒ“ƒ^[j@@
‘ć48‰ń“ú–{ŠŕŠw‰ď
1989.10.23-25
–źŒĂ‰Ž
@
Plantar fibromatosis ‚Ě‚P—á
–ě‘ş@­•v@@“Ąě@š˜a@@‹gě@–M•F iă‘ĺj @@Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y i‘ĺă˜JĐj@
‘ć295‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.10.28
‘ĺăÔ\Žš•a‰@
@
‰ß‹Ž12”NŠÔ‚ɉ—‚Ż‚éŠç–Ę•”BCC‚ĚŒoŒą
–k‹g@@Œő@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a
‘ć‚V‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ď‘‰ď
1989.11.10
“Œ‹ž
@
ƒŒƒ`ƒmƒCƒ“Ž_‚Ě”|—{l•\”ç×–E‚ɑ΂ˇ‚鑝BE•Ş‰ť’˛ßŒř‰Ę‚ɂ‚˘‚Ä
‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
ƒVƒ“ƒ|ƒWƒEƒ€@ƒŒƒ`ƒmƒCƒh‚Ć‚Ş‚ń
1989.11.10-11
“Œ‹ž
@
iƒVƒ“ƒ|ƒWƒEƒ€‡UGŠŁáj Effect of 1,24-dihydroxyvitamin D3 on the growth of cultured human keratinocytes.
Matsumoto, Ku., Hashimoto, K., Higashiyama, M., Hashiro, M. and Yoshikawa, K.
‘ć14‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď@‘ć‚Q‰ń Clinically Oriented Research Symposium
1989.11.10-11
‹ž“s
@
A successful treatment of PSS with cyclosporin A.
Funai, T., Kume, A., Ueda, K., Hazano, S. and Yoshikawa, K.
2nd Asian Dermatology Congress
1989.11.23-26
Singapore
@
Three cases of cutaneous T-cell lymphoma treated by THP-adriamycin.
Kume, A., Matsuzaki, T., Hazano, S., Funai, T., Hashimoto, K. and Yoshikawa, K.
2nd Asian Dermatology Congress
1989.11.23-26
Singapore
@
Workshop: Human papilloma virus: Types of human papilloma virus isolated from Japanese patients with epidermodysplasia verruciformis.
Kanda, R., Tanigaki, T., Yoshikawa, K., Yutsudo, M. and Hakura, A.
6th Japan Korea Joint Meeting of Dermatology
1989.11.5-6
Tokyo
@
Workshop: Human Papilloma Virus: Clinical observations of patients with epidermodysplasia verruciformis.
Tanigaki, T., Kanda, R. and Yoshikawa, K.
6th Japan Korea Joint Meeting of Dermatology
1989.11.5-6
Tokyo
@
Workshop: Recent Advances of Dermatologic Therapy: Active vitamin D for psoriasis.
Yoshikawa, K., Matsumoto, Ku., Hashimoto, K., Morimoto, S.
6th Japan Korea Joint Meeting of Dermatology
1989.11.5-6
Tokyo
@
‘˝”­˜]œœÜ‚ĚŽĄ—Ă‚ÉŠÖ‚ˇ‚錟“˘
âˆä@–ő•v@@ŽR‹g@@Ž @@—é–؁@ˆę@@Œj“c@‹eŽk i•{—§‹~‹}j
‘ć17‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď
1989.11.6
“Œ‹ž
@
ƒqƒgłíƒPƒ‰ƒ`ƒmƒTƒCƒg‚ĚƒtƒBƒuƒƒlƒNƒƒ“ŽYś‚ɑ΂ˇ‚é TGF-ƒŔ‚̉e‹ż
‰H”’@@˝@@ź–{@–M•v@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć296‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.12.16
_ŒË
@
”|—{ƒqƒg•\”ç×–EƒV[ƒg‚É‚ć‚é”MŽĄ—Ă‚ĚŽŽ‚Ý
ě’Á@—FŽq@@‰Ž‹ň@_Žq@@ˆÉ“Ą@—TŽq@@‰€“c@‘•c iŠÖź˜JĐj @@ź“c@‚ä‚č@@ź–{@–M•v@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj
‘ć296‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.12.16
_ŒË
@
”|—{•\”ç×–E Plasminogen activator iPAj ŠˆŤ‚ɑ΂ˇ‚é dexamethasone ‚̉e‹ż‚ɂ‚˘‚Ä
Šâ˛@^l@@‹´–{@Œö“ń@@ź–{@–M•v@@‰H”’@@˝@@“ŒŽR@^—˘@@‹gě@–M•F
Šî‘b”畆‰Č§˜b‰ď
1989.12.2
L“‡
@
Dexamethasone ‚É‚ć‚é”|—{•\”ç×–E plasminogen activator ŠˆŤ‚̐§Œä‚ɂ‚˘‚Ä
Šâ˛@^l@@‹´–{@Œö“ń@@ź–{@–M•v@@‰H”’@@˝@@“ŒŽR@^—˘@@ź“c@‚ä‚č@@‹gě@–M•F
‘ć19‰ńŠî‘b”畆‰Č§˜b‰ď
1989.12.2
‰ŞŽR
@
TGF-beta ‚Ě”|—{•\”ç×–E‚É‚¨‚Ż‚é plasminogen activator ŠˆŤ‚ɑ΂ˇ‚é‰e‹ż‚ɂ‚˘‚Ä
‹´–{@Œö“ń@@Šâ˛@^l@@ź–{@–M•v@@“ŒŽR@^—˘@@‰H”’@@˝@@ź“c@‚ä‚č@@‹gě@–M•F
‘ć19‰ńŠî‘b”畆‰Č§˜b‰ď
1989.12.2
‰ŞŽR
@
Combined free flap‚ĚŒoŒą
‹g—´@ŸŽq@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a@@Œ´Œł@@’ށ@@Žs–ě@’źŽ÷
‘ć53‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1989.12.2
‘ĺă
@
“–‰Č‚É‚¨‚Ż‚é‘lŒaƒŠƒ“ƒpßŠs´‚ɂ‚˘‚Ä
–k‹g@@Œő@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a@@ŠC˜VŒ´–­Žq
‘ć53‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1989.12.2
‘ĺă
@
‹Ř‘w“ŕ‚ւ̐Z‚Ş”F‚ß‚ç‚ę‚˝D.E.S.P‚Ě‚P—á
ź‰ş@“N–ç@@–{‘˝@•üm i‘ĺă‘Dˆő•ŰŒŻŒ`Źj @@“c‘ă@@ŽŔ@@•Đ‰Ş@—tŽq i“Ż”畆j@ ź–{@ˆŰ–ž@@“Ąě@š˜a@@ź–{@@‘ iă‘ĺj
‘ć53‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1989.12.2
‘ĺă
@
The free lower posterolateral thigh flap‚ĚŒoŒą
ź’J@–ÎŽ÷@@”–@@ä•v@@‹eˆä@’mŽq@@­“c@‰ŔŽq@@‹´–{@—T”V iZ—FŒ`Źj @–k‹g@@Œő iă‘ĺj
‘ć53‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1989.12.2
‘ĺă
@
˜VlŤŠááىş‚‚ĚŽĄ—ĂŒoŒą
—с@@ŕŠw@@‹vŽu–{@“Œ@@‚“c@ÍD@@ó“c@—TŽi
‘ć53‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1989.12.2
‘ĺă
@
• ’ź‹Ř•Ů‚É‚ć‚鉥Šu–Œƒwƒ‹ƒjƒA‚ĚŽĄ—ĂŒoŒą
“úŠ}@@šć@@ź–{@ˆŰ–ž@@‘O“c@@‹@@ź–{@@‘
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1989.12.2
‘ĺă
@
‹›‰î—Ţ‚É‚ć‚éE‹ĆŤÚGĺ@–ƒ]
“ŒŽR@^—˘@@Šâ˛@^l@@‹gě@–M•F
‘ć14‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1989.12.2-3
‘ĺă
@
SLE ‚É•š”­‚ľ‚˝ Linear IgA bullous dermatosis ‚Ě‚P—á
Šâ˛@^l@@ź–{@–M•v@@‹´–{@Œö“ń@@‹gě@–M•F@@––‘ş@łŽ÷
‘ć11‰ń…ávÇŒ¤‹†‰ďEŒúśČ“Á’莞ŠłC ‹H­“ŤŽžŠł’˛¸Œ¤‹†”Ç‘ć‚Q‰ń‘‰ď
1989.2.11
“Ţ—Ç
@
Reactive perforating collagenosis ‚Ě‚P—á
‰““Ą@@ŒO@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć291‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.2.18
‘ĺă
@
Prader-Willi ÇŒóŒQ‚Ě‚P—á
Žs“c@“Nˆę@@Œ‡“c@—ÇŽ™@@’JŠ_@••F@@‹gě@–M•F iă‘ĺj @@‘吟@—˜•v i“ŻŽl“ŕj
‘ć291‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.2.18
‘ĺă
@
Holoprosencephaly‚𔺂Á‚˝18P-ÇŒóŒQ‚Ě‚P—á
“cŒ´@—RŽq@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj@@“cŠ@äŽk iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć17‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1989.2.5
L“‡
@
Š‘ŽƒŠƒ“ƒpß‚Ɉړ]‚đ—ˆ‚ľ‚˝Šî’ęă”ç×–EŽî‚Ě‚P—á
–k‹g@@Œő@@ź–{@ˆŰ–ž@@‘O“c@@‹@@Š_•Ł@ł’j
‘ć17‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď’†‘EŽl‘’n•ű‰ď—á‰ď
1989.2.5
L“‡
@
ˆŤŤüˆŰŤ‘gD‹…Žî
ě“ŕ@@•×@@‰H”’@@˝@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć80‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1989.3.16
‘ĺă
@
—Ž‚ż‚Č‚˘‰ťĎ–@‚Ĺ”­ś‚ľ‚˝‚ƍl‚Ś‚ç‚ę‚é‹ÇŠƒTƒ‹ƒRƒCƒh”˝‰ž‚Ě‚P—á
‘ž“c@‡Žq@@Žs“c@“Nˆę@@’JŠ_@••F@@‹gě@–M•F
‘ć292‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.3.25
˜a‰ĚŽR
@
Pacinian neurofibroma ‚Ě‚P—á
–k‹g@@Œő@@‹ŕ@@˜aŽq@@‹´–{@Œö“ń@@Šě‘˝–쐪•v@@‹gě@–M•F@
‘ć292‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.3.25
˜a‰ĚŽR
@
Pacinian neurofibroma‚Ě‚P—á
–k‹g@@Œő iă‘ĺŒ`Źj @@‹ŕ@@˜aŽq@@‹´–{@Œö“ń@@Šě‘˝–쐪•v@@‹gě@–M•F i“Ż”畆j
‘ć292‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1989.3.25
˜a‰ĚŽR
@
ŠŁá‚Ćƒrƒ^ƒ~ƒ“D3 i“Á•Ęu‰‰j
‹gě@–M•F
‘ć‚X‰ń“ú”ç‰ďˆ¤•Q’n•ű‰ď
1989.3.4
źŽR
@
Šç–ʐł’†•”Œ`Ź•s‘S‚É‹Nˆö‚ľ‚˝C ‚˘‚í‚ä‚é‹UŤł’†O—ô‚Ě“ÁˆŮŒ^‚ɂ‚˘‚Ä
âˆä@–ő•v@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj@@“cŒ´@—RŽq iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć32‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1989.4.20
“Œ‹ž
@
O—ôŽčppŽŽ‚ƏăŠ{Ž•‘…‹|‚ĚŒ`‘ԕωť‚ɂ‚˘‚Ä
‚“c@ÍD i‘ĺăŒxŽ@Œ`Źj @@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj @@–î”ö@˜a•F@@_Œ´@@C i‘ĺăŽ•‘召Ž™Ž•‰Čj @@‘D‰z@‰ĂŞ iŒ§—§‚ą‚Ç‚ŕŽ•‰Čj
‘ć32‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1989.4.20
“Œ‹ž
@
‚’ź•űŒü‚ĚŠáâ|ˆĘ’uˆŮí‚̏Cł‚ÉŠÖ‚ˇ‚éŒoŒą
ă’n@@‹M@@ˆÉ“Ą@@G@@“n•Ó”ü—R‹I@@÷ˆä@@~@@Ź—ѐ˝ˆę˜Y@@‘ĺXŠě‘ž˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć32‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1989.4.20
“Œ‹ž
@
ƒVƒŠƒRƒ“‚ɑ΂ˇ‚él‘Ě‚ĚˆŮ•¨”˝‰ž‚¨‚ć‚ѐś‘ĚŢ—ż‚ÉŠÖ‚ˇ‚é“Ž•¨ŽŔŒą
ˆäă@—TŽj@@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj @@ˆÉ“Œ@@G i_‘ĺ‘ćˆę•a—j
‘ć32‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1989.4.21
“Œ‹ž
@
—V—Ł• ’ź‹Ř”ç•Ů‚É‚ć‚éŠáâ|C ăŠ{‚ĚˆŤŤŽîᇐ؏œŒă‚ĚÄŒš
Š_•Ł@ł’j@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a@@–k‹g@@Œő@@ó“c@—TŽi
‘ć32‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1989.4.21
“Œ‹ž
@
ŒŒŠÇ•ż•t—V—Ł_ŒoˆÚA‚ĚŒoŒą|Ž¨‰ş‘BˆŤŤŽîᇐ؏œŒă‚ĚŠç–ʐ_ŒoˆęŠú“IÄŒš‚ɂ‚˘‚ā|
‘O“c@@‹@@ź–{@ˆŰ–ž@@“Ąě@š˜a@@ź‰ş@“N–ç@@Œ´Œł@@’Ş
‘ć32‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1989.4.21
“Œ‹ž
@
—V—ŁŒăœŠÔ”ç•Ů‚É‚ć‚éŒűo“ŕÄŒš
“Ąě@š˜a@@ź–{@ˆŰ–ž@@‘O“c@@‹@@–k‹g@@Œő@@Š_•Ł@ł’j
‘ć32‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1989.4.21
“Œ‹ž
@
Histopathological features of malignant lymphomas in Japan.
Aozasa, K. and Yoshikawa, K.
1st Tricontinental Meeting of the Society for Investigative Dermatology
1989.4.26-30
Washington DC
@
TGF-beta decreases high-affinity receptors for EGF in human keratinocytes.
Hashiro, M., Hashimoto, K., Matsumoto, Ku., Higashiyama, M., Iwasa, M., Ueda, K., Kim, K., Nishida, Y., Tago, H. and Yoshikawa, K.
1st Tricontinental Meeting of the Society for Investigative Dermatology
1989.4.26-30
Washington DC
@
Discrepancy of expression of TGF-beta effects in human epithelial cell lines.
Higashiyama, M., Hashimoto, K., Matsumoto, Ku., Iwasa, M., Hashiro, M., Ueda, K., Kim, K., Nishida, Y., Tago, H. and Yoshikawa, K.
1st Tricontinental Meeting of the Society for Investigative Dermatology
1989.4.26-30
Washington DC
@
TGF-beta increases both urokinase plasmonogen activator and plasminogen activator inhibitor-1
Iwasa, M., Hashimoto, K., Matumoto, Ku., Higashiyama, M., Hashiro, M., Ueda, K., Kim, K., Nishida, Y., Tago, H. and Yoshikawa, K.
1st Tricontinental Meeting of the Society for Investigative Dermatology
1989.4.26-30
Washington DC
@
Organization and disorganization of actin filaments in human epidermal keratinocytes
Kitano, Y. and Okada, N.
1st Tricontinental Meeting of the Society for Investigative Dermatology
1989.4.26-30
Washington DC
@
1ƒż, 25-dihydroxyvitamin D3 inhibits cell growth and decreases high-affinity receptors for EGF in human keratinocytes.
Matsumoto, Ku., Hashimoto, K., Higashiyama, M., Iwasa, M., Hashiro, M., Ueda, K., Kim, K., Nishida, Y., Tago, H. and Yoshikawa, K.
1st Tricontinental Meeting of the Society for Investigative Dermatology
1989.4.26-30
Washington DC
@
Expression of proliferating cell nuclear antigen/cyclin in human keratinocytes
Miyagawa, S., Okada, N., Takasaki, Y., Iida, T., Kitano, Y., Yoshikawa, K., Sakamoto, K. and Steinberg, M.L.
1st Tricontinental Meeting of the Society for Investigative Dermatology
1989.4.26-30
Washington DC
@
Proliferating cell nuclear antigen/cyclin in human epidermal tumor cells
Okada, N., Miyagawa, S., Takasaki, Y., Kitano, Y., Yoshikawa, K., Sakamoto, K. and Steinberg, M.L.
1st Tricontinental Meeting of the Society for Investigative Dermatology
1989.4.26-30
Washington DC
@
Transforming growth factor-ƒŔiTGF-ƒŔj ‚É‚ć‚鐳íƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě‘B§Œä
‰H”’@@˝@@ź–{@–M•v@@“ŒŽR@^—˘@@ź“c@‚ä‚č@@“c‹˝@GŽq@@ă“c@´—˛@@‹ŕ@@˜aŽq@@Šâ˛@^l@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć88‰ń“ú”ç‰ď‘‰ď
1989.5.11-13
‹ŕ‘ň
@
ä\•”‚̓Ť”ç]‚đ•š”­‚ľ‚˝ƒ_ƒŠƒG•a‚Ě‚P—á
‰““Ą@@ŒO@@’˛@@—TŽŸ@@‹´–{@Œö“ń@@’JŠ_@••F@@‹gě@–M•F
‘ć88‰ń“ú”ç‰ď‘‰ď
1989.5.11-13
‹ŕ‘ň
@
ƒ~ƒmƒTƒCƒNƒŠƒ““ŕ•ž‚É‚ć‚萜‚ś‚˝”畆F‘f’ž’…
‰Ş“c“Ţ’ĂŽq@@Žç‰Ž–MŽq@@ź“cŒ’Ž÷@@Šě‘˝–쐪•v@@‹gě–M•F
‘ć88‰ń“ú”ç‰ď‘‰ď
1989.5.11-13
‹ŕ‘ň
@
•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚ĚƒAƒNƒ`ƒ“×üˆŰˆę”­Šŕ‘Łi•¨Žż‚ĆˆŤŤ‰ť‚É‚ć‚é•Ş•zó‘Ԃ̕ωť
Šě‘˝–쐪•v@@‰Ş“c“Ţ’ĂŽq
‘ć88‰ń“ú”ç‰ď‘‰ď
1989.5.11-13
‹ŕ‘ň
@
“VávግR‘Ě‚É‚ć‚é•\”ç×–E‚É‚¨‚Ż‚é Urokinase iu-PAj mRNA ‚Ě—U“ą
‹´–{@Œö“ń@@ź–{@–M•v@@‹ŕ@@˜aŽq@@“ŒŽR@^—˘@@Lazarus@@G.S.
‘ć88‰ń“ú”ç‰ď‘‰ď
1989.5.11-13
‹ŕ‘ň
@
ƒqƒg”|—{ƒPƒ‰ƒ`ƒmƒTƒCƒg‚ɑ΂ˇ‚銈ŤŒ^ƒrƒ^ƒ~ƒ“D3‚Ě‘B‘jŠQě—p
ź–{@–M•v@@“ŒŽR@^—˘@@ź“c@‚ä‚č@@‰H”’@@˝@@Šâ˛@^l@@ă“c@´—˛@@‹ŕ@@˜aŽq@@“c‹˝@GŽq@@‹´–{@Œö“ń@@‹gě@–M•F@
‘ć88‰ń“ú”ç‰ď‘‰ď
1989.5.11-13
‹ŕ‘ň
@
Žs—§ä•a‰@”畆‰Č‚É‚¨‚Ż‚é–ň]‚Ě“Œvi1985-1988j
“Œ@@âZ•F@@ź‘ş@‰ëŽŚ@@ˆéƒmă@ł–ž@@Šâ˛@^l@@‹î‘ş@Œö”ü
‘ć88‰ń“ú”ç‰ď‘‰ď
1989.5.11-13
‹ŕ‘ň
@
łíƒqƒg•\”炨‚ć‚ŃŠŁá•a•Ď•”•\”ç‘gD‚É‚¨‚Ż‚é TGF-ƒż itransforming growth factor type-alphaj ‚ĚˆÓ‹`‚ɂ‚˘‚Ä
“ŒŽR@^—˘@@‹´–{@Œö“ń@@ź–{@–M•v@@‹gě@–M•F
‘ć88‰ń“ú”ç‰ď‘‰ď
1989.5.11-13
‹ŕ‘ň
@
Žč‚Ě“î•”ˆŤŤŽîᇂ̌Ÿ“˘
Š_•Ł@ł’j@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a@@ź‰ş@“N–ç
‘ć32‰ńŽč‚ĚŠO‰ČŠw‰ďŽGŽ
1989.5.12
–k‹ăB
@
ł’†_Œo‚̐üˆŰŽ‰–bŤ”ě‘ĺ‚Ěˆę—á
“cŒ´@—RŽq@@ˆäă@—TŽj@@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj @–Ř‘ş@@”Ž iŒö•śŠO‰Čj@@‰¤@@şG i“ŻŽŒ`ŠO‰Čj
‘ć32‰ńŽč‚ĚŠO‰ČŠw‰ďŽGŽ
1989.5.12
–k‹ăB
@
Ä”­‚đŒJ‚č•Ô‚ľ‚˝ŠO‰A•”BCC
‹vŽu–{@“Œ@@‚“c@ÍD@@—с@@ŕŠw@@ŠC˜VŒ´–­Žq
‘ć52‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1989.6.10
˜a‰ĚŽR
@
ŠC–ĘóŒŒŠÇŽî‚ĚŽĄ—ĂŒoŒą
Œ´Œł@@’ށ@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a@@Š_•Ł@ł’j@@–k‹g@@Œő@@ź‰ş@“N–ç@@ó“c@—TŽi
‘ć52‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1989.6.10
˜a‰ĚŽR
@
‘˝Ę‚Ȑ_ŒoŠw“IŠŒŠ‚đŽŚ‚ľ‚˝Holoprosencephaly‚Ě‚P—á
“cŒ´@—RŽq@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj@@“cŠ@äŽk iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć52‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1989.6.10
˜a‰ĚŽR
@
Ž¨‰ş‘B—Ěˆć‚ɐś‚ś‚˝Žîᎂ̌oŒą
—с@@ŕŠw@@‹vŽu–{@“Œ@@‚“c@ÍD@@ŠC˜VŒ´–­Žq
‘ć52‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1989.6.10
˜a‰ĚŽR
@
Vitamin D and the Skin.
Yoshikawa, K.
International Conference on Skin Aging
1989.6.17
Kyoto
@
Š‘ŽƒŠƒ“ƒpß“]ˆÚ‚đŽŚ‚ľ‚˝Šî’ę×–Eă”çŽî‚Ě‚P—á
–k‹g@@Œő@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a@@Š_•Ł@ł’j
‘ć82‰ń‹ß‹EW’k‰ď
1989.6.18
‘ĺă
@
”ě‘名”畆œ–ŒÇ‚Ě‚P—á
źˆä@Šě•F@@źˆä@–F•v@@‘O“c@@‹@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj@@‹{‰ş@‘Ps@@”‹Œ´@r’j iŽl“ŕj @@
‘ć82‰ń‹ß‹EW’k‰ď
1989.6.18
‘ĺă
@
‹´–{•a‚đ‡•š‚ľ‚˝ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚Ě‚P—á
ě“ŕ@@•×@@źč@@ł@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć293‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.6.3
‘ĺă
@
“÷Žî—l‘gD‘œ‚đ’ć‚ľC ’ˇŠú‚ĚŒo‰ß‚đ‚˝‚Ç‚Á‚˝—Lž™×–EŠŕ‚Ě‚P—á
‘ž“c@‡Žq@@ă“c”ü‹IŽq@@‘Dˆä@—´•F@@Šě‘˝–쐪•v@@‹gě@–M•F
‘ć293‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.6.3
‘ĺă
@
Ží“——l…ávÇ‚ĚŒő‰ß•qŤ‚ɂ‚˘‚Ä‚ĚŒŸ“˘
˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć11‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1989.6.8-9
‹ž“s
@
”|—{ƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚ɑ΂ˇ‚éƒrƒ^ƒ~ƒ“D3‚Ě‘B‘jŠQě—p‚ɂ‚˘‚Ä
ź–{@–M•v@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć237‰ńŽ‰—nŤƒrƒ^ƒ~ƒ“‘‡Œ¤‹†ˆĎˆő‰ď
1989.7.21
‘ĺă
@
PSS ŠłŽŇ‚ɑ΂ˇ‚é Cyclosporin A ‚ĚŽĄ—ĂŒoŒą ‘ć‚Q•ń
ă“c@´—˛@@‰€“c@‘•c@@”Ą–ě@@“N@@‘Dˆä@—´•F@@‹gě@–M•F
‹­”çÇ’˛¸Œ¤‹†”ljď‹c
1989.7.22
“Œ‹ž
@
Amelanotic melanoma ‚Ě‚P—á
‘ž“c@‡Žq@@Žç‰Ž@–MŽq@@“Ą’J@—TŽq@@Šâ˛@^l@@Œ´Œł@@’ށ@@‘O“c@@‹@@Šě‘˝–쐪•v@@‹gě@–M•F@
‘ć294‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.7.29
‘ĺă
@
Eruptive vellus hair cyst ‚Ě‚R—á
‰€“c@‘•c iŠÖź˜JĐj @@‹ŕ@@˜aŽq@@‰Ş“c“Ţ’ĂŽq@@‹´–{@Œö“ń@@Šě‘˝–쐪•v@@‹gě@–M•F iă‘ĺj@@
‘ć294‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1989.7.29
‘ĺă
@
ŠŁá‚Ě•a‘Ô‚Ćƒrƒ^ƒ~ƒ“‚c3‚ĚŒř‰Ę i“Á•Ęu‰‰j
‹gě@–M•F
‘ć274‰ń“ú”ç‰ďVŠƒ’n•ű‰ď
1989.7.8
VŠƒ
@
DDS “ŕ•ž‰Á—Ă‚đ‘ą‚ŻłíŽ™‚đ•Ş•Ř‚ľ“ž‚˝C linear IgA dermatosis ‚Ě‚P—á
Šâ˛@^l@@ź–{@–M•v@@‹´–{@Œö“ń@@‹gě@–M•F@@“Ą–{@@˜j@@r“c@ŽŸ˜Y
ŒúśČ“Á’莞ŠłC ‹H­“ŤŽžŠł’˛¸Œ¤‹†”Ç‘ć‚R‰ń‘‰ď
1989.8.25
“Œ‹ž
@
Refined and improved method of auricular reconst ruction in microtia, empasis on conchal creation
MatsumotoC K.
The 5th congress of the Asian Pacific Section(International confederation for plastic and reconstructive surgery
1989.9
Istanbul Turky
@
ƒ}ƒEƒX”玉‘B‚É‚¨‚Ż‚éƒrƒ^ƒ~ƒ“A‚Ě’™‘ ”\
źˆä@–F•v@@‹gě@–M•F iă‘ĺj @@“Ą“c@Ž’j
‘ć21‰ń“ú–{—Տ°“dŽqŒ°”÷‹žŠw‰ď‘‰ď
1989.9.
_ŒË
@
Chondrodermatitis nodularis chronica helicis ‚Ě‚P—á
‘Dˆä@—´•F@@‹gě@–M•F
‘ć85‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1990.1.25
‘ĺă
@
ƒGƒ`ƒŒƒgƒi[ƒg’ˇŠú“ŕ•ž‚É‚¨‚Ż‚é—LŒřŤ‚ĆˆŔ‘SŤ‚ĚÄŒŸ“˘
‰Ş“c“Ţ’ĂŽq@@“ŒŽR@^—˘@@‹gě@–M•F iă‘ĺj @@X–{@Ă•v i“Ż•úŽËü‰Čj
‘ć41‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1990.10.12-13
•Ÿˆä
@
ƒXƒeƒƒCƒh—Ł’E SLE Źl’jŽq‚É”­Ç‚ľ‚˝ Linear IgA Bullous Dermatosis
˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć41‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1990.10.12-13
•Ÿˆä
@
ŠˆŤŒ^ Vitamin D3‚ĚƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě×–EŽüŠú‚Ć•Ş‰ť‚ɑ΂ˇ‚é‰e‹ż
Ź—с@Ć–ž@@’†’J@G‘˘@@‰œ‘ş@GM@@ź–{@–M•v@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć41‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1990.10.12-13
•Ÿˆä
@
–Œ‰Š‚đ•š”­‚ľ‚˝ PSS ‚Ć‘˝”­Ť‹Ř‰Š‚Ě Overlap Syndrome
“cŒű@”ŽN@@Ź—с@Ć–ž@@“ŒŽR@^—˘@@‘Dˆä@—´•F@@‹gě@–M•F
‘ć42‰ń“ú”ç‰ďź•”Žx•”‘‰ď
1990.10.27-28
L“‡
@
Role of 1,24R-Dihydroxyvitamin D3, a novel synthetic analogue of vitamin D3 in growth and differentiation of human keratinocytes.
Yoshikawa, K., Matsumoto, Ku., Hashimoto, K. and Kiyoki M.
7th annual symposium of Skin Pharmacology Society
1990.10.30-31
Hiroshima
@
Involvement of endogenously produced 1,25-dihydroxyvitamin D3 in the regulation of humankeratinocyte.
Hashimoto, K., Matsumoto, Ku., Kiyoki, M. and Yoshikawa K.
‘ć15‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1990.10.5-7
‰YˆŔ
@
Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-beta 1.
Hashiro, M., Okumura, H., Matsumoto, Ku., Hashimoto, K. and Yoshikawa, K.
‘ć15‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1990.10.5-7
‰YˆŔ
@
Immunocytechemical localization of the 1,25-dihydroxyvitamin D3-receptor in normal and psoriatic epidermis.
Higashiyama, M., Matsumoto, Ku., Hashimoto, K., Yoshikawa, K., Matsumoto, S., Yamaoka, K., Tanaka, H. and Seino, Y.
‘ć15‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1990.10.5-7
‰YˆŔ
@
Retinoic acidiRAj modulation of urokinase type plasminogen activator and their inhibitors in human keratinocytes.
Iwasa, M., Hashimoto, K., Ikuta, H., Higashiyama, M., Hashiro, M., Okumura, H. and Yoshikawa, K.
‘ć15‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1990.10.5-7
‰YˆŔ
@
A new method for quantifying keratinocyte differentiation using immunofluorescent staining of involucrin and cytefluorography.
Okumura, H., Hashimoto, K., Matsumoto, Ku. and Yoshikawa, K.
‘ć15‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1990.10.5-7
‰YˆŔ
@
A simple system to irradiate cultured fibroblasts with UVA light.
Sato, K. and Yoshikawa, K.
‘ć15‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1990.10.5-7
‰YˆŔ
@
Šç–ʐisŤŽ‰–bˆŢkÇ‚Ě‚PÄŒš—á
âˆä@–ő•v@@“Ąě@š˜a@@‚“c@ÍD@@ź–{@ˆŰ–ž
‘ć‚W‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ď‘‰ď
1990.11.10
‹ŕ‘ň
@
łí•\”ç‹y‚ŃŠŁá•a•Ď•”•\”ç‚É‚¨‚Ż‚é 1,25-iOHj2D3ƒŒƒZƒvƒ^[‚̖Ɖu‘gDŠw“IŒŸ“˘
“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F@@ź–{@–M•v iă‘ĺj @@ź–{Ź•S‡@@ŽR‰Ş@ŠŽŽŸ@@“c’†@O”V@@´–ě@‰Ŕ‹I@
‘ć20‰ńŠî‘b”畆‰Č§˜b‰ď
1990.11.10-11
“Œ‹ž
@
“ď’Ž‚𔺂Á‚˝ Relapsing Polychondritis
“ŒŽR@^—˘@@‹gě@–M•F
‘ć301‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.11.16-17
‘ĺă
@
Cutaneous calcium oxalate deposition in hemodialized patient.
Isonokami, M., Nishida, K., Yoshikawa, K. and Sugimoto, K.
2nd Joint Meeting of Japan-China Dermatological Association
1990.11.19-20
Shanghai
@
A case of disseminated lymphocytoma cutis
Nakatani, S., Okada, N. and Yoshikawa, K.
2nd Joint Meeting of Japan-China Dermatological Association
1990.11.19-20
Shanghai
@
‚˘‚í‚ä‚éƒWƒ…[ƒŠƒ“ƒOávfó”畆‰Š‚Ć SLE ‚̍‡•š i…ávŤƒGƒŠƒeƒ}ƒg[ƒfƒXj
Šâ˛@^l@@˛“Ą@Œ’“ń@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć12‰ń…ávÇŒ¤‹†‰ď
1990.11.2
•Ÿ“‡
@
International Symposium on Occupational Dermatoses: Summary and prospects of occupational dermatoses.
Yoshikawa, K.
‘ć15‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1990.11.30-12.2
–źŒĂ‰Ž
@
•ÇŽ†’†‚Ě Formaldehyde ‚É‚ć‚éÚG”畆‰ŠC ŽŠ‰ĆŠ´ěŤŽź]‚Ě‚P—á
Šâ˛@^l@@‰œ‘ş@GM@@’Šě—R‰Ŕ—˘@@‹gě@–M•F
‘ć15‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1990.11.30-12.2
–źŒĂ‰Ž
@
Kathon CG ‚É‚ć‚éƒAƒŒƒ‹ƒM[ŤÚG”畆‰Š‚Ě‚P—á
’Šě—R‰Ŕ—˘@@Šâ˛@^l@@‰œ‘ş@GM@@‹gě@–M•F
‘ć15‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1990.11.30-12.2
–źŒĂ‰Ž
@
375nm ‚Ě’PFŒő‚ĹŽí“——l…ávÇŠłŽŇ‚É—U”­‚ł‚ę‚˝Ž‡”Á‚ɂ‚˘‚Ä
˛“Ą@Œ’“ń@@’Ň‘ş”ü•äŽq@@‹gě@–M•F@@Šě‘˝–쐪•v
‘ć‚U‰ńŒőś•¨ŠwƒVƒ“ƒ|ƒWƒEƒ€
1990.12.11-12
“Œ‹ž
@
“úŒő‚ĚŒ÷ß|”畆‚Ćƒrƒ^ƒ~ƒ“D
‹gě@–M•F
ƒVƒ“ƒ|ƒWƒEƒ€FŽ‡ŠOü–hŒä‚đl‚Ś‚é
1990.12.13
“Œ‹ž
@
ƒAƒ“ƒ`ƒZƒ“ƒX c-myc ƒIƒŠƒSƒkƒNƒŒƒIƒ`ƒh‚É‚ć‚鐳íƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě‘B—}§‚Ć•Ş‰ť‚Ć‚ĚŠÖ˜A‚ɂ‚˘‚Ä
‰H”’ ˝@@‰œ‘ş@GM@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć‚T‰ń×–EœŠiŒ¤‹†‰ď
1990.12.19
‘ĺă
@
”|—{łíƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě‘BE•Ş‰ť‚ɑ΂ˇ‚é TNFƒż‚̉e‹ż
‰œ‘ş@GM@@ěŒű@@@@ś“c@GŽq@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć302‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.12.22
‘ĺă
@
BartÇŒóŒQŒZ’í—á‚ĚŒoŒą
ˆäă@—TŽj@@‘ĺŒ´@‹`—Y@@ŠC˜VŒ´–­Žq@@ź’J@–ÎŽ÷
‘ć55‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.12.6
_ŒË
@
von Reckinghausen•a‚Ěˆâ“`Žq‰đÍ
ŠC˜VŒ´–­Žq@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj@@ź’J@–ÎŽ÷ iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć55‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.12.8
_ŒË
@
—ź‘¤‰şŠ{ŠÖß“Ë‹NœÜŒă‚Ě•ĎŒ`ŽĄ–ü‚Q—á‚ɑ΂ˇ‚鉺Š{Ž}–îóœŘ‚čp‚đ—p‚˘‚˝ŽĄ—ĂŒoŒą
ŒŽ–ě@‹Ĺ•F@@ă’n@@‹M@@“Ąě@š˜a@@“cŠ@äŽk@@’†ě@’B—T@@ź–{@ˆŰ–ž
‘ć55‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.12.8
_ŒË
@
’܉şŠOœŽî‚ɂ‚˘‚Ä
ź‰ş@“N–ç@@’JŒű@@š iŠÖź˜JĐŒ`Źj
‘ć55‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.12.8
_ŒË
@
“ŞŒz•”ŠŕŘœŒă‚ĚŠáâ|ÄŒš‚ɂ‚˘‚Ä
™Œ´@@Ži@@“Ąě@š˜a@@‚“c@ÍD@@âˆä@–ő•v@@ź–{@ˆŰ–ž
‘ć55‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.12.8
_ŒË
@
Z“űŠŕŘœŒă‚ɍs‚Á‚˝‹š•ÇÄŒš‚ĚŒŸ“˘
ź‘q@“NŽi@@‘O“c@@‹@@‰Yě@W–ç@@—с@@ŕŠw@@ź–{@@‘ i‘ĺăŒxŽ@Œ`Źj
‘ć55‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.12.8
_ŒË
@
”LŽ¨”ç•Ů–@ iˆŔŁj ‚É‚ć‚é–„–vŽ¨Cł‚ĚŒoŒą
ź–{@@‘@@‘O“c@@‹@@‰Yě@W–ç@@—с@@ŕŠw@@ź‘q@“NŽi i‘ĺăŒxŽ@Œ`Źj
‘ć55‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.12.8
_ŒË
@
“–‰Č‚É‚¨‚Ż‚é‰ß‹Ž10”NŠÔ‚Ě“ű–[ÄŒšp
­“c@‰ŔŽq@@‹´–{@—T”V@@Šě‘˝@—zŽq@@×ě@@˜i@@‹eˆä@’mŽq@@”–@@ä•v iZ—FŒ`Źj
‘ć55‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.12.8
_ŒË
@
O—ôŠO•@CłŽčp‚É‚¨‚Ż‚鎨‰î•Ą‡ˆÚA‚ĚŒŸ“˘
”–@@ä•v@@‹eˆä@’mŽq@@×ě@@˜i@@­“c@‰ŔŽq@@‹´–{@—T”V@@Šě‘˝@—zŽq iZ—FŒ`Źj
‘ć55‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.12.8
_ŒË
@
‰şŒűOˆŤŤŽîᇐ؏œŒă‚̍L”͈͌‡‘š‚ɑ΂ˇ‚éÄŒš–@‚ĚŒŸ“˘
–{‘˝@•üm@@“cŒ´@—RŽq@@“úŠ}@@šć i‘ĺă‘DˆőŒ`Źj @@“Ąě@š˜a iă‘ĺj@@‘q“c‘‘‘ž˜Y@@Ž›Žt@_l i‘ĺ•Şˆă‘ĺ”畆j
‘ć55‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.12.8
_ŒË
@
’_ŠÇŠŕ‚̔畆“]ˆÚ‚Ě‚P—á
ă“c@´—˛@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj @@‹ŕˆä@r—Y i“Ż“ńŠOj
‘ć297‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.2.17
‘ĺă
@
Proliferating cell nuclear antigen iPCNAj/cyclin in cultured human keratinocytes
Okada, N., Miyagawa, S., Takasaki, Y. and Yoshikawa, K
15th Annual Meeting of Pacific Skin Research Club
1990.3.17-19
Tokyo
@
Down regulation of EGF receptor in human keratinocytes by EGF and TGF-alpha.
Higashiyama, M., Yoshimasa HH, Nishida, Y., Matsumoto, Ku., Hashimoto, K. and Yoshikawa, K.
15th Annual Meeting of Pacific Skin Research Club
1990.3.18-19
Tokyo
@
Šç–Ę‚ÉÄ”­‚ˇ‚é‰óŽ€Ť“÷‰čŽîŤ•a•Ď|f’f—á|
“A@@‰pŽ÷@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj @@Ş—ˆ@@–Î i“ŻŽO“ŕj
‘ć298‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.3.24
“Ţ—Ç
@
‘Ť’ę‚É“]ˆÚŤŽîᎂ𐶂ś‚˝t×–EŠŕ‚Ě‚P—á
‘ęK@’żd@@“úŠ}@@šć@@–k‹g@@Œő@@‹gě@–M•F iă‘ĺj@@•Ŕ–؁@Š˛•v i“Ż”ĺ”AŠí‰Čj @@
‘ć298‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.3.24
“Ţ—Ç
@
“–‰Č‚É‚¨‚Ż‚ét‘š—á‚ĚŒŸ“˘
âˆä@–ő•v@@ŽR‹g@@Ž @@Ź“c@ł”V@@ź’J@Œő–ž@@Œj“c@‹eŽk i•{—§‹~‹}j
‘ć‚S‰ń“ú–{ŠOŒ¤‹†‰ď
1990.4.20
‘ĺă
@
‹}ŤƒAƒjƒŠƒ“’†“Ĺ‚Ě‚Q—á
âˆä@–ő•v@@—é–؁@ˆę@@‘叼@łG@@Œj“c@‹eŽk@@‹{“‡@Œ[Žq@@‹g“c@r–ž@@•˝“c@@‰q@@“c•Ł@••v i•{—§‹~‹}j
‘ć10‰ń“ú–{’†“ĹŒ¤‹†‰ďź“ú–{•”‰ď
1990.4.28
_ŒË
@
‚U‰żƒNƒƒ€‚É‚ć‚éL”͈͔M‚ĚŒoŒą
—с@@ŕŠw@@‹vŽu–{@“Œ@@‚“c@ÍD@@ó“c@—TŽi i‘ĺăŒxŽ@Œ`Źj
‘ć33‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1990.4.5
“Œ‹ž
@
‚í‚ę‚í‚ę‚ĚŒoŒą‚ľ‚˝”畆Ź‡Žű—e22—á‚ɂ‚˘‚Ä‚ĚŒŸ“˘
ŠC˜VŒ´–­Žq@@ź–{@ˆŰ–ž@@‘O“c@@‹@@“Ąě@š˜a@@“cŒ´@—RŽq@@‹g—´@ŸŽq iă‘ĺj @@‹vŽu–{@“Œ i‹vŽu–{ƒNƒŠƒjƒbƒNj
‘ć33‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1990.4.5
“Œ‹ž
@
‚—îŽŇ‚É‚¨‚Ż‚éƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[
–k‹g@@Œő@@ź–{@ˆŰ–ž@@“Ąě@š˜a@@ź‰ş@“N–ç@@“úŠ}@@šć iă‘ĺj @‘O“c@@‹ i‘ĺăŒxŽ@Œ`Źj @@–{‘˝@•üm i‘ĺă‘Dˆő•ŰŒŻŒ`Źj
‘ć33‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1990.4.5
“Œ‹ž
@
ƒqƒg–Ń•ď×–E‚Ě”|—{
‘q“c‘‘‘ž˜Y@@Ž›Žt@_l i‘ĺ•Şˆă‘ĺŒ`Źj @@”ÂŒŠ@@’q@@‚ˆŔ@@i i“Ż”畆j
‘ć33‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1990.4.6
“Œ‹ž
@
Combined Free Flap‚ĚŒoŒą
‘O“c@@‹@@ź–{@ˆŰ–ž@@“Ąě@š˜a@@–k‹g@@Œő@@ź–{@@‘@@Žs–ě@’źŽ÷ iă‘ĺj @@Š_•Ł@ł’j i•{—§Źl•aƒZƒ“ƒ^[Ž¨•@‰Čj
‘ć33‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1990.4.6
“Œ‹ž
@
”畆Šŕ×–E‚É‚¨‚Ż‚鑝B×–EŠjRŒ´‚Ě”­Œť‚ɂ‚˘‚Ä
‰Ş“c“Ţ’ĂŽq@@‹{ě@KŽq@@‚č@–FŹ@@‹gě@–M•F
‘ć89‰ń“ú”ç‰ď‘‰ď
1990.5.10-12
“ż“‡
@
”|—{×–E‚ɑ΂ˇ‚é—ő‰ż‚ō‚ƒGƒlƒ‹ƒM[‚Č UVA ĆŽÓ‘•’u‚ĚŠJ”­
˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć89‰ń“ú”ç‰ď‘‰ď
1990.5.10-12
“ż“‡
@
ÄŠ´ő‚ލl‚Ś‚ç‚ę‚˝Œ°Ç”~“Ĺ‚Ě‚QÇ—á
Žs“c@“Nˆę@@’JŠ_@••F@@’Ïă@‹v–í
‘ć89‰ń“ú”ç‰ď‘‰ď
1990.5.10-12
“ż“‡
@
‘Ť’ę’×ᇂ𔺂ȂÁ‚˝ˆâ“`ŽqŤŠ´ŠoŤƒjƒ…[ƒƒpƒ`[ iHSNj ‚Ě‚P—á
Ź—с@Ć–ž@@“cŒű@”ŽN@@“ŒŽR@^—˘@@‘Dˆä@—´•F@@‹gě@–M•F@@“Ą‘ş@°r@@’†@@@—˛@@‘ž“c@‡Žq
‘ć89‰ń“ú”ç‰ď‘‰ď
1990.5.10-12
“ż“‡
@
‘BŤ“VávጠiHallopeau Œ^j ‚Ě‚P—á
’JŒű@—´ś@@Šâ˛@^l@@‹ŕ@@˜aŽq@@‘Dˆä@—´•F@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć89‰ń“ú”ç‰ď‘‰ď
1990.5.10-12
“ż“‡
@
Induction of proliferating cell nuclear antigen/cyclin by retinoic acid in SV40-transformed human keratinocytes
Okada, N., Miyagawa, S., Takasaki, K. and Yoshikawa, K.
51st Annual Meeting of the Society for Investigative Dermatology
1990.5.2-5
Washington DC
@
Anaphylactic symptoms due to chlorhexidine gluconate.
Okano, M.
Clinical Dermatology in the year 2000
1990.5.22-25
London
@
”M‚É‚ć‚éŒz•”‚̏Ź”͈͔MŒă‚ɍ‚“x‚ĚˆôA“Ş•‚Žî‚đ‚Ť‚˝‚ľ‚˝‚R—cŽ™—á
âˆä@–ő•v@@“Œ@@FŽŸ@@ź’J@Œő–ž@@Œj“c@‹eŽk i•{—§‹~‹}j @@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć16‰ń“ú–{”MŠw‰ď
1990.5.25
“Œ‹ž
@
Chronic GVHD ‚Ě‚P—á
’†’J@G‘˘@@‹gě@–M•F
‘ć94‰ń“ú”ç‰ďŽl‘’n•ű‰ď
1990.5.26
źŽR
@
Soft tissue chondroma ‚Ě‚P—á
Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@“Ąě@š˜a iă‘ĺj
‘ć83‰ń‹ß‹EW’k‰ď
1990.6.17
_ŒË
@
‹ÇŠƒŠƒ“ƒpß“]ˆÚ‚đ—ˆ‚˝‚ľ‚˝ Triple Extramammary Paget •a‚Ě‚P—á
–k‹g@@Œő@@ź–{@ˆŰ–ž@@“Ąě@š˜a@@ź‰ş@“N–ç@@Žs–ě@’źŽ÷@@‹gě@–M•F
‘ć83‰ń‹ß‹EW’k‰ď
1990.6.17
_ŒË
@
‘ĺ—Ę“fŒŒ‚đ—ˆ‚˝‚ľ‚˝ Pseudoxanthoma elasticum ‚Ě‚P—á
’JŒű@—´ś@@“ŒŽR@^—˘@@–ě‘ş@­•v@@‹gě@–M•F iă‘ĺj @@ŽR–{@Œ[—Y@@“c•š@‹v”V i“ŻĐŠQŠO‰Čj@
‘ć83‰ń‹ß‹EW’k‰ď
1990.6.17
_ŒË
@
‰óŽ€Ť‹Ř–Œ‰Š‚đÄ“x‡•š‚ľC ‚ť‚ĚŠÔ–ňÜŤ”ÄŒŒ‹…Œ¸­Ç‚Š8 trisomy ‚𔺂¤ MDS ‚Ɉڍs‚ľ‚˝‚P—á
’r“c@O˜a@@ź‘ş@@“ž@@ź‰Y@“N—Y@@ź‘ş@—˛’ʁ@@‹ŕŽR@—Ç’j@@•Ä‘ň@@‹B@@‚ˆä´ˆę˜Y iă‘ĺ“ń“ŕj @@źˆä@‘P•F@@‘Dˆä@—´•F@@‹gě@–M•F i“Ż”畆‰Čj
‹ß‹EŒŒ‰tŠw’n•ű‰ď
1990.6.2
@
@
Ä”­ŤŽq‹{čňŠŕ‚ɍ‡•š‚ľ‚˝ƒKƒX‰óát
Ż“c—T‹IŽq@@“ŒŽR@^—˘@@‹gě@–M•F iă‘ĺj @@”‹Œ´@ł‹v i“Ż•wl‰Čj
‘ć299‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.6.2
“ňč
@
‹‘ĺŒŒŠÇŽî‚Ě‚P—á
’†‘ş@‹`–ž@@HŒł@—˛“š i‘ĺă•{—§j @@“Ąě@š˜a iă‘ĺj
‘ć299‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.6.2
“ňč
@
“Ť‘Ť’ę’×ᇂƊç–Ę‚Ě•sŠŽ‘S’EF‘f”Á‚đ‚Ý‚˝’‹ŒŤ‚炢‚Ě‚P—á
‘q’m‹MŽu˜Y@@“ŒŽR@^—˘@@‘Dˆä@—´•F@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj@@–q–ě@ł’ź i•{—§Œö‰qŒ¤j @@
‘ć299‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.6.2
“ňč
@
‚­‚č‚Ę‚Ťˆło–@‚É‚ć‚éƒAƒeƒ[ƒ}‚ĚŽĄ—Ă
Žs–ě@’źŽ÷@@ź–{@ˆŰ–ž@@“Ąě@š˜a@@–k‹g@@Œő@@“cŒ´@—RŽq
‘ć54‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.6.2
_ŒË
@
”Má­‚É”­ś‚ľ‚˝Ž‰–b“÷Žî‚Ě‚P—á
ź–{@@‘@@ź–{@ˆŰ–ž@@ź’J@–ÎŽ÷@@ź‰ş@“N–ç@@‹g—´@ŸŽq
‘ć54‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.6.2
_ŒË
@
Campomelic syndrome‚Ě‚P—á
“cŠ@äŽk@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj@@ŠC˜VŒ´–­Žq iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć54‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.6.2
_ŒË
@
Medial Plantar Flap‚É‚ć‚éƒXƒ|[ƒNŠO‚ĚŽĄ—ĂŒoŒą
“Ąě@š˜a@@ź–{@ˆŰ–ž@@–k‹g@@Œő@@ź‰ş@“N–ç@@“úŠ}@@šć
‘ć54‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1990.6.2
_ŒË
@
”öĺ•”‚ɐś‚ś‚˝Mucinous Cyst Adenoma‚ĚŽĄ—ĂŒoŒą
—с@@ŕŠw@@ó“c@—TŽi@@‚“c@ÍD@@‘O“c@@‹
‘ć54‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖź’n•ű‰ď
1990.6.2
_ŒË
@
ƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚é TGF-b ‚É‚ć‚é c-myc ”­Œť’˛ß
‰œ‘ş@GM@@‰H”’@@˝@@ź–{@–M•v@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć‚T‰ńŠp‰ťÇŒ¤‹†‰ď
1990.6.2
“Œ‹ž
@
ƒGƒŠƒbƒNƒX“_Šá‰t$5001‚É‚ć‚éÚG”畆‰Š‚Ě‚Q—á
Šâ˛@^l@@’Šě—R‰Ŕ—˘@@‰œ‘ş@GM@@‹gě@–M•F iă‘ĺj @@“Ą–{@Œ\ˆę iZ—Fj
‘ć20‰ńRŒ´Œ¤‹†‰ď
1990.6.30-7.1
“Œ‹ž
@
łí”|—{ƒqƒg•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚ć‚é25-OH-D3‚Š‚ç‚Ě1,25-iOHj2D3‚ĚŽYś
‹gě@–M•F@@ź–{@–M•v@@‹´–{@Œö“ń iă‘ĺj @@´–؁@@Œě‹gě@–M•F@@ź–{@–M•v@@‹´–{@Œö“ń iă‘ĺj @@´–؁@@Œě
‘ć242‰ńŽ‰—nŤƒrƒ^ƒ~ƒ“‘‡Œ¤‹†ˆĎˆő‰ď
1990.7.20
‘ĺă
@
‹­”çÇ‚ƐS‹Ř•a•Ď iS‹ŘƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚É‚ć‚é‰đÍj
‹gě@–M•F@@’J@@–ž”Ž@@‘ęK@’żd
‹­”çÇ’˛¸Œ¤‹†”ǁ@•˝Ź‚Q”N“x‘ć‚P‰ń”ljď‹c
1990.7.28
“Œ‹ž
@
iƒVƒ“ƒ|ƒWƒEƒ€F—˜_‚ÉŠî‚Ă‚­V‚ľ‚˘ŽĄ—Âɂ‚˘‚āj @ƒrƒ^ƒ~ƒ“D‚É‚ć‚éŠŁá‚ĚŽĄ—Ă
‹gě@–M•F
‘ć300‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.7.6-7
‘ĺă
@
iƒ[ƒNƒVƒ‡ƒbƒvF”畆‰Č—Ěˆć‚É‚¨‚Ż‚éĹ‹ß‚̐i•ŕ‚ɂ‚˘‚āj @V‚ľ‚˘RŠjR‘Ě i‰źĚPTNAj ‚̉đÍ
‹{ě@KŽq@@ˆîŠ_@ˆŔ‹I@@‰Ş“c“Ţ’ĂŽq@@‹g‰Ş@@Í@@A–؁@G–ž@@‹gě@–M•F@@”’ˆä@—˜•F
‘ć300‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.7.6-7
‘ĺă
@
Transforming growth factor ‚Ɣ畆
‹´–{@Œö“ń
‘ć300‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.7.6-7
‘ĺă
@
Median Raphe Cyst of the Penis ‚Ě‚P—á
Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@ˆéƒmăł–ž iă‘ĺj
‘ć300‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.7.6-7
‘ĺă
@
‘ĺă’n•ű‰ď‚đU•Ô‚Á‚Ä
˛–ě@žÄt
‘ć300‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.7.6-7
‘ĺă
@
”牺Ž‰–bD‰Š”ç]‚Ĺ”­Ç‚ľ‚˝”畆 T ×–EŤƒŠƒ“ƒpŽî‚Ě‚P—á
’M’J@Ÿm@@‰€“c@‘•c@@”Ą–ě@@“N@@“ŒŽR@^—˘@@‘Dˆä@—´•F@@‹´–{@Œö“ń@@‹gě@–M•F@
‘ć300‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1990.7.6-7
‘ĺă
@
ƒŒƒ`ƒm[ƒ‹‚É‚ć‚éƒqƒg‘@ˆŰ‰č×–E‚Ěƒgƒ‰ƒ“ƒXƒtƒH[ƒƒCƒVƒ‡ƒ“‚Ě—}§
˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć12‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1990.8.3-4
‚ź
@
œ‘Ťƒvƒƒgƒ|ƒ‹ƒtƒBƒŠƒ“Ç‚Ě‚Q—á
Ź—с@Ć–ž@@Ż“c—T‹IŽq@@˛“Ą@Œ’“ń@@‹gě@–M•F iă‘ĺj@ ”¨@´ˆę˜Y i‘ĺă˜JĐj@@
‘ć12‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1990.8.3-4
‚ź
@
ƒPƒ‰ƒ`ƒmƒTƒCƒg“ŕ‚ŐśŹ‚ł‚ę‚˝ŠˆŤŒ^ƒrƒ^ƒ~ƒ“‚c3‚Ş‚ť‚Ě‘BC •Ş‰ť‚ÉŠÖ—^‚ˇ‚é‰Â”\Ť‚ɂ‚˘‚Ä
ź–{@–M•v@@‰œ‘ş@GM@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć63‰ń“ú–{ś‰ťŠw‰ď
1990.9.12-15
‘ĺă
@
Epidermal cell differentiation inhibitor iEDINj
›ˆä@Šîs@@‹´–{@Œö“ń@@ˆäă@LŒá@@ź–{@–M•v@@Œă“Ą@”ޏd@@‘ĺŠL@G—Y@@Žş‰Ş@‹`Ÿ@@^@@‰p–ž@@‹gě@–M•F@@™’†@GŽő
‘ć63‰ń“ú–{ś‰ťŠw‰ď
1990.9.12-15
‘ĺă
@
”畆‚̍\‘˘‚Ć‹@”\
‹gě@–M•F
“ú–{‰Ć­Šw‰ď”í•ž‰qśŠw•”‰ď@‘ć‚X‰ń”í•ž‰qśŠwƒZƒ~ƒi[
1990.9.20-21
L“‡
@
1a,25-dihydroxyvitamin D3‚¨‚ć‚Ń1a,24R-dihydroxyvitamin D3‚̐łí‚¨‚ć‚ŃŠŁá•a•Ď•”•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚ɑ΂ˇ‚é‰e‹ż
‹´–{@Œö“ń@@ź–{@–M•v@@“ŒŽR@^—˘@@Ź—с@Ć–ž@@´–؁@@Œě@@‹gě@–M•F
‘ć‚T‰ń“ú–{ŠŁáŠw‰ď
1990.9.7-8
Ž­Ž™“‡
@
SLE ‚É•š”­‚ľ‚˝ Duhring áv]ó”畆‰Š iLinear IgA bullous dermatosisj ‚Ě‚P—á
Šâ˛@^l@@ź–{@–M•v@@‹´–{@Œö“ń@@‹gě@–M•F@@––‘ş@łŽ÷
ş˜a63”N“x‘ĺă•{äPŒ´•aŒ¤‹†‰ď
1991
‘ĺă
@
Possible group A xeroderma pigmentosum patient with mild neurological abnormalities.
Sato, K. and Yoshikawa, K.
7th Korea-Japan Joint Meeting of Dermatology
1991.10.18-19
Seoul
@
Šj‹y‚Ń•Ş—ô‚ÉŠÖ—^‚ˇ‚é×–E“ŕŹŠíŠŻ‚ɑ΂ˇ‚郂ƒmƒNƒ[ƒiƒ‹R‘Ě‚đ—p‚˘‚˝ƒvƒŠƒ“ƒOƒ‹•a×–EC ‘gD‚ĚŒ`‘ÔŠw“IŒ¤‹†
‹ŕ“c@^—@@‹gě@–M•F
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ljď‹c@•˝Ź‚R”N“x‘ć‚P‰ń
1991.10.24
“Œ‹ž
@
“ű–[ƒy[ƒWƒFƒbƒg•a‚Ě‚P—á
ŠŁ@@dŽ÷@@ˆéƒmăł–ž@@’JŠ_@••F@@‹gě@–M•F
‘ć307‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.10.5
‘ĺă
@
Proliferating trichilemmal cyst ‚Ě‚P—á
“Ąč@O”V@@ˆéƒmăł–ž@@‘ęK@’żd@@‹gě@–M•F
‘ć307‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.10.5
‘ĺă
@
Ž‰–bD‰Š‚𔺂˘ŠÔŽżŤ”x‰Š‚ĹŽ€–S‚ľ‚˝”畆‹Ř‰Š‚Ě‚P—á
‘q’m‹MŽu˜Y@@ˆéƒmăł–ž@@‹gě@–M•F iă‘ĺj @@Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@Ž­–ě@@•× i“Ż“ŕ‰Čj@
‘ć307‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.10.5
‘ĺă
@
“ŞŠWŠç–Ę‹‘ĺŽîᎂ̈ę—á
Œ´Œł@@’ށ@@ŠÖŒű@‡•ă@@Ź—ѐ˝ˆę˜Y@@‚—œ@^‹ł@@‘ĺXŠě‘ž˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć‚X‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1991.11.1
‰Ą•l
@
ăŠ{ÄŒšp‚É‚¨‚Ż‚é•@oěŹ‚ĚŒŸ“˘
âˆä@–ő•v@@“Ąě@š˜a@@ź–{@ˆŰ–ž iă‘ĺj @@‘O“c@@‹ i‘ĺăŒxŽ@Œ`Źj
‘ć‚X‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ď‘‰ď
1991.11.1
‰Ą•l
@
“ŞŒz•”Šŕ‚É‚¨‚Ż‚éŠáâ|‘S“EŒă‚ĚÄŒš‚ɂ‚˘‚Ä
“Ąě@š˜a@@âˆä@–ő•v@@ŠC˜VŒ´–­Žq@@ź–{@ˆŰ–ž
‘ć‚X‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ď‘‰ď
1991.11.1
‰Ą•l
@
œ‘Ťƒvƒƒgƒ|ƒ‹ƒtƒBƒŠƒ“Ç‚Ě‚P—á
˛“Ą@Œ’“ń@@“cŒű@”ŽN@@‹gě@–M•F
‘ć97‰ń“ú”ç‰ďŽl‘’n•ű‰ď
1991.11.2
“ż“‡
@
Furlow–@‚É‚ć‚éŒűŠWŒ`Źp‚ĚŒŸ“˘
ˆäă@—TŽj@@ź’J@–ÎŽ÷@@‹g—´@ŸŽq@@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć‚X‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1991.11.2
‰Ą•l
@
Tissue Expansion‘ĚŠO–@‚ĚˆęH•v
ź’J@–ÎŽ÷@@ˆäă@—TŽj@@‘ĺŒ´@‹`—Y@@‹g—´@ŸŽq iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć‚X‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1991.11.2
‰Ą•l
@
‘OŠz‚̏pŒăŒ`‘Ԃɂ‚˘‚Ä‚ĚŒŸ“˘
Š_•Ł@ł’j@@Ź—ѐ˝ˆę˜Y@@‚–؁@@ł@@‘q•Đ@@—D@@–ě‘ş@’qŽj@@‘ĺXŠě‘ž˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć‚X‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1991.11.2
‰Ą•l
@
ć“VŤŠááىş‚‚É‚¨‚Ż‚é‹“‹Ř’Zkp‚Ě“K‰ž
ŠC˜VŒ´–­Žq@@“Ąě@š˜a@@ź–{@ˆŰ–ž
‘ć57‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.11.30
‹ž“s
@
œ•ĎŒ`‚𔺂Á‚˝Šç–ĘŒŒŠÇŽî‚Ě‚PŽĄ—Ă—á
ŒK]@ŽŽ÷@@ă’n@@‹M@@ź–{@ˆŰ–ž
‘ć57‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.11.30
‹ž“s
@
Šá‹…“EoŒă•úŽËüĆŽË‚É‚ć‚éˆŢkŤ•ĎŒ`‚Ě‚PŽĄ—Ă—á
×ě@@˜i@@­“c@‰ŔŽq@@‹´–{@—T”V@@‹eˆä@’mŽq@@”–@@ä•v iZ—FŒ`Źj
‘ć57‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.11.30
‹ž“s
@
—V—Ł“ŕ‘¤‘Ť’ę”ç•Ů‚É‚ć‚éćů•”ˆČŠO‚Ě‰×d•”ˆĘÄŒš
âˆä@–ő•v@@“Ąě@š˜a@@ź–{@ˆŰ–ž
‘ć57‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.11.30
‹ž“s
@
č󕔍œŘœ‚đ•š—p‚ľ‚˝‰şŠ{•ŞßœŘ‚čp‚ĚŒoŒą
ă’n@@‹M@@ź–{@ˆŰ–ž@@ŒŽ–ě@‹Ĺ•F
‘ć57‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.11.30
‹ž“s
@
‰ş‘Ú’×ᇂ̎Ą—ĂŒoŒą
ź‘q@“NŽi@@‘O“c@@‹@@‰Yě@W–ç@@—с@@ŕŠw@@Žs–ě@’źŽ÷ i‘ĺăŒxŽ@Œ`Źj
‘ć57‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.11.30
‹ž“s
@
‰şˆô“ŞŠŕÄŒšŒă‚̐ېH”­ş‹@”\‚ĚŒŸ“˘
–k‹g@@Œő@@˛“Ą@•’j@@‹g–ě@–Mr@@”n’J@Ž‘Ľ@@“Ąˆä@@—˛@@ˆÉ“Ą@@‘@@•Ÿ“c@˜a‘× i•{—§Źl•aƒZƒ“ƒ^[Ž¨•@‰Čj
‘ć57‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.11.30
‹ž“s
@
ƒy[ƒXƒ[ƒJ[˜IoÇ—á‚ĚŽĄ—Ă
—с@@ŕŠw@@‘O“c@@‹@@‰Yě@W–ç@@Žs–ě@’źŽ÷@@ź‘q@“NŽi i‘ĺăŒxŽ@Œ`Źj
‘ć57‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.11.30
‹ž“s
@
‹š”w“ŽĂ–Ź‚đŒŒŠÇ•ż‚Ć‚ˇ‚錨bœˆÚA‚É‚ć‚éÄŒš—á
–{‘˝@•üm@@ó“c@—TŽi@@“cŠ@äŽk i‘ĺă‘DˆőŒ`Źj @@“Ąě@š˜a iă‘ĺj@@X‰ş@ł–ž i‘ĺă•{—§Ž•‰ČŒűoŠO‰Čj
‘ć57‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.11.30
‹ž“s
@
ƒVƒ“ƒ|ƒWƒEƒ€F”|—{Šp‰ť×–E‚ĚŽĄ—Âւ̉ž—p
‹´–{@Œö“ń
‘ć42‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1991.11.30-12.1
_ŒË
@
”DPŤáv]
Œ´@@—mŽq@@ˆäăç’ĂŽq i‘ĺŽč‘Oj @@“ŒŽR@^—˘ iă‘ĺj
‘ć42‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1991.11.30-12.1
_ŒË
@
F‘fŤŠŁ”çÇŠłŽŇ‚É“K‚ľ‚˝‰Ä—p•ž’n‚ɂ‚˘‚Ä
˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć42‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1991.11.30-12.1
_ŒË
@
‚Ž‰ŒŒÇ‚𔺂Á‚˝‘˝”­Ť‰ŠFŽîÇ‚Ě‚Q—á
ŹŕVŒ’‘ž˜Y@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć42‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1991.11.30-12.1
_ŒË
@
ŠÖßÇŤŠŁá‚É‘˝”­Ťœ‘Žî‚Ɣ畆”S‰tŽî‚đ‡•š‚ľ‚˝‚PÇ—á
ź‰Ş@@‰@@ŽR‘ş@’íˆę@@‹gě@–M•F
‘ć42‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1991.11.30-12.1
_ŒË
@
‹}Ťœ‘Ť”’ŒŒ•a‚ĚŒo‰ß’†‚É”­Ç‚ľ‚˝ƒtƒUƒŠƒEƒ€Š´őÇ
“ŒŽR@^—˘@@‹gě@–M•F iă‘ĺj @@‘q‹´@_Ž÷@@‘˝˜a@ş—Y i“ŻŹŽ™‰Čj
‘ć42‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1991.11.30-12.1
_ŒË
@
Šj‹y‚ѐőF‘̂ɑ΂ˇ‚郂ƒmƒNƒ[ƒiƒ‹R‘́@|äPŒ´•a‚̉đÍ‚É‚Ţ‚Ż‚ā|
‹ŕ“c@^—@@‹gě@–M•F iă‘ĺj @@‹ŕ“c@ˆŔŽj i×–EHŠwƒZƒ“ƒ^[j@@EpsteinC A. i“ěƒJ‘ĺj @@
‘ć42‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1991.11.30-12.1
_ŒË
@
ƒqƒg•\”ç×–E‚Ě‘BE•Ş‰ť‚É‚¨‚Ż‚é FK506‚̍ě—p‹@\‚̉đÍ
Šâ˛@^l@@‹´–{@Œö“ń@@“ŒŽR@^—˘@@ěŒű@@@@‹gě@–M•F
‘ć308‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.12.14
‘ĺă
@
“ú–{l‚Ě“úŒő”˜˜I•”‚ɐś‚ś‚é”ń•FŽî”畆Šŕ‚Ě”­ś—ŚF1976-80”N‚Ć1986-90”N‚Ě‚QŠú”äŠr
Žs‹´@łŒő@@ŕ_“c@”P•v@@˛“Ą@Œ’“ń@@‘ź31–ź
‘ć308‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.12.14
‘ĺă
@
ƒqƒgüˆŰ‰č×–E‚ɑ΂ˇ‚é UVA ĆŽËƒŠƒ{ƒtƒ‰ƒrƒ“‚Ě’vŽ€ě—p
˛“Ą@Œ’“ń@@“cŒű@”ŽN@@‹gě@–M•F
‘ć‚V‰ńŒőś•¨ŠwƒVƒ“ƒ|ƒWƒEƒ€
1991.12.17-18
‘ĺă
@
ƒqƒgüˆŰ‰č×–E‚ɑ΂ˇ‚é UVA ĆŽËƒsƒŠƒhƒLƒVƒ“‚̉e‹ż
“cŒű@”ŽN@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć‚V‰ńŒőś•¨ŠwƒVƒ“ƒ|ƒWƒEƒ€
1991.12.17-18
‘ĺă
@
ƒŒƒ`ƒmƒCƒh’ˇŠú“Š—^‚É”ş‚¤œC ŠÖßˆŮí
‰Ş“c“Ţ’ĂŽq@@“ŒŽR@^—˘@@‹gě@–M•F
‘ć‚R‰ńƒŒƒ`ƒmƒCƒhƒVƒ“ƒ|ƒWƒEƒ€
1991.12.6-7
“Œ‹ž
@
ŒŒŠÇ•ż•tœ”ç•ŮˆÚA‚É‚ć‚éćůœœ‘‰ŠŒă•ĎŒ`‚ĚŽĄ—ĂŒoŒą
‚–؁@@ł@@Ź—ѐ˝ˆę˜Y@@ŠÖŒű@‡•ă i“Œ‹žŒxŽ@Œ`Źj
‘ć18‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1991.12.7
‘ĺ‹{
@
—V—Ł“Ş”ç”ç•Ů‚ĚŒŸ“˘
Š_•Ł@ł’j@@Ź—ѐ˝ˆę˜Y@@HŒŽ@Ží‚@@—^Ŕ@@ăŕ@@‘q•Đ@@—D@@‘ĺXŠě‘ž˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć18‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1991.12.7
‘ĺ‹{
@
“–‰Č‚É‚¨‚Ż‚é‹ŕ‘Žƒpƒbƒ`ƒeƒXƒgŹŃ
Šâ˛@^l@@’Šě—R‰Ŕ—˘@@“¨@@‡Žq@@‹gě@–M•F@@LŁ‚Ě‚čŽq
‘ć16‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1991.12.7-8
‘ĺă
@
ƒƒtƒFƒiƒ€Ž_‚É‚ć‚éŒĹ’č–ň]|•a•Ď•”‚Ĺ‚Ě‚Ý“\•tŽŽŒą‚É”˝‰ž‚đŽŚ‚ľ‚˝—á
“ŒŽR@^—˘@@Šâ˛@^l@@‹gě@–M•F
‘ć16‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1991.12.7-8
‘ĺă
@
ƒOƒŠƒ`ƒƒ““ŕ•ž‚É‚ć‚čC ‹UŤƒAƒ‹ƒhƒXƒeƒƒ“Ç‚đ‚Ť‚˝‚ľ‚˝Ç—á|”畆‹Ř‰Š‚đ‹^‚Á‚˝‰Ý•źóŽź]‚Ě‚P—á
źŽR@@i@@’M’J@Ÿm@@‘ęK@’żd@@‹gě@–M•F
‘ć303‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.2.16
‘ĺă
@
ƒPƒgƒvƒƒtƒFƒ“‚É‚ć‚éŒőÚG”畆‰Š‚Ě‚P—á
‹î‘ş@Œö”ü iă˜aň–kj @@Ź’ˁ@—Y–Ż i‘—§‘ĺăj @@‹gě@–M•F iă‘ĺj
‘ć304‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.3.30
‘ĺă
@
uƒqƒgƒqƒtƒoƒGv Dermatobia hominis ‚É‚ć‚é”畆”ˆĺvÇ i–{–M‚W—á–ځj
Œ´“c@@˝ i‘ĺăŽsj @@‹´–{@Œö“ń iă‘ĺj @@–î–ě@Œ’ˆę i“Ż”÷Œ¤j
‘ć304‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.3.30
‘ĺă
@
L”͈͊O‰A•”ƒpƒWƒFƒbƒg•a‚Ě‚R—á
ŹŕVŒ’‘ž˜Y@@•x“c@’qŽj@@Ż“c—T‹IŽq@@™Œ´@@Ži@@ŒŽ–ě@‹Ĺ•F@@“úŠ}@@šć@@‹gě@–M•F
‘ć304‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.3.30
‘ĺă
@
‰ß‹Ž‚Q”NŠÔ‚É—ˆ‰@‚ľ‚˝‘яóáv] iŹl…áv‚đŠÜ‚ށj Ç—á‚ĚŽĄ—ÐŹŃ‚ɂ‚˘‚Ä
ź‰i@‰xŽĄ i‹ß‹E’†‰›j @@’r“c@‘”V i“Ż“ŕ‰Čj @@Ź—с@Ć–ž@@‹´–{@Œö“ń iă‘ĺj
‘ć304‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.3.30
‘ĺă
@
Œă“VŤ•\”琅ávÇ‚Ě‚P—á
•x“c@’qŽj@@ˆéƒmăł–ž@@“ŒŽR@^—˘@@‘ęK@’żd@@‹´–{@Œö“ń@ʋgě@–M•F iă‘ĺj @@›Œ´@_”V i“Ż“ń“ŕj @@“y‹@•q–ž i”Ş”öŽs—§j@
‘ć304‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.3.30
‘ĺă
@
–L‹špŒă‚ɐś‚ś‚˝ˆŮ•¨Ť’×ᇂ̂P—á
‹g—ǁ@ł_@@™Œ´@@Ži@@ź–{@ˆŰ–ž@@‹gě@–M•F
‘ć282‰ń“ú”ç‰ďVŠƒ’n•ű‰ď
1991.4.13
VŠƒ
@
ƒrƒfƒIƒ}ƒNƒƒXƒR[ƒv‚É‚ć‚éŠŁá•a•Ď‚ĚŠÓ•Ę
‰Ş“c“Ţ’ĂŽq@@’†’J@G‘˘@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć90‰ń“ú”ç‰ď‘‰ď
1991.4.26-28
‹ž“s
@
–Ť“úŒő‰ß•q”畆‰Š‚Ě‚Q—á
˛“Ą@Œ’“ń@@‰““Ą@@ŒO@@’JŒű@—´•v@@‹v•Ä@şœA@@‹gě@–M•F
‘ć90‰ń“ú”ç‰ď‘‰ď
1991.4.26-28
‹ž“s
@
•úŽËü”畆‰Š‚É”­ś‚ľ‚˝•˝ŠŠ‹Ř“÷Žî
ŽR‘ş@’íˆę@@‚“c@ÍD@@“ŒŽR@^—˘@@‹gě@–M•F
‘ć90‰ń“ú”ç‰ď‘‰ď
1991.4.26-28
‹ž“s
@
‚UË—Ž™‚É”­Ç‚ľ‚˝qíŤ“Vávጂ̂P—á
Ż“c—T‹IŽq@@ź‰Ş@@‰@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć90‰ń“ú”ç‰ď‘‰ď
1991.4.26-28
‹ž“s
@
Non Hodgkin's lymphoma of large multinucleated cell type ‚Ě‚P—á
ź‰Ş@@‰@@Ż“c—T‹IŽq@@ˆéƒmăłş@@“ŒŽR@^—˘@@‘ęK@’żd@@ŽR‘ş@’íˆę@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć90‰ń“ú”ç‰ď‘‰ď
1991.4.26-28
‹ž“s
@
‘яóáv]Œă_Œo’É iPHNj ‚Ć‘Ńóáv]E…“—ƒEƒCƒ‹ƒX iVZVj ‚Ě“Ž‘Ô
’JŠ_@••F@@‹gě@–M•F iă‘ĺj @@”’–؁@ŒöN@@–Ř–{@’B—Y
‘ć90‰ń“ú”ç‰ď‘‰ď
1991.4.26-28
‹ž“s
@
–łŒŒ´”|—{–@‚đ—p‚˘‚˝”|—{l•\”çƒV[ƒg‚Ě—Ő°‰ž—p
“ŒŽR@^—˘@@ěŒű@@@@âˆä@–ő•v@@“Ąě@š˜a@@‹´–{@Œö“ń@@ź–{@ˆŰ–ž@@‹gě@–M•F
‘ć90‰ń“ú”ç‰ď‘‰ď
1991.4.26-28
‹ž“s
@
A double immunocytochemical analysis on cell kinetics and differentiation of human keratinocytes in culture.
Nakatani, S., Okada, N. and Yoshikawa, K.
16th Pacific Skin Research Club Meeting
1991.4.29-5.1
San Juan Island, Wash USA
@
Involvement of increase of EGF receptor and TGF-ƒż in epidermal hyperplasia of pemphigus vegetans.
Hashimoto, K., Higashiyama, M., Iwatsuki, K., Yoshikawa, K.
52nd Annual Meeting of the Society for Investigative Dermatology
1991.5.1-4
Seattle Wash USA
@
Minisymposium ‡U: Growth inhibition of human keratinocytes by antisense c-myc oligomer is not coupled to induction of differentiation.
Hashiro, M., Hashimoto, K., Okumura, H., Matsumoto, Ku. and Yoshikawa, K.
52nd Annual Meeting of the Society for Investigative Dermatology
1991.5.1-4
Seattle Wash USA
@
Production of plasminogen activator inhibitor-1 iPAI-1j of human keratinocytes is induced by 1,25-dihydroxyvitamin D3.
Iwasa, M., Hashimoto, K., Hashiro, M. and Yoshikawa, K.
52nd Annual Meeting of the Society for Investigative Dermatology
1991.5.1-4
Seattle Wash USA
@
A novel antibody against extractable nuclear antigens in sera of patients with childhood idiopathic thrombocytopenic purpura.
Miyagawa, S., Inagaki, Y., Okada, N., Yoshioka, A., Ueki, H., Yoshikawa, K. and Shirai, T.
52nd Annual Meeting of the Society for Investigative Dermatology
1991.5.1-4
Seattle Wash USA
@
A double immunocytochemical analysis on cell kinetics and differentiation of human keratinocytes in culture.
Nakatani, S., Okada, N. and Yoshikawa, K.
52nd Annual Meeting of the Society for Investigative Dermatology
1991.5.1-4
Seattle Wash USA
@
Characterization of the pigmented granules in minocycline induced cutaneous pigmentation.
Okada, N., Nishida, K., Sato, S. and Yoshikawa, K.
52nd Annual Meeting of the Society for Investigative Dermatology
1991.5.1-4
Seattle Wash USA
@
Effect of tumor necrosis factor-alpha on growth and differentiation of human keratinocytes.
Okumura, H., Hashimoto, K., Hashiro, M., and Yoshikawa, K.
52nd Annual Meeting of the Society for Investigative Dermatology
1991.5.1-4
Seattle Wash USA
@
ፍ­Sk‚É‚ć‚é”畆–c—˛•ĎŒ`‚Ě”­ś‹@˜‚ɂ‚˘‚Ä
×ě@@˜i@@”–@@ä•v@@‹eˆä@’mŽq@@­“c@‰ŔŽq@@‹´–{@—T”V iZ—FŒ`Źj
‘ć34‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1991.5.22
ź–{
@
Wrap Around Flap to Finger‚ĚŒoŒą
“Ąě@š˜a@@âˆä@–ő•v@@™Œ´@@Ži@@ź–{@ˆŰ–ž iă‘ĺj @@–{‘˝@•üm@@“úŠ}@@šć i‘ĺă‘Dˆő•ŰŒŻŒ`Źj
‘ć34‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1991.5.22
ź–{
@
Šç–Ę”­ˆç•s‘S‚Ěƒ‚ƒfƒ‹ƒ}ƒEƒX
ŠC˜VŒ´–­Žq iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć34‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1991.5.23
ź–{
@
Ž—e‚đ–Ú“I‚Ć‚ľ‚˝ă‰şŠ{•ŞßœŘ‚čp‚ĚŒoŒą
ă’n@@‹M@@‚“c@ÍD@@“Ąě@š˜a@@ź–{@ˆŰ–ž
‘ć34‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1991.5.23
ź–{
@
‘gDL“W–@‚É‚¨‚Ż‚é”畆‰„—Ś‚Ě•ŞÍ
ź’J@–ÎŽ÷@@‘ĺŒ´@‹`—Y@@ˆäă@—TŽj@@ŠC˜VŒ´–­Žq iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć34‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1991.5.23
ź–{
@
”|—{ŠO–ŃŞâ×–E‚É‚ć‚é‘n”핢|ƒk[ƒhƒ}ƒEƒX‚Ö‚ĚˆÚAŽŔŒą|
‘q“c‘‘‘ž˜Y@@Ž›Žt@_l@@Îˆä@‹`‹P@@a’J@”Ž”ü i‘ĺ•Şˆă‘ĺŒ`Źj @@”ÂŒŠ@@’q@@‚ˆŔ@@i i“Ż”畆j
‘ć34‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1991.5.23
ź–{
@
Ž¨‰î“‚¨‚ć‚Ń˜]“‚ĚChondron Unit‚ɂ‚˘‚Ä
–{‘˝@•üm@@“cŒ´@—RŽq@@“úŠ}@@šć i‘ĺă‘DˆőŒ`Źj
‘ć34‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1991.5.23
ź–{
@
‚í‚ę‚í‚ę‚Ě•Đ‘¤O—ô•@‚QŽŸCłp
“cŠ@äŽk@@ź–{@ˆŰ–ž@@“Ąě@š˜a@@‚“c@ÍD@@ă’n@@‹M
‘ć34‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1991.5.24
ź–{
@
O—ôŽčppŽŽ‚ƏăŠ{Ž•‘…‹|‚ĚŒ`‘ԕωť‚ɂ‚˘‚Ä
‚“c@ÍD@@ź–{@ˆŰ–ž iă‘ĺj @@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj @@–î”ö@˜a•F@@_Œ´@@C i‘ĺăŽ•‘召Ž™Ž•‰Čj
‘ć34‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1991.5.24
ź–{
@
—Տ°“I‚É“ÁˆŮ‚ČŒo‰ß‚đ‚Ć‚Á‚˝qíŤ“Vávጂ̂P—á
ˆéƒmăł–ž@@źŽR@@i@@‘ęK@’żd@@’JŠ_@••F@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć84‰ń‹ß‹EW’k‰ď
1991.6.16
‹ž“s
@
Diffuse symmetrical lipomatosis ‚Ě‚P—á
‘q’m‹MŽu˜Y@@Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@ă’n@@‹M iă‘ĺj
‘ć84‰ń‹ß‹EW’k‰ď
1991.6.16
‹ž“s
@
ƒ‹ƒr[ƒŒ[ƒU[‘•’u‚ĚŽg—pŒoŒą
“cŠ@äŽk@@‚“c@ÍD@@“Ąě@š˜a@@ă’n@@‹M@@ź–{@ˆŰ–ž@@‹gě@–M•F
‘ć84‰ń‹ß‹EW’k‰ď
1991.6.16
‹ž“s
@
˜Vl•a‰@‚É‚¨‚Ż‚éámᝂ̓Œv
‹î‘ş@Œö”ü iă˜aň–kj @@‹gě@–M•F iă‘ĺj
‘ć305‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.6.22
‘ĺă
@
ƒXƒ‹ƒsƒŠƒ“‚É‚ć‚é–ň]‚Ě‚P—á
˛“Ą@Œ’“ń@@ź‰Ş@@‰@@‹gě@–M•F
‘ć305‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.6.22
‘ĺă
@
Źl‚É‚¨‚Ż‚鎉‘B•ę”Á|24—á‚Ě‘gDŠw“IŒŸ“˘
™‰Y@ŸŒČ@@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj @@źˆä@Šě•F@@–{‘˝@•üm i‘Dˆő•ŰŒŻj@
‘ć305‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.6.22
‘ĺă
@
Effect of Cefpodoxime proxetil iCPDXPRj on various staphyrococcus skin infection.
Tada, M. and Yoshikawa, K.
17th International Congress of Chemotherapy
1991.6.23-28
Berlin
@
ƒƒgƒgƒŒƒLƒT[ƒg‚ĆƒGƒgƒŒƒ`ƒi[ƒg‚É‚ć‚éˆŰŽ—Ă–@‚É‚ć‚Á‚Ä‚P”NˆČă‚ŕŠÉ‰đ‚Ş“ž‚ç‚ę‚Ä‚˘‚é non-Hodgkin lymphoma, T cell type ‚Ě‚P—á
’M’J@Ÿm@@‰€“c@‘•c@@”Ą–ě@@“N@@“ŒŽR@^—˘@@‘Dˆä@—´•F@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć‚V‰ń“ú–{”畆ˆŤŤŽîᇊw‰ď
1991.6.8-9
_ŒË
@
EGF receptor and TGF-ƒż in pemphigus vegetans.
Higashiyama, M., Hashimoto, K. and Yoshikawa, K.
‘ć16‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1991.7.10-12
’ˇč
@
Effect of TV-02 on the differentiation and the proliferation of epidermal keratinocytes.
Matsunaga, T., Kiyoki, M., Kuroki, T., Hashimoto, K. and Yoshikawa, K.
‘ć16‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1991.7.10-12
’ˇč
@
Down-regulation of EGF receptor by TGF-ƒż.
Okumura, H., Hashimoto, K., Higashiyama, M. and Yoshikawa, K.
‘ć16‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1991.7.10-12
’ˇč
@
A possible group-A XP patient with mild neurological abnormalities.
Sato, K. and Yoshikawa, K.
‘ć16‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1991.7.10-12
’ˇč
@
Dibbell's rhinoplasty‚ĚŒoŒą
ˆäă@—TŽj@@ŠC˜VŒ´–­Žq@@‘ĺŒ´@‹`—Y@@ź’J@–ÎŽ÷ iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
“–‰Č‚É‚¨‚Ż‚éŽčŽwŽîᇂ̌Ÿ“˘
‰Yě@W–ç@@‘O“c@@‹@@—с@@ŕŠw@@ź–{@@‘@@ź‘q@“NŽi i‘ĺăŒxŽ@Œ`Źj
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
‚—îŽŇ‚É‚¨‚Ż‚é“ŞŠWŠç–Ę‘˝”­œÜ‚ĚŽĄ—ĂŒoŒą
ŒŽ–ě@‹Ĺ•F@@ă’n@@‹M@@âˆä@–ő•v@@ź–{@ˆŰ–ž
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
Ž¨b‰îŽc‘śŒ^ŹŽ¨Ç‚É‚¨‚Ż‚é“ˆÚAC Ž¨‹N‚ą‚ľ“ŻŽžŽčp
×ě@@˜i@@­“c@‰ŔŽq@@‹´–{@—T”V@@‹eˆä@’mŽq@@”–@@ä•v iZ—FŒ`Źj
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
secondary flap‚ĚŒoŒą‚Š‚ç
×ě@@˜i@@­“c@‰ŔŽq@@‹´–{@—T”V@@‹eˆä@’mŽq@@”–@@ä•v iZ—FŒ`Źj
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
ăŠ{ÄŒšp‚É‚¨‚Ż‚é•@oŒ`Ź‚ĚŒŸ“˘
âˆä@–ő•v@@™Œ´@@Ži@@“Ąě@š˜a@@ź–{@ˆŰ–ž
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
Ž¨‰î“ˆÚA‚đ—p‚˘‚˝Šáâ|“ŕ•ÇC ‰ş•ÇœÜ‚ĚŽĄ—ĂŒoŒą
ź‰ş@“N–ç@@’JŒű@@š iŠÖź˜JĐŒ`Źj
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
‹ó’°‚É‚ć‚é‹š•”H“šÄŒš‚ĚŒoŒą
ź‘q@“NŽi@@‘O“c@@‹@@‰Yě@W–ç@@—с@@ŕŠw@@ź–{@@‘ i‘ĺăŒxŽ@Œ`Źj
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
‹š•Ç’×ᇂđŒ`Ź‚ľ‚˝—Ź“ŽƒVƒŠƒRƒ“’“ü‚É‚ć‚é–L‹šp‚Ě‚Q—á
‚“c@ÍD@@“cŒ´@—RŽq i•{—§•ęŽq•ŰŒ’‘ˆăƒZƒ“Œ`Źj @@“Ąě@š˜a@@ź–{@ˆŰ–ž iă‘ĺj@
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
ƒ‹ƒr[ƒŒ[ƒU[‘•’u‚ĚŽg—pŒoŒą
“cŠ@äŽk@@“Ąě@š˜a@@‚“c@ÍD@@ă’n@@‹M@@ź–{@ˆŰ–ž iă‘ĺj@@‹gě@–M•F i“Ż”畆‰Čj
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
“ŞŠWœ•t“‡ó”ç•Ů‚É‚ć‚鉺Š{L”͈͌‡‘š‚ĚÄŒš
“úŠ}@@šć@@–{‘˝@•üm@@“cŒ´@—RŽq i‘ĺă‘Dˆő•ŰŒŻŒ`Źj @@ă’n@@‹M@@“Ąě@š˜a@@âˆä@–ő•v@@ź–{@ˆŰ–ž iă‘ĺj@@
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
ƒnƒCƒhƒƒRƒƒCƒhƒhƒŒƒbƒVƒ“ƒN iƒfƒ…ƒIƒAƒNƒeƒCƒuj ‚đŽg‚Á‚˝—V—Ł‹ó’°”ç•Ů‚ĚŒŒ—Źƒ‚ƒjƒ^[–@
–k‹g@@Œő@@˛“Ą@•’j@@‹g–ě@–Mr@@”n’J@Ž‘Ľ i•{—§Źl•aŽ¨•@‰Čj@@“Ąˆä@@—˛@@ˆÉ“Ą@@‘@@•Ÿ“c@˜a‘× i“Ż“ŞŒz•”ŠO‰Čj @@
‘ć56‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1991.7.13
‘ĺă
@
Regulation of protein phosphatases by G proteins in smooth muscle
Nomura, M., Stull, J.T., Kamm, K.E. and Mumby, M.C.
FASEB Summer Conference on Smooth Muscle
1991.7.15-19
Colorado
@
Effects of TGF-ƒż, TGF-ƒŔ and IL-6 on growth and differentiation of cultured human keratinocytes.
Hashimoto, K., Okumura, H., Matsumoto, Ku. and Yoshikawa, K.
5th Japan-U.S. Joint Seminor on the Biology of the Epidermis
1991.7.21-25
Niseko
@
‹­”çÇ‚ƐS‹Ř•a•Ď@ iÇ—á’ljÁj
‘ęK@’żd@@ˆéƒmăłş@@‹´–{@Œö“ń@@‹gě@–M•F
‹­”çÇ’˛¸Œ¤‹†”ǁ@•˝Ź‚R”N“x‘ć‚P‰ń”ljď‹c
1991.7.26
“Œ‹ž
@
Nevus lipomatosus superficialis ‚Ě‚P—á
źŽR@@i@@‰H”’@@˝@@‹gě@–M•F
‘ć306‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.7.27
‘ĺă
@
’O“Ĺ‚Ě‚Q—á
ˆéƒmăł–ž@@’JŠ_@••F@@‹gě@–M•F iă‘ĺj @@“Ą–{@Œ\ˆę@@‹´–{@˝ˆę iZ—Fj@@•Đ‰Ş@—tŽq i‘Dˆő•ŰŒŻj
‘ć306‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.7.27
‘ĺă
@
‘gDŠw“I‚É‹ť–Ą‚ ‚鏊ŒŠ‚đ’ć‚ľ‚˝ Paget •a‚Ě‚P—á
źˆä@Šě•F@@“c‘ă@@ŽŔ@@•Đ‰Ş@—tŽq@@–{‘˝@•üm i‘Dˆő•ŰŒŻj @@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj@@
‘ć306‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1991.7.27
‘ĺă
@
ƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě‘BC •Ş‰ť‚Ć’˛ßˆöŽq i“Á•Ęu‰‰j
‹gě@–M•F
‘ć‚U‰ńŠp‰ťÇŒ¤‹†‰ď
1991.7.6
“Œ‹ž
@
”^ávŤŠŁá‚ɐś‚ś‚˝”^ávŒ^–ň]‚Ě‚P—á
źŽR@@i@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć‚U‰ńŠp‰ťÇŒ¤‹†‰ď
1991.7.6
“Œ‹ž
@
‘S‘‘˝’č“_‚Ĺ‚ĚŽ‡ŠOü‘Ş’č
˛“Ą@Œ’“ń
‘ć13‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1991.8.2-3
‹ŕ‘ň
@
“úŒő”˜˜I•”‘OŠŕÇ‚¨‚ć‚є畆Šŕ‚Í‘‰Á‚ľ‚Ä‚˘‚é‚Š
˛“Ą@Œ’“ń
‘ć13‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1991.8.2-3
‹ŕ‘ň
@
ƒqƒgüˆŰ‰č×–E‚ɑ΂ˇ‚é UVA ĆŽËƒŠƒ{ƒtƒ‰ƒrƒ“‚Ě’vŽ€ě—p
˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć13‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1991.8.2-3
‹ŕ‘ň
@
ƒvƒ‰ƒXƒ`ƒbƒN‰ÁH‹ĆŽŇ‚É”F‚ß‚ç‚ę‚˝ÚG”畆‰ŠC ŽŠ‰ĆŠ´ěŽź]‚Ě‚P—á
Šâ˛@^l@@“ŒŽR@^—˘@@’Šě—R‰Ŕ—˘@@‹gě@–M•F
‘ć21‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1991.8.31-9.1
Ž­Ž™“‡
@
F‘fŤŠŁ”çÇ
˛“Ą@Œ’“ń
‘ć‚U‰ń‘ĺăƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX
1991.8.4
ŽOd
@
œŠ×‰š‚ɑ΂ˇ‚édiced cartilage grafts
­“c@‰ŔŽq@@‹´–{@—T”V@@×ě@@˜i@@‹eˆä@’mŽq@@”–@@ä•v iZ—FŒ`Źj@@“cŒ´@^–ç i_‘厨•@j
“ú–{Œ`ŹŠO‰ČŠw‰ď‘ć22‰ń’†‘EŽl‘Žx•”ŠwpW‰ď
1991.9.1
źŽR
@
ƒVƒ“ƒ|ƒWƒEƒ€@”^ávŤŠŁáFƒGƒgƒŒƒ`ƒi[ƒg’ˇŠú“Š—^‚Ě–â‘č“_
‰Ş“c“Ţ’ĂŽq
‘ć‚U‰ń“ú–{ŠŁáŠw‰ď
1991.9.6-7
’š‰H
@
‚R˘‘ă‚É‚í‚˝‚Á‚ĐqíŤŠŁá‚ƏśçG”^ávÇ‚đ”­Ç‚ľ‚˝‚P‰ĆŒn—á
ź‰Ş@@‰@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć‚U‰ń“ú–{ŠŁáŠw‰ď
1991.9.6-7
’š‰H
@
ŠŁáŠłŽŇ‚̐HKŠľ‚Ć‚ť‚Ě‘ź‚Ě‘žˆŤˆöŽq‚ÉŠÖ‚ˇ‚éƒAƒ“ƒP[ƒg’˛¸
“ŒŽR@^—˘@@‘ęK@’żd@@‹gě@–M•F
‘ć‚U‰ń“ú–{ŠŁáŠw‰ď
1991.9.6-7
’š‰H
@
‘Ě×–Eƒ‚ƒUƒCƒNŤ‚đŽŚ‚ˇ XP ŠłŽŇ‚Ě XPAC ˆâ“`Žqă‚Ě•ÎˆĘ‚Ě‰đÍ
‰Á“Ą@—F‹v@@Îč@Š°ŽĄ@@˛“Ą@Œ’“ń iă‘ĺj @@’r‰i@–žś
‘ć35‰ń“ú–{•úŽËü‰e‹żŠw‰ď
1992.10.
‘ĺ’Ă
@
XP ŠłŽŇ‚É‚¨‚Ż‚é ras ˆâ“`Žq‚Ě•ĎˆŮ
Îč@Š°ŽĄ@@’†ˆä@^Ž@@’r‰i@–žś@@’Ň‘ş@‹œ@@‹ŃDç‰ŔŽq@@˛“Ą@Œ’“ń iă‘ĺj
‘ć35‰ń“ú–{•úŽËü‰e‹żŠw‰ď
1992.10.
‘ĺ’Ă
@
A case of pemphigus vegetans ithe Hallopeau typej.
Hashimoto, K., Higashiyama, M., Iwasa, M. and Yoshikawa, K.
3rd China-Japan Joint Meeting of Dermatology
1992.10.1-3
Dahlian, China
@
Effect of eicosapentaenoic acid on the proliferataion of cultured human epidermal keratinocytes.
Lu, L., Nakatani, S., Okada, N. and Yoshikawa, K.
3rd China-Japan Joint Meeting of Dermatology
1992.10.1-3
Dahlian, China
@
Epidermal cell differentiation inhibitor iEDINj ADP-ribosylates small GTP-binding proteins.
Hashimoto, K., Sugai, M., Kikuchi, A., Takai, Y. and Yoshikawa, K.
‘ć17‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1992.10.16-17
ĺ‘ä
@
Growth inhibition of keratinocytes by 1,25-dihydroxy vitamin D3 linked to prevention of retinoblastoma gene product phosphorylation.
Kobayashi, T., Hashimoto, K. and Yoshikawa, K.
‘ć17‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1992.10.16-17
ĺ‘ä
@
Enhanced expression of ICAM-1 and ELAM-1 and proliferation of cultured endothelial cells by TNFƒż
Nakatani, S., Lu, L., Okada, N. and Yoshikawa, K.
‘ć17‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1992.10.16-17
ĺ‘ä
@
Eicosapentaenoic acid inhibits angiogenesis in vascular endothelial cells in vitro
Okada, N., Lu, L., Nakatani, S. and Yoshikawa, K.
‘ć17‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1992.10.16-17
ĺ‘ä
@
Pyridoxine toxicity to cultured fibroblasts caused by near-ultraviolet light.
Sato, K., Taguchi, H. and Yoshikawa, K.
‘ć17‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1992.10.16-17
ĺ‘ä
@
EB ƒEƒCƒ‹ƒXŽ‘ąŠ´ő‚sƒŠƒ“ƒp‹…Ť”’ŒŒ•a×–E‚Ě in vitro ‚Ĺ‚Ě”|—{‚Č‚ç‚тɉđÍ
ó“c@G•v@@‰Ş“c“Ţ’ĂŽq@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@‹ß“Ą@ˆę”Ž@@ŽRź@Oˆę@
‘ć40‰ń“ú–{ƒEƒCƒ‹ƒXŠw‰ď‘‰ď
1992.10.28-30
_ŒË
@
ŠŁá‚ĚŽĄ—Ă
‹gě@–M•F
‘ć43‰ń“ú”ç‰ď‹łˆçuK‰ď i’†•”Žx•”Šé‰ćj
1992.10.30
–źŒĂ‰Ž
@
ŠŽ‘SŠ°‰đŒă‚ɔ牺ŽîᎂōĔ­‚ľ‚˝ AMoL ‚Ě‚PÇ—á
Œă“Ą@GŽ÷@@ˆéƒmăł–ž@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@“Ąč@O”V@@‰Ş‘ş@—˛s@@‘˝˜a@ş—Y i“ŻŹŽ™‰Čj@@
‘ć43‰ń“ú”ç‰ď’†•”Žx•”‰ď
1992.10.31-11.1
–źŒĂ‰Ž
@
”|—{łíƒqƒg•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě•Ş‰ť—U“ą‚É‚ć‚éŠŕ—}§ˆâ“`Žq i–Ô–Œ‰č×–EŽîƒ^ƒ“ƒpƒNj ‚Ě•Ď“Ž
Ź—с@Ć–ž@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć43‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1992.10.31-11.1
–źŒĂ‰Ž
@
ƒCƒIƒwƒLƒ\[ƒ‹ iƒIƒ€ƒjƒp[ƒN$5001j ‚É‚ć‚é–ň]‚Ě‚P—á
‘O“c@’mŽq@@ˆéƒmăł–ž@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć43‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1992.10.31-11.1
–źŒĂ‰Ž
@
“ű–[ŠO Paget's •a‚ĚĹ‹ß10”NŠÔ‚ĚÇ—á‚ĚŒŸ“˘
—с@@ßŠw@@‘O“c@@‹ i‘ĺăŒxŽ@j @@‹gě@–M•F iă‘ĺj
‘ć43‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1992.10.31-11.1
–źŒĂ‰Ž
@
Œ‹ßŤ”]d‰ťÇ‚ĚŠłŽŇ—R—ˆ”|—{×–E‚̍RŠjC RőF‘̍R‘Ě‚É‚ć‚éŒ`‘ÔŠw“IŒ¤‹†
‹ŕ“c@^—@@‹gě@–M•F
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ǁ@•˝Ź‚S”N“x‘ć‚P‰ń‘‰ď
1992.10.8
@
@
•\”ç×–E‚É‚¨‚Ż‚éî•ń“`’B‹@\
‹gě@–M•F
‰ČŠwƒVƒ“ƒ|ƒWƒEƒ€@gƒqƒ…[ƒ}ƒ“ƒwƒ‹ƒXƒTƒCƒGƒ“ƒX‚Ɣ畆h
1992.11.14-15
“Œ‹ž
@
SCC ‚đÄ”­‚ľ‚˝—ňŤ‰h—{áŠQŒ^ć“VŤ•\”琅ávÇ‚Ě‚P—á
‰Ôě@@–ő@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć99‰ń“ú”ç‰ďŽl‘’n•ű‰ď
1992.11.14-15
“ż“‡
@
‘ĺ“Ž–Ź‰ŠÇŒóŒQ‚đ‡•š‚ľ‚˝…ávŤ—Ţ“Vávጂ̂P—á
‹´–{@Œö“ń@@Šâ˛@^l@@‹gě@–M•F
‘ć14‰ń…ávÇŒ¤‹†‰ď
1992.11.2
‹ŕ‘ň
@
—V—ŁŒ¨bœ•Ů‚É‚ć‚édŒűŠWÄŒš‚ĚŒoŒą
Š_•Ł@ł’j@@“Ąě@š˜a@@–k‹g@@Œő@@ź–{@@‘@@ŽRč@Œ¤Žu@@ź–{@ˆŰ–ž
‘ć59‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.11.28
‹ž“s
@
21ƒgƒŠƒ\ƒ~[‚𔺂¤Dandy WalkerÇŒóŒQ‚Ě‚P—á
‹g—´@ŸŽq@@ˆäă@—TŽj@@‘ĺŒ´@‹`—Y
‘ć59‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.11.28
‹ž“s
@
‘O˜r”ç•Ů iRadial forearm flapj ‚É‚¨‚Ż‚éperforating vein‚ɂ‚˘‚Ä
‚–؁@@ł@@“cŒ´@^–ç i_‘ĺ”畆‰Čj @@“V’Á@–r—Y i“ŻŽ¨•@‰Čj
‘ć59‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.11.28
‹ž“s
@
Šáâ|‰ş•ÇŒ‡‘š‚đ”F‚ß‚˝–j•”‹‘ĺ”X–E‚ĚŽĄ—ĂŒoŒą
ŽR–{@@”Ž@@’JŒű@@š@@ź‰ş@“N–ç iŠÖź˜JĐŒ`Źj @@™Œ´@@Ži iŒ’˜a‰ďŠO‰Čj
‘ć59‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.11.28
‹ž“s
@
• ’ź‹Ř”ç•Ů‚É‚ć‚éăcŠu‚ĚÄŒš
ź–{@@‘@@“Ąě@š˜a@@–k‹g@@Œő@@ŠC˜VŒ´–­Žq@@Ą‰Ş@@Œ’@@ź–{@ˆŰ–ž
‘ć59‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.11.28
‹ž“s
@
‘”rŸ•oŠO”˝Ç‚ĚŒoŒą
ŒK]@ŽŽ÷@@‚“c@ÍD i•ęŽqˆă—ĂƒZƒ“ƒ^[Œ`Źj @@“‡“c@Œ›ŽŸ i“Ż”ĺ”AŠí‰Čj@@ˆŔˆä@‰Äś i“ŻŽŒ`ŠO‰Čj
‘ć59‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.11.28
‹ž“s
@
Wrap Around Flap‚É‚ć‚Á‚ĈęŠú“IÄŒš‚đs‚Á‚˝Malignant Melanoma in Situ‚Ě‚P—á
ó“c@—TŽi@@–{‘˝@•üm@@“cŠ@äŽk i‘ĺă‘Dˆő•ŰŒŻŒ`Źj @@•Đ‰Ş@—tŽq i“Ż”畆j@@Š_•Ł@ł’j@@“Ąě@š˜a iă‘ĺj
‘ć59‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.11.28
‹ž“s
@
Œő‚Ć‚Ě•t‚Ť‡‚˘•ű |‚ą‚ę‚Š‚ç‚ĚƒAƒEƒgƒhƒAƒ‰ƒCƒtƒXƒ^ƒCƒ‹‚ÉŠÖ‚ˇ‚éˆę‚‚̒ńŒž
‹gě@–M•F
‘ž—zŽ‡ŠOü–hŒäŒ¤‹†ˆĎˆő‰ď‘ć‚R‰ńƒVƒ“ƒ|ƒWƒEƒ€ u‘ž—zŽ‡ŠOü‚ĆŒ’Nv
1992.12.10
‹ž“s
@
‘ž—zŽ‡ŠOü‚Ě‚Č‚˘śŠˆ‹óŠÔ |Ž‡ŠOü‚đ–h‚ŽƒKƒ‰ƒXC ƒvƒ‰ƒXƒ`ƒbƒNC ‘@ˆŰ|
˛“Ą@Œ’“ń
‘ž—zŽ‡ŠOü–hŒäŒ¤‹†ˆĎˆő‰ď‘ć‚R‰ńƒVƒ“ƒ|ƒWƒEƒ€ u‘ž—zŽ‡ŠOü‚ĆŒ’Nv
1992.12.10
‹ž“s
@
Œ‹ßŤ”]d‰ťÇŠłŽŇ—R—ˆ”|—{×–E‚É‚¨‚Ż‚é“ÁˆŮ“IRŒ´‚ĚŒŸő|–Ɖu‘gD‰ťŠw“I“Ż’č|
‹ŕ“c@^—@@‹gě@–M•F
‘ć314‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.12.19
Š€Œ´
@
Low Nickel Diet ‚É‚ć‚éƒjƒbƒPƒ‹ƒAƒŒƒ‹ƒM[‚ĚŽĄ—Âɂ‚˘‚Ä
Šâ˛@^l@@’Šě—R‰Ŕ—@@‹gě@–M•F@@œAŁ‚Ě‚čŽq
‘ć17‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1992.12.5-6
“Œ‹ž
@
‰~Œ`’E–ŃÇ‚Ě SADBE iƒXƒNƒAƒŠƒbƒNŽ_j ŠO—p—Ă–@
Šâ˛@^l@@“ŒŽR@^—˘@@‹gě@–M•F
‘ć17‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1992.12.5-6
“Œ‹ž
@
‘˝Ü—ż‚É‚ć‚éÚG”畆‰Š‚Ě‚P—á
œAŁ‚Ě‚čŽq@@Šâ˛@^l@@’Šě—R‰Ŕ—@@‹gě@–M•F
‘ć17‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1992.12.5-6
“Œ‹ž
@
‘˝”­Ť”畆üˆŰŽî‚Ě‚P—á
ź‰Ş@@‰@@ŽR‘ş@’íˆę@@‹gě@–M•F
‘ć309‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.2.15
ä
@
MRSA Š´őÇ‚Ş‚Ý‚ç‚ę‚˝ƒAƒgƒs[Ť”畆‰Š‚Ě‚P—á
’JŠ_@••F i‹ß‹E’†‰›j @@Ź—с@Ć–ž@@‹gě@”üŽq iă‘ĺj
‘ć309‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.2.15
ä
@
“Ş•”‚É”­ś‚ľ‚˝‹‘ĺ‚Č clear cell hidradenoma ‚Ě‚P—á
’J–{@‹M”ü@@âˆä@–ő•v@@ŽR‘ş@’íˆę@@‹gě@–M•F
‘ć309‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.2.15
ä
@
Eccrine angiomatous hamartoma ‚Ě‚P—á
“Ą”ö@‰Žq@@‘q’m‹MŽu˜Y@@“cŠ@äŽk@@ŽR‘ş@’íˆę@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć309‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.2.15
ä
@
Linear IgA bullous dermatosis ‚ĆŽv‚í‚ę‚é‚P—á
ˆéƒmăł–ž@@“ŒŽR@^—˘@@‹gě@–M•F iă‘ĺj @@ě“ŕ@@•× iă˜aj
‘ć310‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.3.28
‘ĺă
@
‘˝”­ŤŽ‰‘B”XŽîÇ‚̏dÇ—á‚ɑ΂ˇ‚é‹zˆř—Ă–@
˛“Ą@Œ’“ń@@“cŒű@”ŽN@@‹gě@–M•F
‘ć310‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.3.28
‘ĺă
@
Keratinocytes and Wound Healing The Growth Regulation of Keratinocytes
Hashimoto, K.
‘ć91‰ń“ú”ç‰ď‘‰ď
1992.4.10-12
ç—t
@
In vivo wound healing model and clinical application of growth factors pig wound healing model.
Higashiyama, M.
‘ć91‰ń“ú”ç‰ď‘‰ď
1992.4.10-12
ç—t
@
“ÁˆŮ]‚̏o–v‚đŽŚ‚ľ‚˝‹}Ť’P‹…Ť”’ŒŒ•a‚Ě‚P—á
ŠŁ@@dŽ÷@@źŽR@@i@@ˆéƒmăł–ž@@‘ęK@’żd@@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj @@Îě@@~@@Ź‘ň@‰p“ń@
‘ć91‰ń“ú”ç‰ď‘‰ď
1992.4.10-12
ç—t
@
ƒqƒgüˆŰ‰č×–E‚ɑ΂ˇ‚é UVA ĆŽËƒŠƒ{ƒtƒ‰ƒrƒ“‚Ě’vŽ€ě—p
˛“Ą@Œ’“ń@@“cŒű@”ŽN@@‹gě@–M•F
‘ć91‰ń“ú”ç‰ď‘‰ď
1992.4.10-12
ç—t
@
KID iKeratitis,ichthyosis, deafnessj ÇŒóŒQ‚Ě‚Q—á
‘O“c@’mŽq@@ˆéƒmăł–ž@@‘ęK@’żd@@™‰Y@ŸŒČ@@‘q’m‹MŽu˜Y@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć91‰ń“ú”ç‰ď‘‰ď
1992.4.10-12
ç—t
@
Scedosporium apiospermum ‚É‚ć‚é”畆[ÝŤ^‹ŰÇ‚Ě‚P—á
“Ąč@O”V@@ˆéƒmăł–ž@@‘ęK@’żd@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć91‰ń“ú”ç‰ď‘‰ď
1992.4.10-12
ç—t
@
ƒGƒCƒRƒTƒyƒ“ƒ^ƒGƒ“Ž_‚Ě”|—{lƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě‘B‚ɑ΂ˇ‚éě—p‚ĚŒŸ“˘
—¤@@@ i˜Hj @@’†’J@G‘˘@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć91‰ń“ú”ç‰ď‘‰ď
1992.4.10-12
ç—t
@
ŒŒŠÇ‰č×–EŽî i’†ěj ‚Ě“dŽqüŽĄ—Ă
ź‰Ş@@‰@@ˆéƒmăł–ž@@‘ęK@’żd@@‹gě@–M•F iă‘ĺj @@Žč“‡@şŽ÷@@ˆäă@r•F i“Ż•úŽËü‰Čj @@ě’Á@’qĽ i‘ĺă’üMj@@
‘ć91‰ń“ú”ç‰ď‘‰ď
1992.4.10-12
ç—t
@
–D‡‹¸ł–@‚É‚ć‚é–„–vŽ¨‚ĚŽĄ—Ă
ˆäă@—TŽj@@ź’J@–ÎŽ÷@@‹g—´@ŸŽq@@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć35‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1992.4.11
“Œ‹ž
@
ƒXƒv[ƒ“óŽč‚ĚŽwŠÔŒ`Źp‚É‚¨‚Ż‚é‚PlŽ@
Œ´Œł@@’ށ@@ŠÖŒű@‡•ă@@‚“c@—TŽq@@—^Ŕ@@‘@@‘q•Đ@@—D i“Œ‹žŒxŽ@Œ`Źj
‘ć35‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1992.4.11
“Œ‹ž
@
—V—Ł“ŕ‘¤‘Ť’ę”ç•Ů‚É‚ć‚éćů•”ˆČŠO‚Ě‰×d•”ˆĘÄŒš
âˆä@–ő•v@@“Ąě@š˜a@@ź–{@ˆŰ–ž
‘ć35‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1992.4.11
“Œ‹ž
@
”|—{ƒqƒgŠO–ŃŞâ×–E‚É‚ć‚é‘n–ʔ핢
‘q“c‘‘‘ž˜Y i‘ĺ•Şˆă‘ĺŒ`Źj @@”ÂŒŠ@@’q i“Ż”畆j
‘ć35‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1992.4.11
“Œ‹ž
@
ƒ‹ƒr[ƒŒ[ƒU[‚ĚŽg—pŒoŒą
“cŠ@äŽk@@ó“c@—TŽi@@–{‘˝@•üm i‘ĺă‘Dˆő•ŰŒŻŒ`Źj @@“Ąě@š˜a@@ź–{@ˆŰ–ž iă‘ĺj
‘ć35‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1992.4.11
“Œ‹ž
@
Growth inhibitory effect of eicosapentaenoic acid on cultured human epidermal keratinocytes.
Lu, L., Nakatani, S., Okada, N. and Yoshikawa, K.
53rd Annual Meeting of the Society for Investigative Dermatology
1992.4.29-5.2
Baltimore, Maryland
@
Œo‰ß’†‚ɍ‚ Ca ŒŒÇ‚đ’ć‚ľ‚˝ ATL ‚Ě‚P—á
Œă“Ą@GŽ÷@@•x“c@’qŽj@@ˆéƒmăł–ž@@‘ęK@’żd@@‹gě@–M•F
‘ć100‰ń“ú”ç‰ďŽ­Ž™“‡’n•ű‰ď
1992.4.4
Ž­Ž™“‡
@
Ž—e–Ú“I‚̉şŠ{œŘ‚č‚ĚŒoŒą
ă’n@@‹M@@âˆä@–ő•v@@ŒK]@ŽŽ÷
‘ć35‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1992.4.9
“Œ‹ž
@
ƒtƒ@ƒW[„˜_–@‚É‚ć‚éInformed Consent‚Ě•]‰ż
ź’J@–ÎŽ÷ i•{—§Źl•aŽ¨•@‰Čj @@ˆäă@—TŽj@@‘ĺŒ´@‹`—Y@@‹g—´@ŸŽq iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć35‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1992.4.9
“Œ‹ž
@
‹š”w“ŽĂ–Ź iAngular Branchj ‚đŒŒŠÇŒs‚Ć‚ˇ‚錨bœˆÚA‚ɂ‚˘‚Ä
“Ąě@š˜a@@ź–{@ˆŰ–ž@@âˆä@–ő•v@@–k‹g@@Œő@@ŠC˜VŒ´–­Žq iă‘ĺj@@–{‘˝@•üm i‘ĺă‘DˆőŒ`Źj
‘ć35‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď
1992.4.9
“Œ‹ž
@
ăüâ|‚ɐś‚ś‚˝ƒAƒ|ƒNƒŠƒ“‘BŠŕ‚Ě‚P—á
Ź—с@Ć–ž@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@ź‰i@‰xŽĄ@@č•”@“Ä“š
‘ć‚W‰ń”畆ˆŤŤŽîᇊw‰ď
1992.5.
ŽD–y
@
ƒŒƒ`ƒmƒCƒh’ˇŠú“Š—^‚ލœEŠÖß‚É‚¨‚ć‚Ú‚ˇ‰e‹ż
’†’J@G‘˘@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć‚W‰ń“ú–{—Տ°”畆‰ČˆăŠw‰ď
1992.5.16-17
‘ĺă
@
Psoriasis ‚Ć25”N
‹gě@–M•F
‘ć311‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.5.9
_ŒË
@
Epidermal differentiation inhibitor (EDIN) Staphylococcus aureus ‚ĚŽYś‚ˇ‚é•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě•Ş‰ť—}§ˆöŽq‚ɂ‚˘‚Ä
‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@›ˆä@Šîs iL‘ĺ×‹Űj
‘ć311‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.5.9
_ŒË
@
Irritant contact dermatitis causes by povidone-iodine.
Okano, M.
18th World congress of Dermatology
1992.6.12-18
New York
@
‰–Ž_ƒƒLƒVƒŒƒ`ƒ“‚É‚ć‚莇”ÁŒ^–ň]‚ƍDŽ_‹…Ť”x‰Š‚đ•š”­‚ľ‚˝‚P—á
“Ą”ö@‰Žq@@“”H@Žj˜Y@@ˆéƒmăł–ž@@Šâ˛@^l@@‹gě@–M•F
‘ć22‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1992.6.27-28
ź]
@
Forearm flap‚É‚ć‚é”A“šÄŒš‚Ěˆę—á
ˆäă@—TŽj@@‹g—´@ŸŽq@@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj @@’J•—@ŽO˜Y i“Ż”ĺ”AŠí‰Čj
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
‘Sg‚ÉŒŔ‹ÇŤ‹­”çÇ‚̔畆•a•Ď‚𔺂Á‚˝Romberg•a‚Ě‚P—á
ŠC˜VŒ´–­Žq@@“Ąě@š˜a@@–k‹g@@Œő@@ŒK]@ŽŽ÷@@ź–{@ˆŰ–ž
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
‹š•Ç‚É”­ś‚ľ‚˝Periostealchondroma‚Ě‚P—á
‹g—´@ŸŽq@@ˆäă@—TŽj@@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
ƒNƒ[ƒo[ó“ŞŠWÇŒóŒQ‚ĚŽĄ—ĂŒoŒą
ŒK]@ŽŽ÷@@ă’n@@‹M@@ź–{@ˆŰ–ž
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
ŽíX‚Ěä`Œ`Źp‚ɂ‚˘‚Ä
‚“c@ÍD@@“cŒ´@—RŽq
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
‹‘ĺŒŒŠÇŽî‚ĚŒoŒą
Žs–ě@’źŽ÷@@‘O“c@@‹@@‰Yě@W–ç@@—с@@ŕŠw@@ź‘q@“NŽi i‘ĺăŒxŽ@Œ`Źj
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
‘O“ލœŠáâ|‰‚ɐś‚ś‚˝DŽ_‹…“÷‰čŽî‚Ě‚P—á
™Œ´@@Ži@@’JŒű@@š@@ź‰ş@“N–ç iŠÖź˜JĐŒ`Źj
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
Double Cross Lip Flaps‚É‚ć‚鉺ŒűO‘ĺŒ‡‘š‚ĚÄŒš
ó“c@—TŽi@@“cŠ@äŽk@@–{‘˝@•üm i‘ĺă‘Dˆő•ŰŒŻŒ`Źj @@“Ąě@š˜a iă‘ĺj
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
ŽíX‚Ěä`Œ`Ź‚ɂ‚˘‚Ä
“cŒ´@—RŽq@@‚“c@ÍD i•ęŽqˆă—ĂƒZƒ“ƒ^[Œ`Źj
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
ŒŒŠÇ•ż•tœˆÚA i’°œ‚ĆŒ¨bœj ‚É‚ć‚鉺Š{ÄŒš‚Ě”äŠr
–k‹g@@Œő@@“Ąě@š˜a@@âˆä@–ő•v@@ź–{@ˆŰ–ž
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
’‹ŒŤŠç–ʐ_Œo–ƒáƒ‚ɑ΂ˇ‚鑤“Ş‹ŘˆÚsp‚ĚŒoŒą
—с@@ŕŠw@@‘O“c@@‹@@‰Yě@W–ç@@Žs–ě@’źŽ÷@@ź‘q@“NŽi i‘ĺăŒxŽ@Œ`Źj
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
Ž‰–bŽî‹zˆřpŒăÄ”­—á‚ĚŒoŒą
×ě@@˜i@@­“c@‰ŔŽq@@‹eˆä@’mŽq@@”–@@ä•v iZ—FŒ`Źj@@‚–؁@@ł i_‘厨•@‰Čj
‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1992.6.6
•P˜H
@
ˆŤŤŠÖßƒŠƒEƒ}ƒ`‚É”ş‚¤“Ť‰ş‘Ú’×ᇂ̂P—á
ˆéƒmăł–ž@@™‰Y@ŸŒČ@@’JŠ_@••F@@‹gě@–M•F
‘ć85‰ń‹ß‹EW’k‰ď
1992.6.7
‘ĺă
@
“űŠŕŞŽĄp‚Ě13”NŒă‚É“Ż‘¤ă˜r‚É Angiosarcoma ‚𐜂ś‚˝‚P—á
™‰Y@ŸŒČ@@Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@ă’n@@‹M iă‘ĺj
‘ć85‰ń‹ß‹EW’k‰ď
1992.6.7
‘ĺă
@
‘召‚Ě’×ᇂ𔺂Á‚˝ Ecthyma ‚Ě‚P—á
‘ž“c@ŒhŽĄ i”Ş”ö“żF‰ďj @@–x–؁@@ăŕ iŠÖźˆă‘ĺj @@ŽR‘ş@’íˆę iă‘ĺj
‘ć85‰ń‹ß‹EW’k‰ď
1992.6.7
‘ĺă
@
•@o“ŕC ‘Ťćä‚ɈŤŤ•FŽî‚đ‡•š‚ľ‚˝WernerÇŒóŒQ‚Ě‚P—á
’J–{@‹M”ü@@âˆä@–ő•v@@ˆéƒmăł–ž@@ŽR‘ş@’íˆę@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć85‰ń‹ß‹EW’k‰ď
1992.6.7
‘ĺă
@
Keratinocyte and Retinoblastoma protein ipRBj
Ź—с@Ć–ž
Šp‰ť×–EŒ¤‹†‰ď
1992.7.
‘ ‰¤
@
KID ÇŒóŒQ‚Ě‚Q—á
‘O“c@’mŽq@@ˆéƒmăł–ž@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć‚V‰ńŠp‰ťÇŒ¤‹†‰ď
1992.7.11
“Œ‹ž
@
ƒŒƒbƒNƒŠƒ“ƒOƒnƒEƒ[ƒ“•a‚Ě‘oŽq—á
ŠŁ@@dŽ÷@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj @@’Ł–ě@ł—_ i“ŻŠá‰Čj
‘ć312‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.7.18
‘ĺă
@
Blue rubber bleb nevus syndrome ‚ĆŽv‚í‚ę‚˝‚PÇ—á
Œă“Ą@GŽ÷@@ˆéƒmăł–ž@@‹gě@–M•F iă‘ĺj @@‰œ‘ş@—˛Ži i“ŻŽ¨•@‰Čj
‘ć312‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.7.18
‘ĺă
@
ƒqƒgüˆŰ‰č×–E‚ɑ΂ˇ‚é UVA ĆŽËƒsƒŠƒhƒLƒVƒ“‚Ě’vŽ€ě—p
“cŒű@”ŽN@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć14‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1992.7.31-8.1
“Œ‹ž—Žqˆă‘ĺ
@
ŠŁá‚ĚŽĄ—Á@ iľ‘ҍu‰‰j
‹gě@–M•F
‰ŞŽR”畆‰ČˆăŽt‰ď
1992.7.7
‰ŞŽR
@
ƒTƒCƒNƒƒXƒ|ƒŠƒ“A‚Ćƒƒ\ƒgƒŒƒLƒZ[ƒg‚Ě“Š—^‚đ—v‚ľ‚˝ŠÖßÇŠŁá‚Ě‚P—á
ŠŁ@@dŽ÷@@ˆéƒmăł–ž@@‹gě@–M•F
‘ć‚V‰ń“ú–{ŠŁáŠw‰ď
1992.8.
ŽD–y
@
Angiocentric T-cell lymphoma ‚Ě‚P—á
źˆä@Šě•F@@“c‘ă@@ŽŔ@@•Đ‰Ş@—tŽq i‘Dˆő•ŰŒŻj @@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj @
‘ć11‰ń”畆ƒŠƒ“ƒtƒH[ƒ}Œ¤‹†‰ď
1992.8.20-21
‘ĺă
@
ƒTƒCƒNƒƒXƒ|ƒŠƒ“A‚ĆƒƒgƒgƒŒƒLƒZ[ƒg‚Ě“Š—^‚đ—v‚ľ‚˝ŠÖßÇŤŠŁá‚Ě‚P—á
ŠŁ@@dŽ÷@@ˆéƒmăł–ž@@‹gě@–M•F
‘ć‚V‰ń“ú–{ŠŁáŠw‰ď
1992.8.29-30
ŽD–y
@
qíŤŠŁá‚̋ߐڐłí•”‚Š‚ç•a•Ď•”‚Ö‚ĚˆÚs•”ˆĘ‚É‚¨‚Ż‚é TGF-ƒż‚¨‚ć‚Ń EGF Žó—e‘̖̂Ɖu‘gDŠw“IŒŸ“˘
‹´–{@Œö“ń@@“ŒŽR@^—˘@@‹gě@–M•F
‘ć‚V‰ń“ú–{ŠŁáŠw‰ď
1992.8.29-30
ŽD–y
@
ŠŁá‚ĚŽĄ—Ă iľ‘ҍu‰‰j
‹gě@–M•F
‘ć‚X‰ń’ˇč”畆‰ČƒZƒ~ƒi[
1992.8.6
’ˇč
@
”|—{ŒŒŠÇ“ŕ”ç×–E‚Ě‘B‚Ć ICAM-1, ELAM-1‚Ě”­Œť‚É‹y‚Ú‚ˇ TNF-ƒż‚̉e‹ż
’†’J@G‘˘@@—¤@@@ i˜Hj @@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
The 7th Osaka Conference for Biology, Biochemistry and Physiology of the Skin
1992.8.9
–ź’Ł
@
Intravascular papillary endothelial hyperplasia ‚Ě‚P—á
ŠŁ@@dŽ÷@@Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y
‘ć101‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1992.9
‘ĺăŽs
@
ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ě‚P—á
ŠŁ@@dŽ÷@@Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y
‘ć313‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.9
˜a‰ĚŽR
@
Ă–ŹÄŒš‚đs‚Á‚˝”’E‘š‚ĚŽĄ—ĂŒoŒą
Œ´Œł@@’ށ@@Ź—ѐ˝ˆę˜Y@@ŠÖŒű@‡•ă@@–ě‘ş@’qŽj i“Œ‹žŒxŽ@Œ`Źj
‘ć19‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1992.9.24
ŽD–y
@
“–‰Č‚É‚¨‚Ż‚é—V—Ł• ’ź‹Ř”ç•Ů‚ĚŒoŒą
‰Yě@W–ç@@‘O“c@@‹@@ă’n@@‹M@@Žs–ě@’źŽ÷ i‘ĺăŒxŽ@Œ`Źj
‘ć19‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1992.9.25
ŽD–y
@
“ŕ‘Ÿ•a•Ď‚đ‡•š‚ľ‚˝ƒƒLƒVƒ`[ƒ‹‚É‚ć‚é–ň]‚Ě‚Q—á
’†‘ş@•q–ž@@“Ą”ö@‰Žq@@ˆéƒmăł–ž@@Šâ˛@^l@@‹gě@–M•F
‘ć313‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.9.26
˜a‰ĚŽR
@
‘Sg‚É‘˝”­‚ľ‚˝ŠÂó“÷‰čŽî‚Ě‚P—á
•x“c@’qŽj@@–ě‘ş@­•v@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj @@‰Ô–[@rş i“Ż“ń“ŕj
‘ć313‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1992.9.26
˜a‰ĚŽR
@
Riboflavin toxicity to cultvred fibroblasts caused by UVA and/or Visible Light.
Sato, K., Yoshikawa, K.
11th International Congress on Photobiology
1992.9.7-12
Kyoto
@
Dr. Nobuyuki Mizuno and photomedicine.
Yoshikawa, K.
11th International Congress on Photobiology
1992.9.7-12
Kyoto
@
Pyridoxine toxicity to cultured fibroblasts caused by UVA light.
Taguchi, H., Sato, K. and Yoshikawa, K.
11th International Congress Photobiology
1992.9.7-12
Kyoto
@
‹łˆçu‰‰:ƒ`ƒKƒ\ƒ“
‰Ş“c“Ţ’ĂŽq
“ú–{”畆‰ČŠw‰ďę–ĺˆă‘OŠúŒ¤CuK‰ď
1993.1.16
‘ĺă
@
ƒ‰ƒbƒg—V—Ł‹ó’°ˆÚAƒ‚ƒfƒ‹‚É‚¨‚Ż‚鐜’…ŽžŠú‚ɂ‚˘‚Ä
‚–؁@@ł@@“cŒ´@^–ç i_‘厨•@j
‘ć‚Q‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1993.10.10
ĺ‘ä
@
EB ƒEƒCƒ‹ƒXŽ‘ąŠ´őT×–EŠ” iEBT-8j ‚̉đÍ
ó“c@G•v@@‹´–{@Œö“ń@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj @@ź˜AŽ›@„@@ŽRź@Oˆę@@
‘ć41‰ń“ú–{ƒEƒCƒ‹ƒXŠw‰ď‘‰ď
1993.10.13-15
ŽD–y
@
Localization of Transforming Growth Factor-ƒŔ iTGF-ƒŔj Isoforms in Normal and psoriatic Epidermis
Wataya-Kaneda, M., Hashimoto, K. and Yoshikawa, K.
Combined Meeting of the gth International Lymphokine Workshop and the 4th International Workshop
1993.10.19
Osaka
@
ŒŒŸ÷ŒđŠˇ‚Ş—LŒř‚Ĺ‚ ‚Á‚˝—Ž—tó“Vávጂ̂P—á
źˆä@Šě•F@@‰Ź“°@—DŽq@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć45‰ń“ú”ç‰ďź•”Žx•”‘‰ď
1993.10.20-21
‘ĺ•Ş
@
Phenotipic modulation of cultured endothelial cells in collagen matricesinduced by tumor necrosis factor alpha.
Nakatani, S., Lu, L., Okada, N., and Yoshikawa, K.
18th Pacific Skin Research Club Meeting
1993.10.22-23
Nara
@
Mandibular Reconstruction : Free Scapular Osteocutaneous Flap Versus Free Iliac Crest Osteocutaneous Flap
Kitasyosi, H., FujikawaC M., MatsumotoC K.
The 6th Asian Pacific Congress of I. P. R. S.
1993.10.26
Korea
@
Repairing facial bone fractures by using a new navigation system
SakaiC Y., OhkuboC E., WatanabeC E., OhmoriC K. (Tokyo Police)
the 5th Int. Congress of Cranio-Maxillo-Facial Surgery
1993.10.28
Mexico
@
Establishmant of a T-Cell Line Containing Ebstein-Barr Virus Genome and Its Charateristics.
Asada, H., Hashimoto, K., Okada, N. and Yoshikawa K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
HB-EGF, a new member of EGF family, is an autocrine growth factor for normal human keratinocytes.
Hashimoto, K., Higashiyama, M., Asada, H., Kobayashi, T. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
Immunochemical localization of HB-EGF, a new member of EGF family, in normal skin.
Higashiyama, M., Hashimoto, K., Higashiyama, S. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
A report of two cases of Hallopeau type pemphygus vegetans with detection of anati-desmocollins I and II autoantibodies by immunoblot analysis.
Iwasa, M., Hashimoto, K., Higashiyama, M., Hashimoto, T. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
Endogeneous EGF-family growth factors are neccessary for transition G1 to S phase in human keratinocytes.
Kobayashi, T., Hashimoto, K., Okumura, H., Asada, H. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
Eicosapentaenoic acid induced changes in keratinocyte membrane fluidity in vitro.
Lu, L., Nakatani, S., Okada, N. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
Photosensitization of human fibroblasts with water-soluble and water-insoluble vitamins.
Maeda, T., Taguchi, H., Sato, K. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
Endogeneous activation of latent TGF-ƒŔ by induction of differentiation of human keratinocytes.
Matsui, Y., Hashimoto, K., Asada, H. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
Phenotipic modulation of cultured endothelial cells in collagen matrices induced by tumor necrosis factor alpha.
Nakatani, S., Lu, L., Okada, N. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
Role of hydrogen peroxide in UVA-induced riboflavin cytotoxicity.
Sato, K., Taguchi, H., Maeda, T. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
Contribution of active oxygen species to pyridoxine photosensitization.
Taguchi, H., Maeda, T., Sato, K. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
The cells from the patient of Tuberous Sclerosis lost the nuclear antigen detected by anti-chromosomal monoclonal antibody M108.
Wataya-Kaneda, M., Kaneda, Y., Hashimoto, K. and Yoshikawa, K.
2nd Tricontinental Meeting of the JSID, SID and ESDR
1993.10.28-31
Kyoto
@
Growth regulation of human keratinocyte by autocrine EGF family growth factors.
Hashimoto, K., Higashiyama, S., Asada, H., Higashiyama, M. and Yoshikawa, K.
International Symposium on Wound Healing
1993.11.1
Kyoto
@
A system to supply cultured keratinocyte sheets for wound repair. iSpecial lecturej
Yoshikawa, K., Hashimoto, K., Izumi, K. and Hashimura, E.
International Symposium on Wound Healing
1993.11.1
Kyoto
@
”|—{łíƒqƒg•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě1,25-dihydroxyvitamin D3‚É‚ć‚é–Ô–Œ‰č×–EŽîƒ^ƒ“ƒpƒN‚Ě•Ď“Ž
Ź—с@Ć–ž@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć258‰ńŽ‰—nŤƒrƒ^ƒ~ƒ“‘‡Œ¤‹†ˆĎˆő‰ď
1993.11.11
” Ş
@
“ŞŠWŠç–ʍœ–D‡ü‘Šú–ü‡Ç‚ĚŽĄ—ĂŒoŒą
ă’n@@‹M@@’†ě@’B—T@@‘O“c@@‹ i‘ĺăŒxŽ@Œ`Źj
‘ć11‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1993.11.13
ŽD–y
@
‘–ŒŽîÄX”­—áŘœŒă“ŞŠW’ę“ŞŠWŠĽÄŒš‚ĚŒoŒą
‘O“c@@‹@@ă’n@@‹M@@‰Yě@W–ç@@ŒŽ–ě@‹Ĺ•F i‘ĺăŒxŽ@Œ`Źj
‘ć11‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1993.11.13
ŽD–y
@
”S–Œ‰şŒűŠW—ô‚đ‡•š‚ľ‚˝Cornelia de LangeÇŒóŒQ‚Ě‚Q—á
‹g—´@ŸŽq i‘ĺă‘DˆőŒ`Źj @@ˆäă@—TŽj@@‘ĺŒ´@‹`—Y@@“úŠ}@@šć iŒ§—§‚ą‚Ç‚ŕŒ`Źj@
‘ć11‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1993.11.13
ŽD–y
@
ś‘Ě“ŕ UVA ƒNƒƒ‚ƒtƒHƒA‚É‚ć‚é×–EáŠQŤ
˛“Ą@Œ’“ń@@“cŒű@”ŽN@@‘O“c@’mŽq@@“ě@@G“T
‘ć23‰ńŠî‘b”畆‰Č§’k‰ď
1993.11.13
_ŒË
@
ŠŁá i“Á•Ęu‰‰j
‹gě@–M•F
‘ć26‰ń‘ĺă”畆‰Čę–ĺˆă‰ď
1993.11.13
‘ĺă
@
O—ôC ŒűŠW—ô‚É‚¨‚Ż‚éŠ{—ô•”œˆÚA‚ĚŽĄ—ĂŒoŒą
‚“c@ÍD@@ŽRč@Œ¤Žu i•ęŽqˆă—ĂƒZƒ“ƒ^[Œ`Źj @@ź”ö‡‘ž˜Y@@–k‘ş@—´“ń@@‹{ŠŰ‰pˆę˜Y i“ŻŒűoŠO‰Čj @•˝–ě@‹gŽq i“Ż‹¸łŽ•‰Čj
‘ć61‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.11.20
‘ĺ’Ă
@
–„–vŽ¨‚ĚŽčp–@‚ĚŒŸ“˘
ŽRč@Œ¤Žu@@‚“c@ÍD i•ęŽqˆă—ĂƒZƒ“ƒ^[Œ`Źj
‘ć61‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.11.20
‘ĺ’Ă
@
ƒƒ“ƒo[ƒO•a‚Ě“ŞŠWEŠç–ʍœ•Ď‰ť‚ɂ‚˘‚ā|‚RŽŸŒłCT‚É‚ć‚錟“˘
ź–{@@‘@@“Ąě@š˜a i‘ĺă•{Œ`Źj @@Š_•Ł@ł’j@@ź–{@ˆŰ–ž iă‘ĺj
‘ć61‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.11.20
‘ĺ’Ă
@
—ôŽč‚É‚¨‚Ż‚éŽw—ńˆÚsE‰ń“]œŘ‚čp‚É‚ć‚é•ęŽw‘Η§ÄŒšp‚ĚŒoŒą
“Ąě@š˜a@@ź–{@@‘ i•{—§Œ`Źj
‘ć61‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.11.20
‘ĺ’Ă
@
Posterior thigh flap‚É‚ć‚éäSÄŒš‚đs‚Á‚˝Mayer-RokitanskyÇŒóŒQ‚Ě‚P—á
“úŠ}@@šć@@ˆäă@—TŽj iŒ§—§‚ą‚Ç‚ŕŒ`Źj @@’J•—@ŽO˜Y@@ă‰Ş@Ž•F i“Ż”ĺ”AŠí‰Čj
‘ć61‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.11.20
‘ĺ’Ă
@
‰ß“x‚ČŠááً“‹Ř’Zkp‚É‚ć‚萜‚ś‚˝“eŠá‚đ‘¤“Ş‹Ř–ŒˆÚA‚É‚ć‚čC•œ‚ľ‚˝‚P—á
–k‹g@@Œő@@×ě@@˜i@@ŽR–{@@”Ž iŠÖź˜JĐŒ`Źj
‘ć61‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.11.20
‘ĺ’Ă
@
ŽŠ‰Ć‘¤“Ş‹Ř–ŒˆÚA‚É‚ć‚éăŠááٌă‘ŢÇ‚ĚŽĄ—Ă
–k‹g@@Œő@@×ě@@˜i@@ŽR–{@@”Ž iŠÖź˜JĐŒ`Źj
‘ć61‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.11.20
‘ĺ’Ă
@
Expanded free scalp flap
Š_•Ł@ł’j@@ó“c@—TŽi@@ź–{@ˆŰ–ž iă‘ĺj @@“cŠ@äŽk@@–{‘˝@•üm i‘ĺă‘Dˆő•ŰŒŻŒ`Źj
‘ć61‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.11.20
‘ĺ’Ă
@
‹Ř‘w‚ɂ܂ŐZ‚ľ‚˝Œz•”G•˝ă”çŠŕ‚ĚŽĄ—ĂŒoŒą
ź‰ş@“N–ç@@”–@@ä•v@@‹eˆä@’mŽq@@­“c@‰ŔŽq iZ—FŒ`Źj@@“cŒ´@^–ç i_‘厨•@‰Čj
‘ć61‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.11.20
‘ĺ’Ă
@
—œóâ|ᑂ̂P—á
‘ĺ’J@@”Ž@@‹g—´@ŸŽq@@“cŠ@äŽk@@–{‘˝@•üm i‘ĺă‘Dˆő•ŰŒŻŒ`Źj@@Š™“c@U‹g iă‘召Ž™ŠO‰Čj
‘ć61‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.11.20
‘ĺ’Ă
@
‰ş‘Ú‚ÉŒŒŠÇŒs•t—V—Ł‘gDˆÚA‚đs‚Á‚˝Ç—á‚É‚¨‚Ż‚é‘Ť•”‚ւ̉e‹ż‚ɂ‚˘‚Ä i‘ć‚Q•ńj
âˆä@–ő•v@@ŠÖŒű@‡•ă@@‚—œ@^‹ł@@–ě‘ş@’qŽj@@Œü“c@‰ëŽi@@‘“c@’őˆę i“Œ‹žŒxŽ@Œ`Źj
‘ć20‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1993.11.25
–źŒĂ‰Ž
@
‰ş‘Ú‚ÉŒŒŠÇŒs•t—V—Ł‘gDˆÚA‚đs‚Á‚˝Ç—á‚É‚¨‚Ż‚é‘Ť•”‚ւ̉e‹ż‚ɂ‚˘‚Ä i‘ć‚Q•ńj
âˆä@–ő•v@@ŠÖŒű@‡•ă@@‚—œ@^‹ł@@–ě‘ş@’qŽj@@Œü“c@‰ëŽi@@‘“c@’őˆę i“Œ‹žŒxŽ@Œ`Źj
‘ć20‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1993.11.26
–źŒĂ‰Ž
@
ƒ[ƒNƒVƒ‡ƒbƒvF×–EŹ’ˇˆöŽq‚̔畆‚É‚¨‚Ż‚é–đŠ„‚É‚Â‚˘‚Ä
‹´–{@Œö“ń@@“ŒŽR@^—˘@@‹ŕ“c@^—
‘ć44‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1993.11.27-28
Žl“úŽs
@
Œő”畆‰ČŠwC Ĺ‹ß‚ĚŠTŠĎ
˛“Ą@Œ’“ń
‘ć44‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1993.11.27-28
Žl“úŽs
@
Calcipotriol iMC903j ‚Ě”|—{łíƒqƒg•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚鑝BC •Ş‰ťC ×–EŽüŠúC Šŕ—}§ˆâ“`Žq i–Ô–Œ‰č×–EŽîƒ^ƒ“ƒpƒNj ‚É‚¨‚ć‚Ú‚ˇ‰e‹ż
Ź—с@Ć–ž@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć44‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1993.11.27-28
Žl“úŽs
@
ŽŠ‰Ć”|—{•\”ç×–EƒV[ƒgA”çp‚Ş—LŒř‚Ĺ‚ ‚Á‚˝d‚˘’×ᇂ̂P—á
źˆä@Šě•F@@ź–{@ç•ä@@–ě‘ş@­•v@@Žń“Ą@@@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć44‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1993.11.27-28
Žl“úŽs
@
Žˆ’[‰óŽ€‚đŽĺÇó‚Ć‚ľŽá”N—Ť‚É”­Ç‚ľ‚˝ Polyarteritis Nodosa
“c’†@‚Ü‚č@@ăŒ´@‹M”ü@@“ŒŽR@^—˘@@ˆéƒmăł–ž@@źˆä@Šě•F@@–ě‘ş@­•v@@‹gě@–M•F@
‘ć44‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1993.11.27-28
Žl“úŽs
@
‘ĺă‘ĺŠw•‘Ž•a‰@”畆‰Č‚É‚¨‚Ż‚é”畆Šŕ‚ĚŠTŠĎ‚ĆŒo”N•Ď‰ť
•x“c@’qŽj@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@‘ĺ–Š@@–Î iQ‰Žě•ŰŒ’Šj
‘ć44‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1993.11.27-28
Žl“úŽs
@
ƒRƒ“ƒsƒ…[ƒ^ƒNƒ‰ƒuFƒ}ƒbƒN‚đŽg‚¨‚¤
–ě‘ş@­•v
‘ć44‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1993.11.27-28
Žl“úŽs
@
”|—{ƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě×–EŽüŠú‚Ć–Ô–Œ‰č×–EŽîƒ^ƒ“ƒpƒN ipBRj ‚Ě’EƒŠƒ“Ž_‰ť‚ɂ‚˘‚Ä
Ź—с@Ć–ž
‘ć‚W‰ń”畆ŽžŠł‚Ě•a‘Ô‚ĆŽĄ—ĂƒVƒ“ƒ|ƒWƒEƒ€ “ú–{ƒŠƒfƒCƒAƒIƒŠƒŠ[‹Ś‰ďC •\”ç×–E‹y‚щŠÇŒ¤‹†‘g‡“Ż•ń‰ď
1993.12.11
“Œ‹ž
@
Ž‡ŠOü‚a‚Ş‹y‚Ú‚ˇÚGŤ‰ß•q”˝‰ž’ቺ‚ĚƒƒJƒjƒYƒ€‚ɂ‚˘‚Ä
ŒI–{@@ŠŢ@@‹gě@„Ži@@‹gě@–M•F iă‘ĺj @@Streilein, J.W. iHarvard‘ĺj
‘ć320‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.12.18
–L’†
@
Riboflavin cytotoxity induced by UVA radiation under aerobic conditions.
Sato, K., Taguchi, H., Maeda, T., Minami, H. and Yoshikawa, K.
2nd Annual Meeting of the Photomedicine Society
1993.12.3
Washington DC
@
ƒXƒeƒƒCƒhŠO—pÜ‚É‚ć‚éÚG”畆‰Š‚Ě‚R—á
‹î‘ş@Œö”ü@@“ŒŽR@^—˘@@‹ŕ“c@^—@@’†“Œ@“TŽq@@Šâ˛@^l@@‹gě@–M•F
‘ć18‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1993.12.4-5
‘ĺă
@
Cis-urocanic acid ‚Ć UVB ‚Ě’x‰„Œ^”˝‰ž‚ɑ΂ˇ‚é‰e‹ż
ŒI–{@@ŠŢ@@‹gě@–M•F iă‘ĺj @@J. Wayne Streilein iHarvard‘ĺj
‘ć18‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1993.12.4-5
‘ĺă
@
Intravascular papillary endothelial hyperplasia ‚Ě‚P—á
ŠŁ@@dŽ÷@@Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y
‘ć315‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.2
‘ĺă
@
•\ÝŠg‘ĺŒ^•FŽî‚Ě‚P—á
Œ´@@—mŽq@@’JŠ_@••F i‹ß‹E’†‰›j @@ŠC˜VŒ´–­Žq iă‘ĺj
‘ć315‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.2.13
‘ĺă
@
Žčś‘ŤçG‚ɐ…áv‚đŒ`Ź‚ľ‚˝ámᝂ̂Q—á
“¨@‡Žq@@“ŕ“Ą@”üŽq iă˜aň–kj @@•x“c@’qŽj@@‹gě@–M•F iă‘ĺj
‘ć315‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.2.13
‘ĺă
@
Œűo’ęG•˝ă”çŠŕ‚Ć‘Ť’ęˆŤŤ•FŽî‚̏d•ĄŠŕ‚Ě‚P—á
ź–{@ç•ä@@źˆä@Šě•F@@–ě‘ş@­•v@@ź–{@@‘@@“Ąě@š˜a@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@´…’JŒöŹ i“Ż•úŽËü‰Čj@
‘ć315‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.2.13
‘ĺă
@
“ÁˆŮ‚Č—Ő°‘œ‚đ’ć‚ľ‚˝ˆŤŤƒŠƒ“ƒpŽî‚Ě‚P—á
“c’†@‚Ü‚č@@źˆä@Šě•F@@–ě‘ş@­•v@@ŽR‘ş@’íˆę@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@‘ĺ˜a’JiŽq iŽs—§’r“cj@
‘ć315‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.2.13
‘ĺă
@
Œ‹ßŤ”]d‰ťÇŠłŽŇ—R—ˆ×–E‚̍RŠjRőF‘̍R‘Ě‚É‚ć‚éŒ`‘ÔŠw“IŠĎŽ@
‹ŕ“c@^—@@‹´–{@Œö“ń@@‹gě@–M•F
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ǁ@•˝Ź‚S”N“x‘ć‚Q‰ń‘‰ď
1993.2.18
“Œ‹ž
@
ŒŒŠÇ•Ť‡‚É‚ć‚é• o“ŕ¸‘ƒˆÚA‚Ě’ˇŠúŒo‰ß
ˆäă@—TŽj@@‹g—´@ŸŽq@@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj @@’J•—@ŽO˜Y i“Ż”ĺ”AŠí‰Čj
‘ć‚U‰ń•şŒÉŒ§ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[§˜b‰ď
1993.2.27
_ŒË
@
‰EŽčŽŚ’†ŠÂŽwŒ‡‘š‚ɑ΂ˇ‚éfree groin flap‚Ć’°œˆÚA‚É‚ć‚éÄŒš—á
×ě@@˜i@@­“c@‰ŔŽq@@‹eˆä@’mŽq@@”–@@ä•v iZ—FŒ`Źj
‘ć‚U‰ń•şŒÉŒ§ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[§˜b‰ď
1993.2.27
_ŒË
@
‘BŤ“VávጠiHallopeau Œ^j ‚Ě‚P—á
ź–{@ç•ä@@źˆä@Šě•F@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F@
‘ć104‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1993.3.18
‘ĺă
@
ƒJƒƒ`ƒm[ƒVƒX‚𔺂Á‚˝ anorexia nervosa ‚Ě‚P—á
”‹“°@—DŽq@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj @@‹Ęˆä@WŒá i“Ż‚Q“ŕj
‘ć316‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.3.27
ź‹{
@
ƒZƒtƒHƒ`ƒAƒ€‹y‚ŃƒzƒXƒzƒ}ƒCƒVƒ“‚É‚ć‚é–ňÜƒAƒŒƒ‹ƒM[‚Ě‚P—á
•—{@@M@@Šâ˛@^l@@źˆä@Šě•F@@–ě‘ş@­•v@@‹gě@–M•F
‘ć316‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.3.27
ź‹{
@
ŠŁá‚̐V‚ľ‚˘ŽĄ—Ă–@ i“Á•Ęu‰‰j
‹gě@–M•F
‘ć33‰ń•şŒÉŒ§”畆‰Čˆă‰ďŠwpu‰‰‰ď
1993.3.5
_ŒË
@
Effect of oxygen depletion on the cytotoxicity of UVA radiation in the presence of riboflavin
Sato, K., Taguchi, H., Maeda, T. and Yoshikawa, K.
23rd Annual Meeting of Eunopean Society for Dermatological Research
1993.4.5
Amsterdam
@
ƒGƒgƒŒƒ`ƒi[ƒg’ˇŠú“ŕ•žŠłŽŇ‚̍œ‰–—ʂɂ‚˘‚Ä
‰Ş“c“Ţ’ĂŽq@@–ě‘ş@­•v@@‹gě@–M•F@@X–{@–ΐl@@”‹Œ´@r’j
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
lłí”畆‚É‚¨‚Ż‚é TGFƒŔƒAƒCƒ\ƒ^ƒCƒv iTGFƒŔ1,ƒŔ2,ƒŔ3j ‚Ě‹ÇÝ‚É‚Â‚˘‚āE–Ɖu‘gD‰ťŠw“I“Ż’č
‹ŕ“c@^—@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
Ž_‘fŒ‡–R‰ş‚Ĺ‚Ě UVA ĆŽËƒŠƒ{ƒtƒ‰ƒrƒ“‚Ě×–EáŠQŤ
˛“Ą@Œ’“ń@@“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
ƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě‘B’˛ß@‘BŠÖ˜A’`”’EŠŕˆâ“`ŽqC Šŕ§Œäˆâ“`Žq‚Ć‚ť‚Ěˆâ“`Žq‚ɂ‚˘‚Ä
Ź—с@Ć–ž
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
‘BŠÖ˜A’`”’ EŠŕˆâ“`ŽqC Šŕ—}§ˆâ“`Žq‚Ć‚ť‚Ěˆâ“`ŽqŽY•¨‚ɂ‚˘‚Ä
Ź—с@Ć–ž
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
EB ƒEƒCƒ‹ƒXŽ‘ąŠ´őTƒŠƒ“ƒp‹…Ť”’ŒŒ•a×–E‚Ě in vitro ‚Ĺ‚Ě”|—{‚Č‚ç‚тɉđÍ
ó“c@G•v@@‰Ş“c“Ţ’ĂŽq@@“A@@‰pŽ÷@@ŽR‘ş@’íˆę@@‹´–{@Œö“ń@@‹gě@–M•F@@‹ß“Ą@ˆę”Ž@@ŽRź@Oˆę
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
…—nŤƒrƒ^ƒ~ƒ“C Ž‰—nŤƒrƒ^ƒ~ƒ“‚É‚ć‚é photosenitization ‚Ě‘Š‘ΔäŠr
‘O“c@’mŽq@@“cŒű@”ŽN@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
ƒGƒCƒRƒTƒyƒ“ƒ^ƒGƒ“Ž_‚Ě”|—{ŒŒŠÇ“ŕ”ç×–E‚̐ڒ…•ŞŽq”­Œť‚ƩǍoŒ`Ź‚É‹y‚Ú‚ˇ‰e‹ż
’†’J@G‘˘@@—¤@@ i˜Hj @@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F@@”‘ň@Œh“ń
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
Pyridoxine photosensitization ‚É‚¨‚Ż‚銈ŤŽ_‘fŽí‚ĚŠÖ—^
“cŒű@”ŽN@@‘O“c@’mŽq@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
”|—{•\”çƒV[ƒgŽŠ‰ĆˆÚA‚ŞŒř‰Ę‚Ě‚ ‚Á‚˝‰Ć‘°Ť—ǐŤ–Ť“Vávጂ̂P—á
–î•~@@“ց@@ź‰Ş@@‰@@’˛@@—TŽŸ@@‘ž“c@ƒŽq@@ě’Á@’qĽ i‘ĺă’üMj@ ‹´–{@Œö“ń iă‘ĺj @@
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
Malignant histiocytosis ‚Ě‚P—á
‰Ôě@@–ő@@ˆéƒmăł–ž@@źˆä@Šě•F@@–ě‘ş@­•v@@‹gě@–M•F iă‘ĺj@@’†ě@‰ëŽj i“ŻŽO“ŕj @@
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
CA19-9‚ލ‚’l‚đ’ć‚ľ‚˝ eccrine carcinoma ‚Ě‚P—á
źˆä@Šě•F@@ŽR‘ş@’íˆę@@‹gě@–M•F iă‘ĺj @@•Đ‰Ş@—tŽq@@“c‘ă@@ŽŔ@@–{‘˝@•üm i‘Dˆő•ŰŒŻj@@
‘ć92‰ń“ú”ç‰ď‘‰ď
1993.4.9-11
Šň•Œ
@
Tumoral calcinosisyN ‚Ě‚P—á
ŠŁ@@dŽ÷@@Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y
‘ć105‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1993.5
‘ĺăŽs
@
ŒŒŠÇ•Ť‡‚É‚ć‚é• o“ŕ¸‘ƒˆÚA‚Ě’ˇŠúŒo‰ß
ˆäă@—TŽj iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1993.5.14
ˇ‰Ş
@
•şŒÉŒ§—§‚ą‚Ç‚ŕ•a‰@‚É‚¨‚Ż‚é‰ß‹Ž22”NŠÔ‚̐O—ôŒűŠW—ô‚Ě“Œv“IlŽ@
‹g—´@ŸŽq@@ˆäă@—TŽj@@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1993.5.14
ˇ‰Ş
@
ˆŤŤŽîᇐ؏œŒă‚ĚŠáâ|ŽüˆÍ‚ĚÄŒš
Š_•Ł@ł’j@@ź–{@ˆŰ–ž@@ŠC˜VŒ´–­Žq iă‘ĺj @@“Ąě@š˜a@@ź–{@@‘ i‘ĺă•{—§Œ`Źj @@ă’n@@‹M i‘ĺăŒxŽ@Œ`Źj@@–k‹g@@Œő iŠÖź˜JĐŒ`Źj
‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď@
1993.5.14
ˇ‰Ş
@
ƒƒ“ƒo[ƒO•a‚ĚŽĄ—Ă‚É‚¨‚Ż‚é–â‘č“_
“Ąě@š˜a@@ź–{@@‘ i‘ĺă•{—§Œ`Źj @@ź–{@ˆŰ–ž@@Š_•Ł@ł’j@@–k‹g@@Œő@@ŠC˜VŒ´–­Žq iă‘ĺj @@‘O“c@@‹ i‘ĺăŒxŽ@Œ`Źj
‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1993.5.14
ˇ‰Ş
@
ŒŒŠÇ•ż•t‚ŤœˆÚA‚É‚ć‚鉺Š{‚ĚÄŒš|ÄŒš•”ˆĘC Œ‡‘š—ʁC ĚW•”‚Ě‹]ľ‚É‚¨‚Ż‚é’°œ‚ĆŒ¨bœ‚Ć‚Ě”äŠr|
–k‹g@@Œő iŠÖź˜JĐŒ`Źj @@“Ąě@š˜a i‘ĺă•{—§Œ`Źj @@ź–{@ˆŰ–ž@@Š_•Ł@ł’j iă‘ĺj
‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1993.5.14
ˇ‰Ş
@
‚í‚ę‚í‚ę‚̍s‚Á‚Ä‚˘‚é‘lŒaƒŠƒ“ƒpßŠs´p
ź–{@@‘@@“Ąě@š˜a@@Š_•Ł@ł’j@@–k‹g@@Œő@@ŠC˜VŒ´–­Žq@@ź–{@ˆŰ–ž
‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
1993.5.15
ˇ‰Ş
@
Localization of transforming growth factor-ƒŔiTGF-ƒŔj isoforms in normal and psoriatic epidermis.
Hashimoto, K., Kaneda, M. and Yoshikawa, K.
Dermatology 2000
1993.5.18-21
Vienna
@
Effect of TNF on tube-formation and expression of cell adhesion molecules of vascular endothelial cells in three dimensional culture.
Nakatani, S., Okada, N., Lu, L. and Yoshikawa, K.
Dermatology 2000
1993.5.18-21
Vienna
@
RśÜ‚É‚ć‚é”^ávŒ^–ň]‚Ě‚Q—á
‹î‘ş@Œö”ü@@źŽR@@i@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj @@’M’J@Ÿm@@ŽR“c“O‘ž˜Y iŽs—§–L’†j @
‘ć‚X‰ń“ú–{—Տ°”畆‰ČˆăŠw‰ď
1993.5.22-23
“Œ‹ž
@
ƒ_ƒCƒŒ[ƒU[‚ĚŽg—pŒoŒą
“cŠ@äŽk@@–{‘˝@•üm@@ó“c@—TŽi@@‘ĺ’J@@”Ž i‘ĺă‘Dˆő•ŰŒŻŒ`Źj
‘ć‚V‰ń‘ĺăŒ`ŹŠO‰ČW’k‰ď
1993.5.29
‘ĺă
@
Chemotherapy-induced acral erythema ‚Ě‚S—á
‹î‘ş@Œö”ü@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@’|“c@@Œ‰@@–Ř‘ş@—T”ü@@’J@@Œc•F@@Źě@Œ[‹ą i“ŻŽO“ŕj@
‘ć317‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.5.8
‘ĺă
@
R‘ć‚uˆöŽqR‘Ě iŽŠŒČR‘́j ‚𔺂Á‚˝…ávŤ—Ţ“Vávጂ̂P—á
’†‘ş@•q–ž@@‹´–{@Œö“ń@@źˆä@Šě•F@@–ě‘ş@­•v@@‹gě@–M•F iă‘ĺj@@Ž›’J@’ő^ i“Żˆę“ŕj @@
‘ć317‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.5.8
‘ĺă
@
Ř’f’[•”‚ɐś‚ś‚˝ Polypoid hypertrophy in chronic lymphoedema ‚Ě‚P—á
Šâ˛@^l@@‹gě@–M•F
‘ć86‰ń‹ß‹EW’k‰ď
1993.6.20
‘ĺă
@
‰ş‘ڂɉ󎀐Ť•a•Ď‚đ”F‚ß‚˝ PSS ‚Ě‚P—á
Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@ŠŁ@@dŽ÷ iă‘ĺj
‘ć86‰ń‹ß‹EW’k‰ď
1993.6.20
‘ĺă
@
Hallopeau Œ^‘BŤ“Vávጂ̂P—á
ź–{@ç•ä@@źˆä@Šě•F@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj@@“y‹@•q–ž i”Ş”öŽs—§j @@
‘ć86‰ń‹ß‹EW’k‰ď
1993.6.20
‘ĺă
@
Effects of cefpodoxime proxetil dry syrup on impetigo contagiosa in children.
Kawatsu, T. and Yoshikawa, K.
18th International Congress of Chemotherapy
1993.6.27-7.2
Stockholm
@
EB ƒEƒCƒ‹ƒXŽ‘ąŠ´ő‚s×–EŠ” iEBT-8j ‚̉đÍ
ó“c@G•v@@‹´–{@Œö“ń@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj @@ź˜AŽ›@„@@ŽRź@Oˆę@
‘ć‚W‰ńƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ď
1993.6.28
–źŒĂ‰Ž
@
A case of herpes gestationis iHGj with HG factor and anti-ICS antibody.
Higashiyama, M., Hashimoto, K., Hara, Y., Inoue, C., Hashimoto, T. and Yoshikawa, K.
8th Japan-Korea Joint Meeting of Dermatology
1993.6.3-4
Sapporo
@
Von Recklinghausen's disease in monozygotic twins.
Inui, S., Okada, N., Yoshikawa, K. and Harino, S.
8th Japan-Korea Joint Meeting of Dermatology
1993.6.3-4
Sapporo
@
‚Ü‚ę‚ČŽ¨‰î•ĎŒ`‚𔺂Á‚˝Craniofacial Microsomia‚Ě‚P—á
ŠC˜VŒ´–­Žq@@Š_•Ł@ł’j@@ŽRč@Œ¤Žu@@ź–{@ˆŰ–ž
‘ć60‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.7.10
‘ĺă
@
‰AŒsÄŒš‚Ě‚P—á
Š_•Ł@ł’j@@ŠC˜VŒ´–­Žq@@ź–{@ˆŰ–ž@@–k‹g@@Œő iŠÖź˜JĐŒ`Źj
‘ć60‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.7.10
‘ĺă
@
”畆Z‚đ”F‚ß‚˝‰E‘¤Œ‹’°ŠŕŘœŒă‚ĚÄŒš
ŽRč@Œ¤Žu@@Š_•Ł@ł’j@@ź–{@ˆŰ–ž iă‘ĺj @@ź–{@@‘ i‘ĺă•{—§Œ`Źj
‘ć60‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.7.10
‘ĺă
@
Šá‹…ŒĹ’čˆĘŠłŽŇ‚ĚŠááىş‚ÇŽĄ—Ă‚ĚŒoŒą
ŽR–{@@”Ž@@×ě@@˜i@@–k‹g@@Œő@@’JŒű@@š iŠÖź˜JĐŒ`Źj
‘ć60‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.7.10
‘ĺă
@
ˆă—Ă—pƒqƒ‹‚ĚŽg—pŒoŒą
Žs–ě@’źŽ÷@@‘O“c@@‹@@ă’n@@‹M@@‰Yě@W–ç@@’†ě@’B—T i‘ĺăŒxŽ@Œ`Źj
‘ć60‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.7.10
‘ĺă
@
Ž¨‰î‚Ěˆę•”‚Ě‚˛‚Ć‚ŤŒ`‚đŽ¨‘O•”‚É—L‚ˇ‚鎨‰î•ĎŒ`‚Ě‚Q—á
­“c@‰ŔŽq@@ź‰ş@“N–ç@@‹eˆä@’mŽq@@”–@@ä•v
‘ć60‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.7.10
‘ĺă
@
Ž¨‰î“ˆÚA‚É‚ć‚é•@Œ`Źp‚ɂ‚˘‚Ä
ź–{@@‘@@“Ąě@š˜a i•{—§Œ`Źj @@‚“c@ÍD i•ęŽqˆă—ĂƒZƒ“ƒ^[Œ`Źj
‘ć60‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.7.10
‘ĺă
@
‚Žü”g‹@Ší‚É‚¨‚Ż‚é”M‚ĚŽĄ—ĂŒoŒą
’†ě@’B—T@@‘O“c@@‹@@ă’n@@‹M@@‰Yě@W–ç@@Žs–ě@’źŽ÷ i‘ĺăŒxŽ@Œ`Źj
‘ć60‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.7.10
‘ĺă
@
‘ŤćäˆÚA‚É‚ć‚éŽčŽwÄŒš‚É‚¨‚Ż‚é–â‘č“_
“Ąě@š˜a@@ź–{@@‘ i•{—§Œ`Źj
‘ć60‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.7.10
‘ĺă
@
“ű–[ŽîᎂƂľ‚Ä”­ŒŠ‚ł‚ę‚˝ˆŤŤ•FŽî‚Ě‚P—á
“úŠ}@@šć@@–î•”@@Œ‰@@™Œ´@@Ži@@ŒF’J@‰Ă—˛ iŒ’˜a‰ďŠO‰Čj @‘ŠŒ´@@i i“Ż•a—•”j
‘ć60‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1993.7.10
‘ĺă
@
ŠŁá‚̐V‚ľ‚˘ŽĄ—Á@ iŽw’ču‰‰j
‹gě@–M•F
‘ć‚X‰ń“ú—Ő”ç‹ß‹EŽx•”‘‰ď
1993.7.11
_ŒË
@
œ‘e頏ǂ𔺂Á‚˝ƒXƒeƒƒCƒh”畆‰Š‚Ě‚P—á
‘唨@ç‰Ŕ@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć318‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.7.17
_ŒË
@
Œz•”‚ɐś‚ś‚˝ˆŮŠŤ“•ę”Á‚Ě‚P—á
—с@@ŕŠw@@‹gě@–M•F
‘ć318‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.7.17
_ŒË
@
ŒŒŸ÷ŒđŠˇ—Ă–@‚đ•š—p‚ľ‚˝ Hallopeau Œ^‘BŤ“Vávጂ̂P—á
Šâ˛@^l@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć15‰ń…ávÇŒ¤‹†‰ď
1993.7.24
ˆŽě
@
ƒUƒWƒeƒ““_Šá–ň‚É‚ć‚éÚG”畆‰Š‚Ě‚Q—á
Šâ˛@^l@@’†“Œ@“TŽq@@‹î‘ş@Œö”ü@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć23‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1993.7.3-4
‹ž“s
@
Aminoglycoside ŒnRś•¨Žż‚É‚ć‚éÚG”畆‰Š‚Ě‚Q—á
‹î‘ş@Œö”ü@@“ŒŽR@^—˘@@‹ŕ“c@^—@@’†“Œ@“TŽq@@Šâ˛@^l@@‹gě@–M•F
‘ć23‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1993.7.3-4
‹ž“s
@
2-Chloromethyl, 8-Hydroxy Quinoline ‚É‚ć‚éƒAƒŒƒ‹ƒM[ŤÚG”畆‰Š‚Ě‚P—á
ź–{@ç•ä@@˛“Ą@Œ’“ń@@Šâ˛@^l@@ˆéƒmăł–ž@@–ě‘ş@­•v@@‹gě@–M•F
‘ć23‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1993.7.3-4
‹ž“s
@
‰ßŽ_‰ť…‘f‚ĚŠČ•Ö‚Č‘Ş’č•ű–@‚ɂ‚˘‚Ä
˛“Ą@Œ’“ń@@“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F
‘ć15‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1993.7.30
ĺ‘ä
@
300nm ‚ĚŒő‚Ĺ—U”­‚ľ“ž‚˝“úŒőĺ@–ƒ]
‘O“c@’mŽq@@˛“Ą@Œ’“ń@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć15‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1993.7.30
ĺ‘ä
@
Pyridoxine photosensitization ‚ĆŠˆŤŽ_‘fŽí‚ĚŠÖ—^
“cŒű@”ŽN@@‘O“c@’mŽq@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć15‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1993.7.30
ĺ‘ä
@
Ž‡ŠOü‚É‚ć‚é”畆áŠQ
˛“Ą@Œ’“ń
‘ĺă•{ˆăŽt‰ďśŠUŒ¤CƒVƒXƒeƒ€“o˜^Œ¤C‰ď
1993.8.21
ä
@
FK 506 in the treatment of psoriasis iResults of early phase 2 studyj.
Nakagawa, H., Ishibashi, Y., Nakayama, J., Hori, Y., Aiba. S., Tagami, H., Hashimoto, K. and Yoshikawa, K.
Europ Assoc Derm. Venereol
1993.9
Copenhagen
@
…áv—lŠOŠĎ‚đ’ć‚ľ‚˝ÎŠD‰ťă”çŽî‚Ě‚P—á
ŠŁ@@dŽ÷@@‹gě@–M•F iă‘ĺj @@Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y i‘ĺă˜JĐj
‘ć319‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.9.11
‘ĺă
@
Œ‹ßŤ”]d‰ťÇ‚É‚¨‚Ż‚éŠç–ĘŒŒŠÇüˆŰŽî‚̉t‘Ě’‚‘f—Ă–@
‹ŕ“c@^—@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć319‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.9.11
‘ĺă
@
ƒAƒ[ƒ‰ƒXƒ`ƒ“‚Ş‘tŒř‚ľ‚˝“úŒőĺ@–ƒ]‚Ě‚P—á
‘O“c@’mŽq@@˛“Ą@Œ’“ń@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć319‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.9.11
‘ĺă
@
• •”‚É”­ś‚ľ‚˝ƒGƒbƒNƒŠƒ“Šž‘BŠŕ
’JŠ_@••F@@Œ´@@—mŽq@@“n•Ó@‰ëŽq i‹ß‹E’†‰›j @@ŠC˜VŒ´–­Žq iă‘ĺj
‘ć319‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1993.9.11
‘ĺă
@
ƒjƒ…[ƒƒiƒrƒQ[ƒ^[‚đ—p‚˘‚Ä“Eo‚ľ‚˝˜•”•ščI‚Ě‚P—á
âˆä@–ő•v@@“n•Ó@‰pŽő@@HŒŽ@Ží‚@@Œü“c@‰ëŽi@@‘ĺXŠě‘ž˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć‚Q‰ńƒRƒ“ƒsƒ…[ƒ^[ŠO‰ČŒ¤‹†‰ď
1993.9.23
“Œ‹ž
@
Transforming growth factor-ƒŔ iTGF-ƒŔj isoforms ‚̐łíl‹y‚ѐqíŤŠŁáŠłŽŇ‚Ě•\”ç‚É‚¨‚Ż‚é‹ÇÝ
‹ŕ“c@^—@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć‚W‰ń“ú–{ŠŁáŠw‰ď
1993.9.3-4
‰Ą•l
@
ŠŁá•a•Ď•”‚É‚¨‚Ż‚é Elafin iElastase-specific-inhibitorj ‚Ě‹ÇÝ‚ÉŠÖ‚ˇ‚é–Ɖu‘gDŠw“IŒŸ“˘
“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć‚W‰ń“ú–{ŠŁáŠw‰ď
1993.9.3-4
‰Ą•l
@
ƒqƒXƒ`ƒWƒ“’E’YŽ_y‘fŠˆŤ‚Ć‘~áy‚ĚŠÖŒW
˛“Ą@Œ’“ń@@ź‰Ş@@‰@@“ě@@G“T@@‹gě@–M•F iă‘ĺj@ Ą‘ş@ˆç’j i“Ż‚Q–ň—j@@
‘ć‚R‰ńáy‚݃Vƒ“ƒ|ƒWƒEƒ€
1993.9.5
‘ĺă
@
“ŕŽ‹‹ž‚¨‚ć‚Ńƒjƒ…[ƒƒiƒrƒQ[ƒ^[‰ş‚É‘OŠz•”íœp‚đŽ{s‚ľ‚˝‚P—á
âˆä@–ő•v@@“n•Ó@‰pŽő@@‰Şč@@–r@@HŒŽ@Ží‚@@‘ĺXŠě‘ž˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć‚R‰ńƒRƒ“ƒsƒ…[ƒ^[ŠO‰ČŠw‰ď
1994.10.16
“Œ‹ž
@
Œ‹ßŤ”]d‰ťÇ‚É‚¨‚˘‚ÄŒ¸­‚Ş”F‚ß‚ç‚ę‚˝’`”’P40‚̉đÍ
‹ŕ“c@^—@@‹ŕ“c@ˆŔŽj@@‹´–{@Œö“ń@@‹gě@–M•F
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ǁ@•˝Ź‚U”N‘ć‚P‰ń‘‰ď
1994.10.27
“Œ‹ž
@
ŽŠ‰Ć”|—{•\”çƒV[ƒgˆÚA‚É‚ć‚é—ňŤ‰h—{áŠQŒ^ć“VŤ•\”琅ávÇ‚É‚¨‚Ż‚é“Ť’×ᇂ̎Ą—Ă
ˆŔ“Œ@˜Đ”ü@@‹{–{@•üŽq@@źˆä@Šě•F@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@
‘ć45‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1994.10.29-30
‹ž“s
@
Infantile digital fibromatosis ‚Ě‚P—á
Œ‡“c@—ÇŽ™@@ˆŔ“Œ@˜Đ”ü@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@ź‘ş@‰ëŒb i–Ľ–ĘŽs—§j @@“úŠ}@@šć iă‘ĺj
‘ć45‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1994.10.29-30
‹ž“s
@
CEA ‚’l‚𔺂Á‚˝ŠZóŠŕ‚Ě‚P—á
ź‘ş@‰ëŒb@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@—é–؉Á—]Žq iŽs—§’r“cj @@‘ĺ˜a’JiŽq i–Ľ–ĘŽs—§j
‘ć45‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1994.10.29-30
‹ž“s
@
ƒ[ƒNƒVƒ‡ƒbƒvFTGF-ƒŔ1,IFN-ƒÁ‚É‚ć‚éƒ}ƒEƒX•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě×–E‘B—}§‹@\‚É‚¨‚Ż‚é Interferon-regulatory factor 1 iIRF-1j ‚Ě‹@”\‰đÍ
’M’J@Ÿm@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@–kě@Œłś@@’JŒű@’ź”V i×–EHŠwƒZƒ“ƒ^[j @@@
‘ć45‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1994.10.29-30
‹ž“s
@
ƒ[ƒNƒVƒ‡ƒbƒvFŠŁá‚̏dÇ“x‚ĆŽĄ—Ă‚Ě‘I‘đ
“ŒŽR@^—˘@@–ě‘ş@­•v@@‹gě@–M•F
‘ć45‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1994.10.29-30
‹ž“s
@
ƒJƒŠƒNƒŠƒ“A‚É‚ć‚é•\”ç×–EƒCƒ“ƒ{ƒ‹ƒNƒŠƒ“‚Ě—U“ą
–ě‘ş@­•v@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć45‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1994.10.29-30
‹ž“s
@
Effect of free tissue transfer to the lower leg on the foot
SakaiC Y., SekiguchiC J., KobayasiC S., AkizukiC T., OhmoriC K. (Tokyo Police)
the 12th Congress of the Int. Microsurgical Society
1994.10.6
Nara
@
ăŠ{‚Ö‚ĚŒŒŠÇ•ż•tœˆÚA‚ɂ‚˘‚Ä
Š_•Ł@ł’j@@×ě@@˜i@@–î–ě@Œ’“ń@@“úŠ}@@šć@@™Œ´@@Ži iă‘ĺj
‘ć21‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1994.11.11
O‘O
@
‰ş‘Ú‚É‘˝”­‚ľ‚˝ atypical fibroxanthoma ‚Ě‚P—á
Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@ŠŁ@@dŽ÷ iă‘ĺj
‘ć46‰ń“ú”ç‰ďź•”Žx•”‘‰ď
1994.11.12-13
‰F•”
@
Hodgkin •a‚ɍ‡•š‚ľ‚˝ Thrombophlebitis migrans
“ŒŽR@^—˘@@‹gě@–M•F iă‘ĺj @@—é–؁@ŒŤˆę@@…–Ř–ž˛‰›@@‘Ňˆä@—˛Žu i“ŻŒŒ‰tŽîᇓŕ‰Čj
‘ć46‰ń“ú”ç‰ďź•”Žx•”‘‰ď
1994.11.12-13
‰F•”
@
”牺ŽîᎂđŒ`Ź‚ľ‚˝—Lž™×–EŠŕ
ˆŔ“Œ@˜Đ”ü@@Œ‡“c@—ÇŽ™@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@Š_•Ł@ł’j iă‘ĺj
‘ć114‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1994.11.17
‘ĺă
@
ƒqƒg”|—{•\”çƒV[ƒg‚ĚˆÚAŹŃ
Š_•Ł@ł’j@@×ě@@˜i@@–î–ě@Œ’“ń@@“úŠ}@@šć@@™Œ´@@Ži iă‘ĺj @‹´–{@Œö“ń@@‹gě@–M•F i“Ż”畆‰Čj @@‘O“c@@‹ i‘ĺăŒxŽ@Œ`Źj @‚“c@ÍD i‘ĺă•{—§•ęŽqˆă—ĂŒ`Źj @@“Ąě@š˜a i‘ĺă•{—§Œ`Źj @–{‘˝@•üm i‘ĺă‘DˆőŒ`Źj @
‘ć‚R‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1994.11.18-19
‰Ą•l
@
Immunosuppression by UVB radiation
Kurimoto, I., Yoshikawa, T., Yoshikawa, K. and Streilein, J.W.
2nd International Congress of Pathophysiology
1994.11.19-24
Kyoto
@
‘˝Œ`Ť‘BŽî‚Ě‹¤‘ś‚ˇ‚鎨‰ş‘B“ŕŠOƒƒ‹ƒ`ƒ“Žîᇂ̂P—á
ŽR–{@@”Ž i‘ĺă•{—§Œ`Źj @@×ě@@˜i iă‘ĺj @@–k‹g@@Œő iŠÖź˜JĐŒ`Źj
‘ć12‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1994.11.24
“Œ‹ž
@
‹‘ĺ‚Č–j•”Žî᎑œ‚đ’ć‚ľ‚˝“űŽ™üˆŰŤ‰ßŒëŽî‚Ě‚P—á
“úŠ}@@šć@@×ě@@˜i@@Š_•Ł@ł’j@@ŒI“c@’q”V
‘ć12‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1994.11.24
“Œ‹ž
@
“ŕŽ‹‹ž‰şLeFortIŒ^œŘ‚čp‚ĚŒoŒą
âˆä@–ő•v@@Ź—ѐ˝ˆę˜Y@@‘q•Đ@@—D@@‘ĺXŠě‘ž˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć12‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ď
1994.11.25
‰YˆŔ
@
“ŕŽ‹‹ž‰şŠç–ʍœœŘ‚čp‚ĚŒoŒą
âˆä@–ő•v@@Ź—ѐ˝ˆę˜Y@@‘q•Đ@@—D@@‘ĺXŠě‘ž˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć‚V‰ń“ŕŽ‹‹ž‰şŠO‰ČŒ¤‹†‰ď
1994.11.26
ĺ‘ä
@
ƒŠƒVƒm[ƒ‹Ž_‚É‚ć‚éÚGŒűO‰Š‚Ě‚Q—á
‹î‘ş@Œö”ü@@‹gě@–M•F iă‘ĺj @@Ź’ˁ@—Y–Ż i‘—§‘ĺăj @˛“Ą@Œ’“ń i–źŽs‘ĺj
‘ć19‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1994.11.26-27
•xŽR
@
”畆‚ĆŠˆŤŒ^ƒrƒ^ƒ~ƒ“D
Ź—с@Ć–ž@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć10‰ńƒrƒ^ƒ~ƒ“‚cƒ[ƒNƒVƒ‡ƒbƒv
1994.11.4-5
‰Ą•l
@
–@ŒűŠWŒ`Źp‚É‚¨‚Ż‚錸’ŁŘŠJ‚̍H•v
ˆäă@—TŽj@@’†ě@’B—T iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
ŠOŤ‰AŒs‰A”XŘœ‚Ě‚P—á
‹g‰Ş@’źl@@“Ąě@š˜a@@ŽR–{@@”Ž i•{—§Œ`Źj@@“Ą–{@éł@@ˆÉ“ĄŠěˆę˜Y i“Ż”ĺ”AŠí‰Čj@@“Œ@@FŽŸ i“Ż‹~‹}f—Éȁj@@–k‹g@@Œő iŠÖź˜JĐŒ`Źj
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
ŽčŽw‚Ö‚ĚŒŒŠÇ•ż•tŠÖßˆÚA‚ĚŒoŒą
ŒŽ–ě@‹Ĺ•F@@‘O“c@@‹@@‰Yě@W–ç@@ź–{@@‘@@‘O“c@•ś•F i‘ĺăŒxŽ@Œ`Źj
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
ŽÎŠç–Ę—ô‚𔺂Á‚˝Golts syndrome‚Ěˆę—á
ŽRč@Œ¤Žu@@‚“c@ÍD i•{—§•ęŽqˆă—ĂŒ`Źj
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
–jœ•”Fibrous dysplasia‚ɑ΂ˇ‚éˆęŠú“IÄŒš‚Ě‚P—á
ŽR–{@@”Ž@@“Ąě@š˜a@@‹g‰Ş@’źl i‘ĺă•{—§Œ`Źj @@X‰ş@ł–ž i“ŻŒűoŠO‰Čj@@ź–{@@‘ i‘ĺăŒxŽ@Œ`Źj @
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
Ž¨Œă•”‚Ěisland flap‚É‚ć‚é–„–vŽ¨‚ĚŽčp–@
Ą‰Ş@@Œ’@@ź–{@ˆŰ–ž@@–k‹g@@Œő iŠÖź˜JĐŒ`Źj
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
ł’†Œz—ô‚ĚŒoŒą
ź‰ş@“N–ç i‘ĺăŒúś”N‹ŕŒ`Źj @@”–@@ä•v@@‹eˆä@’mŽq@@­“c@‰ŔŽq iZ—FŒ`Źj
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
‰äX‚ĚŒoŒą‚ľ‚˝á­Šŕ
ź–{@@‘@@‘O“c@@‹@@‰Yě@W–ç@@ŒŽ–ě@‹Ĺ•F@@‘O“c@•ś•F i‘ĺăŒxŽ@Œ`Źj
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
‰ş‘Ú’×ᇂɑ΂ˇ‚鎥—Ă‚ĚŽŽ‚Ý
ó“c@—TŽi@@–{‘˝@•üm@@‹g—´@ŸŽq@@Îˆä@‘P‹P i‘ĺă‘DˆőŒ`Źj @@ˆéƒmăł–ž@@Ź’ˁ@—Y–Ż i‘—§‘ĺă”畆‰Čj
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
ć“VŤăŒűOł’†á‘E‚Ě‚Q—á
’†ě@’B—T@@ˆäă@—TŽj iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
‰şŠááق̓Ž‚Ť‚ɂ‚˘‚āF‘ć‚P•ń
“úŠ}@@šć@@×ě@@˜i@@Š_•Ł@ł’j@@–î–ě@Œ’“ń@@‘ĺŽR@’mŽ÷@@ŒI“c@’q”V
‘ć63‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.12.10
‘ĺă
@
ŽĄ—Ă‚É“ďa‚ľ‚˝ĺœ•”•úŽËü’×ᇂ̈ę—á
“cŠ@äŽk@@‘q“c‘‘‘ž˜Y@@Ž›Žt@_l i‘ĺ•Şˆă‘ĺŒ`Źj
‘ć11‰ń‘ĺ•ŞŒ`Ź§˜b‰ď
1994.12.14
‘ĺ•Ş
@
“ŤƒEƒCƒ‹ƒXŤ”畆ŽžŠł‚ɑ΂ˇ‚é OK-432‹Ç’—Ă–@
ŠŁ@@dŽ÷@@ó“c@G•v@@źˆä@Šě•F@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć326‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.12.17
˜a‰ĚŽR
@
—Lž™×–EŠŕ‚đ•š”­‚ľ‚˝—ń˜ŤŠžEŠp‰ťÇ‚Ě‚P—á
’†’J@G‘˘@@Œ´@@—mŽq@@“n•Ó@‰ëŽq@@’JŠ_@••F i‹ß‹E’†‰›j @–î–ě@Œ’“ń iă‘ĺj @@
‘ć326‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.12.17
˜a‰ĚŽR
@
Paget •a‚đŽv‚í‚š‚é—Տ°‘œ‚đ’ć‚ľ‚˝Šî’ę×–Eă”çŽî‚Ě‚P—á
žw‘ň@F”V@@ŒI“c@’q”V@@Šp’҂قÂ݁@@–î–ě@Œ’“ń@@‹gě@„Ži@@Š_•Ł@ł’j@@‹gě@–M•F
‘ć326‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.12.17
˜a‰ĚŽR
@
‰şŽˆĂ–ŹáŽ‚̍d‰ť—Ă–@‚É‚ć‚鎥—ĂŒoŒą
ˆéƒmăł–ž@@•—{@@M@@™‰Y@ŸŒČ@@“c糁@@¸@@Ź’ˁ@—Y–Ż i‘—§‘ĺăj@@Š_•Ł@ł’j@@ó“c@—TŽi iă‘ĺj
‘ć321‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.2.12
‹ß‘ĺ
@
–Ř‘şŽ•a‚Ě‚P—á
ś“‡@”ü•ä@@źˆä@Šě•F@@ŒI–{@@ŠŢ@@‹gě@–M•F
‘ć321‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.2.12
‹ß‘ĺ
@
OK432‹ÇŠ’ŽË—Ă–@‚É‚ć‚čŒy‰ő‚ľ‚˝ Bowenoid papulosis ‚Ě‚P—á
ó“c@G•v@@ŠŁ@@dŽ÷@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć321‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.2.12
‹ß‘ĺ
@
ƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě‘B‚Ć•Ş‰ť |ŠˆŤŒ^ƒrƒ^ƒ~ƒ“‚c3‚̍ě—p‚𒆐S‚Ɂ| i–î‘ş‹L”Ou‰‰j
‹gě@–M•F
‘ć93‰ń“ú”ç‰ďL“‡’n•ű‰ď
1994.2.13
L“‡
@
”|—{•\”çƒV[ƒg‚É‚ć‚é”M‚ĚŽĄ—Ă
Š_•Ł@ł’j@@ź–{@ˆŰ–ž iă‘ĺŒ`Źj @@‹´–{@Œö“ń@@‹gě@–M•F i“Ż”畆j
‘ć‚Q‰ń“ú–{”MŠw‰ď‹ß‹E’n•ű‰ď
1994.2.19
ŽçŒű
@
SKIN BANKING‚ĚFROZEN ALLO SKIN‚đŽg—p‚ľ‚˝d”MŠłŽŇ‚ĚŽĄ—ĂŒoŒą
ź‘q@“NŽi@@ź“‡@’mG@@‘OŒ´@ˆę@@žÄ@@”ŽŽj@@‰––ě@@–΁@@Œü’‡@^‘ @@b”ă@’B˜N@@‘ž“c@@•v iç—˘‹~–˝j
‘ć‚Q‰ń“ú–{”MŠw‰ď‹ß‹E’n•ű‰ď
1994.2.19
ŽçŒű
@
“ŤƒEƒCƒ‹ƒXŤ”畆ŽžŠł‚ɑ΂ˇ‚é OK-432‹Ç’—Ă–@
ŠŁ@@dŽ÷@@ó“c@G•v@@źˆä@Šě•F@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć326‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.2ŒŽ
˜a‰ĚŽRŽs
@
ƒ~ƒmƒTƒCƒNƒŠƒ“ŤF‘f’ž’…‚Ě’ˇŠúŠĎŽ@—á
‰Ş“c“Ţ’ĂŽq@@ź“cŒ’Ž÷@@‹gě–M•F iă‘ĺj @@˛“ĄšŽO
‘ć355‰ń“ú”ç‰ď–k—¤’n•ű‰ď
1994.3.12
‹ŕ‘ň
@
ŠŁá‚Ćƒrƒ^ƒ~ƒ“D i“Á•Ęu‰‰j
‹gě@–M•F
‘ć110‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1994.3.17
‘ĺă
@
“€Œ‹”|—{•\”ç‚Ě—Ő°ŹŃ
źˆä@Šě•F@@‹´–{@Œö“ń@@‹gě@–M•F@@Š_•Ł@ł’j
‘ć‚S‰ń”|—{•\”çƒOƒ‰ƒtƒgŒ¤‹†‰ď
1994.3.19
‘ĺă
@
”|—{•\”çˆÚA‚Ş—LŒř‚Ĺ‚ ‚Á‚˝“–‰Č‚Ĺ‚ĚŽĄ—Ă—á
źˆä@Šě•F@@‹´–{@Œö“ń@@‹gě@–M•F@@Š_•Ł@ł’j
‘ć‚S‰ń”|—{•\”çƒOƒ‰ƒtƒgŒ¤‹†‰ď
1994.3.19
‘ĺă
@
ŒŒŠÇ•ż•tœˆÚA‚Ć—V—Ł”ç•Ů‚É‚ć‚é‹`Šá°‚̍쐬‚ɂ‚˘‚Ä
Š_•Ł@ł’j@@ź–{@ˆŰ–ž@@ź’J@–ÎŽ÷@@ŠC˜VŒ´–­Žq
‘ć‚T‰ń‹`Šá°ŽčpŒ¤‹†‰ď
1994.3.19
‘ĺă
@
ŠŁáŒ¤‹†‚Ě‹O“š‚ƏŤ—ˆ‚Ě–˛ i“Á•Ęu‰‰j
‹gě@–M•F
‘ć50‰ń‹L”OŽOd”畆‰ČŒ¤‹†‰ď
1994.3.24
’Á@
@
_ŒoÇó‚ޏ­‚ľŒy‚˘AŒQF‘fŤŠŁ”çÇ‚Ě‚S—á
˛“Ą@Œ’“ń@@‘O“c@’mŽq@@“ě@@G“T@@“cŒű@”ŽN@@ó“c@—TŽi@@‹gě@–M•F
‘ć322‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.3.26
‘ĺă
@
—V—ŁŠÖßˆÚA‚Ěˆę—á
‰Yě@W–ç@@‘O“c@@‹@@ă’n@@‹M@@’†ě@’B—T@@ŒŽ–ě@‹Ĺ•F i‘ĺăŒxŽ@Œ`Źj
‘ć‚V‰ń•şŒÉŒ§ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[§˜b‰ď
1994.3.5
_ŒË
@
Prefabricated chondrocutaneous free flap‚É‚ć‚é‹CŠÇÄŒš‚ĚŒoŒą
×ě@@˜i@@–k‹g@@Œő@@ŽR–{@@”Ž iŠÖź˜JĐŒ`Źj
‘ć‚V‰ń•şŒÉŒ§ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[§˜b‰ď
1994.3.5
_ŒË
@
”畆‰Č‚Ćƒrƒ^ƒ~ƒ“ ƒ_[ƒ}ƒgƒƒWƒJƒ‹@ƒrƒ^ƒ~ƒmƒƒW[‚̉ߋŽEŒťÝE–˘—ˆ
‹gě@–M•F
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
ƒrƒ^ƒ~ƒ“D3‚Ě•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚ւ̉e‹ż
‹´–{@Œö“ń
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
×–EŹ’ˇˆöŽq‚É‚ć‚é•\”瑝B‚̐§ŒäE‚ť‚Ě“ń–ʐŤ‚ɂ‚˘‚Ä
‹´–{@Œö“ń
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
Ž‡ŠOüB‚đĆŽË‚ł‚ę‚˝ƒ}ƒEƒX‚̔畆^”çRŒ´’掌×–E‚̐ڐG‰ß•q”˝‰ž icontact hypersensitivityj ‚Ć tolerance ‚É‚¨‚Ż‚é–đŠ„
ŒI–{@@ŠŢ@@‹gě@–M•F iă‘ĺj @@Streilein, J.W. iHarvard‘ĺj
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
łíƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě×–EŽüŠú“Ż’˛Žž‚Ě–Ô–Œ‰č×–EŽîƒ^ƒ“ƒpƒN ipRBj ‚Ě•Ď“Ž
Ź—с@Ć–ž@@‹´–{@Œö“ń@@‰œ‘ş@GM@@‹gě@–M•F
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
ƒXƒeƒƒCƒhŒ¸—Ę‚ÉŒŒŸ÷ŒđŠˇ—Ă–@‚Ş—LŒř‚Ĺ‚ ‚Á‚˝“Vávጂ̂Q—á
źˆä@Šě•F@@“c’†@‚Ü‚č@@‘唨@ç‰Ŕ@@ˆéƒmăł–ž@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
EB ƒEƒCƒ‹ƒXŽ‘ąŠ´őT×–EŠ”‚̉đÍ
ó“c@G•v@@‹´–{@Œö“ń@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F iă‘ĺj @@ź˜AŽ›@„@@ŽRź@Oˆę@
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
d“x‚̐_ŒoÇó‚đ’ć‚ľ‚˝AŒQ XP ŠłŽŇ‚Ěˆâ“`Žq‰đÍ
‘O“c@’mŽq@@˛“Ą@Œ’“ń@@“ě@@G“T@@“cŒű@”ŽN@@‹gě@–M•F
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
ƒpƒbƒ`ƒeƒXƒgŽŽ–ň‹ŕ‘Ž11•i–Ú‚Ě—Ő°f’fă‚ĚˆÓ‹`‚ɂ‚˘‚Ä
’†ŽR@G•v@@Î‹´@Nł i“Œ‘ĺj @@Œ´“cş‘ž˜Y@@–{“c@Œő–F@@ă“c@@G@@‘ě@—ĽŽq i–ź‘ĺj @@‹gě@–M•F iă‘ĺj @@‹g“c•F‘ž˜Y i’ˇč‘ĺj @@ˆäă@šK
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
TNF-ƒż, IFN-ƒÁ‚Ě”|—{ŒŒŠÇ“ŕ”ç×–E‚Ě‘B‚ƩǍoŒ`Ź‚É‹y‚Ú‚ˇ‰e‹ż
’†’J@G‘˘@@—¤@@@ i˜Hj @@ ‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
Pyridoxine photosensitization ‚É‚¨‚Ż‚éŒő•Ş‰đŽY•¨‚ĚŠÖ—^
“cŒű@”ŽN@@“ě@@G“T@@‘O“c@’mŽq@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
ŠŁá•a•Ď•”‚É‚¨‚Ż‚é Elafin ielastase-specific-inhibitorj ‚Ě‹ÇÝ‚ÉŠÖ‚ˇ‚é–Ɖu‘gDŠw“IŒŸ“˘
“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
áy‚Ý‚đ—L‚ˇ‚鉊ÇŤ”畆•a•Ď‚Ĺ‚ĚƒqƒXƒ`ƒWƒ“’E’YŽ_‘fŠˆŤ
˛“Ą@Œ’“ń@@ź‰Ş@@‰@@“ě@@G“T@@“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F iă‘ĺj @@Ą‘ş@ˆç’j i“Ż‚Q–ň—j@
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
áy‚Ý‚ĆƒqƒXƒ^ƒ~ƒ“ŠÖ˜Ay‘f
˛“Ą@Œ’“ń@@“ě@@G“T@@ź‰Ş@@‰@@“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F iă‘ĺj @@Ą‘ş@ˆç’j i“Ż‚Q–ň—j@
‘ć93‰ń“ú”ç‰ď‘‰ď
1994.4.20-23
•Ÿ‰Ş
@
Identification of cutaneous antigan presenting cell responsible for induction of contact hypersensitivity and UVB-dependent tolerance
Kurimoto, I., Yoshikawa, T., Yoshikawa, K. and Streilein, J.W.
55th Annual Meeting of the Society for Investigative
1994.4.27-30
Baltimore
@
Influence of eicosapentaenoic acids on membrane fluidity and cell adhesion molecules in cultured epidermal keratinocytes.
Lu, L., Okada, N., Nakatani, S. and Yoshikawa, K.
55th Annual Meeting of the Society for Investigative
1994.4.27-30
Baltimore
@
Relation between the mutation sites of XPAC gene and severity of neurological abnormality in Japanese group A XP patients.
Maeda, T., Sato, K., Minami, H., Taguchi, H. and Yoshikawa, K.
55th Annual Meeting of the Society for Investigative
1994.4.27-30
Baltimore
@
High activity of histidine decarboxylase in itchy skin lesions.
Sato, K., Minami, H., Taguchi, H., Maeda, T., Matsuoka, Y., Yoshikawa, K. and Imamura, I.
55th Annual Meeting of the Society for Investigative
1994.4.27-30
Baltimore
@
O—ô•@‚Ěalar-columella web•ĎŒ`‚ɑ΂ˇ‚é‹eˆä”ç•Ů i‰źĚj ‚Ě—L—pŤ‚ɂ‚˘‚Ä
âˆä@–ő•v@@Ź—ѐ˝ˆę˜Y@@ŽR“c@@˜N@@’ˇŁ@@Œh@@‘ĺXŠě‘ž˜Y i“Œ‹žŒxŽ@Œ`Źj
‘ć37‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1994.4.7
“Œ‹ž
@
Šáâ|“ŕüˆŰŽî‚Ě‚Q—á
“úŠ}@@šć@@ˆäă@—TŽj@@‘ĺŒ´@‹`—Y iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć37‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1994.4.8
“Œ‹ž
@
…—nŤƒrƒ^ƒ~ƒ“‘śÝ‰ş‚Ě UVA ĆŽË‚É‚ć‚é’e—͐üˆŰ
˛“Ą@Œ’“ń
‘ć‚R‰ńŽ‘ś“°”畆˜V‰ťŒ¤‹†ƒtƒ@ƒ“ƒhŽó—ĚŽŇŒ¤‹†”­•\‰ď
1994.4.9
“Œ‹ž
@
“]ˆÚŤ”畆Šŕ‚đ‹^‚Á‚˝“űŠŕ‚Ě‚P—á
ˆŔ“Œ@˜Đ”ü@@ŒI–{@@ŠŢ@@źˆä@Šě•F@@Š_•Ł@ł’j@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@‘“c@TŽO i“Ż“ńŠOj‘ć@
323‰ń“ú”ç‰ď‘ĺă’n•ű‰ď @
1994.5.14
•şŒÉˆă‘ĺ
@
ŒŒŸ÷ŒđŠˇ–@‚Ş‘tŒř‚ľ‚˝—Ž—tó“Vávጂ̂P—á
’J@@@Žç@@ŒI–{@@ŠŢ@@źˆä@Šě•F@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć323‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.5.14
•şŒÉˆă‘ĺ
@
Papillary eccrine adenoma ‚Ě‚P—á
“y‹@•q–ž@@—§‰Ô@@—ş i”Ş”öŽs—§j @@Šp’Ň‚Ů‚Ă‚Ý iă‘ĺj @@
‘ć323‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.5.14
•şŒÉˆă‘ĺ
@
Papillary eccrine adenoma ‚Ě‚P—á
“y‹@•q–ž@@—§‰Ô@@—ş i”Ş”öŽs—§j @@Šp’Ň‚Ů‚Ă‚Ý i‘ĺă‘ĺj
‘ć323‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1994.5.14
ź‹{
@
Growth inhibition of human keratinocytes by 1,25-dihydroxyvitamin D3 is linked to dephosphorylation of retinoblastoma gene product.
Kobayashi, T., Hashimoto, K. and Yoshikawa, K.
9th Workshop on vitamin D
1994.5.28-6.2
Orland, Florida, USA
@
“Á•Ęu‰‰FŒűo”S–Œ•a•Ď‚đŽŚ‚ˇ”畆ŽžŠł‚ɂ‚˘‚Ä
‹´–{@Œö“ń
‘ć‚S‰ńŒűo”S–ŒŽžŠłŒ¤‹†‰ď
1994.6.10
‘ĺă
@
—ź‰ş‘ÚƒŠƒ“ƒp•‚Žî‚𔺂¤‰ş‘ÚˆŤŤŽîᇐ؏œŒă‚ÉäCœ”ç•Ů‚đ—p‚˘‚˝‚P—á
Š_•Ł@ł’j@@ź–{@ˆŰ–ž@@ź’J@–ÎŽ÷@@‹g‰Ş@’źl
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
“î•”‘gD‚Ě‚Ý‚É‚ć‚é‹š•ÇÄŒš‚ĚŒŔŠE‚ƍl‚Ś‚ç‚ę‚˝‚PÇ—á
‹g‰Ş@’źl@@ź–{@ˆŰ–ž@@Š_•Ł@ł’j@@ŠC˜VŒ´–­Žq
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
“űŠŕ‹š•ÇÄ”­‚ɑ΂ˇ‚éÄŒšp‚ɂ‚˘‚Ä
ŒŽ–ě@‹Ĺ•F@@‰Yě@W–ç@@ź–{@@‘@@’†ě@’B—T@@‘O“c@@‹ i‘ĺăŒxŽ@Œ`Źj
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
L”ÍˆÍ‚Č“Ş”çE“ŞŠWœŒ‡‘š‚𔺂¤—r–Œ”j—ôƒV[ƒNƒGƒ“ƒX‚ĚŒoŒą
ŽRč@Œ¤Žu@@‚“c@ÍD i•ęŽqˆă—ĂƒZƒ“ƒ^[Œ`Źj
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
Šç–Ę•”ÄŒš‚É‚¨‚Ż‚éWashio”ç•Ů‚Ě—L—pŤ‚̍čl
ŽR–{@@”Ž@@“Ąě@š˜a@@‹g‰Ş@’źl i‘ĺă•{—§Œ`Źj
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
‘OcŠu‹CŠÇŒűÇ—á‚ĚŒŸ“˘
Žs–ě@’źŽ÷@@‹g–ě@–Mr i•{—§Źl•aŽ¨•@‰Čj
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
ŽŠŤŠO‰A•”ƒŠƒ“ƒp•‚Žî‚Ě‚P—á
‘ĺ’J@@”Ž@@–{‘˝@•üm i‘ĺă‘DˆőŒ`Źj
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
“–‰Č‚É‚¨‚Ż‚éŽhÂŠłŽŇ‚ĚCŒ^ŠĚ‰ŠƒEƒCƒ‹ƒXŠ´ő—Ś’˛¸
’†ě@’B—T@@‘O“c@@‹@@‰Yě@W–ç@@ź–{@@‘@@ŒŽ–ě@‹Ĺ•F i‘ĺăŒxŽ@Œ`Źj
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
Medial Plantar flap‚É‚ć‚éćůÄŒš‚Ě’ˇŠúŒo‰ß‚ɂ‚˘‚Ä
“Ąě@š˜a@@ŽR–{@@”Ž@@‹g‰Ş@’źl i•{—§Œ`Źj
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
⿍œ“´Œ´”­‚̉Ą–ĺ‹Ř“÷Žî‚Ěˆę—á
“úŠ}@@šć@@ˆäă@—TŽj iŒ§—§‚ą‚Ç‚ŕŒ`Źj
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
RŠŕÜ‚ĚŒŒŠÇŠO˜Ro‚É‚ć‚萜‚ś‚˝’×ᇂ̎Ą—Ă–@‚ɂ‚˘‚Ä‚ĚŒŸ“˘
ź‰ş@“N–ç@@”–@@ä•v@@‹eˆä@’mŽq@@­“c@‰ŔŽq iZ—FŒ`Źj@ “cŒ´@^–ç i_‘厨•@‰Čj
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
“ŞŠWŒ`ŹpŒăŠ´őÇ‚ɑ΂ˇ‚錌ŠÇ•ż•t“ŞŠWœ•ŮŽg—p‚ĚŒoŒą
ă’n@@‹M i_|Œ`Źj @@•˝ˆä@@Žű i“Ż”]ŠOj @@’†ě@’B—T@@‘O“c@@‹ i‘ĺăŒxŽ@Œ`Źj@@
‘ć62‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1994.6.4
‘ĺă
@
Keratosis follicularis squamosa iDohi1903j ‚Ě‚P—á
˛“Ą@Œ’“ń@@–쐣@—˛•v@@‹gě@–M•F
‘ć‚X‰ńŠp‰ťÇŒ¤‹†‰ď
1994.6.4
“Œ‹ž
@
Hypomelanosis of Ito iincontinentia pigmenti achromiansj ‚Ě‚P—á
ź‘ş@‰ëŒb@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@‰iˆä—˜ŽO˜Y i“ŻŹŽ™‰Čj@@‹g•ô@rŽ÷ i“Ż”]ŠOj @@
‘ć87‰ń‹ß‹EW’k‰ď
1994.6.5
‹ž“s
@
—؏ó–ѕŠp‰ťÇ i“y”ě1903j ‚Ě‚P—á
–쐣@—˛•v@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć87‰ń‹ß‹EW’k‰ď
1994.6.5
‹ž“s
@
łíƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě×–EŽüŠú‚Ć RB ’`”’Žż‚Ě•Ď“Ž
Ź—с@Ć–ž@@ŠŁ@@dŽ÷@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć‚X‰ń‘ĺăƒJƒ“ƒtƒ@ƒŒƒ“ƒX
1994.7.
ŽOd
@
ƒŒ[ƒU[‚ɂ‚˘‚Ä
“cŠ@äŽk@@‘q“c‘‘‘ž˜Y@@Ž›Žt@_l i‘ĺ•Şˆă‘ĺŒ`Źj
‘ć10‰ń‘ĺ•ŞŒ`Ź§˜b‰ď
1994.7.1
‘ĺ•Ş
@
‘Ť”w‘O‘Ť•”‚̍Sk•ĎŒ`ŽĄ—Ă‚É‚¨‚Ż‚鉥Ž˛ƒA[ƒ`ěŹ‚ĚŒoŒą
âˆä@–ő•v@@‘“c@’őˆę@@ŠÖŒű@‡•ă i“Œ‹žŒxŽ@Œ`Źj
‘ć19‰ń“ú–{‘Ť‚ĚŠO‰ČŠw‰ď
1994.7.1
“Œ‹ž
@
”畆ŽžŠł‚Ćáy‚Ý i“Á•Ęu‰‰j
‹gě@–M•F
‘ć‚V‰ń‚Š‚ä‚Ý‚ĚŒ¤‹†‰ď
1994.7.12
•Ÿ‰Ş
@
Scleromyxedema ‚Ě‚P—á
ˆŔ“Œ@˜Đ”ü@@‘O“c@’mŽq@@ŒI–{@@ŠŢ@@źˆä@Šě•F@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F@
‘ć324‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.7.16
‘ĺă
@
‹‘ĺ‚Č‘lŒa•”ƒŠƒ“ƒpß“]ˆÚ‚đ—ˆ‚˝‚ľ‚˝ˆŤŤ•FŽî‚Ě‚P—á
Šp’҂قÂ݁@@ŒI–{@@ŠŢ@@źˆä@Šě•F@@“cŠ@äŽk@@Š_•Ł@ł’j@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć324‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.7.16
‘ĺă
@
ƒ~ƒmƒTƒCƒNƒŠƒ“Ă’‚É‚ÄŠ°‰đ‚š‚ľ‚ß‚˝…ávŤ—Ţ“Vávጂ̂P—á
Šp’҂قÂ݁@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć16‰ń…ávÇŒ¤‹†‰ď
1994.7.23
Š—ŒS
@
Ž‡ŠOü‚É‚ć‚é–Ɖu—}§‚Ć”­Šŕ@|ƒ}ƒEƒX‚Ćƒqƒg|
ŒI–{@@ŠŢ@@‹gě@–M•F iă‘ĺj @@Steilein, J.W. iƒ}ƒCƒAƒ~‘ĺj
‘ć16‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1994.7.29-30
ˆÉ¨
@
ƒŠƒ{ƒtƒ‰ƒrƒ“ŒőŠ´ě‚É‚¨‚Ż‚é’Z–˝ŠˆŤŽ_‘f‚Ě“­‚­đŒ
˛“Ą@Œ’“ń@@“ě@@G“T i–źŽs‘ĺj @@“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F iă‘ĺj
‘ć16‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1994.7.29-30
ˆÉ¨
@
UVA ĆŽË‰ş‚É‚¨‚Ż‚éƒrƒ^ƒ~ƒ“‚a6‚Ě×–EáŠQŤ
‘O“c@’mŽq@@“cŒű@”ŽN@@‹gě@–M•F iă‘ĺj @@“ě@@G“T@@˛“Ą@Œ’“ń i–źŽs‘ĺj
‘ć16‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1994.7.29-30
ˆÉ¨
@
Pyridoxine photosensitization ‚É‚¨‚Ż‚éŒő•Ş‰đŽY•¨‚ĚŠÖ—^
“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F iă‘ĺj @@“ě@@G“T@@˛“Ą@Œ’“ń i–źŽs‘ĺj
‘ć16‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1994.7.29-30
ˆÉ¨
@
•Ą”‚ĚŽU“ľÜ‚É‚ć‚éÚG”畆‰Š‚Ě‚P—á
‹î‘ş@Œö”ü@@Šâ˛@^l@@’†“Œ@“TŽq@@“¨@@‡Žq@@‹gě@–M•F
‘ć24‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1994.7.9-10
‘ĺă
@
”ě–ž×–E”C ƒqƒXƒ^ƒ~ƒ“ŠÖ˜Ay‘fŠˆŤ‚Ć$3001áy‚ĚŠÖŒW
“ě@@G“T@@˛“Ą@Œ’“ń i–źŽs‘ĺj @@“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F iă‘ĺj @Ą‘ş@ˆç’j i“Ż“ń–ňj
‘ć‚S‰ńáy‚݃Vƒ“ƒ|ƒWƒEƒ€
1994.8.27
“Œ‹ž
@
An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promotor-luciferase construct.
Inui, S., Asada, H., Hashimoto, K. and Yoshikawa, K.
‘ć19‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1994.8.31-9.2
‘ĺă
@
Effect of a vitamin D3 analogue on the growth, differentiation, cell cycle, and retinoblastoma protein of cultured normal human keratinocytes.
Kobayashi, T., Hashimoto, K. and Yoshikawa, K.
‘ć19‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1994.8.31-9.2
‘ĺă
@
Effect of polyunsaturated fatty acids on membrane fluidity and cell adhesion molecules in cultured epidermal keratinocytes.
Lu, L., Okada, N., Nakatani, S. and Yoshikawa, K.
‘ć19‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1994.8.31-9.2
‘ĺă
@
Phototoxicity of vitamin B6s induced by UVA Light.
Maeda, T., Taguchi, H., Minami, H., Sato, K. and Yoshikawa, K.
‘ć19‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1994.8.31-9.2
‘ĺă
@
Relationship of the number of mast cells and the activity of histidine decarboxylase iHDCj.
Minami, H., Sato, K., Taguchi, H., Maeda, T. and Yoshikawa, K.
‘ć19‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1994.8.31-9.2
‘ĺă
@
Riboflavin photosensitization under anaerobic conditions.
Sato, K., Minami, H., Maeda, T., Taguchi, H. and Yoshikawa, K.
‘ć19‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1994.8.31-9.2
‘ĺă
@
Contribution of decomposition photoproductisj to pyridoxine photosensitization.
Taguchi, H., Minami, H., Maeda, T., Sato, K. and Yoshikawa, K.
‘ć19‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1994.8.31-9.2
‘ĺă
@
The reduction of chromosomal protein P40 in tuberous sclerosis.
Wataya-Kaneda, M., Kaneda, Y., Hashimoto, K. and Yoshikawa, K.
‘ć19‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1994.8.31-9.2
‘ĺă
@
“ú–{‚É‚¨‚Ż‚é‚`ŒQ XP ŠłŽŇ‚̐_ŒoÇó‚Ć PCR-RFLP ‚É‚ć‚é•Ş—Ţ
‘O“c@’mŽq@@“cŒű@”ŽN@@‹gě@–M•F iă‘ĺj @@“ě@@G“T@@˛“Ą@Œ’“ń i–źŽs‘ĺj
‘ć24‰ńŠî‘b”畆‰Č§˜b‰ď
1994.8.5-6
Ž­Ž™“‡
@
Plasminogen activator inhibitor-1 promotor-luciferase”­ŒťƒxƒNƒ^[‚đƒgƒ‰ƒ“ƒXƒtƒFƒNƒg‚ľ‚˝×–E‚É‚ć‚éTGF-b‘Ş’č
ŠŁ@@dŽ÷@@ó“c@G•v@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć19‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ďŠwp‘ĺ‰ď
1994.9
‘ĺă
@
’_”XŠŕ‚̍‡•š‚đ‹^‚Á‚˝”畆‹Ř‰Š‚Ě‚P—á
‰Ôě@@–ő@@źˆä@Šě•F@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć325‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.9.17
‘ĺă
@
‰ß‹Ž10”NŠÔ‚Ě‘ĺă•{‰ş‚É‚¨‚Ż‚é”畆Šŕ‚Ě”­śó‹ľ
•x“c@’qŽj@@‹´–{@Œö“ń@@‹gě@–M•F iă‘ĺj @@‘ĺ–Š@@–Î iQ‰Žě•ŰŒ’Šj
‘ć325‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1994.9.17
‘ĺă
@
A case of pemphigus foliaceus treated with double filtration plasma pheresis and low dose corticosteroids.
Matsui, Y., Hashimoto, K. and Yoshikawa, K.
4th China-Japan Joint Meeting of Dermatology
1994.9.21-23
Chengdu, China
@
Tophiformation after spontaneous remission of gouty arthritis
Nomura, M., Nishida, K. and Yoshikawa, K.
4th China-Japan Joint Meeting of Dermatology
1994.9.21-23
Chengdu, China
@
‰ş‘Ú‚É”­ś‚ľ‚˝ atypical fibroxanthoma ‚Ě‚P—á
Œ‡“c@—ÇŽ™@@ˆŔ“Œ@˜Đ”ü@@”¨@´ˆę˜Y i‘ĺă˜JĐj @@ŠŁ@@dŽ÷ iă‘ĺj
‘ć113‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1994.9.22
‘ĺă
@
ƒRƒ‰[ƒQƒ“ŠîŽż“ŕ‚Ĺ”|—{‚ľ‚˝ŒŒŠÇ“ŕ”ç×–E‚ĚŒ`‘Ԃɑ΂ˇ‚éŽîᇉ󎀈öŽq‚̉e‹ż
’†’J@G‘˘@@—¤@@@˜H@@‰Ş“c“Ţ’ĂŽq@@‹gě@–M•F
‘ć‚X‰ń“ú–{ŠŁáŠw‰ď
1994.9.3-4
‘ĺă
@
ƒAƒNƒ`ƒ_[ƒ€S’P“Ć“\•t‚É‚ć‚é“ŤŠŁá”ç]‚ĚŽĄ—Á@|—LŒř–ňÜ”ńŠÜ—L–§••ƒe[ƒv‚Ć‚Ě”äŠrŒŸ“˘
“ŒŽR@^—˘@@•x“c@’qŽj@@–ě‘ş@­•v@@‹gě@–M•F
‘ć‚X‰ń“ú–{ŠŁáŠw‰ď
1994.9.3-4
‘ĺă
@
Antioxidants can reverse the deleterious effects of ultraviolet B iUVBj radiation on cutaneous immunity.
Nakamura, T., Pinnell, S.R. and Streilein J.W.
1995 annual meeting of the society for investigative dermatology.
1995
Chicago, Illinois
@
Epidermal Langerhans cells and dermal antigen presenting cells are differentially inhibited by transforming growth factor beta-1.
Nakamura, T. and Streilein, J.W.
Langerhans cells-forth international workshop
1995
Scheveningen, The Netherlands
@
qíŤŠŁá•a•Ď•”‚É‚¨‚Ż‚é HB-EGF ‚Ě”­Œť
“ŒŽR@^—˘@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć10‰ńŠŁáŠw‰ď
1995
ŽRŒű
@
“ŤƒEƒCƒ‹ƒXŤ”畆ŽžŠł‚ɑ΂ˇ‚é OK-432‹Ç’—Ă–@
ŠŁ@@dŽ÷@@ó“c@G•v@@źˆä@Šě•F@@“ŒŽR@^—˘@@‹gě@–M•F@@‹´–{@Œö“ń
‘ć22‰ń“ú”ç‰ďˆ¤•Q’n•ű‰ď i‹´–{Œö“ń‹łŽöA”C‹L”Oj
1995.1
źŽR
@
Atypical fibroxanthoma ‚Ě‚P—á
‹{–{@•üŽq@@‰H”’ @˝@@‰€“c@‘•c@@‰œ‘ş@–rŽq
‘ć331‰ń‘ĺă’n•ű‰ď
1995.1
‘ĺă
@
—ź‰ş‘ځC ‘Ťœ‚𒆐S‚Ć‚ľ‚āC Ź…áv‚𔺂Á‚˝ŠÂóŸřoŤg”Á‚̏oŒť‚đŒJ‚č•Ô‚ˇˆę—á
‹v•Ű@—şŽĄ@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć115‰ń“ě‘ĺăÇ—ጟ“˘‰ď
1995.1.19
‘ĺă
@
”|—{•\”çƒV[ƒg‚Ě—Ő°‰ž—p
Š_•Ł@ł’j
‘ć‚Q‰ń”畆‘nŽĄ–üŠÖźƒtƒH[ƒ‰ƒ€
1995.10.14
‘ĺă
@
ć“VŤ Protein C Œ‡‘šÇiHomozygousj‚É‚ć‚čL”͈͔畆‰óŽ€‚đ‚Ť‚˝‚ľ‚˝‚P—á
“y‹@•q–ž@@‹gě@–M•F i‘ĺă‘ĺj @@ź‰Ş@‘ž˜Y i“Ż@ŹŽ™‰Čj
‘ć331‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1995.10.14
‘ĺă
@
ˆŤŤ•FŽî‚Ş‹^‚í‚ę‚˝‰şŠááكAƒ|ƒNƒŠƒ“”X–E‘BŽî‚Ě‚P—á
˛“Ą@ŽĄ–ž@@ź”ö@—R‹I@@Ž›Žt@_l@@“cŠ@äŽk@@‘q“c‘‘‘ž˜Y@@ŽO‰Y@–FŽq@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @
‘ć40‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‹ăBŽx•”ŠwpW‰ď
1995.10.21
ŒF–{
@
Šg‘ĺ•@”w”ç•Ů‚ĚŒoŒą
‹´–{@—S”V@@Žsě@Oé i‘ĺ•ŞˆăŽt‰ď—§ƒAƒ‹ƒƒCƒ_•a‰@Œ`ŹŠO‰Čj@ˆŔ•”@—YŞ i‘ĺ•ŞˆăŽt‰ď—§ƒAƒ‹ƒƒCƒ_•a‰@“ŕ‰Čj @@‘q“c‘‘‘ž˜Y@@˛“Ą@ŽĄ–ž@@“cŠ@äŽk i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @@@
‘ć40‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‹ăBŽx•”ŠwpW‰ď@@
1995.10.21
ŒF–{
@
‰ş‘Ú‚Ě”p—pŤ‹ŘˆŢk‚ɑ΂ľC Œ’‘¤‚Š‚ç‚ĚäC• ‹ŘˆÚA‚đs‚Á‚˝ˆę—á
—с@@łN@@×ě@@˜i@@Š_•Ł@ł’j@@‹g—´@ŸŽq@@–î–ě@Œ’“ń
‘ć‚T‰ń‘ĺăƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Œ¤‹†‰ď
1995.10.21
‘ĺă
@
“Şčň•”ÄŒš‚É—p‚˘‚˝—V—Ł• ’ź‹Ř”ç•Ů
ź–{@@‘@@Š_•Ł@ł’j@@×ě@@˜i@@‘O“c@@‹@@‰Yě@W–ç@@“úŠ}@@šć@@ŒŽ–ě@‹Ĺ•F@@‘O“c@•ś•F@
‘ć22‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1995.10.26
ŽD–y
@
—V—Ł‘O˜r”ç•Ů400—á‚ĚŒŸ“˘
“úŠ}@@šć@@‘O“c@@‹@@‰Yě@W–ç@@“Ąě@š˜a@@×ě@@˜i@@Š_•Ł@ł’j
‘ć22‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1995.10.26
ŽD–y
@
‰şŽˆ”畆’×ᇂɑ΂ˇ‚é—V—Ł”ç•ŮˆÚAp‚ĚŒŸ“˘
‹g—´@ŸŽq@@×ě@@˜i@@Š_•Ł@ł’j
‘ć22‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1995.10.27
ŽD–y
@
˜]“•t• ’ź‹Ř”ç•Ů‚ɂčČš‚ľ‚˝Ä”­ŤƒGƒiƒƒ‹ă”çŽî‚Ě‚P—á
–î–ě@Œ’“ń@@×ě@@˜i@@Š_•Ł@ł’j
‘ć22‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1995.10.27
ŽD–y
@
”DP‚ć‚č‘ˆŤ‚ľ‚˝Œă“VŤ•\”琅ávÇ‚Ěˆę—á
‹v•Ű@—şŽĄ@@źˆä@Šě•F@@“ŒŽR@^—˘@@‹gě@–M•F@@ˆäăç’ĂŽq@@‹´–{@@—˛@@‹´–{@Œö“ń
‘ć46‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1995.10.28
“Ţ—Ç
@
”|—{ƒqƒgƒƒ‰ƒmƒTƒCƒg‚ɑ΂ˇ‚é’jŤƒzƒ‹ƒ‚ƒ“ě—p‚ĚŒŸ“˘
“cŠ@äŽk–@@”ÂŒŠ@@’q@@Ž›Žt@_l@@‘q“c‘‘‘ž˜Y@@‚ˆŔ@@i
‘ć‚S‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1995.10.6
‘q•~
@
ŠČ•Ö‚Č“€Œ‹•Ű‘ś–@‚É‚ć‚č“ŻŽíŒŒŠÇˆÚA‚ɂ‚˘‚Ä‚ĚŒŸ“˘
Š_•Ł@ł’j@@×ě@@˜i@@–î–ě@Œ’“ń@@‹g—´@ŸŽq@@‘ĺŽR@’mŽ÷@@ŒI“c@’q”V
‘ć‚S‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1995.10.7
‘q•~
@
‰ß‹Ž10”NŠÔ‚É‚¨‚Ż‚é”畆‚Ş‚ń‚Ě”­śó‹ľ
•x“c@’qŽj@@‹gě@–M•F@@‘ĺ–Š@@–Î
‘ć19‰ń‘ĺă•{ˆăŽt‰ďˆăŠw‰ď‘‰ď
1995.11.23
‘ĺă
@
ŽŠ‰Ć”|—{•\”çƒV[ƒgˆÚA‚Ş‘tŒ÷‚ľ‚˝‰h—{áŠQŒ^ć“VŤ•\”琅ávÇ‚Ěˆę—á
‹v•Ű@—şŽĄ@@ŒI–{@@ŠŢ@@źˆä@Šě•F@@“ŒŽR@^—˘@@‹gě@–M•F@@‹´–{@Œö“ń@@´…@@G@
‘ć47‰ń“ú”ç‰ďź•”Žx•”‘‰ď
1995.11.26
–k‹ăB
@
•Đ‘¤Ť‰şO‰ş§‹Ř’f—ô‚Ěˆę—á
“cŠ@äŽk@@˛“Ą@ŽĄ–ž@@‘q“c‘‘‘ž˜Y@@Ž›Žt@_l i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj
‘ć65‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1995.11.30
“c
@
”|—{ƒqƒgƒƒ‰ƒmƒTƒCƒg‚ɑ΂ˇ‚é’jŤƒzƒ‹ƒ‚ƒ“ě—p‚ĚŒŸ“˘|‘ć‚Q•ń|
“cŠ@äŽk@@”ÂŒŠ@@’q@@Ž›Žt@_l@@‘q“c‘‘‘ž˜Y@@‚ˆŔ@@i
‘ć65‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1995.11.30
“c
@
ƒ‰ƒbƒg‚ɉ—‚Ż‚錌ŠÇ•ż•t‹CŠÇA“ވڐAƒ‚ƒfƒ‹‚ĚŽŽ‚Ý
‹g—´@ŸŽq@@ź–{@@‘@@Š_•Ł@ł’j@@×ě@@˜i
‘ć65‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1995.11.4
–L’†
@
”š‘n‚É‚ć‚é• •Ç”j—ô‚ĚˆęŽĄ—Ă—á
‘ĺŽR@’mŽ÷@@“Ąě@š˜a@@ŽR–{@@”Ž@@Š_•Ł@ł’j
‘ć65‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1995.11.4
–L’†
@
•ęćäˆČŠO‚Ě’ZŒŒŠÇ•ż‘ŤćäˆÚAp‚ĚŒoŒą
‘ĺ–ě@ł_@@×ě@@˜i@@Š_•Ł@ł’j@@‹g—´@ŸŽq
‘ć65‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1995.11.4
–L’†
@
ăŠááٌă‘ŢÇ‚É‘Î‚ľ‚ÄŠááً“‹Ř‚ĚŒă“]‚đs‚Á‚˝‚P—á
’†ˆä@š ”Ž@@×ě@@˜i@@Š_•Ł@ł’j@@‹g—´@ŸŽq
‘ć65‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1995.11.4
–L’†
@
‚RŽŸŒł CT ŽŔ‘Ěƒ‚ƒfƒ‹‚É‚ć‚é“ŞŠWŠç–ĘŽčp‚ĚŒoŒą
Š_•Ł@ł’j@@×ě@@˜i@@‹g—´@ŸŽq@@ă’n@@‹M
‘ć13‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1995.11.9
“Œ‹ž
@
—V—Ł•Ą‡ˆÚA‚đ—p‚˘‚˝ŒűO‚ĚÄŒš•ű–@|ŒűOˆŤŤŽîᇂX—á‚ĚŒoŒą|
Ž›Žt@_l*@@‘q“c‘‘‘ž˜Y*@@‹´–{@—S”V**@@“cŠ@äŽk*@@˛“Ą@ŽĄ–ž*i*‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Č@@ **‘ĺ•ŞˆăŽt‰ď—§ƒAƒ‹ƒƒCƒ_•a‰@Œ`ŹŠO‰Čj
‘ć13‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1995.11.9
“Œ‹ž
@
‰ş‘Ú‚É”­ś‚ľ‚˝ Merkell cell carcinoma ‚Ě‚P—áv
Ź—с@”ü—ç@@‘q’m‹MŽu˜Y@@ˆäăç’ĂŽq
‘ć332‰ń‘ĺă’n•ű‰ď
1995.12
‘ĺă
@
‹š•”‚É”­ś‚ľ‚˝‰óásŤ”^”çÇ‚Ě‚P—á
’Ň“c@@•q@@ŒI–{@@ŠŢ@@‘ź
‘ć332‰ń‘ĺă’n•ű‰ď
1995.12
@
@
uŹlŒ^ƒAƒgƒs[Ť”畆‰Šv ŠłŽŇ‚Ě’EƒXƒeƒƒCƒhŽž‚ÉŽg—p‚ľ‚Ä‚˘‚˝ŠO—pÜ‚É‚ć‚éÚG”畆‰Š
˛“Ą@Œ’“ń@@“ě@@G“T@@ŽR“ŕ@—ĽŽq@@“n•Ó@KŒb@@‚‹´‹Ig]@@ŕV“c–œ‹LŽq@@’ҁ@@‘ě•v@@›–ě@@d@
‘ć194‰ń“ŒŠC’n•ű‰ď
1995.12.10
–źŒĂ‰Ž
@
‰AŒŇ•”‚É–ł‹ŰŤŹ”^áv‚𔺂¤g”Á‚𐜂ś‚˝ěč•a‚Ěˆę—á
‹v•Ű@—şŽĄ@@’JŒű@—´ś@@’JŠ_@••F@@‰Íă@çq@@ŽO–q@FŽŠ
‘ć332‰ń‘ĺă’n•ű‰ď
1995.12.16
@
@
‹š•”‚É”­ś‚ľ‚˝‰óásŤ”^”çÇ‚Ě‚P—á
’Ň“c@@•q@@ŒI–{@@ŠŢ@@‹gě@„Ži@@źˆä@Šě•F@@ˆŔ“Œ@˜Đ”ü@@ź–{@ç•ä@@Š_•Ł@ł’j@@‹gě@–M•F
‘ć332‰ń‘ĺă’n•ű‰ď
1995.12.16
@
@
ÔF202†‚É‚ć‚éÚGŒűO‰Š‚Ě‚P—á
ˆŔ“Œ@˜Đ”ü@@‹î‘ş@Œö”ü@@‹gě@–M•F
‘ć20‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1995.12.2-3
_ŒË
@
Occupational contact urticaria due to epoxy resin
‹{–{@•üŽq@@‰œ‘ş@–rŽq
‘ć20‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1995.12.2-3
_ŒË
@
ƒtƒ}ƒ‹Ž_ƒPƒgƒ`ƒtƒFƒ“ ‚É‚ć‚éÚG”畆‰Š‚Ě‚R—á@
‹î‘ş@Œö”ü@@‘O“c@’mŽq@@“ŒŽR@^—˘@@˛–ě@‰h‹I@@‹gě@–M•F
‘ć20‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1995.12.2-3
_ŒË
@
‘•g‹ď‹ŕ‘Ž‚É‚ć‚éÚG”畆‰ŠÇŒóŒQ‚Ě‚Q—á
ź–{@ç•ä@@‹î‘ş@Œö”ü@@˛–ě@‰h‹I@@‹gě@–M•F
‘ć20‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1995.12.2-3
_ŒË
@
ŽE’ŽÜ’“ü‚É‚ć‚éL”ÍˆÍ”ç‰ş‰óŽ€‚Ěˆę—á
‹´–{@—S”V i‘ĺ•ŞˆăŽt‰ď—§ƒAƒ‹ƒƒCƒ_•a‰@Œ`ŹŠO‰Čj@@Žsě@Oé i‘ĺ•ŞˆăŽt‰ď—§ƒAƒ‹ƒƒCƒ_•a‰@”畆‰Čj @@‘q“c‘‘‘ž˜Y@@˛“Ą@ŽĄ–ž@@“cŠ@äŽk i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @@
‘ć58‰ń“ú–{”畆‰ČŠw‰ď‘ĺ•Ş’n•ű‰ď@@
1995.12.3
‘ĺ•Ş
@
ć“VŤ•\”琅ávÇ‚Ě•aŒ^f’f‚Ć”|—{•\”çƒV[ƒgˆÚA‚É‚ć‚鎥—Ă‚ĚŒ¤‹†
‹v•Ű@—şŽĄ@@’ˇŕV@’q•F@@ŒI–{@@ŠŢ@@źˆä@Šě•F@@“ŒŽR@^—˘@@‹gě@–M•F@@”’•ű@—TŽi@@‹´–{@Œö“ń@@´…@@G@
‹H“ď”ç”Ç•˝Ź‚V”N‘ć‚Q‰ń‘‰ď
1995.12.9
‹v—Ż•Ä
@
”|—{•\”çƒV[ƒg‚đ—p‚˘‚˝‘ŠúŽčp
Š_•Ł@ł’j@@×ě@@˜i@@–î–ě@Œ’“ń@@‘ĺŽR@’mŽ÷@@ŒI“c@’q”V
‘ć‚R‰ń“ú–{”MŠw‰ď‹ß‹E’n•ű‰ď
1995.2.18
‚’Î
@
”M’×ᇂɂ¨‚Ż‚é’×ᇎĄ—ĂÜ‚ĚŒř‰Ę‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒ¤‹†|ƒuƒNƒ‰ƒfƒVƒ“ƒiƒgƒŠƒEƒ€“îp‚ĆƒgƒŒƒ`ƒmƒCƒ“ƒgƒRƒtƒFƒŠƒ‹“îp‚Ě”äŠr|
ŒI“c@’q”V@@×ě@@˜i@@–î–ě@Œ’“ń@@Š_•Ł@ł’j@@“úŠ}@@šć@@‘ĺŽR@’mŽ÷
‘ć‚R‰ń“ú–{”MŠw‰ď‹ß‹E’n•ű‰ď
1995.2.18
‚’Î
@
Contact cheilitis due to ricinoleic acid
Komamura, H., Kozuka, T., Sato, K. and Yoshikawa, K.
3rd Asia-Pacific Environmental and Occupational Dermatology Symposium
1995.3.24-26
–źŒĂ‰Ž
@
‘˝”­Ť_ŒoâŽî‚Ěˆę—á
“cŠ@äŽk@@‘q“c‘‘‘ž˜Y@@Ž›Žt@_l@@˛“Ą@ŽĄ–ž@@”ÂŒŠ@@’q@@ˆÉ¨@’mŽq i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj
‘ć38‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‹ăBŽx•”ŠwpW‰ď
1995.3.25
•Ÿ‰Ş
@
_ŒoZ‚đ‚Ä‚˘‚ľ‚˝á­Šŕ‚Ěˆę—á
“cŠ@äŽk@@‘q“c‘‘‘ž˜Y@@Ž›Žt@_l@@˛“Ą@ŽĄ–ž i‘ĺ•Şˆă‰Č‘ĺŠw”畆j
‘ć12‰ń‘ĺ•ŞŒ`Ź§˜b‰ď
1995.4.11
‘ĺ•Ş
@
Incontinentia pigmenti achromians ‚Ě‚P—á
Ź—с@”ü—ç@@‘q’m‹MŽu˜Y@@ˆäă@ç’ĂŽq
‘ć330‰ń‘ĺă’n•ű‰ď
1995.5
‘ĺă
@
Genetic counseling for siblings of xeroderma pigmentosum patients by PCR-RFLP analysis of their DNA
‘O“c@’mŽq@@˛“Ą@Œ’“ń@@‘ź‚S–ź
‘ć56‰ń@SID
1995.5
@
@
PCR-RFLP ‚đ—p‚˘‚˝ XP ŠłŽŇ‚Ěˆâ“`‘Š’k
‘O“c@’mŽq@@“ě@@G“T@@‘ź‚S–ź
‘ć94‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1995.5
@
@
”牺ŽîᎂđŒ`Ź‚ľ‚˝—Lž™×–EŠŕ
ˆŔ“Œ@˜Đ”ü@@Œ‡“c@—ÇŽ™@@‘ź‚P–ź
‘ć329‰ń‘ĺă’n•ű‰ď
1995.5.13
@
@
ƒrƒ…[ƒ‰[ ieyelash curlerj ‚É‚ć‚éÚG”畆‰Š‚Ě‚Q—á
‹î‘ş@Œö”ü@@“y‹@•q–ž@@źˆä@Šě•F@@‹gě@–M•F
‘ć329‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1995.5.13
‘ĺă‹ˇŽR
@
Chronic actinic dermatitis ‚Ě‚P—á[ƒVƒNƒƒXƒ|ƒŠƒ“‰Á—Ă‚ĚlŽ@[
ŽO‰Y@G”V@@‘O“c@’mŽq@@‹î‘ş@Œö”ü@@źˆä@Šě•F@@ŒI–{@@ŠŢ@@‹gě@–M•F@@˛“Ą@Œ’“ń@@“c’†@‚Ü‚č@@‘ĺ˜a’JiŽq
‘ć94‰ń“ú”ç‰ď‘‰ď
1995.5.19-21
‰Ą•l
@
Â”NŠú”­Ç‚Ě”ń“TŒ^ć“VŤœ‘Ťƒ|ƒ‹ƒtƒBƒŠƒ“Ç‚Ě‚P—á
˛“Ą@Œ’“ń@@“ě@@G“T@@‘O“c@’mŽq@@“cŒű@”ŽN@@‹gě@–M•F
‘ć94‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1995.5.19-21
‰Ą•l
@
PCR-RFLP ‚đ—p‚˘‚˝ XP ŠłŽŇ‰Ć‘°‚Ěˆâ“`‘Š’k
“cŒű@”ŽN@@“ě@@G“T@@‘O“c@’mŽq@@‹gě@–M•F@@˛“Ą@Œ’“ń
‘ć94‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1995.5.19-21
‰Ą•l
@
Pyridoxine phptosensitization ‚É‚¨‚Ż‚éŒő•Ş‰đŽY•¨‚ĚŠÖ—^ i‘ą•ńj
“cŒű@”ŽN@@“ě@@G“T@@‘O“c@’mŽq@@‹gě@–M•F@@˛“Ą@Œ’“ń
‘ć94‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1995.5.19-21
‰Ą•l
@
dÇ uŹlŒ^ƒAƒgƒs[Ť”畆‰Šv ŠłŽŇ‚ĚƒXƒeƒƒCƒhŠO—pÜ—Ł’E‚ɂ‚˘‚Ä
“ě@@G“T@@˛“Ą@Œ’“ń@@ŠŁ@@dŽ÷@@‘O“c@’mŽq@@“cŒű@”ŽN@@‹gě@–M•F
‘ć94‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1995.5.19-21
‰Ą•l
@
—V—Ł”ç•Ů1013—á‚ĚŒŸ“˘
Š_•Ł@ł’j@@×ě@@˜i@@–î–ě@Œ’“ń@@“úŠ}@@šć@@‘ĺŽR@’mŽ÷@@ŒI“c@’q”V
‘ć38‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1995.5.25-27
–‹’Ł
@
”ç•Ů‹“ă‘O‚É‚¨‚Ż‚錌s‰ü‘P‚ĚˆÓ‹`@ƒAƒNƒgƒVƒ““îp‚É‚ć‚éŽŔŒą“IŒŸ“˘
ź’J@–ÎŽ÷@@×ě@@˜i@@Š_•Ł@ł’j
‘ć38‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1995.5.25-27
–‹’Ł
@
‰şŠááق̓Ž‚Ť‚ɂ‚˘‚āF‘ć‚Q•ń
“úŠ}@@šć@@×ě@@˜i@@Š_•Ł@ł’j@@–î–ě@Œ’“ń@@ŒI“c@’q”V@@‘ĺŽR@’mŽ÷
‘ć38‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1995.5.25-27
–‹’Ł
@
“ű–[ŠOƒx[ƒWƒFƒbƒg•a42—á‚Ě“Œv“IŠĎŽ@
–î–ě@Œ’“ń@@×ě@@˜i@@Š_•Ł@ł’j@@“úŠ}@@šć@@‘ĺŽR@’mŽ÷@@ŒI“c@’q”V
‘ć38‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1995.5.25-27
–‹’Ł
@
”MA”çp‚É‚¨‚Ż‚é‹zŽűŤƒXƒLƒ“ƒXƒeƒCƒvƒ‰[‚Ě—L—pŤ
‹´–{@—S”V*@@‘q“c@‘‘‘ž˜Y**@@˛“Ą@ŽĄ–ž**@@“cŠ@äŽk**@@Žsě@Oé*** i*‘ĺ•ŞˆăŽt‰ď—§ƒAƒ‹ƒƒCƒ_•a‰@Œ`ŹŠO‰Č@**‘ĺ•Şˆă‰Č‘ĺŠw”畆‰ČŒ`ŹŠO‰Čf—Ă”Ç ***‘ĺ•ŞˆăŽt‰ď—§ƒAƒ‹ƒƒCƒ_•a‰@”畆‰Čj
‘ć21‰ń“ú–{”MŠw‰ďŠwpW‰ď@@
1995.6.1
Œ˘ŽR
@
ƒXƒeƒƒCƒhŠO—pÜ ‚É‚ć‚éÚG”畆‰Š‚Ě‚Q—á@
‹î‘ş@Œö”ü@@ŠŁ@@dŽ÷@@“y‹@•q–ž@@‹gě@–M•F
‘ć25‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1995.6.1-3
’ˇč
@
‰şŠ{œŹ’ˇ•s‘S‚ĚŽĄ—ĂŒoŒą
ŒI“c@’q”V@@×ě@@˜i@@Š_•Ł@ł’j@@–î–ě@Œ’“ń@@‹g—´@ŸŽq@@‘ĺŽR@’mŽ÷
‘ć64‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1995.6.17
‹ž“s
@
”j—ôŤä`‘Ńƒwƒ‹ƒjƒA‚ĚˆęŽĄ—Ă—á
‘ĺŽR@’mŽ÷@@×ě@@˜i@@Š_•Ł@ł’j@@–î–ě@Œ’“ń@@‹g—´@ŸŽq@@ŒI“c@’q”V
‘ć64‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1995.6.17
‹ž“s
@
ƒXƒeƒƒCƒhŽĄ—Ă‚É’ďR‚ľC ’E“îp‚ʼnü‘PŒXŒü‚đ”F‚ß‚˝ƒAƒgƒs[Ť”畆‰Š‚Ě‚P—á
“ě@@G“T@@–k“‡@iŽi@@˛“Ą@Œ’“ń@@’ҁ@@‘ě•v
‘ć192‰ń“ŒŠC’n•ű‰ď
1995.6.18
–źŒĂ‰Ž
@
_ŒoZ‚𔺂Á‚˝—Lž™×–EŠŕ‚Ě‚P—á
H“Ą@@–Ť@@˛“Ą@ŽĄ–ž@@Ž›Žt@_l@@“cŠ@äŽk@@‘q“c‘‘‘ž˜Y@@H“Ą@–FŽq i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @@
‘ć57‰ń“ú–{”畆‰ČŠw‰ď‘ĺ•Ş’n•ű‰ď
1995.6.18
‘ĺ•Ş
@
ăŒűO•”Šî’ę×–Eă”çŽî‚ɑ΂ˇ‚é‰äX‚ĚŽčp•ű–@ i•”ˆĘ•ĘŘœ–@‚ƁC ‚ť‚ę‚ź‚ę‚ĚÄŒš–@j
Ž›Žt@_l@@‘q“c‘‘‘ž˜Y@@“cŠ@äŽk@@H“Ą@–FŽq@@˛“Ą@ŽĄ–ž@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @@‹´–{@—S”V i‘ĺ•ŞˆăŽt‰ď—§ƒAƒ‹ƒƒCƒ_•a‰@Œ`ŹŠO‰Čj @@
‘ć57‰ń“ú–{”畆‰ČŠw‰ď‘ĺ•Ş’n•ű‰ď
1995.6.18
‘ĺ•Ş
@
von Recklinghausen •a‚É‚¨‚Ż‚é Blue-red macules
‹v•Ű@—şŽĄ@@“ŒŽR@^—˘@@‹ŕ“c@^—@@‹gě@–M•F@@–î–ě@Œ’“ń@@×ě@@˜i@@“Ą–{@Œ\ˆę@
‘ć88‰ń‹ß‹E”畆‰ČW’k‰ď
1995.6.18
‘ĺă
@
ćů•””Má­•”‚ɐś‚ś‚˝_ŒoZ‚𔺂¤—Lž™×–EŠŕ‚Ě‚P—á
ĺ”g@‹IŽq@@“cŠ@äŽk@@H“Ą@–FŽq@@Ž›Žt@_l@@‘q“c‘‘‘ž˜Y@@”ÂŒŠ@@’q@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @
‘ć11‰ń“ú–{”畆ˆŤŤŽîᇊw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď
1995.6.23
‹{č
@
“ű–[ÄŒš‚É‚¨‚Ż‚éˆęŠú‚¨‚ć‚Ń“ńŠúÄŒš‚Ě‘I‘đ|pŽŽŒˆ’č‚É‹y‚Ú‚ˇ—vˆö‚ɂ‚˘‚ā|
Š_•Ł@ł’j@@×ě@@˜i@@–î–ě@Œ’“ń@@ź’J@–ÎŽ÷
‘ć20‰ń“ú–{ŠO‰ČŒn˜A‡Šw‰ďŠwpW‰ď
1995.6.23
“Œ‹ž
@
őF‘ĚˆŮí‚ƐV‚˝‚Č“_“Ë‘R•ĎˆŮ‚Ş”F‚ß‚ç‚ę‚˝AŒQ XP ŠłŽŇ‚Ě‚P—á
‘O“c@’mŽq@@˛“Ą@Œ’“ń@@‘ź‚S–ź
17‰ń@“ú–{ŒőˆăŠwŒőś•¨Šw‰ď
1995.7
@
@
Cowden •a‚Ě‚P—á
Ź—с@”ü—ç@@‘q’m‹MŽu˜Y@@ˆäăç’ĂŽq
‘ć330‰ń‘ĺă’n•ű‰ď
1995.7
‘ĺă
@
Źl”­Ç‚Ě Erythrokeratiderma Variabilis ‚Ş‹^‚í‚ę‚˝ˆę—á
‹v•Ű@—şŽĄ@@ŒI–{@@ŠŢ@@źˆä@Šě•F@@‹gě@–M•F
‘ć10‰ńŠp‰ťÇŒ¤‹†‰ď
1995.7.1
“Œ‹ž
@
‹CŠÇŽxŠg’ŁÇŠłŽŇ‚ɐś‚ś‚˝ƒAƒŒƒ‹ƒM[ŤŒŒŠÇ‰Š‚Ěˆę—á
‹v•Ű@—şŽĄ@@“cŒű@”ŽN@@‹gě@„Ži@@ŒI–{@@ŠŢ@@źˆä@Šě•F@@‹gě@–M•F
‘ć330‰ń‘ĺă’n•ű‰ď
1995.7.15
@
@
ƒŠƒ{ƒtƒ‰ƒrƒ“‚̉Ž‹Œő‚É‚ć‚éŒőŠ´ě
˛“Ą@Œ’“ń@@“ě@@G“T@@“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F@@’ҁ@@‘ě•v
‘ć17‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1995.7.28-29
“c
@
őF‘ĚˆŮí‚ƐV‚˝‚Č“_“Ë‘R•ĎˆŮ‚Ş”F‚ß‚ç‚ę‚˝AŒQ XP ŠłŽŇ‚Ě‚P—á
‘O“c@’mŽq@@˛“Ą@Œ’“ń@@“ě@@G“T@@“cŒű@”ŽN@@“c’†@’BĆ@@‹gě@–M•F
‘ć17‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1995.7.28-29
“c
@
Pyridoxine ‚Ě UVA ‚É‚ć‚éŒő•Ş‰đŽY•¨‚ĚŽż—Ę•ŞÍ
“cŒű@”ŽN@@‘O“c@’mŽq@@“ě@@G“T@@‹gě@–M•F@@˛“Ą@Œ’“ń
‘ć17‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1995.7.28-29
“c
@
‘Săč–ĺŠÇ‹y‚Ńăč–ĺŽüˆÍ”畆‚ĚÄŒš iăč–ĺ‹@”\‰ˇ‘śŽčp‚đŽ{s‚ľ‚˝ăč–ĺ•” Paget •a‚ĚŒoŒą‚Š‚çj
Ž›Žt@_l@@“cŠ@äŽk@@‘q“c‘‘‘ž˜Y@@ŽR–{@~Žq@@H“Ą@–FŽq@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @@ŽÄ“c@‹ť•F i‘ĺ•Şˆă‰Č‘ĺŠw‘ć‚QŠO‰Čj @@
‘ć39‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‹ăBŽx•”ŠwpW‰ď
1995.7.8
•Ÿ‰Ş
@
łíƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚ĚƒWƒƒƒNƒXƒ^ƒNƒ‰ƒCƒ“‘B‹@\‚̉đÍ
ŠŁ@@dŽ÷@@“ŒŽR@”ÉŽ÷@@‹´–{@Œö“ń@@‹gě@–M•F@@’JŒű@’ź”V
‘ć‚X‰ń•\”ç×–EŒ¤‹†‰ď
1995.8
Šň•Œ
@
’jŤŒ^’E–ŃŠłŽŇ‚ć‚č“ž‚˝–Ń“ű“ލזE‹y‚Ń•\”ç×–E‚̍Ź‡”|—{ i”ńÚGj Žž‚É‚¨‚Ż‚é×–E‘B‚Ö‚Ěƒ~ƒmƒLƒVƒWƒ‹‚̉e‹ż
‘q“c‘‘‘ž˜Y@@”ÂŒŠ@@’q@@“cŠ@äŽk@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj
ƒ~ƒmƒLƒVƒWƒ‹ě—p‹@˜‚ĚŒ¤‹†@´˜^W i‚Tj
1995.8.5
“Œ‹ž
@
–Ń“ű“ލזE‚É‚¨‚Ż‚éƒAƒ“ƒhƒƒQƒ“ě—p‚ɑ΂ˇ‚éƒ~ƒmƒLƒVƒWƒ‹‚¨‚ć‚Ńƒ~ƒmƒLƒVƒWƒ‹ƒTƒ‹ƒtƒFƒCƒg‚ĚŒř‰Ę
‘q“c‘‘‘ž˜Y@@”ÂŒŠ@@’q@@“cŠ@äŽk@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj
ƒ~ƒmƒLƒVƒWƒ‹ě—p‹@˜‚ĚŒ¤‹†@´˜^W i‚Tj
1995.8.5
“Œ‹ž
@
łíƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě juxtacrine ‘B‹@\‚̉đÍ
ŠŁ@@dŽ÷@@“ŒŽR@”ÉŽ÷@@‹´–{@Œö“ń@@‹gě@–M•F@@’JŒű@’ź”V
‘ć68‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď
1995.9
ĺ‘ä
@
_ŒoâŽî‚Ě‚Q—á
“ě@@G“T@@ŽO”ö@´t@@–k“‡@iŽi@@˛“Ą@Œ’“ń@@’ҁ@@‘ě•v
‘ć193‰ń“ŒŠC’n•ű‰ď
1995.9.23
–źŒĂ‰Ž
@
‰ÂŽ‹ŒőĆŽËƒŠƒ{ƒtƒ‰ƒrƒ“—n‰t‚Ě×–EáŠQŤ
˛“Ą@Œ’“ń@@“ě@@G“T@@“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F@@’ҁ@@‘ě•v
‘ć20‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1995.9.6-8
‰ŞŽR
@
HPLC-analysis of possible toxic photoproductisj from UVA-irradiated pyridoxine
“cŒű@”ŽN@@‘O“c@’mŽq@@“ě@@G“T@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć20‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1995.9.6-8
‰ŞŽR
@
’áŽ_‘f UVA ĆŽËƒŠƒ{ƒtƒ‰ƒrƒ“…—n‰t‚Ě×–EáŠQŤ‚ĚĆŽË—ĘˆË‘śŤ
“ě@@G“T@@˛“Ą@Œ’“ń@@“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F@@’ҁ@@‘ě•v
‘ć20‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1995.9.6-8
‰ŞŽR
@
Precise genetic evidence that polymorphism at Tnfa dictates UVB-susceptibility in mice.
Nakamura,T., Kurimoto, I. amd Streilein, J.W.
1996 annual meeting of the society for investigative dermatology
1996
Washington, D.C.
@
‘SÁ‰ťŠÇ‚Ƀ|ƒŠƒ|[ƒVƒX‚đ”F‚߁C ‘ĺ’°Šŕ‚đ‡•š‚ľ‚˝ Cowden •a‚Ě‚P—á
Ź—с@”ü—ç@@‘q’m‹MŽu˜Y@@ˆäăç’ĂŽq@@Ł”ö@—Y“ń@@“y‹Kˆę˜Y
‘ć332‰ń‘ĺă’n•ű‰ď
1996
@
@
Œ‹ßŤd‰ťÇ‚É‚¨‚˘‚Ä“ÁˆŮ“IŒ¸­‚Ş”F‚ß‚ç‚ę‚˝’`”’p40‚̉đÍ
‹ŕ“c@^—@@‹gě@–M•F@@‹ŕ“c@ˆŔŽj
‘ć95‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1996
ŽD–y
@
‚Š‚Ô‚ę iÚG”畆‰Šj ‚ĚŒ´ˆö
‹î‘ş@Œö”ü@@‹gě@–M•F
‘ć20‰ń‘ĺă•{ˆăŽt‰ďˆăŠw‰ď‘‰ď
1996. 11.17
‘ĺă
@
Letter-Siwe •a‚Ě‚P—á
ˆŔ“Œ˜Đ”ü@@ź“cŒ’Ž÷@@“y‹•q–ž@@‹gě„Ži@@ŒI–{@ŠŢ@@źˆäŠě•F@@“ŒŽR^—˘@@‹gě–M•F@
Ž­Ž™“‡’n•ű‰ď
1996.1.14
Ž­Ž™“‡
@
50”NŠÔă‰şŠááيO”˝‚đ’ć‚ľ‚˝íŽž”M‚Ě‚P—á
‚–؁@˝Ži@@×ě@@˜i@@Š_•Ł@ł’j@@ź–{@@‘@@‹g—´@ŸŽq
‘ć‚S‰ń“ú–{”MŠw‰ď‹ß‹E’n•ű‰ď
1996.1.20
‚’Î
@
”畆Žîá‡‚Ć Kaposi's sarcoma-associated herpes virus iKSHVj ‚ĚŠÖ˜A
ź–{@@‘@@×ě@@˜i@@Š_•Ł@ł’j@@‹gě@–M•F@@ˆîé@—ćŽq@@ŽRź@Oˆę
‘ć‚T‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1996.10.17-18
’ˇč
@
Œ˘™ů‚É‚ć‚é—cŽ™—܏ŹŠÇ’f—ô‚Ě‚QÇ—á
ź”ö@—R‹I@@˛“Ą@ŽĄ–ž@@Ž›Žt@_l@@“cŠ@äŽk@@‘q“c‘‘‘ž˜Y i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj
‘ć42‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‹ăBŽx•”ŠwpW‰ď
1996.10.26
•Ę•{
@
“ŕŽ‹‹ž‚đ—p‚˘‚˝L”w‹Ř•ŮˆÚAp
Îˆä@‹`‹P@@–{‘˝@•üm@@˛“Ą@ŽĄ–ž@@“ĄŒ´@‹MŽj@@“Ąě@š˜a@@Š_•Ł@ł’j@@ó“c@—TŽi@
‘ć43‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‹ăBŽx•”ŠwpW‰ď
1996.10.26
•Ę•{
@
’ˇŠúŽg—p‚ľ‚Ä‚˘‚˝ƒUƒWƒfƒ““_Šá–ň‚É‚ć‚éÚG”畆‰Š‚Ě‚P—á
‘Ť—§@@€@@‹gě@–M•F@@Â–؁@•q”V
‘ć270‰ń’ˇč’n•ű‰ď
1996.10.6
’ˇč
@
A Case of Hyperlipidemia with Eruptive Xanthoma on the Elbow and Palmar Xanthoma
Doi, T., Itami, S. and Yoshikawa, K.iOsaka Univj
The 5th China-Japan Joint Meeting of Dermatology
1996.10.9-11
Pejin
@
ˆŤŤÎŠD‰ťă”çŽî‚Ě‚P—á
‹{–{@•üŽq@@‰H”’ @˝@@‰€“c@‘•c@@‰œ‘ş@–rŽq
‘ć47‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1996.11
‹ž“s
@
ŒŒŠÇ•ż•t‚ŤœˆÚA‚É‚ć‚鉺Š{ÄŒš
Š_•Ł@ł’j@@…–ě@´s@@×ě@@˜i@@‹g—´@ŸŽq@@ź–{@@‘@@“Ąě@š˜a@@–k‹g@@Œő
“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1996.11.14-15
–L’†
@
ƒqƒgŠO–ŃŞâ×–E‹y‚Ń–Ń“ű“ލזE‚É‚¨‚Ż‚é17ƒŔhydrogenose ‚Ě”­Œť
ˆŔ“Œ@˜Đ”ü@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć47‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1996.11.2
‹ž“s
@
ÂF•ę”Á‚ɑ΂ˇ‚郊ƒ{ƒtƒ‰ƒrƒ“-Œőü—Ă–@
˛“Ą@Œ’“ń@@ĺŒ´@‘ăK@@“ě@@G“T@@’ҁ@@‘ě•v
‘ć47‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1996.11.2-3
‹ž“s
@
—ź‘¤‘ć‚P‘ć‚S’†‘Ťœ’ZkÇ‚Ě‚PŽĄ—Ă—á
‹v•Ű@‚‹M@@×ě@@˜i@@Š_@@ł’j@@ź–{@@‘@@‹g—´@ŸŽq@@•Ÿ“c@Œ’“ń
‘ć67‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1996.11.30
“Ţ—Ç
@
—ź‘¤‘ć‚P‘ć‚S’†‘Ťœ’ZkÇ‚Ě‚PŽĄŒą—á
‹v•Ű@‚‹M@@×ě@@˜i@@Š_•Ł@ł’j@@‹g—´@ŸŽq@@•Ÿ“c@Œ’Ž™
‘ć67‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1996.11.30
“Ţ—Ç
@
ć“VŤ•\”琅ávÇ‚Ěˆę—‘Ť‘ośŽ™‘o•ű‚É”­Ç‚ľ‚˝—LŽh×–EŠŕ
ź“c@@Œ’@@×ě@@˜i@@Š_•Ł@ł’j@@ź–{@@‘@@‹g—´@ŸŽq@@•Ÿ“c@Œ’“ń@@“ŒŽR@^—˘
‘ć67‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1996.11.30
“Ţ—Ç
@
“ŕŽ‹‹ž‚đ—p‚˘‚˝—V—ŁL”w‹Ř•ŮˆÚAp
Îˆä@‹`‹P@@–{‘˝@•üm@@˛“Ą@ŽĄ–ž@@“ĄŒ´@‹MŽj@@“Ąě@š˜a@@Š_•Ł@ł’j@@ó“c@—TŽi
‘ć67‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1996.11.30
“Ţ—Ç
@
–Ń“ű“ލזEC ŠO–ŃŞâ×–E‚É‚¨‚Ż‚é17beta-hydroxysteroid dehydrogenase ‚Ě”­Œť
ˆŔ“Œ@˜Đ”ü@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć‚S‰ń–Ń”Ż‰ČŠwŒ¤‹†‰ď
1996.11.9
@
@
Spitz Nevus ‚Ş‹^‚í‚ę‚˝‚P—á
ˆî‹{@’m”ü@@“c’†@‚Ü‚č@@“ŒŽR@^—˘@@˛–ě@‰h‹I@@‹v•Ű@‚‹M@@‹g—´@ŸŽq@@Š_•Ł@ł’j@@×ě@@˜i@@”ÂŒŠ@@’q@@‹gě@–M•F@@‹vŽu–{@“Œ@
‘ć337‰ń‘ĺă’n•ű‰ď
1996.12
‘ĺă
@
AŒQ XP ‰Ć‘°‚Ěˆâ“`‘Š’k‚ĚŒ‹‰Ę‚ĆŠłŽ™oŽY‚ĚŠm—§
˛“Ą@Œ’“ń@@‘O“c@’mŽq@@“ě@@G“T
‘ć47‰ń–źŒĂ‰ŽŽs—§‘ĺŠwˆăŠw‰ď‘‰ď
1996.12.1
–źŒĂ‰Ž
@
Scalp expansion for cicatric baldness.
Kakibuchi M, Hosokawa K, Nishimoto S, Yoshitatsu S and Asada Y.
The 5th International Congress of Oriental Aesthetic Plastic Surgery
1996.12.2-5
Taipei, TAIWAN
@
ƒNƒƒ‚ƒOƒŠƒNŽ_ƒiƒgƒŠƒEƒ€ ‚É‚ć‚éÚG”畆‰Š‚Ě‚P—á
‹î‘ş@Œö”ü@@źˆä@Šě•F@@‹gě@–M•F
‘ć21‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1996.12.7-8
Ž­Ž™“‡@
@
ƒvƒƒ|ƒŠƒX‚É‚ć‚éÚG”畆‰Š‚Ě‚P—á
’J@@@Žç@@‹î‘ş@Œö”ü@@‹gě@–M•F
‘ć21‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1996.12.7-8
Ž­Ž™“‡@
@
ŘœpŒă‚U”N–ڂɍĔ­‚ľ‚˝ Chondrodermatitis nodularis Helicis ‚Ě‚P—á
‹v•Ű@—şŽĄ@@’JŒű@—´ś@@’JŠ_@••F@@ź–{@‘
‘ć333‰ń‘ĺă’n•ű‰ď
1996.2.24
@
@
ˆŤŤ•FŽî‚Ş‹^‚í‚ę‚˝‰şŠááكAƒ|ƒNƒŠƒ“”X–E‘BŽî‚Ě‚P—á
˛“Ą@ŽĄ–ž@@ź”ö@—R‹I@@Ž›Žt@_l@@“cŠ@äŽk@@‘q“c‘‘‘ž˜Y@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @@
‘ć41‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‹ăBŽx•”ŠwpW‰ď
1996.3.16
•Ÿ‰Ş
@
Flat ear ‚ĚŽĄ—ĂŒoŒą
Ž›Žt@_l@@ź”ö@—R‹I@@˛“Ą@ŽĄ–ž@@‘˝“c@‰ps@@“cŠ@äŽk@@‘q“c‘‘‘ž˜Y@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @
‘ć41‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‹ăBŽx•”ŠwpW‰ď
1996.3.16
•Ÿ‰Ş
@
CK ă¸‚𔺂í‚Č‚˘”畆ß‰Š‚Ě‚P—á
ŽO‰Y@G”V@@źˆä@Šě•F@@ŒI–{@@ŠŢ@@“ŒŽR@^—˘@@‹gě@–M•F
‘ć328‰ń‘ĺă’n•ű‰ď
1996.3.25
“Ţ—Ç
@
ƒRƒŠƒ“Ťĺ@–ƒ]‚Ě—Ő° iƒVƒ“ƒ|ƒWƒEƒ€j
‘Ť—§@@€
‘ć12‰ń—Տ°”畆‰ČˆăŠw‘‰ďE—Տ°Šwp‘ĺ‰ď
1996.4.13
L“‡
@
Šá—Ö‹Ř‚đŒs‚Ć‚ˇ‚éăŠááٓ‡ó”ç•Ů‚Ěˆę—á
˛“Ą@ŽĄ–ž@@‘q“c‘‘‘ž˜Y@@Ž›Žt@_l@@“cŠ@äŽk@@ŽO‰Y@–FŽq@@‘˝“c@‰ps@@ź”ö@—R‹I i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @@‹´–{@—S”V i‘ĺ•ŞˆăŽt‰ď—§ƒAƒ‹ƒƒCƒ_•a‰@Œ`ŹŠO‰Čj
‘ć39‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1996.4.17
‘ĺă
@
Šááٗ]č”畆‚đ—p‚˘‚˝V‚ľ‚˘ŠááّO—t‚ĚÄŒš–@
‘q“c‘‘‘ž˜Y@@Ž›Žt@_l@@“cŠ@äŽk@@ŽO‰Y@–FŽq@@˛“Ą@ŽĄ–ž@@‘˝“c@‰ps@@ź”ö@—R‹I@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @
‘ć39‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1996.4.17
‘ĺă
@
ƒAƒgƒs[Ť”畆‰Š‚ɑ΂ˇ‚éŠC—m[‘w…‚Ě“ńd–ÓŒŸ–@‚É‚ć‚錟“˘
‘Ť—§@@€@@Šp’҂قÂ݁@@‰““Ą@@ŒO@@Šp@—˛”V@@Â–؁@•q”V
‘ć‚W‰ń“ú–{ƒAƒŒƒ‹ƒM[Šw‰ďtŠú—Տ°‘ĺ‰ď
1996.4.25-27
‰Ą•l
@
Cutis marmorata teleangiectatica conganita ‚Ě‚P—á
–Ń—˜@—LŠó@@˛–ě@‰h‹I@@‹gě@–M•F
‘ć334‰ń‘ĺă’n•ű‰ď
1996.4.6
‘ĺă
@
Activation of p53 tumor suppressor protein by thymidine dinucleotides
Eller, M. S., Maeda, T., et al
57th SID
1996.5
Washington DC
@
Under anaerobic condotions, hydrogen peroxide is faster produced in riboflavin solution during near-ultraviolet irradiation
Sato, K., Minami, H., Taguchi, H., Maeda, T., Yoshikawa, K. and Tsuji, T.
57th Annual Meeting of the Society for Investigative Dermatology
1996.5.1-5
Washington DC
@
Juxtacrine growth in normal human keratinocytes is mediated by the interaction of heparin-binding EGF-like growth fctor and amphiregulin with CD9.
Shigeki Inui, Shigeki Higashiyama, Koji Hshimoto, Mari Higashiyama, Naoyuki Taniguchi, Kunihiko Yoshikawa
57th Annual Meeting The Society for Investigative Dermatology
1996.5.1-5
Washington D.C.
@
Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogenous IL-4.
Asada, H. and Katz, S. I.
57th SID
1996.5.1-5
Washington DC
@
Chronic actinic dermatitis ‚Ě‚P—á
ŽO‰Y@G”V@@‘O“c@’mŽq@@‹î‘ş@Œö”ü@@źˆä@Šě•F@@ŒI–{@@ŠŢ@@‹gě@–M•F@@˛“Ą@Œ’“ń@@“c’†@‚Ü‚č@@‘ĺ˜a’JiŽq@
‘ć94‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1996.5.20
‰Ą•l
@
łíƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě juxtacrine ‘B‹@\‚̉đÍ
ŠŁ@@dŽ÷@@‹gě@–M•F@@‹´–{@Œö“ń@@“ŒŽR@”ÉŽ÷@@’JŒű@’ź”V
‘ć95‰ń“ú–{”畆‰ČŠw‰ď‘‰ď@ƒ[ƒNƒVƒ‡ƒbƒv‡U uŠp‰ť×–Ev
1996.6
ŽD–y
@
qíŤ“VávግRŒ´‚É”˝‰ž‚ˇ‚éR‘Ě‚ŞŒŸo‚ł‚ę‚˝áv]ó“Vávጂ̈ę—á
‹v•Ű@—şŽĄ@@“y‹@•q–ž@@“ŒŽR@^—˘@@ŒI–{@@ŠŢ@@‹gě@„Ži@@źˆä@Šě•F@@‹gě@–M•F@@‹´–{@@—˛@@“V’J@‰ës@
‘ć95‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1996.6.13
ŽD–y
@
ƒ}ƒEƒX”畆“ń’iŠK”­ŠŕŽŔŒą‚đ—p‚˘‚˝ IRF-1ˆâ“`Žq‚ĚŒŸ“˘
’M’J@Ÿm@@“c’†@M”V@@ÎŒ´@ł•F@@‹´–{@Œö“ń@@‹gě@–M•F@@’JŒű@ˆŰĐ
‘ć95‰ń“ú–{”畆‰ČŠw‰ď‘‰ďEŠwp‘ĺ‰ď
1996.6.13
ŽD–y
@
UVA ĆŽËƒrƒ^ƒ~ƒ“B2‚Ě’e—͐üˆŰ‚É—^‚Ś‚é‰e‹ż
˛“Ą@Œ’“ń@@“ě@@G“T@@“cŒű@”ŽN@@‘O“c@’mŽq@@‹gě@–M•F@@’ҁ@@‘ě•v
‘ć95‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1996.6.13-15
ŽD–y
@
‘ĺă•{‚É‚¨‚Ż‚éƒAƒgƒs[Ť”畆‰ŠŽŔ‘Ô’˛¸•ń i‘ć‚P•ńj |’Pƒ“Œv|
‘Ť—§@@€@@Â–؁@•q”V@@‚Ů‚Š“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
‘ć95‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1996.6.13-15
ŽD–y
@
‘ĺă•{‚É‚¨‚Ż‚éƒAƒgƒs[Ť”畆‰ŠŽŔ‘Ô’˛¸•ń i‘ć‚Q•ńj |ƒNƒƒX•ŞÍ|
‘Ť—§@@€@@Â–؁@•q”V@@‚Ů‚Š“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
‘ć95‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1996.6.13-15
ŽD–y
@
‚‘Ź‰t‘ĚƒNƒƒ}ƒgƒOƒ‰ƒtƒB[ iHPLCj ‚Ĺ•ŞŽć‚ľ‚˝ Pyridoxine ‚Ě UVA ‚É‚ć‚éŒő•Ş‰đŽY•¨‚Ě×–EáŠQŤ
“cŒű@”ŽN@@‘O“c@’mŽq@@“ě@@G“T@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć95‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1996.6.13-15
ŽD–y
@
uŹlŒ^ƒAƒgƒs[Ť”畆‰Šv ‚ĚŠO—pÜ—Ł’E—Ă–@‚É‚¨‚Ż‚é–ž‘ŤŠ´‚ĆŒŸ¸ƒf[ƒ^‚ĚŒŸ“˘
“ě@@G“T@@˛“Ą@Œ’“ń@@›–ě@@d@@ŽR“ŕ@—ĽŽq@@“n•Ó@KŒb@@‚‹´‹Ig]@@ŕV“c–œ‹LŽq@@‹gě@–M•F@@’ҁ@@‘ě•v@
‘ć95‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1996.6.13-15
ŽD–y
@
…ávŒ^ć“VŤ‹›—Ř᝗lg”çÇ‚Ě‚P—á
“ŒŽR^—˘@@ź“cŒ’Ž÷@@‹gě–M•F
‘ć11‰ńŠp‰ťÇŒ¤‹†‰ď
1996.6.15
ŽD–y
@
Analysis of Repeated free Flap Transfers in Head and Neck Reconstruction.
Kakibuchi M, Hosokawa K, Nishimoto S and Yoshitatsu S.
13th Congress of the International Microsurgical Society
1996.6.19-23
Quebec, CANADA
@
Head and Neck Reconstruction with Free Rectus Musculocutaneous Flap
Nishimoto S, Kakibuchi M, Hosokawa K and Maeda M.
13th Congress of the International Microsurgical Society
1996.6.19-23
Quebec, CANADA
@
‹š•Ç• •Ç‡•šŘœ‚ĚÄŒš‚ĚŒoŒą
‚–؁@˝Ži@@×ě@@˜i@@Š_•Ł@ł’j@@‹g—´@ŸŽq@@ź–{@@‘@@…“c@—˛r@@“Ąˆä@‹`Œh@
‘ć66‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1996.6.22
“V—
@
malignant endocrine expohthalmus ‚ɑ΂ˇ‚éŠáâ|Œ¸ˆłp‚ĚŒoŒą
’†ˆä@š ”Ž@@×ě@@˜i@@Š_•Ł@ł’j@@‹g—´@ŸŽq@@ź–{@@‘@@–Ô–ě@Ms@@“ú‚@@—m@@”ˆä@@‘ě@@’†]@@•ś@
‘ć66‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1996.6.22
“V—
@
ŠOŤŽhÂ‚ɑ΂ˇ‚éC Œ°”÷‹ž‚đ—p‚˘‚˝Žčp
ź”ö@—R‹I@@˛“Ą@ŽĄ–ž@@Ž›Žt@_l@@“cŠ@äŽk@@‘q“c‘‘‘ž˜Y i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj @@
‘ć59‰ń“ú–{”畆‰ČŠw‰ď‘ĺ•Ş’n•ű‰ď
1996.6.23
‘ĺ•Ş
@
ŹŽ™•@Ş•”‚ɐś‚ś‚˝Œ‹ßŤ”畆‰Š‚Ě‚P—á
ź”ö@—R‹I@@Ž›Žt@_l@@“cŠ@äŽk@@‘q“c‘‘‘ž˜Y@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj
‘ć42‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‹ăBŽx•”ŠwpW‰ď
1996.6.29
•Ÿ‰Ş
@
áٗô‹ˇŹÇŒóŒQ‚ĚŒZ’í—á
‹T“c’m‰ÁŽq@@Š_•Ł@ł’j@@–Ř“ŕ—T”üŽq@@•ž•”@‹§Žu@@ě‘ş@@”Ł@@‰Ş–ě@šŽq@@’|’†@@‹v@@–ž“c@‹v”N@@^–ě@•x–ç
‘ć292‰ń‘ĺăŠá‰ČW’k‰ď
1996.6.8
‘ĺă
@
ƒCƒ{‚ɑ΂ˇ‚é‹ÇŠ—Ă–@@|‚Ć‚­‚ɃsƒVƒoƒj[ƒ‹‹Ç’|
ŠŁ@@dŽ÷@@‹gě@–M•F
‘ć12‰ń“ú–{—Տ°”畆‰ČˆăŠw‰ď‹ß‹EŽx•”Šwp‘ĺ‰ď@ƒVƒ“ƒ|ƒWƒEƒ€
1996.7
‹ž“s
@
łíƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě juxtacrine ‘B‹@\‚̉đÍ
ŠŁ@@dŽ÷@@“ŒŽR@”ÉŽ÷@@“ŒŽR@^—˘@@‹´–{@Œö“ń@@’JŒű@’ź”V@@‹gě@–M•F
‘ć21‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ďŠwp‘ĺ‰ď
1996.7
“Œ‹ž
@
Analysis of Role of IRF-1 gene in Skin Tumor induced by chemical treatmentA
Tarutani, M., Tanaka, N., Ishihara, M., Hashimoto, K., Yoshikawa, K. and Taniguchi, T.
First Joint Meeting of the Japanese and Canadian Societies for Investigative Dermatology
1996.7.1
Whistler, Canada
@
ƒZƒ`ƒ‹ƒAƒ‹ƒR[ƒ‹šńŽG•¨ ‚É‚ć‚éÚG”畆‰Š‚Ě‚P—á
‹î‘ş@Œö”ü@@“y‹@•q–ž@@ŠŁ@@dŽ÷@@‹gě@–M•F
‘ć26‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1996.7.12-14
–źŒĂ‰Ž
@
ƒuƒVƒ‰ƒ~ƒ“iƒŠƒ}ƒ`ƒ‹j ‚É‚ć‚éƒWƒxƒ‹‚΂çF‚Ѝf]Œ^–ň]‚Ě‚P—á
Źă@@”Ž@@‹î‘ş@Œö”ü@@“y‹@•q–ž@@ŒI–{@@ŠŢ@@‹gě@„Ži@@‹gě@–M•F
‘ć26‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1996.7.12-14
–źŒĂ‰Ž
@
|ƒVƒ“ƒ|ƒWƒEƒ€|@ƒAƒgƒs[Ť”畆‰Š‚ĚŽĄ—Á|–ž“ú‚Ö‚Ě–Íő|C “ű—cŽ™‚ĚŽĄ—Âɂ‚˘‚Ä
‘Ť—§@@€
‘ć26‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1996.7.12-14
–źŒĂ‰Ž
@
ƒAƒgƒs[Ť”畆‰Š‚̐ťƒpƒ“‹ĆŽŇ‚É”­ś‚ľ‚˝E‹ĆŤ”畆‰Š‚Ě‚P—á
’ră@—˛‘ž@@‹î‘ş@Œö”ü@@ŒI–{@@ŠŢ@@‹gě@„Ži@@źˆä@Šě•F@@‹gě@–M•F
‘ć26‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1996.7.12-14
–źŒĂ‰Ž
@
HPLC ‚Ĺ•ŞŽć‚ľ‚˝ UVA ĆŽË Pyridoxine ‚ĚŒő•Ş‰đŽY•¨‚QŽî‚Ě×–EáŠQŤ
“cŒű@”ŽN@@‘O“c@’mŽq@@“ě@@G“T@@˛“Ą@Œ’“ń@@‹gě@–M•F
‘ć21‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1996.7.26-27
“Œ‹ž
@
ˆŮ‚Č‚éŽ_‘f”Z“x‰ş‚Ĺ‚Ě UVA ĆŽËƒŠƒ{ƒtƒ‰ƒrƒ“—n‰t’†‚̉ߎ_‰ť…‘f…ŽYś‚É‹y‚Ú‚ˇˆęd€Ž_‘f‚Ě–đŠ„
“ě@@G“T@@˛“Ą@Œ’“ń@@“cŒű@”ŽN@@‘O“c@’mŽq@@’ҁ@@‘ě•v
‘ć21‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1996.7.26-27
“Œ‹ž
@
łí•\”ç‚ĆŠŁá•a•Ď•”‚É‚¨‚Ż‚é HB-EGF ‚Ć CD9‚Ě”­Œť‚̖Ɖu‘gDŠw“IŒŸ“˘
“ŒŽR@^—˘@@ŠŁ@@dŽ÷@@‹gě@–M•F
‘ć22‰ńŒ¤‹†”畆‰ČŠw‰ď
1996.7.26-27
“Œ‹ž
@
ƒAƒ“ƒhƒƒQƒ“•W“I×–E‚Ć‚ľ‚Ä‚Ě”|—{ƒqƒgŠO‰A•”ƒƒ‰ƒmƒTƒCƒg
“cŠ@äŽk@@”ÂŒŠ@@’q i‘ĺă‘ĺŠw”畆‰Čj @@‘q“c‘‘‘ž˜Y@@‚ˆŔ@@i i‘ĺ•Şˆă‰Č‘ĺŠw”畆‰Čj
‘ć21‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ďŠwp‘ĺ‰ď
1996.7.27
“Œ‹ž
@
ƒŠƒ{ƒtƒ‰ƒrƒ“|Œőü—Ă–@‚ɂ‚˘‚Ä
˛“Ą@Œ’“ń@@ĺŒ´@‘ăK@@“ě@@G“T@@’ҁ@@‘ě•v
‘ć18‰ń“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď
1996.7.28-29
‘O‹´
@
ŠÖßÇŤŠŁá‚É‚¨‚Ż‚é“SŒ‡–RŤ•nŒŒ‚̍‡•š‚ɂ‚˘‚Ä
“ŒŽR@^—˘@@˛–ě@‰h‹I@@•x“c@’qŽj@@‹gě@–M•F
‘ć11‰ń“ú–{ŠŁáŠw‰ď
1996.8.31-9.1
O‘O
@
“Ťánć҂ɑ΂ˇ‚é OK-432’ŽË—Ă–@
ŠŁ@@dŽ÷@@‹gě@–M•F@@‹{–{@•üŽq
‘ć326‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
1996.9
@ä@
@
“ű–[ŠOƒy[ƒWƒFƒbƒg•a‚Ě‚P—á
–Ń—˜@—LŠó@@’JŒű@—´ś@@Œ´Œł@@’ށ@@’JŠ_@••F@@ź–{@@‘
‘ć337‰ń‘ĺă’n•ű‰ď
1996.9.7
‘ĺă
@
ŠŁá––˝ŒŒE”ç]‚ɂ̓Cƒ“ƒ^[ƒtƒFƒƒ“ƒÁŽYŤ CD4, CD8×–E‚Ş‘˝‚˘
˛–ě@‰h‹I@@’†‘ş@•q–ž@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć12‰ń“ú–{ŠŁáŠw‰ď
1997
@
@
ƒTƒeƒ‰ƒCƒgƒVƒ“ƒ|ƒWƒEƒ€
”ÂŒŠ@@’q
‘ć12‰ń“ú–{ŠŁáŠw‰ď
1997
@
@
‰óŽ€Ť‹Ř–Œ‰Š|‚UÇ—á‚ĚŒŸ“˘
‹g—ǁ@ł_@@‰Ź“°@—DŽq@@ŽR‘ş@’íˆę
‘ć48‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1997.1
‹ŕ‘ň
@
PSS ŠłŽŇ‚É‚Ý‚ç‚ę‚˝ƒvƒŒƒ^[ƒ‹‚É‚ć‚éŒőü‰ß•qÇ
ŽR–ź@‡Žq@@˛X–Ř˜aŽq@@’†‘ş@•q–ž@@‹î‘ş@Œö”ü@@ˆéƒmăł–ž@@”ÂŒŠ@@’q@@‹gě@–M•F@
‘ć48‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1997.1
‹ŕ‘ň
@
‘ć13ˆöŽqŠÜ—LƒtƒBƒuƒŠƒ“ŠîŽż‚Ş•\”ç×–E‹y‚ѐüˆŰ‰č×–E‚É—^‚Ś‚é‰e‹ż
ŽRŒű@—TŽj@@×ě@˜i@@”ÂŒŠ@@’q@@Vincent Falanga
‘ć‚U‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1997.10.17-18
é‹Ę
@
”|—{”畆üˆŰ‰č×–E—R—ˆƒNƒ[ƒ“‚ĚƒRƒ‰[ƒQƒ“ mRNA ”­Œť‚ɑ΂ˇ‚é•s‹ĎˆęŤ
ŽRŒű@—TŽj@@×ě@@˜i@@”ÂŒŠ@@’q@@Vincent Falanga
‘ć‚U‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1997.10.17-18
é‹Ę
@
TGF-beta1ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX—R—ˆ”畆üˆŰ‰č×–E‚Ě TGF-beta1‚ɑ΂ˇ‚é”˝‰ž
ŽRŒű@—TŽj@@×ě@˜i@@”ÂŒŠ@@’q@@Vincent Falanga
‘ć‚U‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1997.10.17-18
é‹Ę
@
PSS ŠłŽŇ‚É‚Ý‚ç‚ę‚˝ƒvƒŒƒ^[ƒ‹‚É‚ć‚éŒőü‰ß•qÇ
˛X–Ř˜aŽq@@ŽR–ź@‡Žq@@’†‘ş@•q–ž@@‹î‘ş@Œö”ü@@“ŒŽR@^—˘@@ˆéƒmăł–ž@@”ÂŒŠ@@’q@@‹gě@–M•F@
‘ć48‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1997.10.25-26
‹ŕ‘ň
@
“ÁˆŮ‚Č”ç]‚đ‡•š‚ľ‚˝ƒx[ƒ`ƒFƒbƒg•a‚Ě‚P—á
ŽO‰Y@G”V@@źˆä@Šě•F@@ŒI–{@@ŠŢ@@‹gě@„Ži@@Œă“Ą@Í•v@@‹gě@–M•F
‘ć46‰ń“ú”ç‰ď’†•”Žx•”‘‰ď
1997.10.28
“Ţ—Ç
@
‘nŽĄ–ü‚ĆŠO–ŃŞâ
“cŠ@äŽk
‘ć‚R‰ń”畆‘nŽĄ–üŠÖźƒtƒH[ƒ‰ƒ€
1997.11.15
‘ĺă
@
“Şčň•”‚ĚÄŒš‚É‚¨‚Ż‚éŠç–e‚̉ˇ‘ś‚ɂ‚˘‚Ä
Š_•Ł@ł’j@@ŽR“c@MK@@×ě@@˜i@@…–ě@´s@@“Ąě@š˜a@@–{‘˝@•üm
‘ć24‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1997.11.20-21
“Œ‹ž
@
‘ĺ‹š‹Ř”ç•Ů‚É‚ć‚éŒűo’ęÄŒšpŒă‚Ěčň•”‹ü‹ČSk‚ɑ΂ˇ‚é—V—ŁŒa”ç•ŮˆÚA‚ĚŒoŒą
ŽR“c@MK@@Š_•Ł@ł’j
‘ć24‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď
1997.11.20-21
“Œ‹ž
@
ŠE–ĘŠˆŤÜ‚É‚ć‚éE‹ĆŤÚG”畆‰Š‚Ě‚P—á
‹î‘ş@Œö”ü@@‹gě@–M•F
‘ć22‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1997.11.29-30
‰Ą•l
@
ƒEƒRƒ“‚É‚ć‚éÚG”畆‰Š‚Ě‚P—á
÷Ş@ƒŽq@@‹î‘ş@Œö”ü@@ˆéƒmăł–ž@@“cŠ@äŽk@@’†‘ş@•q–ž@@‹gě@–M•F
‘ć22‰ń“ú–{ÚG”畆‰ŠŠw‰ď
1997.11.29-30
‰Ą•l
@
“–‰Č‚É’u‚Ż‚é‰ß‹Ž‚R”NŠÔ‚Ě“Şčň•”ˆŤŤŽîᇂɑ΂ˇ‚éÄŒšŽčp‚ĚŒŸ“˘
ŽR“c@MK@@Š_•Ł@ł’j@@ŒI‰Ô—Žš˜a@@”Ş“c@çL@@ŹŠ}Œ´@Š°@@ăă@‰ëŽj
‘ć126‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď•şŒÉ’n•ű•”‰ď
1997.11.30
ź‹{
@
ŒoŒ‹–ŒƒAƒvƒ[ƒ`‚¨‚ć‚ŃŒo•@“ŕ“IŽ•œ–@‚Ě•š—p‚É‚ć‚éŠáâ|’ęœÜ‚ĚŽĄ—Ă
Š_•Ł@ł’j@@ŽR“c@MK@@[‘ňŒ[“ń˜Y@@ăă@‰ëŽj
‘ć15‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠwpW‰ď
1997.11.7-8
–L’†
@
ATL ‚Ě‚P—á
‹{–{@•üŽq@@‰H”’ @˝@@‘Ť—§@@€@@‰œ‘ş@–rŽq
‘ć344‰ń‘ĺă’n•ű‰ď
1997.12
@
@
–эEŤgFâáf]‚Ě‚P—á
ˆî‹{@’m”ü@@’JŒű@—´ś@@ŒŽ–ě@‹Ĺ•F@@’JŠ_@••F
‘ć343‰ń‘ĺă’n•ű‰ď
1997.12.13
ź‹{
@
ŠĚd•Ď‚ɍ‡•š‚ľ‚˝‰óŽ€Ť—V‘–Ťg”Á‚Ě‚P—á
”~“c@“ń˜Y@@÷Ş@ƒŽq@@“ŒŽR@^—˘@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć344‰ń‘ĺă’n•ű‰ď
1997.12.13
ź‹{
@
Triple Peget •a‚Ě‚P—á
–Ń—˜@—LŠó@@r–؁@ËŽq@@ź–{@ç•ä@@‘ĺ˜a’JiŽq@@Žs–ě@’źŽ÷@@Œ´“c@@‘ń
‘ć344‰ń‘ĺă’n•ű‰ď
1997.12.13
ź‹{
@
–Ń“ű“ލזEC ŠO–ŃŞâ×–E‚É‚¨‚Ż‚é17ƒŔ-hydroxysteroid dehydrogenase ‚Ě”­Œť
ˆŔ“Œ@˜Đ”ü@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć‚T‰ń–Ń”Ż‰ČŠwŒ¤‹†‰ď
1997.12.13
@
@
“–‰Č‚É’u‚Ż‚é‰ß‹Ž‚R”NŠÔ‚Ě“Şčň•”ÄŒšŽčp‚ĚŒŸ“˘
ŽR“c@MK@@Š_•Ł@ł’j@@ă’n@@‹M
‘ć68‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1997.12.13
‚’Î
@
_Œo•ż•t‚Ť—V—ŁL”w‹Ř”ç•Ů‚đ—p‚˘‚˝Šç–ʐ_ŒoÄŒš‚Ěˆę—á
ź“c@@Œ’@@“Ąě@š˜a@@Ą‰Ş@@Œ’@@Š_•Ł@ł’j@@‚–؁@˝Ži
‘ć68‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1997.12.13
‚’Î
@
Xenopus ‚É‚¨‚Ż‚é’†S‘ĚŽü•Ó•¨Žż\Ź’`”’ PCM-1‚ĚƒNƒ[ƒjƒ“ƒO‚Ć‹@”\‰đÍ
‹v•Ű@—şŽĄ@@ź–{@@—T@@ź“c@‰h‰î@@ŒŽ“cłˆę˜Y@@’Ĺ–ź@L‰î
‘ć20‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď
1997.12.17
‹ž“s
@
ŹŽ™‚É”­Ç‚ľ‚˝ pityriosis lichenoides chronica
‹{–{@•üŽq@@˛–ě@‰h‹I@@‹´–{@Œö“ń@@‹gě@–M•F
‘ć327‰ń‘ĺă’n•ű‰ď
1997.2
‘ĺă
@
ŠááفC Šáâ|ŽžŠł‚ĚŽĄ—Ă‚É‚¨‚Ż‚éŒ`ŹŠO‰Č‚Ě–đŠ„
Š_•Ł@ł’j@@…–ě@´s@@×ě@@˜i@@ă’n@@‹M@@‹g—´@ŸŽq@@ź–{@@‘
‘ć‚W‰ń‹`Šá°ŽčpŒ¤‹†‰ď
1997.2.13
‘ĺă
@
ƒvƒƒsƒ‹ƒ`ƒIƒEƒ‰ƒVƒ‹‚É‚ć‚é P-ANCA, C-ANCA ŠÖ˜AŒŒŠÇ‰Š
{–@Ą”ü@@“ŒŽR@^—˘@@˛–ě@‰h‹I@@ˆéƒmăł–ž@@ŹŕVŒ’‘ž˜Y@@“c’†@‚Ü‚č@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć339‰ń‘ĺă’n•ű‰ď
1997.2.22
–žÎ
@
‘BŤ“Vávጂ̂P—á
’Ň“c@@•q@@‰Ž‹ň@_Žq@@ˆäăç’ĂŽq
‘ć339‰ń‘ĺă’n•ű‰ď
1997.2.22
@
@
PSS ŠłŽŇ‚ɍ‡•š‚ľ‚˝‘˝”­Ť”XŽî—l•a•Ď
ŽR–ź@‡Žq@@“ŒŽR@^—˘@@ŹŕVŒ’‘ž˜Y@@“c’†@‚Ü‚č@@ˆéƒmăł–ž@@˛–ě@‰h‹I@@”ÂŒŠ@@’q@@‹gě@–M•F@@‰Ş–{@Œő–L@@×ě@@˜i
ˆ¤•Q’n•ű‰ď
1997.3
ˆ¤•Q
@
Œ`ŹŠO‰Č40”N‚Ě•ŕ‚Ý‚ĆĹ‹ß‚Ě˜b‘č
Š_•Ł@ł’j
‘ć‚R‰ńă_‹Î–ąˆăŽ¨•@ˆôA‰ČŒ¤‹†‰ď
1997.3.18
ź‹{
@
ăC Œűo•”ŘœŒă‚ĚÄŒšŽž‚É—p‚˘‚é”ç•Ů‚ɂ‚˘‚Ä
Š_•Ł@ł’j
‘ć‚R‰ńŠ{Šç–Ę•â’ÔƒZƒ~ƒi[
1997.3.24
ź‹{
@
ƒuƒVƒ‰ƒ~ƒ“ iƒŠƒ}ƒ`ƒ‹j ‚Ş‘tŒ÷‚đŽŚ‚ľ‚˝ŠÖßÇŤŠŁá‚Ě‚S—á
{–@Ą”ü@@“ŒŽR@^—˘@@˛–ě@‰h‹I@@ˆéƒmăł–ž@@ŹŕVŒ’‘ž˜Y@@’†‘ş@•q–ž@@ˆî‹{@’m”ü@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć340‰ń‘ĺă’n•ű‰ď
1997.3.29
˜a‰ĚŽR
@
–ŤŠÖßƒŠƒEƒ}ƒ`‚É•š”­‚ľ‚˝‰óásŤ”^”çÇ
–Ń—˜@—LŠó@@’JŒű@—´ś@@Œ´Œł@@’ށ@@’JŠ_@••F@@‹Ęˆä@és@@“c•Ó@@˝
‘ć340‰ń‘ĺă’n•ű‰ď
1997.3.29
˜a‰ĚŽR
@
–Ń“ű“ލזE‚ɑ΂ˇ‚éƒGƒXƒgƒ‰ƒWƒI[ƒ‹‚̍ě—p
ˆŔ“Œ@˜Đ”ü@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć96‰ń“ú”ç‰ď‘‰ď
1997.4.11
‰ŞŽR
@
–Ń”ŻŹ’ˇ‚̐§Œä‹@\‚Ć’E–ŃÇ‚ĚŽĄ—Âɂ‚˘‚ā|ƒzƒ‹ƒ‚ƒ“‚𒆐S‚É i‹łˆçƒVƒ“ƒ|ƒWƒEƒ€j
”ÂŒŠ@@’q
‘ć96‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1997.4.11
‰ŞŽR
@
AŒQ XP ŠłŽŇ‚Ě“Ż•ń‚Ěˆâ“`‘Š’k‚ĆAŒQ XP ˆâ“`Žq•p“x
˛“Ą@Œ’“ń@@‘O“c@’mŽq@@“ě@@G“T
‘ć96‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1997.4.11-13
‰ŞŽR
@
ƒAƒgƒs[Ť”畆‰Š‚Ě”^’s]‚É”F‚ß‚ç‚ę‚˝AŒQ—nŒŒŤ˜A˝‹…‹Ű‚Ě‚sŒ^•Ş—Ţ
‘Ť—§@@€@@‹gě@–M•F@@‰““Ą@@ŒO@@Šp@—˛”V@@Ź“ˆ@‰vŽq@@Â–؁@•q”V@@Ÿě@çq
‘ć96‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1997.4.11-13
‰ŞŽR
@
•a—‘gD•W–{‚Ěƒ_ƒCƒŒƒNƒgƒXƒLƒƒƒ“–@@|ƒtƒBƒ‹ƒ€ƒXƒLƒƒƒi[‚đ—˜—p‚ľ‚˝’á”{—Ś‰ć‘œ
“y‹•q–ž@@ź“cŒ’Ž÷ i‘ĺă‘ĺj
‘ć96‰ń“ú–{”畆‰ČŠw‰ď‘‰ďƒRƒ“ƒsƒ…[ƒ^—˜—pŒ¤‹†‰ď
1997.4.11-13
‰ŞŽRŽs
@
ƒRƒ“ƒfƒBƒVƒ‡ƒiƒ‹ƒW[ƒ“ƒmƒbƒNƒAƒEƒg‚đ—p‚˘‚˝•\”ç×–EŒ`Ź‚É‚¨‚Ż‚é GPI-ƒAƒ“ƒJ[Œ^’`”’‚Ě–đŠ„‚ĚŒŸ“˘
’M’J@Ÿm@@ˆÉě@łl@@‰Ş•”@@Ÿ@@”ÂŒŠ@@’q@@–؉şƒ^ƒƒE@@’|“c@“ń@@‹gě@–M•F
‘ć96‰ń“ú–{”畆‰ČŠw‰ď‘‰ďEŠwp‘ĺ‰ď
1997.4.12
‰ŞŽR
@
The anabolic steroid stanozolol upregulates collagen synthesis through the action of TGF-beta1.
Falabella, A., Greenberg, A., Zhou, L., Ochoa, S., Yamaguchi, Y., Badiavas, E. and Falanga, V.
1997 Annual Meeting Society for Investigative Dermatology
1997.4.23-27
Washington DC
@
Low oxygen tension upregulates collagen synthesis and transcription through the action of TGF-beta1.
Falanga, V., Zhou, L., Ochoa, S., Murata, H., Yamaguchi, Y. and Badiavas, E.
1997 Annual Meeting Society for Investigative Dermatology
1997.4.23-27
Washington DC
@
Response to TGF-beta1 of dermal fibroblasts from TGF-beta1 knock-out mice.
Yamaguchi,Y., Zhou, L., Falabella, A., Ochoa, S., Tokuda, Y., Badiavas, E. and Falanga,V.
1997 Annual Meeting Society for@Investigative Dermatology
1997.4.23-27
Washington DC
@
Prolonged and enhanced contact sensitivity in mice with germline disruptions in CD28-B7 signaling
Asada, H., Bluestone J.A. and Katz, S. I.
58th SID
1997.4.23-27
Washington DC
@
ŠááفC Šáâ|ŽžŠł‚ĚŽĄ—Ă‚É‚¨‚Ż‚éŒ`ŹŠO‰Č‚Ě–đŠ„
Š_•Ł@ł’j@@×ě@@˜i@@ă’n@@‹M@@‹g—´@ŸŽq@@ź–{@@‘
‘ć40‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1997.4.9-11
‹{č
@
ˆŤŤ•FŽî‚Ě Late recurrenceG‰‰ńpŒă10”NˆČă‚ĹÄ”­‚ľ‚˝‚RÇ—á
‹g—´@ŸŽq@@×ě@@˜i@@Š_•Ł@ł’j@@ź–{@@‘
‘ć40‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1997.4.9-11
‹{č
@
“ŕŽ‹‹ž•â•‰şL”w‹Ř•ŮĚŽćp‚ɂ‚˘‚Ä
Ą‰Ş@@Œ’@@“Ąě@š˜a@@‚–؁@˝Ži@@–{‘˝@•üm@@Îˆä@‹`‹P@@Š_•Ł@ł’j@@×ě@@˜i@
‘ć40‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1997.4.9-11
‹{č
@
ˆŤŤ•FŽî‹^‚˘‚̔畆•a•Ď‚ɑ΂ˇ‚é Excisionel biopsy Œă‚Ě“ń‘wŤ‘ă—p”畆‚Ě—˜—p
•Ÿ“c@Œ’Ž™@@×ě@@˜i@@ă’n@@‹M@@ź–{@@‘@@‹g—´@ŸŽq@@Š_•Ł@ł’j
‘ć40‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1997.4.9-11
‹{č
@
Thymidne dinucleotides enhance repair of UV-induced DNA damage in skin
Eller, M. S., Maeda, T., et al
58‰ń SID
1997.5
@
@
Activation of p53 tumor supressor protein by thymidine dinucleotides:potential upstream regulation by the ATM gene product
Maeda, T.,Eller, M. S., et al
58‰ń@SID
1997.5
@
@
RA ‚ɍ‡•š‚ľ‚˝Ž‹vŤ—˛‹NŤg”Á
ŽR–ź@‡Žq@@“ŒŽR@^—˘@@ŹŕVŒ’‘ž˜Y@@“c’†@‚Ü‚č@@‹ŕ“c@^—@@˛–ě@‰h‹I@@ˆéƒmăł–ž@@”ÂŒŠ@@’q@@‹gě@–M•F@
‘ć341‰ń‘ĺă’n•ű‰ď
1997.5
“ňč
@
ƒXƒvƒƒtƒFƒ“‚É‚ć‚éŒőÚG”畆‰Š‚Ě‚Q—á
‹î‘ş@Œö”ü@@‘Ť—§@@€@@’J@@@Žç@@‹gě@–M•F
‘ć27‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1997.5.10-11
“Œ‹ž
@
ƒgƒjƒbƒNƒEƒI[ƒ^[’†‚ĚƒLƒj[ƒl‚É‚ć‚éŒĹ’č]‚Ě‚P—á
r–؁@ËŽq@@ˆéƒmăł–ž@@‹î‘ş@Œö”ü@@“ŒŽR@^—˘@@ŹŕVŒ’‘ž˜Y@@“c’†@‚Ü‚č@@˛–ě@‰h‹I@@”ÂŒŠ@@’q@@‹gě@–M•F@
‘ć27‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
1997.5.10-11
“Œ‹ž
@
–{–M‚ĚƒqƒgŒ‹ßŤd‰ťÇŠłŽŇ‚É‚¨‚Ż‚éˆâ“`ŽqˆŮ•Ď‚̉đÍ
ŽR‰ş—^Šé•F@@•˝ŽR@žŐŽq@@Ź—с@‰xŽq@@‹ŕ“c@^—@@‹gě@–M•F
‰Ć‘°ŤŽîᇌ¤‹†‰ď
1997.5.12
_ŒË
@
Carbamazepine iƒfƒOƒŒƒg[ƒ‹$5001j ‚É‚ć‚éŒĹ’č–ň]‚Ě‚P—á
“Ą”ö@—RŽq@@ź–{@ç•ä@@r–؁@ËŽq@@‘ĺ˜a’JiŽq
‘ć341‰ń‘ĺă’n•ű‰ď
1997.5.17
“ňč
@
A case of follicular mucinosis
–Ń—˜@—LŠó@@’JŒű@—´ś@@Œ´Œł@@’ށ@@’JŠ_@••F
‘ć341‰ń‘ĺă’n•ű‰ď
1997.5.17
“ňč
@
Rapp-Hodgkin Syndrome ‚Ě‚P—á
ŹŕVŒ’‘ž˜Y@@“ŒŽR^—˘@@‹ŕ“c^—@@ź“cŒ’Ž÷@@”ÂŒŠ@’q@@‹gě–M•F
“ú–{”畆‰ČŠw‰ď“ż“‡’n•ű‰ď
1997.5.31
“ż“‡
@
Fanconi •nŒŒŠłŽ™‚É‹}Œƒ‚ȉóásŤ•a•Ď‚đ’ć‚ľ‚˝Œ´”­Ť[ÝŤ”畆ƒAƒXƒyƒ‹ƒMƒ‹ƒXƒ“Ç
ˆî‹{@’m”ü@@“c’†@‚Ü‚č@@“cŠ@äŽk@@ˆéƒmăł–ž@@˛–ě@‰h‹I@@“ŒŽR@^—˘@@”ÂŒŠ@@’q@@‹gě@–M•F@@‚‹´@‚Ü‚č@@ť“c@~Žq
‘ć90‰ń‹ß‹E”畆‰ČW’k‰ď
1997.6
‘ĺ’Ă
@
A case of contact dermatitis due to impurities of cetyl alcohol
Komamura, H., Doi, T., Inui, S. and Yoshikawa, K.
11th International Symposium on Contact Dermatitis
1997.6.11-13
Singapore
@
Mechanism of action on androgen in human hair follicles
Melbourne
First Intercontinental meeting of Hair Research Sosieties
1997.6.11-14
Melbourne
@
Effects of androgens on human hair follicles
Itami, S.
19th World Congress of Dermatology
1997.6.15-20
Sudney
@
Tissue specific knock-out of the Pig-a gene revealed important roles of GPI-anchored proteins in skin development
Tarutani, M., Itami, S., Tezuka, T., Takeda, J. and Yoshikawa, K.
19th world congress of dermatology
1997.6.16
Sydney Australia
@
A Case with generalized vasculitis positive for anti-neurophill antibodies related to ororylthiouracil therapy
Suma, M., Higashiyama, M., Sano, S., Isonokami, M., Ozawa, K., Itami, S. and Yoshikawa, K.
‘ć19‰ń˘ŠE”畆‰Č‰ď‹c
1997.6.17
ƒVƒhƒj[
@
ŒŒŠÇ•ż•t‚Ť˜]œ‚É‚ć‚鉺Š{ÄŒšp
Š_•Ł@ł’j@@ŹŠ}Œ´@Š°@@”Ş“c@çL@@ŒI‰Ô—Žš˜a@@ăă@‰ëŽj@@×ě@@˜i
‘ć21‰ń“ú–{“Şčň•”Žîᇊw‰ď
1997.6.18-21
•Ÿ‰Ş
@
ŒŒŠÇ•ż•t‚ŤŽ¨‰îˆÚA‚É‚ć‚éčň•”‹CŠÇÄŒš‚ĚŒoŒą
Š_•Ł@ł’j@@…–ě@´s@@ŹŠ}Œ´@Š°@@ăă@‰ëŽj
‘ć68‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1997.6.21
‘ĺă
@
–Ř‘şŽ•a‚đ‹^‚Á‚˝Šáâ|“ŕŽîᇂ̂P—á
‹v•Ű@‚‹M@@×ě@@˜i@@ź–{@@‘@@‘ĺŽR@’mŽ÷@@ă’n@@‹M
‘ć68‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1997.6.21
‘ĺă
@
–Ń”Ż‚Ćƒzƒ‹ƒ‚ƒ“|ƒVƒ“ƒ|ƒWƒEƒ€–ѕ‘BŒn‚đ‰ČŠw‚ˇ‚é
”ÂŒŠ@@’q
‘ć22‰ń“ú–{Ď•iŠw‰ď
1997.6.6
“Œ‹ž
@
–{–M‚ĚƒqƒgŒ‹ßŤd‰ťÇŠłŽŇ‚É‚¨‚Ż‚éˆâ“`ŽqˆŮ•Ď‚̉đÍ
ŽR‰ş—^Šé•F@@•˝ŽR@žŐŽq@@Ź—с@‰xŽq@@‹ŕ“c@^—@@‹gě@–M•F
Medical geneticsŒ¤‹†‰ď
1997.7
_ŒË
@
“œ”A•a‚ɍ‡•š‚ľ‚˝”ńƒNƒƒXƒgƒŠƒWƒEƒ€ŤƒKƒX‰óás
{–@^Ÿ@@‰Ž‹ň@_Žq@@ˆäăç’ĂŽq@@Î‹´@@ŽĄ i‘ĺŽč‘O•a‰@ŽŒ`ŠO‰Čj
‘ć342‰ń‘ĺă’n•ű‰ď
1997.7.19
‚’Î
@
Giant axonal neuropathy ‚Ě‚P—á
’M’JŸm@@“ŒŽR^—˘@@ź“cŒ’Ž÷@@”ÂŒŠ@’q@@‹gě–M•F@@–Ń—˜ˆçŽq@@’J’r‰ëŽq@@–Fě_’j
‘ć342‰ń‘ĺă’n•ű‰ď
1997.7.19
‘ĺă
@
ŒŒŠÇ•ż•t‚ŤŽ¨‰îˆÚA‚É‚ć‚é‹CŠÇÄŒš‚Ě‚P—á
‹g“c@ĘŽq@@“s’z@Œ’ŽO@@Š_•Ł@ł’j@@ŹŠ}Œ´@Š°@@ăă@‰ëŽj@@–{‘˝@Œö—ş
‘ć126‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď•şŒÉŒ§’n•ű•”‰ď
1997.7.5
_ŒË
@
ŒűŠWŽîᇐ؏œŒă‚É—V—Ł‘O˜r”ç•Ů‚¨‚ć‚ŃŠ{‹`Ž•‚É‚ć‚čÄŒš‚ľ‚˝Ç—á
‚ˆŔ@@’č@@”Ş“c@çL@@Š_•Ł@ł’j@@ŹŠ}Œ´@Š°@@ăă@‰ëŽj@@–{“c@Œö—ş
‘ć126‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď•şŒÉŒ§’n•ű•”‰ď
1997.7.5
_ŒË
@
Langerhans cell histiocytosis ‚Ěˆę—á
ě‘ş@‰ŔŽq@@‹v–ě@–F”́@@’ҁ@@‘ě•v@@Ź—с@ł‹I@@“ě@@G“T@@›–ě@‰p’j
‘ć200‰ń“ŒŠC’n•ű‰ď
1997.7.6
–źŒĂ‰Ž
@
”畆”|—{‚Ć—Ő°‰ž—p|”|—{•\”çƒV[ƒg‚Ě—Ő°‰ž—p
“ŒŽR@^—˘@@‹gě@–M•F
‘ć15‰ń“ú–{ƒqƒg×–EŠw‰ď
1997.9.12-13
“Œ‹ž
@
”]ŒŒŠÇáŠQ‚𔺂Á‚˝’e—͐üˆŰŤ‰źŤ‰ŠFŽî‚Ě‚P—á
X“c@”ŽŽq@@“ŒŽR@^—˘@@“cŠ@äŽk@@ˆéƒmăł–ž@@ŹŕVŒ’‘ž˜Y@@”ÂŒŠ@@’q@@‹gě@–M•F@
‘ć343‰ń‘ĺă’n•ű‰ď
1997.9.13
_ŒË
@
Œz•””畆‚ɉ“Šu“]ˆÚ‚đ—ˆ‚ľ‚˝ŠO‰A•” Peget •a
{–@^Ÿ@@‰Ž‹ň@_Žq@@ˆäăç’ĂŽq@@‘q’m‹MŽu˜Y
‘ć343‰ń‘ĺă’n•ű‰ď
1997.9.13
_ŒË
@
Pseudoxanthoma elasticum ‚Ě‚P—á
X“c@”ŽŽq@@ŹŕVŒ’‘ž˜Y@@“cŠ@äŽk@@ˆéƒmăł–ž@@“ŒŽR@^—˘@@”ÂŒŠ@@’q@@‹gě@–M•F@
‘ć343‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1997.9.13
_ŒË
@
The role of notch family in keratinocyte differentiation
ŹŕVŒ’‘ž˜Y@@”ÂŒŠ@@’q@@’M’J@Ÿm@@‘O“c@—S•ă@@’|“c@“ń@@–؉şƒ^ƒƒE@@‹gě@–M•F@
‘ć22‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1997.9.3
‘ĺă
@
Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogenous IL-4.
Asada, H. and Katz, S. I.
‘ć22‰ń@“ú–{Œ¤‹†”畆‰ČŠw‰ď
1997.9.4-5
‘ĺă
@
Œ‹ßŤd‰ťÇ‚É‚¨‚˘‚Ä“ÁˆŮ“IŒ¸­‚Ş”F‚ß‚ç‚ę‚˝’`”’p40‚Ě“Ż’č
‹ŕ“c@^—@@‹gě@–M•F@@‹ŕ“c@ˆŔŽj
‘ć22‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1997.9.4-5
‘ĺă
@
UVA ĆŽË‚É‚ć‚ľś‚ś‚郊ƒ{ƒtƒ‰ƒrƒ“‚Š‚ç‚̉ߎ_‰ť…‘fś‚ĚŒo˜H
˛“Ą@Œ’“ń@@’ҁ@@‘ě•v@@“ě@@G“T
‘ć22‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1997.9.4-5
‘ĺă
@
ŠŁá––˝ŒŒE”ç]‚ɂ̓Cƒ“ƒ^[ƒtƒFƒƒ“ƒÁŽYŤ CD4, CD8×–E‚Ş‘˝‚˘
˛–ě@‰h‹I@@’†‘ş@•q–ž@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć22‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1997.9.4-5
‘ĺă
@
ƒZƒUƒŠ[×–E‚Í paracrine ‚É•Ş”ĺ‚ł‚ę‚é IL-2‚¨‚ć‚Ń IL-7‚É‚ć‚č‘B‚ˇ‚é
˛–ě@‰h‹I@@“ŒŽR@^—˘@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć22‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1997.9.4-5
‘ĺă
@
Failure to respond to exogenous TGF-beta1 of dermal fibroblasts from TGF-beta1 knock-out mice.
Yamaguchi, Y., Zhou, L. and Falanga, V.
‘ć22‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1997.9.4-5
‘ĺă
@
ƒqƒgŠO–ŃŞâ×–E‹y‚Ń–Ń“ű“ލזE‚É‚¨‚Ż‚é17ƒŔhydrogenose ‚Ě”­Œť
ˆŔ“Œ@˜Đ”ü@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć22‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1997.9.5
ă‘ĺ
@
The role of Notch family in keratinocyte differentiation.
Ozawa K, Itami S, Yoshikawa K.
ibid
1998
@
@
•\”çŠp‰ť×–E‚É‚¨‚Ż‚é STAT3‚Ě–đŠ„
˛–ě@‰h‹I
‹ăBŠî‘b”畆‰ČŒ¤‹†‰ď
1998
•Ę•{
@
”畆‘nŽĄ–ü‚É‚¨‚Ż‚é Stat3‚Ě–đŠ„
˛–ě@‰h‹I
‘nŽĄ–üƒtƒH[ƒ‰ƒ€
1998
“Œ‹ž
@
–Ťœ‘Ť”’ŒŒ•aŠłŽŇ‚É‚Ý‚ç‚ę‚˝ Hydroxyurea ‚É‚ć‚鉺‘Ú’×ᇂ̈ę—á
÷Ş@ƒŽq@@ó“c@G•v@@Źă@@”Ž@@’M’J@Ÿm@@“cŠ@äŽk@@ˆéƒmăł–ž@@”ÂŒŠ@@’q@@‹gě@–M•F@
‘ć91‰ń‹ß‹E”畆‰ČW’k‰ď
1998
•şŒÉŒ§—§Źl•aƒZƒ“ƒ^[
@
”畆’×ᇂ̐f’f‚ĆŽĄ—Ă i“Á•Ęu‰‰j
‹gě@–M•F
“ŒŠCƒvƒƒXƒ^ƒOƒ‰ƒ“ƒfƒBƒ“Œ¤‹†‰ď
1998.1.31
–źŒĂ‰Ž
@
ƒAƒgƒs[Ť”畆‰ŠŠłŽŇ––˝ŒŒ’PŠj‹…‚̉ŠFƒuƒhƒE‹…‹Ű—R—ˆŠO“Ĺ‘fŽhŒƒ‚ɑ΂ˇ‚é”˝‰žŤ‚ĚŒŸ“˘|T×–EƒAƒ|ƒg[ƒVƒX‚ĚŠÖ—^|
‹g–ě@@’@@ó“c@G•v@@˛–ě@‰h‹I@@’†‘ş@•q–ž@@”ÂŒŠ @’q@@‹gě@–M•F
‘ć49‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďŠwp‘ĺ‰ď
1998.10.10-11
_ŒË
@
‘Ť’ęánóŠŕ‚đ”­Ç‚ľ‚˝ Olmsted ÇŒóŒQ‚Ěˆę—á
ŽR–{@—˛”V@@Ź“¤ŕVG–ž@@“cŠ@äŽk@@“ŒŽR@^—˘@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć49‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďŠwp‘ĺ‰ď
1998.10.10-11
_ŒË
@
Œ´”­ŤŽˆ’[g’ÉÇ‚Ě•ę–ş—á
ŸNŞ@ƒŽq@@•ŸŒ´@˛•Ű@@˛–ě@‰h‹I@@“cŠ@äŽk@@ó“c@G•v@@”ÂŒŠ@@’q@@@‹gě@–M•F@
‘ć49‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďŠwp‘ĺ‰ď
1998.10.10-11
_ŒË
@
ŠŁáƒ‚ƒfƒ‹ƒ}ƒEƒX‚Ć‚ľ‚Ä‚Ě LIG-1ˆâ“`ŽqŒ‡‘šƒ}ƒEƒX‚̉đÍ
ŸNŞ@ƒŽq@@•ŸŒ´@˛•Ű@@˛–ě@‰h‹I@@“cŠ@äŽk@@ó“c@G•v@@”ÂŒŠ@@’q@@@‹gě@–M•F@@@‹ß“Ą@@Œş@@—é–؁@@–L@@Ź—с@‹ÓŽ @@‚–؁@@•×@
‘ć49‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďŠwp‘ĺ‰ď
1998.10.10-11
_ŒË
@
”畆‚s×–E‘BŤŽžŠł‚̐f’f‚É‚¨‚Ż‚é‚s×–EŽó—e‘ĚƒÁ˝ˆâ“`Žq‚Ě PCR-DGGE –@‚đ—p‚˘‚˝‰đÍ‚Ě—L—pŤ
’ˇ‘ň@’q•F@@”ÂŒŠ@@’q@@‹gě@–M•F@@’†’ˁ@Lˆę@@›–ě@—SK@@Âů@Ž”V
‘ć49‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďŠwp‘ĺ‰ď
1998.10.10-11
_ŒË
@
Application of cultured human keratinocytes sheet for wound repair. iPlenary Lecturej
Yoshikawa K, Higashiyama M
5th Asian Dermatol Congress
1998.10.14-17
Beijing
@
ƒqƒgłí‚¨‚ć‚Ń•a—”畆‘gD‚É‚¨‚Ż‚éƒjƒ…[ƒƒvƒVƒ“ mRNA ‚ĚÄŒť
ŒK]@ŽŽ÷@@×ě@@˜i@@ˆäă@’źŽq@@ŽR’†@”ŽŽ÷@@”ÂŒŠ@@’q@@‹g“c@ŹF@@@‰–”@’ĺ•v@@‹gě@–M•F@
‘ć‚V‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1998.10.22-23
‚ź
@
śçGüˆŰ‰č×–E‚É‚ć‚鏶çGŠO•\”ç×–E‚Ö‚ĚƒPƒ‰ƒ`ƒ“9mRNA ‚ĚÄŒť—U“ą
ŽRŒű@—TŽj@@×ě@@˜i@@”ÂŒŠ@@’q@@Œ´Œł @’ށ@@‹gě@–M•F
‘ć‚V‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1998.10.22-23
‚ź
@
śçGüˆŰ‰č×–E‚É‚ć‚鏶çGŠO•\”ç×–E‚Ö‚ĚƒPƒ‰ƒ`ƒ“9’`”’‚Ě”­Œť—U“ą
ŽRŒű@—TŽj@@×ě@@˜i@@”ÂŒŠ@@’q@@Œ´Œł @ ’ށ@@‹gě@–M•F
‘ć‚V‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1998.10.22-23
‚ź
@
Œ‹ßŤd‰ťÇ‚É‚¨‚˘‚ÄŒ¸­‚ˇ‚é’`”’p40
‹ŕ“c@^—@@‹ŕ“c@ˆŔŽj@@‹gě@–M•F
‘ć13‰ń‘ĺăƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX
1998.10.24-25
ŽOd
@
lH•GŠÖßă‚Ö‚Ě—V—Ł• ’ź‹Ř”ç•ŮˆÚAp
‘ĺ‘ş@ˆťŽq@@×ě@@˜i@@Œ´Œł@@’ށ@@‚–؁@˝Ži@@‹v•Ű@‚‹M
‘ć71‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1998.11.14
‹ž“s
@
Ž¨‰î‚Š‚ç‚Ě—V—Ł•Ą‡‘gDˆÚAp
’†“c@—mŽq@@×ě@@˜i@@Œ´Œł @’ށ@@‚–؁@˝Ži@@‹v•Ű@‚‹M
‘ć71‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1998.11.14
‹ž“s
@
Šáâ|“ŕ‘¤•Ç[•”‚Ĺ‚ĚŒ¸ˆłp‚É‚¨‚Ż‚é ROWE ‚ĚççŽq‚Ě—˜—p
’ҁ@@—˛“ń@@×ě@@˜i@@Œ´Œł@@’ށ@@‚–؁@˝Ži@@‹v•Ű@‚‹M
‘ć71‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1998.11.14
‹ž“s
@
ŠŁá^”çüˆŰ‰č×–E‚É‚¨‚Ż‚é IGF-mRNA ”­Œť‚ĚŒŸ“˘
ŽO‰Y@G”V@@“ŒŽR@^—˘@@˛–ě@‰h‹I@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć13‰ń“ú–{ŠŁáŠw‰ď
1998.11.20-21
‚ź
@
‘nŽĄ–ü‚É‚¨‚Ż‚é STAT3‚Ě–đŠ„
˛–ě@‰h‹I@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć12‰ń•\”ç×–EŒ¤‹†‰ď
1998.11.30
źŽR
@
Isolation of androgen dependent genes in dermal papilla cells from androgenetic alopecia
Taketsugu Tadokoro, Satoshi Itami, Kunihiko Yoshikawa iDepartment of Dermatology, Osaka University School of Medicine, Osaka, Japanj
Second Intercontinental Meeting of Hair Research Societies
1998.11.5-7
Washington D.C.
@
ƒAƒgƒs[Ť”畆‰ŠŠłŽŇ––˝ŒŒ’PŠj‹…‚̉ŠFƒuƒhƒE‹…‹ŰŠO“Ĺ‘fŽhŒƒ‚ɑ΂ˇ‚é”˝‰žŤ‚ĚŒŸ“˘|T×–EƒAƒ|ƒg[ƒVƒX‚ĚŠÖ—^|
‹g–ě@@’@@ó“c@G•v@@˛–ě@‰h‹I@@’†‘ş@•q–ž@@”ÂŒŠ @’q@@‹gě@–M•F
‘ć48‰ń@“ú–{ƒAƒŒƒ‹ƒM[Šw‰ď‘‰ď
1998.12.1-3
_ŒË
@
Œo‰ß’†‚ɃXƒ‹ƒtƒ@ƒƒgƒLƒTƒ][ƒ‹‚É‚ć‚é–ň]‚đ•š”­‚ľC ŽĄ—Ă‚É“ďa‚ľ‚˝qíŤ“Vávጂ̂P—á
Ÿě@–ő”V@@’M’J@Ÿm@@Ź“¤ŕVG–ž@@Ží‘ş@@“ā@@Źă@@”Ž@@ŠŁ@@dŽ÷@@“cŠ@äŽk@@ó“c@G•v@@“ŒŽR@^—˘@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺŠw”畆‰Čj@@ź–{@ç•ä@@‘ĺ˜a’JiŽq iŽs—§–Ľ–Ę•a‰@j
‘ć350‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1998.12.12
‘ĺă
@
GPI ƒAƒ“ƒJ[Œ‡‘š•\”ç‚ÉŒŠ‚ç‚ę‚éŠp‘w‚ĚˆŮíC ‹y‚ŃˆŮíŽ‰Žż‚̉đÍ
’M’J@Ÿm‚P@@”ÂŒŠ@@’q‚P@@‹gě@–M•F‚P@@–؉şƒ^ƒƒE‚Q@@“Œé@”Ž‰ë‚R@@’|“c@“ń‚S i ‚Pă‘ĺEˆăE”畆@@ ‚Q“ŻE”÷Œ¤E–Ɖu•s‘S@@ ‚R“ŻEˆăECŽm•ŞŽqś—@@@‚S“ŻEˆăECŽmŠÂ‹Ťj
‘ć21‰ń“ú–{•ŞŽqś•¨Šw‰ď
1998.12.16
‰Ą•l
@
Œ‹ßŤd‰ťÇ‚Ĺ“ÁˆŮ“I‚ÉŒ¸­‚ľ‚Ä‚˘‚é’`”’p40‚Ě‹@”\‰đÍ‡U
‹ŕ“c@^—@@‹gě@–M•F@@‹ŕ“c@ˆŔŽj
ŒúśČ“Á’莞Šł”畆Œ‹‡‘gDŽžŠł’˛¸Œ¤‹†”ǁ@_Œo”畆ÇŒóŒQ•Ş‰Č‰ď•˝Ź10”N“x‘ć‚Q‰ń‘‰ď
1998.12.18
“Œ‹ž
@
Œ‹ßŤd‰ťÇ‚ĚŠç–Ę‚ĚŒŒŠÇüˆŰŽî‚ɑ΂ˇ‚éƒ^ƒJƒ‹ƒVƒg[ƒ‹“îp‚ĚŽĄ—ĂŒř‰Ę‚ĚŒŸ“˘
‹ŕ“c@^—@@‹gě@–M•F@@Ź–ě@ŽŸ˜N
ŒúśČ“Á’莞Šł”畆Œ‹‡‘gDŽžŠł’˛¸Œ¤‹†”ǁ@_Œo”畆ÇŒóŒQ•Ş‰Č‰ď•˝Ź10”N“x‘ć‚Q‰ń‘‰ď
1998.12.18
“Œ‹ž
@
ˆâ“`ŽqŒ^‚Š‚猊‚˝ƒqƒgŒ‹ßŤd‰ťÇ‚Ě—Ő°‘œ
Ź–ě@ŽŸ˜N@@‹ŕ“c@^—@@‹gě@–M•F@@”ó–ě@‹ť•v
ŒúśČ“Á’莞Šł”畆Œ‹‡‘gDŽžŠł’˛¸Œ¤‹†”ǁ@_Œo”畆ÇŒóŒQ•Ş‰Č‰ď•˝Ź10”N“x‘ć‚Q‰ń‘‰ď
1998.12.18
“Œ‹ž
@
–эEŤgF‹u]‚đ’ć‚ľ‚˝ GVHD ‚Ě‚P—á
Ží‘ş@@“ā@@Źă@@”Ž@@“ŒŽR@^—@@“cŠ@äŽk@@ˆéƒmăł–ž@@”ÂŒŠ@@’q@@Źě@Œ[‹ą i‘ĺă‘ĺŠw‘ćŽO“ŕ‰Čj@@‹gě@–M•F i‘ĺă‘ĺŠw”畆‰Čj @@–î–ě@K—m@@‰hě@@Œ’@@
‘ć345‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1998.2.14
‘ĺă
@
ƒNƒ[ƒ“•a‚đ‡•š‚ľ‚˝‰óŽ€Ť”^”çÇ‚Ě‚P—á
‰ŹŒ´@rŽĄ@@’M’J@Ÿm@@Źă@@”Ž@@“cŠ@äŽk@@ó“c@G•v@@ˆéƒmăł–ž@@˛–ě@‰h‹I@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺŠw”畆‰Čj @@–Ř‘ş@—ł‰î@@‹ŕŕV@Ď] i‘ĺă‘ĺŠw‘ćŽO“ŕ‰Čj @
‘ć346‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1998.3.28
Š€Œ´
@
ŽŠŒČ–ƉuŤ…ávÇ‹y‚ѝG•˝‘Űᝂ̌űo•a•Ď‚ɑ΂ˇ‚é‹ÇŠ—Ă–@‚ĚŽŽ‚Ý
“c’†@‚Ü‚č@@“ŒŽR@^—˘@@ŸNŞ@ƒŽq@@”ÂŒŠ@@’q@@‹gě@–M•F@@ŒS@@FŽq@@ŽR–{@ŽŒČ@@•ě@M•v@
‘ć346‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1998.3.28
“Ţ—Ç
@
œŠOƒ†[ƒCƒ“ƒO“÷Žî‚ĚŽĄ—ĂŒoŒą
ˆÉ“Ą@@—@@‘×ˆŰ@@˜Y@@ź“c@G‘Ľ@@ŒĂŽs@_”ü@@ź‰ş@—zŽq@@ě“Y@@„@@’ˇ”ö@”üŽ÷@@˛“Ą@”üŽ÷@@×ě@@˜i
‘ć41‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1998.4.22-24
‹ž“s
@
ÔO•””ç•Ů‚đ—p‚˘‚˝‰şŒűO•”ÄŒš‚Ěˆę•ű–@
Œ´Œł @’ށ@@×ě@@˜i@@ŒŽ–ě@‹Ĺ•F@@‘ĺXŠě‘ž˜Y
‘ć41‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1998.4.22-24
‹ž“s
@
’ź’°ŘœŒă•úŽËüŽĄ—Ă‚Ě•›ě—p—\–h‚Ě‚˝‚ß‚Ě• ’ź‹Ř•Ů‚ĚŽg—p
‚–؁@˝Ži@@×ě@@˜i@@Œ´Œł@@’ށ@@‹g—´@ŸŽq@@‘ĺŽR@’mŽ÷@@‘ĺŽR@@Ži@@ˆÉ“Ą@šć‹L@@‹|ę@Œ’‹`@@ˆäă@‘P•ś
‘ć41‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1998.4.22-24
‹ž“s
@
‘ć‚P‘ć‚S’†‘Ťœ’ZkÇ‚R—á‚ĚŽĄ—ĂŒoŒą
…–ě@´s@@×ě@@˜i@@‹g—´@ŸŽq@@‰Ş–{@Œő–L@@Œ´Œł@@’ށ@@‘ĺŽR@’mŽ÷@@‚–؁@˝Ži@
‘ć41‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1998.4.22-24
‹ž“s
@
ŠOčň“Ž–ŹŒ‹ăFpŒăC ’ˇŠúŠÔŒo‰ß‚ľ‚˝“ŽĂ–ŹŠďŒ`‚Ě‚Q—á-‘¤•›ŒŒs‚ÉŠÖ‚ˇ‚éˆęlŽ@-
‘ĺŽR@’mŽ÷@@×ě@@˜i@@Œ´Œł@@’ށ@@ˆäă@Œ\“ń@@…–ě@´s
‘ć41‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1998.4.22-24
‹ž“s
@
‰äX‚̍s‚Á‚Ä‚˘‚éăŠ{ÄŒšp-•@oÄŒš–@‚ɂ‚˘‚Ä‚ĚŒŸ“˘-
“úŠ}@@šć@@–{‘˝@•üm@@“Ąě@š˜a@@Ą‰Ş@@Œ’@@×ě@@˜i
‘ć41‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1998.4.22-24
‹ž“s
@
ŽŠ‰Ć“€Œ‹•Ű‘ś–@‚đ—p‚˘‚˝“ű—Ö“ű“ލČš
–î–ě@Œ’“ń@@ź”ö@—R‹I@@×ě@@˜i
‘ć41‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠwpW‰ď
1998.4.22-24
‹ž“s
@
Induction of TR4 orphan receptor by retinoic acid in human HaCaT keratinocytes
Shigeki Inui, Yi-Fen Lee, Anne R Haake, Chawnshang Chang
University of Rochester Research Day Meeting iAwardedj
1998.5
Rochester New York
@
Šj“ŕƒI[ƒtƒ@ƒ“ƒŒƒZƒvƒ^[TR2/4‚ĚƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚é‹@”\
ŠŁ@@dŽ÷@@C-S Chang@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5
‘ĺă
@
Šç–Ę•‚ŽîC ”^áv‚𔺂Á‚˝ƒ]ƒjƒTƒ~ƒh‚É‚ć‚é–ň]‚Ěˆę—á
Ź“¤ŕVG–ž@@’M’J@Ÿm@@ˆéƒmăł–ž@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć347‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1998.5.16
‘ĺă
@
‰~Œ`’E–ŃÇ‚Ě DPCP Š´ě—Ă–@
”ÂŒŠ@@’q@@ˆŔ“Œ@˜Đ”ü@@‹g–ě@@’@@ó“c@G•v
‘ć347‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1998.5.16
‘ĺă
@
ăü–Ń–Ń“ű“ލזE‚É‚¨‚Ż‚é’jŤƒzƒ‹ƒ‚ƒ“‚ĚŠ´ŽóŤ‚ĚŒŸ“˘
ˆŔ“Œ@˜Đ”ü@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29
‘ĺă
@
”畆ƒjƒ…[ƒƒvƒVƒ“‚̖Ɖu‘gD‰ťŠw“IŒŸ“˘
ˆäă@’źŽq@@ŒK]@ŽŽ÷@@×ě@@˜i@@‹gě@–M•F@@‹g“c@ŹF@@‰–”@’ĺ•v
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
Šj“ŕƒI[ƒtƒ@ƒ“ƒŒƒZƒvƒ^[ TR2/4‚ĚƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚é‹@”\
ŠŁ@@dŽ÷@@Chang CS@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
”畆‰Č‚Ě–˘—ˆ i‰ď“ލu‰‰j
‹gě@–M•F
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
•W€ƒVƒŠ[ƒYƒAƒŒƒ‹ƒQƒ“‚É‚ć‚éƒpƒbƒ`ƒeƒXƒgŹŃ
‹î‘ş@Œö”ü@@‹gě@–M•F
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
ƒ}ƒEƒX”畆‚Ě‘nŽĄ–ü‰ß’ö‚¨‚ć‚Ń”|—{•\”ç×–E‚É‚¨‚Ż‚éƒjƒ…[ƒƒvƒVƒ“‚Ě”­Œť
ŒK]@ŽŽ÷@@–k‹g @Œő@@ˆäă@’źŽq@@â”@’ĺ•v@@‹g“c@ŹF@@×ě@@˜i@@”ÂŒŠ@@’q@@‹gě@–M•F@
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
Cre-loxP ƒVƒXƒeƒ€‚đ—˜—p‚ľ‚˝•\”çŠp‰ť×–E“ÁˆŮ“I STAT3ˆâ“`ŽqŒ‡‘šƒ}ƒEƒX‚̍쐬‚ƉđÍ iƒZƒ~ƒvƒŒƒiƒŠ[ƒŒƒNƒ`ƒƒ[j
˛–ě@‰h‹I@@’M’J@Ÿm@@”ÂŒŠ@@’q@@’|“c@“ń@@’|“c@@Œ‰@@R—ǁ@Ă’j@@‹gě@–M•F@
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
śçGüˆŰ‰č×–E‚É‚ć‚éƒPƒ‰ƒ`ƒ“9‚Ě—U“ą
ŽRŒű@—TŽj@@”ÂŒŠ@@’q@@’M’J@Ÿm@@‹gě@–M•F
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
dÇ‹Ř–ł—͏ǂ¨‚ć‚ŃŒă• –ŒŽîᇂ𔺂Á‚˝ paraneoplastic pemphigus ‚Ě‚Q—á
ź‘ş@‰ëŒb@@“ŒŽR@^—˘@@Ź“¤ŕVG–ž@@’ˇ‘ň@@•F@@“y‹@•q–ž@@ˆéƒmăł–ž@@”ÂŒŠ@@’q@@‹gě@–M•F@@ˆî‹{@’m”ü@@‹´–{@@—˛@@Anhalt GJ.@
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
ŠˆŤŽ_‘f‚É‚ć‚é”畆–ƉuŒn‚̏Cü
’†‘ş@•q–ž@@Streilein JW. ŒI–{@@ŠŢ@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
H“š‹ˇó‚𐜂ś‚˝á­Ť—Ţ“Vávጂ̂P—á
“c’†@‚Ü‚č@@“ŒŽR@^—˘@@ŽR–ź@‡Žq@@ˆéƒmăł–ž@@‹gě@–M•F@@ŽR“c“O‘ž˜Y@@‹´–{@@—˛
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
Kindler ÇŒóŒQ‚Ě‚P—á
“ŒŽR^—˘@@ˆéƒmăł–ž@@˛–ě‰h‹I@@ź“cŒ’Ž÷@@”ÂŒŠ@’q@@‹gě–M•F@@{–Ą”ü@@­“cŒjŽq
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
”|—{×–E‘nƒ‚ƒfƒ‹‚É‚¨‚Ż‚é‘n–ĘŽ_‘f”Z“x‚Ě‘Ş’č
“ż“c@ˆŔF@@Crane S, Zhou L, Badiavas E,@@‘ş“c@@_@@Ö“c@r–ž@@ŽRŒű@—TŽj@@Falanga V
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
˜V‰ť‚Ćƒzƒ‹ƒ‚ƒ“
”ÂŒŠ@@’q
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
ƒCƒ“ƒ^[ƒlƒbƒg‚đ—˜—p‚ľ‚˝‰“Šu’nf’fŽx‰‡ƒVƒXƒeƒ€
“y‹•q–ž‚P@@ź“cŒ’Ž÷‚P@@•“c@—T‚Q@@‰Ş‘şF’j‚R@@Œ“Œő@–]‚S@@—ΐě˜ad‚T@@Vˇ‰p˘‚U@@‹´–{Œö“ń‚U@@iă‘ĺ‚P@@ă‘ĺˆă—Ïî•ń•”‚Q@@ƒ}ƒ‹ƒ`ƒƒfƒBƒAƒVƒXƒeƒ€Ž–‹Ć‹Ś“Ż‘g‡‚R@@ˆ¤•QŒ§–k‰F˜aŒSź–ě’Ź‘–ŻŒ’N•ŰŒŻ’†‰›f—ÏŠ•a‰@‚S@@Žs—§‰F˜a“‡•a‰@‚T@@ˆ¤•Q‘ĺ‚Uj
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ďƒRƒ“ƒsƒ…[ƒ^—˜—pŒ¤‹†‰ď
1998.5.29-31
‘ĺă
@
’Pƒ‰ťŠw•¨Žż‚Ɣ畆–Ɖu
ó“c@G•v@@Katz SI
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.29-31
‘ĺă
@
GPI-ƒAƒ“ƒJ[Œ^’`”’Œ‡‘š•\”ç‚ÉŒŠ‚ç‚ę‚éˆŮíŽ‰Žż‚̉đÍ
’M’J@Ÿm@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺj @@–؉şƒ^ƒƒE i“Ż”÷Œ¤j@@ˆđě@ŒşŽŁ i‰Ô‰¤j@@’|“c@“ń i“ŻCŽmŠÂ‹ŤˆăŠwj @@“Œé@”Ž‰ë i“ŻCŽm•ŞŽqś—‰ťŠwj @@‚–؁@@–L @@
‘ć97‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1998.5.30
‘ĺă
@
Regulation of mad family member expression and effects of vitamin D on human kerationcyte differentiation.
Kubayashi T, Squillace K, Pittelkow MR.
International Investigative Dermatology
1998.5.7-10
Cologne iGermanyj
@
Exposure of human dermal fibroblasts to a fibrin gel matrix downregulates aliEjprocollagen transcription.
Crene S, Zhou L, Yamaguchi Y, Ochoa S, Badiavas E, Falanga V.
Third IID Meeting
1998.5.7-10
Colonge
@
Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication : correction with fibronectin and foctor E cross-linking.
Falabella A, Weiss E, Crane S, Yamaguchi Y, Falanga V.
Third IID Meeting
1998.5.7-10
Colonge
@
Induction of keratin 9 in non-palmoplantar keratinocytes by palmoplantar fibroblasts at mRNA levels.
Yamaguchi Y, Itami S, Ando Y, Tarutani M, Hosokawa K, Yoshikawa K.
Third IID Meeting
1998.5.7-10
Colonge
@
Human herpesvirus 6 iHHV6j infects dendritic cells iDCj and suppresses HIV replication in co-infected cultures
Asada H, Klaus-Kovtun V, Golding H, Katz SI, Blauvelt A
International Investigative Dermatology
1998.5.7-10
Cologne, Germany
@
–Ťœ‘Ç”’ŒŒ•aŠłŽŇ‚É‚Ý‚ç‚ę‚˝ Hydroxyurea ‚É‚ć‚鉺‘Ú’×ᇂ̂P—á
ŸNŞ@ƒŽq@@ó“c@G•v@@‘ź‚U–ź
‘ć91‰ń‹ß‹E”畆‰ČW’k‰ď
1998.6
_ŒË
@
“ŤŒűoˆô“ŞŽîᇂɂć‚éˆô“Ş‹ˇó‚ɑ΂ľ—V—Ł‘O˜r”ç•Ů‚É‚ć‚éÄŒš‚đs‚Á‚˝ˆęÇ—á
ˆäă@Œ\“ń@@×ě@@˜i@@Œ´Œł @’ށ@@‘ĺŽR@’mŽ÷@@‚–؁@˝Ži@@‰Í‡Œ’ˆę˜Y
‘ć70‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1998.6.13
‘ĺă
@
čň•”Šf´pŒă Horner ÇŒóŒQ‚đ‚Ť‚˝‚ľ‚˝ˆę—á
‰Í‡Œ’ˆę˜Y@@×ě@@˜i@@‘ĺŽR@’mŽ÷@@Žs–ě@’źŽ÷
‘ć70‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1998.6.13
‘ĺă
@
ŠO‚ĆŽčp‚É‚ć‚é•@•ĎŒ`‚P—á‚ĚŽĄ—ĂŒoŒąF‘¤–e‚đdŽ‹‚ľ‚˝•@Œ`Źp
Œ´Œł @’ށ@@‘ĺŽR@’mŽ÷@@‚–؁@˝Ži@@×ě@@˜i@@ŒŽ–ě@‹Ĺ•F
‘ć70‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1998.6.13
‘ĺă
@
ƒPƒƒCƒh‚đ‡•š‚ľ‚˝ ‚qubinstein-Taybi ÇŒóŒQ‚Ěˆę—á
‚–؁@˝Ži@@×ě@@˜i@@Œ´Œł @’ށ@@‘ĺŽR@’mŽ÷@@…–ě@´s
‘ć70‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
1998.6.13
‘ĺă
@
–Ťœ‘Ť”’ŒŒ•aŠłŽŇ‚É‚Ý‚ç‚ę‚˝ Hydroxyurea ‚É‚ć‚鉺‘Ú’×ᇂ̈ę—á
÷Ş@ƒŽq@@ó“c@G•v@@Źă@@”Ž@@’M’J@Ÿm@@“cŠ@äŽk@@ˆéƒmăł–ž@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺŠw”畆‰Čj
‘ć91‰ń‹ß‹E”畆‰ČW’k‰ď
1998.6.14
_ŒË
@
–{–M‚ĚƒqƒgŒ‹ßŤd‰ťÇŠłŽŇ‚É‚¨‚Ż‚錴ˆöˆâ“`Žq TSC‚P‚¨‚ć‚Ń TSC‚Q‚̉đÍ
ŽR‰ş—^Šé•F@@•˝ŽR@žŐŽq@@Ź—с@‰xŽq@@Ź—с@•q”V@@‹ŕ“c@^—@@‹gě@–M•F@@Ź–ě@ŽŸ˜N@@”ó–ě@‹ť•v
‰Ć‘°ŤŽîᇌ¤‹†‰ď
1998.6.27
“Œ‹ž
@
“ú–{ŒőˆăŠwEŒőś•¨Šw‰ď@20”N‚đU‚č•Ô‚Á‚Ä
‹gě@–M•F
‘ć20‰ńŒőˆăŠwEŒőś•¨Šw‰ď
1998.7.18-19
ŒF–{
@
ƒ`ƒ~ƒWƒ“ƒkƒNƒŒƒIƒ`ƒh‚É‚ć‚é DNA C•œ‚Ě‘Łi
‘O“c@’mŽq@@Eller MS, Gilchrest BA@@‹gě@–M•F
‘ć20‰ńŒőˆăŠwEŒőś•¨Šw‰ď
1998.7.18-19
ŒF–{
@
ŽŠŒČ–ƉuŤ…ávÇ‚ĚŒűo”S–Œ•a•Ď‚ɑ΂ˇ‚é‹ÇŠŽĄ—Ă‚ĚŽŽ‚Ý
“ŒŽR@^—˘@@“c’†@‚Ü‚č@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć20‰ń…ávÇŒ¤‹†‰ď
1998.7.30
ŽD–y
@
ŠO‰Č“IŽĄ—Ă‚Ş‘tŒ÷‚ľ‚˝‰ť”^ŤŠž‘B‰Š‚Ě‚P—á
X“c@”ŽŽq@@’M’J@Ÿm@@Źă@@”Ž@@“cŠ@äŽk@@‹gě@–M•F i‘ĺă‘ĺŠw”畆‰Čj @‚–؁@˝Ži i‘ĺă‘ĺŠwŒ`ŹŠO‰Čj @@”Ą–ě@@“N i”Ş”öŽs—§•a‰@”畆‰Čj @@@@@@@
‘ć348‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1998.7.4
‘ĺă
@
–Ú‚ĹŒŠ‚éŒ`ŹŠO‰Č i“Á•Ęu‰‰j
×ě@@˜i
‘ć58‰ńă_’n‹ćŽ¨•@ˆôA‰Čˆă‰ď
1998.8.1
ź‹{
@
śçGüˆŰ‰č×–E‚É‚ć‚éƒPƒ‰ƒ`ƒ“9‚Ě—U“ą
ŽRŒű@—TŽj@@”ÂŒŠ@@’q@@’M’J@Ÿm@@‹gě@–M•F
‘ć13‰ńŠp‰ťÇŒ¤‹†‰ď
1998.8.8
“Œ‹ž
@
GPI-ƒAƒ“ƒJ[Œ‡‘š•\”ç‚ÉŒŠ‚ç‚ę‚éˆŮíŽ‰Žż‚̉đÍ
’M’J@Ÿm@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺj @@–؉şƒ^ƒƒE i“Ż”÷Œ¤j@@’|“c@“ń i“ŻCŽmŠÂ‹ŤˆăŠwj @@“Œé@”Ž‰ë i“ŻCŽm•ŞŽqś—‰ťŠwj @@‚–؁@@–L@@ˆđě@ŒşŽŁ i‰Ô‰¤j
‘ć13‰ńŠp‰ťÇŒ¤‹†‰ď
1998.8.8
“Œ‹ž
@
ŠŁá‚Ć•a‘ƒŠ´ő i“Á•Ęu‰‰j
‹gě@–M•F
ˆ¤’mŒ§”畆‰Čˆă‰ďŠwpu‰‰‰ď
1998.8.8
–źŒĂ‰Ž
@
ánó‰ŠFŽî iVerucciform Xanthomaj ‚đ‡•š‚ľ‚˝—ňŤ‰h—{áŠQŒ^ć“VŤ•\”琅ávÇ‚Ě‚P—á
Ź“¤ŕVG–ž@@“ŒŽR@^—˘@@“cŠ@äŽk@@ó“c@G•v@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺj @@{–@Ą”ü i‘ĺŽč‘O•a‰@j @
‘ć349‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1998.9.19
‘ĺă
@
ŽŠŒČ–ƉuŤ…ávÇ‚ĚŒűo”S–Œ•a•Ď‚ɑ΂ˇ‚é‹ÇŠŽĄ—Ă
“ŒŽR@^—˘@@“c’†@‚Ü‚č@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć349‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1998.9.19
‘ĺă
@
—˛‹NŤ‹‘ĺŠç–Ę’PƒŤŒŒŠÇŽî‚Ě‚P—á
‰Ş–{@Œő–L@@“úŠ}@@šć@@–{‘˝@•üm@@×ě@@˜i
‘ć16‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď
1998.9.24-25
ŽD–y
@
Œ‹ßŤd‰ťÇŠłŽŇ—R—ˆ”|—{×–E‚ĆƒGƒ“ƒhƒTƒCƒg[ƒVƒX
‹ŕ“c@^—@@‹gě@–M•F
•˝Ź10”N“x‘ć‚P‰ńŒúśČ“Á’莞Šł”畆Œ‹‡‘gDŽžŠł’˛¸Œ¤‹†”ǁ@_Œo”畆ÇŒóŒQ•Ş‰Č‰ď
1998.9.4
“Œ‹ž
@
–{–M‚ĚƒqƒgŒ‹ßŤd‰ťÇŠłŽŇ‚É‚¨‚Ż‚éˆâ“`Žq•ĎˆŮ
ŽR‰ş—^Šé•F@@^“ˆ@Bˆę@@“ú–ě@‹ť•v@@‹ŕ“c@^—@@‹gě@–M•F@@Ź–ě@ŽŸ˜Y
•˝Ź10”N“x‘ć‚P‰ńŒúśČ“Á’莞Šł”畆Œ‹‡‘gDŽžŠł’˛¸Œ¤‹†”ǁ@_Œo”畆ÇŒóŒQ•Ş‰Č‰ď
1998.9.4
“Œ‹ž
@
”畆‰Č‚Ě–˘—ˆ‚đŒŠ‚Â‚ß‚Ä i“Á•Ęu‰‰j
‹gě@–M•F
‘ć10‰ńŽ­Ž™“‡’n‹ć”畆ŽžŠł•a‘ÔŽĄ—ĂŒ¤‹†‰ď
1998.9.6
Ž­Ž™“‡
@
ƒƒLƒVƒXƒƒ}ƒCƒVƒ“‚̓Aƒ“ƒhƒƒQƒ“ƒŒƒZƒvƒ^[EƒRƒAƒNƒeƒBƒx[ƒ^[ ARA55‚̍‚”­Œť‰ş‚ōRƒAƒ“ƒhƒƒQƒ“ě—p‚đŽ‚Â
ŠŁ@@dŽ÷@@’†“‡@•”V@@•Ÿ—˘@—zŽq@@‹gě@–M•F@@”ÂŒŠ@@’q
‘ć‚Q‰ń@”畆ƒ}ƒNƒƒ‰ƒCƒhŒ¤‹†‰ď
1999
@
@
Œ‹ßŤd‰ťÇ‚É‚¨‚˘‚Ä“ÁˆŮ“I‚ÉŒ¸­‚ˇ‚é’`”’p40‚Ě‹@”\‰đÍ‚Q
‹ŕ“c@^—@@‹gě@–M•F iă‘ĺj @@‹ŕ“c@ˆŔŽj iă‘ĺˆâ“`ŽqŽĄ—Áj
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ǁ@•˝Ź10”N“x‘ć‚Q‰ń‘‰ď
1999.1
@
@
Œ‹ßŤd‰ťÇ‚ĚŽĄ—Ă‚Ěˆ×‚ĚŠî‘b“IŒ¤‹†|p40‚ĚŠÖ—^|
‹ŕ“c@^—@@‹gě@–M•F@@‹ŕ“c@ˆŔŽj
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ǁ@•˝Ź11”N‘ć‚P‰ń‘‰ď
1999.1
@
@
–Ú‚ĹŒŠ‚éŒ`ŹŠO‰Č i“Á•Ęu‰‰j
×ě@@˜i
•şŒÉŒ§•a‰@–ňÜŽt‰ď‘ć‚S‰ńź‹{Žx•”—á‰ď iˆ°‰Žj
1999.1.22
ˆ°‰Ž
@
Hair Growth Control Educational Lecture
”ÂŒŠ@@’q
11th Korea-Japan Joint Meeting of Dermatology
1999.10.11-12
Kyongju, Korea
@
dÇƒAƒgƒs[Ť”畆‰Š‚É‚¨‚Ż‚éT×–EƒAƒ|ƒg[ƒVƒX‚ĚŠÖ—^
ó“c@G•v@@‹g–ě@@’@@˛–ě@‰h‹I@@’†‘ş@•q–ž@@”ÂŒŠ@@’q@@‹gě@–M•F
“ú–{ƒAƒŒƒ‹ƒM[Šw‰ď‘‰ď
1999.10.18-20
L“‡
@
’˜–ž‚Č•‚ŽîŤg”Á‚Ɛ…áv‚𔺂Á‚˝”畆‹Ř‰Š‚Ěˆę—á
’†X@@ˆť@@ŒI–{@@ŠŢ@@ŽRŒű@—TŽj@@‹g—ǁ@ł_@@Źă@@”Ž@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺj @@‘“c@‘ĺě@@ŠŰŽR@‹Mś@@ŽR‰ş@Ă–ç@@źŕV—CŽŸ i“Ż@‘ć“ń“ŕ‰Čj
355‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
1999.10.2
–Ľ–Ę
@
•\”çŠp‰ť×–E‚É‚¨‚Ż‚é STAT3‚Ě–đŠ„
‚–؁@˝Ži@@×ě@@˜i@@˛–ě@‰h‹I@@”ÂŒŠ@@’q@@‹g—ǁ@ł_@@‹gě@–M•F@’|“c@“ń
‘ć‚W‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1999.10.28-29
“Œ‹ž
@
•\”ç×–E‚ĚŠˆŤ‰ť‚ÉŠÖ‚ˇ‚é‘S‘wA”çC •Ş‘wA”ç‹y‚Ń•\”çƒV[ƒgˆÚA‚Ě”äŠr
ŽRŒű@—TŽj@@”ÂŒŠ@@’q@@×ě@@˜i@@˛–ě@‰h‹I@@’M’J@Ÿm@@‰Í‡Œ’ˆę˜Y@@…–ě@´s@@Œ´Œł@@’ށ@@‚–؁@˝Ži@@‘ĺŽR@’mŽ÷@@‹gě@–M•F@
‘ć‚W‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď
1999.10.28-29
“Œ‹ž
@
‘ŚŽžŒ^ƒAƒŒƒ‹ƒM[‹y‚ѐڐG”畆‰Š‚đ’ć‚ľ‚˝ƒjƒ“ƒjƒNƒAƒŒƒ‹ƒM[‚Ěˆę—á
”~“c@“ń˜Y@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺj
‘ć51‰ń“ú–{”畆‰ČŠw‰ďź•”Žx•”‘‰ď
1999.10.30
Ž­Ž™“‡
@
Synergistic Effects of Androgen and PKC on Tyrosinase Activities in Human Genital Melanocytes
Taketsugu Tadokoro, Satoshi Itami, Kunihiko Yoshikawa, Vincent J Hearing
‘ć17‰ń‘ŰF‘f×–EŠw‰ď
1999.10.30-11.13
–źŒĂ‰Ž
@
–ŃŽüŠú‚Ě’˛ß‚ÉŠÖ‚í‚é“]ŽĘˆöŽqƒVƒ“ƒ|ƒWƒEƒ€[–Ń”Żś•¨Šw‚̐ś‰ťŠw
”ÂŒŠ@@’q
‘ć72‰ńś‰ťŠw‰ď
1999.10.6-9
‰Ą•l
@
’jŤŒ^’E–Ńƒ‚ƒfƒ‹“Ž•¨ iƒxƒjƒKƒIƒUƒ‹j ‚ɑ΂ˇ‚éRƒAƒ“ƒhƒƒQƒ“ÜRU58841ŠO—p‚ĚŽŽ‚Ý‚Ć‚ť‚̍ě—pƒƒJƒjƒYƒ€‚̉đÍ
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@‹gě@–M•F@@Huei-Ju Pan@@Chawnshang Chang@@‰F–ě@G•v
‘ć‚V‰ń@–Ń”Ż‰ČŠwŒ¤‹†‰ď
1999.11
ŽRŒ`
@
ƒPƒ‰ƒ`ƒmƒTƒCƒg‚ɑ΂ˇ‚鎊ŒČT×–E‚Ě”˝‰žŤ
Ź“¤ŕVG–ž@@Źă@@”Ž@@Gao, Xing-Hua, ”ÂŒŠ@@’q@@‹gě@–M•F
‘ć29‰ń@“ú–{–ƉuŠw‰ď
1999.12.1-3
‹ž“s
@
––˝“Ž–Ź‚Ě•ÂÇ‚đ”ş‚Á‚˝DŽ_‹…‘‘˝Ç
Šâˆä@ç‰Ř@@ŠŁ@@dŽ÷@@ŒI–{@@ŠŢ@@’M’J@Ÿm@@Źă@@”Ž@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺŠwj @@•ŸŒ´@˛•Ű iŽs—§–Ľ–Ę•a‰@j @@‹gˆä@”ü i‘—§‹ž“s•a‰@j@@˛“Ą@Kl@@źˆä@”ü–G iŒ§—§“ňč•a‰@j @
‘ć356‰ń‘ĺă’n•ű‰ď
1999.12.4
_ŒË
@
Šç–Ę‚ĚÄ”­Ť‰óásŤ‹u]‚𔺂Á‚˝č÷—ąƒŠƒ“ƒp‹…‘BÇŠłŽŇ‚ć‚č•Ş—Ł‚ľ‚˝EBƒEƒCƒ‹ƒXŠ´őNK/T×–E‚̉đÍ iƒe[ƒ}‰‰‘čj
ó“c@G•v@@ˆŔ“Œ@˜Đ”ü@@”ÂŒŠ@@’q@@‹gě@–M•F@@‰Ş“c“Ţ’ĂŽq
‘ć356‰ń‘ĺă’n•ű‰ď
1999.12.4
_ŒË
@
Centriolar Satellite ‚Í”÷ŹŠÇˆË‘śŤ‚É—A‘—‚ł‚ę‚éV‹K”ń–ŒŒnƒIƒ‹ƒKƒlƒ‰‚Ĺ‚ ‚é
‹v•Ű@—şŽĄ@@˛X–Ř”Ž”V@@‹v•Ű i‹|ęj ˆŸ‹IŽq@@ŒŽ“cłˆę˜Y@@’Ĺ–ź@L”V
ERATOŒŽ“c×–EŽ˛ƒvƒƒWƒFƒNƒg@@‹ž‘ĺˆă•ŞŽq×–Eî•ńŠw@@ă‘ĺˆă”畆‰ČŠw@@ŽœŒbˆă‰đ–UŠw@@‘ć22‰ń“ú–{•ŞŽqś•¨Šw‰ď
1999.12.7-10
•Ÿ‰Ş
@
GPI-ƒAƒ“ƒJ[Œ^’`”’Œ‡‘š•\”ç‚ĚŠp‘w‚É‚¨‚Ż‚éˆŮíŽ‰Žż‚̉đÍ
’M’J@Ÿm@@”ÂŒŠ@@’q@@‹gě@–M•F@@–؉şƒ^ƒƒE@@“Œé@”Ž‰ë@@’|“c@“ń
‘ć22‰ń“ú–{•ŞŽqś•¨Šw‰ď
1999.12.9
•Ÿ‰Ş
@
Stat3Œ‡Ž¸•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚̐ڒ…”Á ‚É‚¨‚Ż‚éƒ`ƒƒVƒ“ƒŠƒ“Ž_‰ťƒVƒOƒiƒ‹‚Ě ˜´i
‹g—ǁ@ł_@@˛–ě@‰h‹I@@”ÂŒŠ@@’q@@‚–؁@˝Ži@@ŽRŒű@—TŽj@@’M’J@Ÿm@@’|“c@“ń@@‹gě@–M•F
‘ć22‰ń“ú–{•ŞŽqś•¨Šw‰ď
1999.12.9-10
•Ÿ‰Ş
@
Time Trends of Incidence for Cutaneous Melanoma Among the Japanese Population:an Analysis of Osaka Cancer Registry Date, 1964-95
Hideo Tanaka, Hideaki Tsukuma, Satoshi Tomita, Wakiko Ajiki, Takako Kitagawa, Noriko Kinoshita, Kunihiko Yoshikawa, and Akira Oshima
International Workshop on the Health Effects of Ultraviolet Radiation
1999.2.17-19
“Œ‹ž
@
f’f—áFPemphigus herpetiformis
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@•ŸŒ´@˛•Ű@@’M’J@Ÿm@@“y‹@•q–ž@@‹gě@–M•F
‘ć140‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
1999.3
‘ĺă
@
Granular cell tumor ‚Ě‚P—á
ŸNŞ@ƒŽq@@r–؁@ËŽq@@‘ź‚Q–ź
‘ć352‰ń‘ĺă’n•ű‰ď
1999.3
@
@
ƒEƒCƒ‹ƒXŤ”畆ŽžŠł‚ɑ΂ˇ‚é OK-432‹Ç’‚¨‚ć‚є牺’ŽË—Ă–@FŹŃ‚Ě‚Ü‚Ć‚ß
ŠŁ@@dŽ÷@@ó“c@G•v@@‹{–{@•üŽq@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć352‰ń“ú”ç‰ď‘ĺă’n•ű‰ď iź’†Ź_‹łŽö‘ŢŠŻ‹L”OŠw‰ďFƒe[ƒ}‰‰‘čj
1999.3
˜a‰ĚŽR
@
”畆‚Ě‹@”\E–đŠ„E“ÁŤ
“y‹@•q–ž i‘ĺă‘ĺj
‘ć15‰ń“ú–{‹`Žˆ‘•‹ďŠw‰ďƒZƒ~ƒi[
1999.3.20-21
_ŒË
@
”畆‚ĚŽžŠł i‹`Žˆ‘•‹ď‚Ě‘•’…‚É‚ć‚é‚ŕ‚̂𒆐S‚Ɂj
“y‹@•q–ž i‘ĺă‘ĺj
‘ć15‰ń“ú–{‹`Žˆ‘•‹ďŠw‰ďƒZƒ~ƒi[
1999.3.20-21
_ŒË
@
–Ťœ‘’P‹…Ť”’ŒŒ•a iCMMoLj ‚É”ş‚Á‚˝ Sweet •a‚Ě‚P—á
Ź“¤ŕVG–ž@@ó“c@G•v@@’M’J@Ÿm@@’ˇ‘ň@’q•F@@˛–ě@‰h‹I@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺ”畆‰Čj @@ŽRéŒŤ‘ž˜Y@@ă“c@Žü“ń iŒŒ‰tEŽîᇓŕ‰Čj @Âů@Ž”V i•a—•a‘ÔŠwj @@
ě’n•ű‰ď
1999.3.22
‚ź
@
ƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚˘‚ÄŠj“ŕƒI[ƒtƒ@ƒ“ƒŒƒZƒvƒ^[ TR4‚̓Œƒ`ƒmƒCƒ“Ž_‚ĚƒlƒKƒeƒBƒuƒtƒB[ƒhƒoƒbƒNƒŒƒMƒ…ƒŒ[ƒ^[‚Ć‚ľ‚Ä“­‚­
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@‹gě@–M•F@@Anne R Haake@@Lowell A Goldsmith@
‘ć98‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1999.4
“Œ‹ž
@
Œ‹ßŤd‰ťÇ‚Ěˆâ“`ŽqŒ^‚Ć—Ő°Çó
‹ŕ“c@^—@@‹gě@–M•F@@Ź–ě@ŽŸ˜N@@ŽR‰ş—^Šé•F@@ŁŽR@–M–ž@@”ó–ě@‹ť•v
‘ć99‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1999.4
@
@
–Ń“ű“ލזE‚É‚¨‚Ż‚é IgF-1mRNA ‚Ě”­Œť‚ɑ΂ˇ‚éƒ~ƒmƒLƒVƒWƒ‹‚̉e‹ż
ˆŔ“Œ@˜Đ”ü@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć98‰ń“ú”ç‰ď‘‰ď
1999.4.11
“Œ‹ž
@
STAT3ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚É‚¨‚Ż‚é”畆‘nŽĄ–ü’x‰„‚Ě‹@\
˛–ě@‰h‹I@@”ÂŒŠ@@’q@@ŽO‰Y@G”V@@’M’J@Ÿm@@’|“c@“ń@@‹gě@–M•F
‘ć98‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1999.4.9
“Œ‹ž
@
dÇƒAƒgƒs[Ť”畆‰ŠŠłŽŇ––˝ŒŒ’PŠj‹…‚̉ŠFƒuƒhƒE‹…‹ŰŠO“Ĺ‘fŽhŒƒ‚ɑ΂ˇ‚é ”˝‰žŤ‚̒ቺ@|T×–EƒAƒ|ƒg[ƒVƒX‚ĚŠÖ—^|
‹g–ě@@’@@ó“c@G•v@@˛–ě@‰h‹I@@’†‘ş@•q–ž@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć98‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1999.4.9-11
“Œ‹ž
@
ˆŮŠŤ•\”ç|^”ç‘ŠŒÝě—p‚đ‰ž—p‚ľ‚˝‘Ť’ę”畆Œ‡‘š‘n‚Ö‚Ě•\”çˆÚA‚É‚ć‚鏶çGŒ^”畆‚Ě—U“ą
ŽRŒű@—TŽj@@”ÂŒŠ@@’q@@’M’J@Ÿm@@ó“c@G•v@@˛–ě@‰h‹I@@×ě@@˜i@@‹gě@–M•F@
‘ć98‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1999.4.9-11
“Œ‹ž
@
ƒqƒgƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚UŒ^‚ĚŽ÷ó×–E‚Ö‚ĚŠ´ő‚Ć HIV ‘B—}§Œř‰Ę
ó“c@G•v@@‹gě@–M•F@@Katz SI@@Blauvelt A
‘ć98‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1999.4.9-11
“Œ‹ž
@
ƒƒ`ƒ‹ƒƒ^ƒNƒŠƒ‹Ž_‚É‚ć‚鎕‰ČˆăŽt‚ĚŽč‚̐ڐG”畆‰Š
“ú–ě“Ţ•ŰŽq@@“y‹@•q–ž@@•x“c@@’q@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺj
‘ć98‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
1999.4.9-11
“Œ‹ž
@
FlashPix ‚đ—p‚˘‚˝‰ć‘œƒf[ƒ^ƒx[ƒX‚̔畆‰Čf—ĂŒťę‚ւ̉ž—p
“y‹•q–ž@@ź“cŒ’Ž÷ i‘ĺă‘ĺj @@ź‘şŠě‹v’j i‚ ‚ł‚Ѝ‚‘ŹˆóüKKj@@‰Ş–{@‘× iKKƒNƒCƒbƒNƒXj @@‚‹”ވę˜Y i“ŒŠCƒ\ƒtƒgKKj @@
‘ć98‰ń“ú–{”畆‰ČŠw‰ď‘‰ďƒRƒ“ƒsƒ…[ƒ^—˜—pŒ¤‹†‰ď
1999.4.9-11
“Œ‹ž
@
Stat3 is required for skin remodeling
S.Sano, S.Itami, M.Kira, S.Takagi, Y.Yamaguchi, M.Tarutani, J.Takeda, K.Yoshikawa
60th Annual Meeting The Society for Investigative Dermatology
1999.5-9
Chicago
@
Coordinate Regulation of EGF-Related Growth Factor Expression and EGF receptor Activation by1,25-dihydroxyvitamin D3 in Human Keratinocytes.
Teruaki Kobayashi
60th Annual Meeting The Society for Investigative Dermatology
1999.5-9
Chicago
@
Induction of keratin 9 in non-palmoplantar keratinocytes by palmoplantar fibroblasts through mesenchymal-epithelial interactions.
Y Yamaguchi, S Imami, M Tarutani, K Hosokawa, K Yoshikawa
60th Annual Meeting The Society for Investigative Dermatology
1999.5.10
Chicago
@
Impaired responses of mononuclear cells to staphylococcal superantigen in patients with severe atopic dermatitis. A role of T-cell apoptosis
Asada H, Yoshino T, Sano S, Nakamura T, Itami S, Yoshikawa K
60th Annual Meeting The Society for Investigative Dermatology
1999.5.5-9
Chicago
@
Induction of TR4 orphan receptor by retinoic acid in human HaCaT keratinocytes
Shigeki Inui, Satoshi Itami, Anne R Haake, Lowell A Goldsmith, Kunihiko Yoshikawa, Chawnshang Chang
60th Annual Meeting The Society for Investigative Dermatology
1999.5.5-9
Chicago
@
H“š•a•Ď‚𔺂Á‚˝ IgA “VáváŒ
ŠŁ@@dŽ÷@@•ŸŒ´@˛•Ű@@”ÂŒŠ@@’q@@’M’J@Ÿm@@“y‹@•q–ž@@‹gě@–M•F
‘ć92‰ń‹ß‹E”畆‰ČW’k‰ď
1999.6
‘ĺă
@
TSC2ŠˆŤ‚Ć endocytosis ”\‚Ě‘ŠŠÖ
‹ŕ“c@^—@@‹gě@–M•F
‘ć24‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1999.7
@
@
|Ž_ƒNƒƒ‹ƒ}ƒWƒmƒ“ iƒvƒƒXƒ^[ƒ‹$5001j ‚É‚ć‚é–ň]‚Ě‚P—á
ŸNŞ@ƒŽq@@ź–{@ç•ä@@‘ź‚Q–ź
‘ć354‰ń‘ĺă’n•ű‰ď
1999.7
@
@
ƒqƒg ”|—{ƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚é Vitamin D3 ‚Ě Myc, Mad ”­Œť§Œä‚ɂ‚˘‚Ä
Ź—с@Ć–ž
‘ć284‰ńŽ‰—nŤƒrƒ^ƒ~ƒ“‘‡Œ¤‹†ˆĎˆő‰ď
1999.7.16
˜a‰ĚŽR
@
•\”çŠp‰ť×–E‚Ě“ŕÝŤRŒ´‚Ě‹@”\@
Gao, Xing-Hua, @Źă@@”Ž@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć24‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1999.7.30-31
_ŒË
@
•\”ç×–E‚ĚŠˆŤ‰ť‚ÉŠÖ‚ˇ‚é‘S‘wA”ç iFTSGjC •Ş‘wA”ç iSTSGj ‹y‚Ń•\”çƒV[ƒgˆÚA iPESGj ‚Ě”äŠr
ŽRŒű@—TŽj@@”ÂŒŠ@@’q@@×ě@@˜i@@‹gě@–M•F
‘ć24‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1999.7.30-31
_ŒË
@
–Ɖu—Ă–@’ďRŤ‰~Œ`’E–яǩłŽŇ‚É‚¨‚Ż‚é––˝ŒŒ’PŠj‹…‚Ěƒ}ƒCƒgƒWƒFƒ“ŽhŒƒ‚É‘Î ‚ˇ‚é’á”˝‰žŤ
ó“c@G•v@@‹g–ě@@’@@ˆŔ“Œ@˜Đ”ü@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć24‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1999.7.30-31
_ŒË
@
ƒqƒg”|—{ƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚é UVB‚ĚMyc, Mad ”­Œť§Œä‚ɂ‚˘‚Ä
Ź—с@Ć–ž
‘ć24‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď‘‰ď
1999.7.30-31
_ŒË
@
Novel negative ffedback regulation by orpahn receptor TR4 in retinoid-mediated signal
Shigeki Inui, Satoshi Itami, Kunihiko Yoshikawa, Anne R Haake, Lowell A Goldsmith, Chawnshang Chang
The Japanese Society For Investigative Dermatology 24th Annual Meeting
1999.7.31
Kobe
@
Stat3 regulates phophorylation of focal adhesions required for keratinocyte migration
Shigetoshi Sano, Masahiro Kira, Satoshi Itami, Satoshi Takagi, Yuji Yamaguchi, Masahito Tarutani, Junji Takeda, Kunihido Yoshikawa
The Japanese Society For Investigative Dermatology 24th Annual Meeting
1999.7.31
Kobe
@
Stat3‚ĚŒ‡Ž¸‚Í•\”çŠp‰ť×–E‚É‚¨‚Ż‚éÚ’…”Á ifocal contactj ‚ĚˆŮí‚𐜂ś‚é
‹g—ǁ@ł_@@˛–ě@‰h‹I@@”ÂŒŠ@@’q@@‚–؁@˝Ži@@ŽRŒű@—TŽj@@’M’J@Ÿm@@’|“c@“ń@@‹gě@–M•F
‘ć24‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
1999.7.31
_ŒË
@
Šç–Ę‚ĚÄ”­Ť‰óásŤ‹u]‚𔺂Á‚˝‘ĺŒ^č÷—ąƒŠƒ“ƒp‹…Ť”’ŒŒ•aŠłŽŇ‚ć‚čŽ÷—§‚ľ‚˝ EB ƒEƒCƒ‹ƒXö•šŠ´őT×–EŠ”‚̉đÍ iľżu‰‰j
ó“c@G•v
”畆ƒŠƒ“ƒtƒH[ƒ}Œ¤‹†Šw‰ď
1999.8.21-22
ŽR—œ
@
’jŤŒ^’E–Ńƒ‚ƒfƒ‹“Ž•¨ iƒxƒjƒKƒIƒUƒ‹j ‚ɑ΂ˇ‚éRƒAƒ“ƒhƒƒQƒ“Ü RU58841ŠO—p‚ĚŽŽ‚Ý‚Ć‚ť‚̍ě—pƒƒJƒjƒYƒ€‚̉đÍ
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@‹gě@–M•F@@Huei-Ju Pan@@Chawnshang Chang@@@‰F–ě@G•v@
‘ć50‰ń“ú”ç‰ď’†•”Žx•”‘‰ď iƒ[ƒNƒVƒ‡ƒbƒv‡T u”畆ŽžŠł iƒAƒgƒs[Ť”畆‰Š‚đœ‚­j ‚ɑ΂ľ‚ÄŽŽ‚Ý‚ç‚ę‚˝V‚ľ‚˘ŽĄ—Ă–@‚Ć‚ť‚̐Ź‰Ęvj
1999.9
–źŒĂ‰Ž
@
G“‚Ć‚ĚŠÖ˜A‚ŞŽŚ´‚ł‚ę‚˝”^ávÇ‚Ě‚P—á
Ź“¤ŕVG–ž@@ó“c@G•v@@Ží‘ş@@“ā@@Šâˆä@ç‰Ř@@ŠŁ@@dŽ÷@@ˆéƒmăł–ž@@”ÂŒŠ@@’q@@‹gě@–M•F
’†•”Žx•”‘‰ď
1999.9.19
–źŒĂ‰Ž
@
śçG”^ávÇ‚É‚¨‚Ż‚éG“ŽhŒƒ—U”­ŽŽŒą‚ĚƒT[ƒ‚ƒOƒ‰ƒtƒB[‚É‚ć‚锝’č
ó“c@G•v@@Ź“¤ŕVG–ž@@Ží‘ş@@“ā@@”ÂŒŠ@@’q@@‹gě@–M•F@@“c‘ş@@Šw
‘ć14‰ń“ú–{ŠŁáŠw‰ď
1999.9.4-5
‹ž“s
@
Lig-1Œ‡‘šƒ}ƒEƒX‚ĆŠŁá‚Ě—ŢŽ—Ťƒ[ƒNƒVƒ‡ƒbƒv[ŠŁá‚Ěƒ‚ƒfƒ‹
”ÂŒŠ@@’q@@˛–ě@‰h‹I@@ŽO‰Y@G”V@@‹gě@–M•F@@—é–؁@@–L
‘ć14‰ń“ú–{ŠŁáŠw‰ď
1999.9.4-5
‹ž“s
@
Œ‹ßŤd‰ťÇ‚ĚŽĄ—Ă‚Ěˆ×‚ĚŠî‘b“IŒ¤‹†|p40‚ĚŠÖ—^|
‹ŕ“c@^—@@‹gě@–M•F@@‹ŕ“c@ˆŔŽj
ŒúśČ“Á’莞Šł@_Œo”畆ÇŒóŒQ’˛¸Œ¤‹†”ǁ@•˝Ź11”N‘ć‚Q‰ń‘‰ď
2000.1
@
@
ƒAƒ“ƒhƒƒQƒ“ƒŒƒZƒvƒ^[EƒRƒAƒNƒeƒBƒx[ƒ^[ ARA55‚đ‰î‚ľ‚˝‚´áŒ‚Ě•a‘Ôƒ‚ƒfƒ‹ |ƒƒLƒVƒXƒƒ}ƒCƒVƒ“‚̍RƒAƒ“ƒhƒƒQƒ“Ü‚Ć‚ľ‚Ẳ”\Ť
ŠŁ@@dŽ÷@@’†“‡@•”V@@•Ÿ—˘@—zŽq@@‹gě@–M•F@@”ÂŒŠ@@’q
‘ć‚R‰ń”畆ƒ}ƒNƒƒ‰ƒCƒhŒ¤‹†‰ď
2000.11.11
“Œ‹ž
@
”畆RŒ´‚ĚƒNƒƒX|ƒvƒ‰ƒCƒ~ƒ“ƒO‚É‚ć‚é CD8+ T×–E‚Ě“Ž‘Ô
Źă@@”Ž@@Ź“¤ŕV@G–ž@@Gao, Xing-Hua@@‚‹´@@Œ÷@@”ÂŒŠ@@’q@@‹gě@–M•F@
‘ć30‰ń“ú–{–ƉuŠw‰ď‘‰ď
2000.11.14-16
ĺ‘ä
@
V‹KƒAƒ“ƒhƒƒQƒ“ƒŒƒZƒvƒ^[ƒRƒAƒNƒeƒBƒx[ƒ^[ ARA55‚ĚƒNƒ[ƒjƒ“ƒO‚Ć–Ń“ű“ލזE‚É‚¨‚Ż‚é‹@”\
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@•Ÿ—˘@—zŽq@@’†“‡@•”V@@‹gě@–M•F@@“Ą–{@’ź_
‘ć‚W‰ń–Ń”Ż‰ČŠwŒ¤‹†‰ď
2000.11.18
“ż“‡
@
Šj“ŕƒI[ƒtƒ@ƒ“ƒŒƒZƒvƒ^[ TR4‚̓Œƒ`ƒmƒCƒ“Ž_ƒVƒOƒiƒ‹‚ĚƒlƒKƒeƒBƒuƒtƒB[ƒhƒoƒbƒN’˛ßˆöŽq‚Ć‚ľ‚Ä“­‚­
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć290‰ńŽ‰—nŤƒrƒ^ƒ~ƒ“‘‡Œ¤‹†ˆĎˆő‰ď
2000.12.8
_ŒË
@
Œ‹–Œ•a•Ď‚đ‡•š‚ľ‚˝qíŤ“Vávጂ̂P—á
’‡‘ş@‰ë˘@@ŠŁ@@dŽ÷@@ŹŕV@Œ’‘ž˜Y@@ŽRŒű@—TŽj@@‹g—ǁ@ł_@@Ź—с@Ć–ž@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺj
‘ć362‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
2000.12.9
‘ĺă
@
g”ÁŒ^“]ˆÚŤ”畆Šŕ‚Ě‚P—á
ŸNŞ@ƒŽq@@ź–{@ç•ä@@‘ź‚Q–ź
‘ć357‰ń‘ĺă’n•ű‰ď
2000.2
@
@
Cross-presentation of the antigen expressed in keratinocytes leads to the activation of CD8+ T cells
Hiroshi kosaka, Hiroaki Azukizawa, Xing-Hua Gao, Satoshi Itami, and Kunihiko Yoshikawa
Keystone Symposia
2000.3.31-4.6
Steamboat, USA
@
“ÁˆŮ‚Č”ç]‚đ’ć‚ľ‚˝č÷—ąƒŠƒ“ƒp‹…‘BÇŠłŽŇ‚ć‚čŽ÷—§‚ľ‚˝ EB ƒEƒCƒ‹ƒXŠ´őT×–EŠ”‚̉đÍ
ó“c@G•v
NKŽîᇌ¤‹†‰ď
2000.4.1
“Œ‹ž
@
Negative Feedback Regulation by TR4 Orphan Nuclear Receptor in Peroxisome Proliferator-Activeted Receptor a Signal in Human HaCaT Keratinocytes
S Inui, S Itami, K Yoshikawa, and C Chang
61TH Annual Meeting of the SID
2000.5.10-14
Chicago
@
Stat3 Deficiency Leads to Focal Contact Abnormalities in Keratinocytes.
M Kira, S Sano, S Itami, S Takagi, M Tarutani, K Yoshikawa, and J Takeda
The Society for Investigative Dermatology's 61st Annual Meeting
2000.5.13
Chicago
@
•\”çŠp‰ť×–E‚Ƀ‚ƒfƒ‹RŒ´‚đ”­Œť‚ˇ‚éƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚É‚¨‚Ż‚é CD8+T×–E‚̍RŒ´”FŽŻ‹@\‚̉đÍ
Źă@@”Ž@@Ź“¤ŕVG–ž@@Gao, Xing-Hua@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć99‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2000.5.26-28
ĺ‘ä
@
‰áƒAƒŒƒ‹ƒM[‚đ’ć‚ľ‚˝č÷—ąƒŠƒ“ƒp‹…‘BÇŠłŽŇ—R—ˆ‚Ě EB ƒEƒCƒ‹ƒXŠ´ő NK ×–E‚̉đÍ
ó“c@G•v@@ˆŔ“Œ@˜Đ”ü@@‹g–ě@@’@@“Ąˆä@Gs@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć99‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2000.5.26-28
ĺ‘ä
@
‘ĺă‘ĺŠw”畆‰Č‚É‚¨‚Ż‚é•a—‘gDƒf[ƒ^ƒx[ƒXƒVƒXƒeƒ€
ź“cŒ’Ž÷@@“y‹•q–ž@@‹gě–M•F@@–ě‘ş­•v
‘ć99‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2000.5.27
ĺ‘ä
@
ƒqƒgƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚˘‚ÄŠj“ŕƒI[ƒtƒ@ƒ“ƒŒƒZƒvƒ^[TR4‚Í peroxisome proliferator-activeted receptor a iPPARajƒVƒOƒiƒ‹‚ĚƒlƒKƒeƒBƒuƒtƒB[ƒhƒoƒbƒN’˛ßˆöŽq‚Ć‚ľ‚Ä“­‚­
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć99‰ń“ú–{”畆‰ČŠw‰ď‘‰ď iƒ[ƒNƒVƒ‡ƒbƒvj
2000.5.28
ĺ‘ä
@
Tissue regeneration: hair follicle sa a model
Itami S
IVth annual meeting of dermatology for basic research and treatment
2000.6.16-18
ŽD–y
@
ANALYSIS OF UV-INDUCED DNA DAMAGE IN SKIN WITHIN RACIAL /ETHNIC GROUPS
Taketsugu Tadokoro.Nobuhiko Kobayashi, Janusz Z. Beer, Barbra Z. Zmudzka, Katalin S.Korossy, Vincent j.Hearing
‘ć‚X‰ńƒpƒ“ƒAƒƒŠƒJƒ“F‘f×–EŠw‰ď
2000.6.25-28
Texas in USA
@
śçG”^ávÇ‚É‚¨‚Ż‚éG“ŽhŒƒ—U”­ŽŽŒą‚ĚƒT[ƒ‚ƒOƒ‰ƒtƒB[‚É‚ć‚锝’č
ó“c@G•v@@Ź“¤ŕVG–ž@@Ží‘ş@@“ā@@”ÂŒŠ@@’q@@‹gě@–M•F@@“c‘ş@@Šw
‘ć360‰ń‘ĺă’n•ű‰ď
2000.7.15
@
@
Eccrine Poroid Hidradenoma ‚Ě‚P—á
ŸNŞ@ƒŽq@@ź–{@ç•ä@@‘ź‚R–ź
‘ć360‰ń‘ĺă’n•ű‰ď
2000.7.15
@
@
ƒAƒgƒs[Ť”畆‰ŠŠłŽŇŒŒ´’†‚ĚT×–E‘B—}§ˆöŽq‚̉đÍ
“Ąˆä@Gs@@ó“c@G•v@@”ÂŒŠ@@’q@@‹gě@–M•F
“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď
2000.7.22-23
‘ĺă
@
‘O—§‘BŠŕ‚Š‚ç–Ń“ű“ލזE‚ցFƒAƒ“ƒhƒƒQƒ“Žó—e‘Ě‹¤–đˆöŽq ARA55/Hic-5‚É‚ć‚éƒzƒ‹ƒ‚ƒ“Š´ŽóŤ‚Ě’˛ß
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@’†“‡@•”V@@•Ÿ—˘@—zŽq@@‹gě@–M•F@@“Ą–{@’ź_
‘ć15‰ń‘ĺăƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX
2000.8.27
ŽOd
@
Stat3Œ‡Ž¸•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ĺ‚Íp130cas ‚Ěƒ`ƒƒVƒ“ƒŠƒ“Ž_‰ť‚ޘ´i‚ľ‚Ä‚˘‚é
‹g—ǁ@ł_@@˛–ě@‰h‹I@@‚–؁@˝Ži@@’|“c@“ń@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć25‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2000.9.1
Šň•Œ
@
Staphylococcal Enterotoxin ŽYś—}§‚É‚ć‚éV‹K Atopic Dermatitis ŽĄ—ĂÜ‚ĚŠJ”­
r“‡@‰ëŽ÷@@—t’J@@˛@@‰œ‘ş@GM@@Ž›ˆä@@T@@ó“c@G•v@@‹gě@–M•F
‘ć25‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2000.9.1-2
Šň•Œ
@
dÇƒAƒgƒs[Ť”畆‰ŠŠłŽŇŒŒ´’†‚ĚT×–E‘B—}§ˆöŽq‚̉đÍ
“Ąˆä@Gs@@ó“c@G•v@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć25‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2000.9.1-2
Šň•Œ
@
•\”çŠp‰ť×–E‚Ƀ‚ƒfƒ‹RŒ´‚đ”­Œť‚ľ‚˝ƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚É‚¨‚Ż‚éT×–E‚̖Ɖu‰ž“š
Ź“¤ŕVG–ž*1@@Źă@@”Ž*1@@Gao, Xing-Hua*1C*‚Q@@”ÂŒŠ@@’q*1@@‹gě@–M•F*1i *1‘ĺă‘ĺ@@*2’†‘ˆă‰Č‘ĺE‘ćˆę—Տ°Šw‰@j
‘ć25‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2000.9.1-2
Šň•Œ
@
ƒqƒg”|—{ƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚é1a,25-dihydroxyvitamin D3‚Ě IEX-1§Œä‚ɂ‚˘‚Ä
Ź—с@Ć–ž
‘ć25‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď‘‰ď
2000.9.1-9.2
Šň•Œ
@
Cases of Regimen-related Toxicity iRRTj of the Skin
Hiroshi Kosaka, Satoshi Itami, Kunihiko Yoshikawa
i6j China-Japan Joit Meeting of Dermatology
2000.9.15-17
źˆŔC ’†‘
@
Treatment of palmoplantar wounds by pure nonpalmoplantar epidermal sheet grafting.
Yamaguchi Y, Itami S, Tarutani M, Sano S, Asada H, Yoshikawa K
6th China-Japan Joint Meeting of Dermatology
2000.9.15-17
Xian
@
Diagnosis of focal tonsillar infection in palnoplantar pustulosis by provocation test using thermography.
Asada H, Azukizawa H, Tanemura A, Itami S, Yoshikawa K, Tamura M
Chaina-Japan Joint Meeting of Dermatology
2000.9.15-17
Xi'an
@
Cloning of a novel androgen receptor coactivator, ARA55, and analysis of its possible function in dermal papilla cells"
S Inui, S Itami, N Fujimoto, Y Fukuzato, T Nakajima, K Yoshikawa
25th Annual Meeting of JSID iPlenary Sessionj
2000.9.2
Šň•Œ
@
ƒrƒ^ƒ~ƒ“D‚Ć•\”çƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě×–E‘BC •Ş‰ť
Ź—с@Ć–ž
•˝Ź11”N“x“ú–{”畆‰ČŠw‰ďŠî‘bˆăŠwŒ¤‹†”ďŽó—ĚŽŇŒ¤‹†”­•\‰ď
2000.9.23
“Œ‹ž
@
EXAMINATION OF DNA DAMAGE INDUCED BY ULTRAVIOLET IRRADIATION OF HUMAN SKIN WITHIN RACIAL/ETHNIC GROUPS
Taketsugu Tadokoro. Noobuhiko Kobayashi. Janusz Z. Beer, Barbra Z. Zmudzka, Katalin S.Korossy, Vincent j.Hearing
‘ć‚X‰ńƒˆ[ƒƒbƒpF‘f×–EŠw‰ď
2000.9.27-10.1
Ulm in Germany
@
“œ”A•aŤ’×ᇂɑ΂ˇ‚é•\”çƒV[ƒgˆÚA‚Ě‚P—á
ŽRŒű@—TŽj@@Îě@Œ’ŽĄ@@‹g—ǁ@ł_@@Ź—с@Ć–ž@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć51‰ń’†•”Žx•”‘‰ď
2000.9.30
‘ĺă
@
ƒVƒ“ƒ|ƒWƒEƒ€ŠŁáˆâ“`ŽqƒvƒƒWƒFƒNƒg‚ĚŒť‹ľ‚Ć“W–][qíŤŠŁá‚ĆŠ˛×–E
”ÂŒŠ@@’q
‘ć15‰ń“ú–{ŠŁáŠw‰ď
2000.9.8-9
•Ÿ“‡
@
Stat3 in Epidermal Keratinocytes Functions as UV-Sensor.
S Sano, M Kira, S Tkagi, M Tarutani, J Takeda, S Itami, K Yoshikawa, Osaka,Japan.
ESDR
2001
Stockholm
@
•\”ç×–E“ÁˆŮ“I Bcl-xL ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX—R—ˆƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě in vivo ‹y‚Ń in vitro ‚É‚¨‚Ż‚é‰đÍ
”~“c@“ń˜Y@@˛–ě@‰h‹I@@“n粁@@•@@‹gě@–M•F@@”ÂŒŠ@@’q@@’|“c@“ń
‘ć26‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2001.09.07
ˆ¤•Q
@
Œ‹ßŤd‰ťÇ‚ĚŽĄ—Ă‚Ěˆ×‚ĚŠî‘b“IŒ¤‹†‚R|p40‚ĚŠÖ—^|
‹ŕ“c@^—@@‹ŕ“c@ˆŔŽj@@‹gě@–M•F
Œúś‰ČŠwŒ¤‹†”ď•â•‹ŕC “Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ć@_Œo”畆ÇŒóŒQ‚̐V‚ľ‚˘ŽĄ—Ă–@‚ĚŠJ”­‚ĆŽĄ—ĂŽwjěť‚ÉŠÖ‚ˇ‚錤‹†”ǁ@•˝Ź12”N‘ć‚Q‰ń‘‰ď
2001.1
@
@
‘O—§‘BŠŕ‚Š‚ç–Ń“ű“ލזE‚ցFƒAƒ“ƒhƒƒQƒ“Žó—e‘Ě‹¤–đˆöŽq ARAR55/Hic-5‚É‚ć‚éƒzƒ‹ƒ‚ƒ“Š´ŽóŤ‚Ě’˛ß
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@’†“‡@•”V@@•Ÿ—˘@—zŽq@@‹gě@–M•F@@“Ą–{@’ź_
‘ć74‰ń“ú–{ś‰ťŠw‰ď
2001.10.25
‹ž“s
@
’܍bF‘füđ‚đ’ć‚ľC HPV-6‚ŞŒŸo‚ł‚ę‚˝’܉ş Bowen •a‚Ěˆę—á
ŹŕVŒ’‘ž˜Y@@ó“c@G•v@@ŽRŒű@—TŽj@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺŠwj
‘ć53‰ń“ú–{”畆‰ČŠw‰ďź•”Žx•”Šwp‘ĺ‰ď
2001.10.27-28
’ˇč
@
androgen action in human hair follicles
”ÂŒŠ@@’q
‘ć12‰ń“úŠŘ‡“Ż”畆‰ČŠw‰ď@ƒTƒeƒ‰ƒCƒgƒZƒ~ƒi[
2001.11
“Œ‹ž
@
Albinism ‚É”ş‚Á‚˝ Amelnotic melanoma ‚Ě‚P—á
ŸNŞ@ƒŽq@@{–@Ą”ü@@‘ź‚R–ź
‘ć52‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďC Šwp‘ĺ‰ď
2001.11
‹ž“s
@
$3002ጂƒjŤƒzƒ‹ƒ‚ƒ“[ƒƒLƒVƒXƒƒ}ƒCƒVƒ“‚̍R’jŤƒzƒ‹ƒ‚ƒ“‚Ć‚ľ‚Ẳ”\Ť ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[ጁ|New topics|
”ÂŒŠ@@’q
‘ć52‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďEŠwp‘ĺ‰ď
2001.11.
‹ž“s
@
ƒƒLƒVƒXƒƒ}ƒCƒVƒ“‚ĚŠŁá‚ւ̐V‚ľ‚˘ě—p‹@˜
ŠŁ@@dŽ÷@@‹gě@–M•F@@”ÂŒŠ@@’q
‘ć‚S‰ń”畆ƒ}ƒNƒƒ‰ƒCƒhŒ¤‹†‰ď
2001.11.17
‹ž“s
@
‘ĚŠ˛•”‚ɐś‚ś‚˝ Pseudo-Kaposi's sarcoma iStewart-Bluefarb typej ‚Ěˆę—á
‹g—ǁ@ł_@@“cč@“TŽq@@ŽRŒű@—TŽj@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć52‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďC Šwp‘ĺ‰ď
2001.11.4
‹ž“s
@
Cloning of a novel androgen receptor coactivator, ARA55/Hic-5, and analysis of its possible function in dermal papilla cells.
Inui S, Fujimoto N, Fukuzato Y, Nakajima T, Yoshikawa K, Itami S.
The 12th Japan-Korea Joint Meeting of Dermatology
2001.11.8-9
“Œ‹ž
@
‹š‘B\‘˘ˆŰŽ”\•s‘S‚đŽŚ‚ˇ Stat3Œ‡Ž¸‹š‘Bă”ç×–E‚Ěˆâ“`Žq”­ŒťˆŮ
˛–ě@‰h‹I@@‚•l@—m‰î@@W.V.EWIJK@@’|“c@“ń i‘ĺă‘ĺE‰@ˆăE”畆@@“ż“‡‘ĺEƒQƒmƒ€‹@”\Œ¤@@ƒGƒ‰ƒXƒ€ƒX‘ĺE×–Eś•¨ˆâ“`@@‘ĺă‘ĺEˆăECŽmŽĐ‰ďŠÂ‹ŤˆăŠwj @@
“ú–{–ƉuŠw‰ď
2001.12.11
‘ĺă
@
CD8+T ×–E‚É Cross-priming ‚ˇ‚éRŒ´’ńŽŚ×–E
Ź“¤ŕVG–ž‚P@@Źă@@”Ž‚P@@‚‹´@@Œ÷‚Q@@Gao, Xing-Hua‚R@@”ÂŒŠ@@’q‚P@@‹gě@–M•F‚P i ‚P‘ĺă‘ĺEˆăE”畆‰Č@@ ‚Q•ŞŽq§Œä“ŕ‰Č@@‚R’†‘ˆă‰Č‘ĺE‘ćˆę—Տ°Šw‰@E”畆‰Čj
“ú–{–ƉuŠw‰ď‘‰ď
2001.12.12.
‘ĺă
@
—Ť‚Ě‘s”NŤ’E–яÇ
‹ŕ“c@^—@@ŠŁ@@dŽ÷
‘ćŒÜ‰ńŒ’NƒZƒ~ƒi[
2001.2.
@
@
EB ƒEƒCƒ‹ƒX‚Ɣ畆ƒŠƒ“ƒpŽî iƒVƒ“ƒ|ƒWƒEƒ€‡V|”­Šŕ‚Š‚玥—Â܂Łj
ó“c@G•v
‘ć64‰ń@“ú”ç‰ď“Œ‹žŽx•”‘‰ď
2001.2.10-11
“Œ‹ž
@
ă”ç|ŠÔ—tŒn‘ŠŒÝě—p‚Ě—Ő°‰ž—p iśçGˆČŠO‚Ě•\”çƒV[ƒg‚đ—p‚˘‚˝śçG”畆Œ‡‘š‘n‚ĚŽĄ—Áj
ŽRŒű@—TŽj@@”ÂŒŠ@@’q@@ó“c@G•v@@˛–ě@‰h‹I@@’M’J@Ÿm@@‹gě@–M•F
363‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2001.2.3
ź‹{
@
BCG ÚŽíŒă‚ɐś‚ś‚˝”畆Œ‹Šj‚Ě‚Q—á
ŸNŞ@ƒŽq@@ź–{@ç•ä@@‘ź‚P–ź
‘ć364‰ń‘ĺă’n•ű‰ď
2001.3
@
@
—L‹@‰ťŠwŽŔŒą’†‚ɐś‚ś‚˝Šö”­Ť•¨Žż‚Ĺ—U”­‚ł‚ę‚˝ĺ@–ƒ]‚Ě‚P—á
Ÿě@–ő”V@@ŠŁ@@dŽ÷@@ó“c@G•v@@’M’J@Ÿm@@‹g—ǁ@ł_@@’†X@@ˆť@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć108‰ń@L“‡’n•ű‰ď
2001.3.19-20
L“‡
@
ƒŠƒ|ƒCƒh—Ţ‰óŽ€Ç‚É‚¨‚Ż‚é AGE iadvanced g;ycation productj Œ`Ź
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć‚R‰ń@”畆“œ”A•azŠÂáŠQŒ¤‹†‰ď
2001.4.19
‘ĺă
@
DNA Damage and Melanin Production Induced by Ultraviolet Radiation in Human Skin within Various Racial/Etthnic groups and Skin types
T Tadokoro, N Kobayashi, J Z Beer, B Z Zmudzka, K S Korossy, S Ito, K Wakamatsu, and V J Hearing
International workshop on molecular
2001.4.26-29
Nice in France
@
ƒqƒg”|—{ƒPƒ‰ƒ`ƒmƒTƒCƒg‚É‚¨‚Ż‚é Ultraviolet B ‚Ě IEX-1§Œä‚ɂ‚˘‚Ä
Ź—с@Ć–ž
‘ć100‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2001.4.6-10
“Œ‹ž
@
dÇƒAƒgƒs[Ť”畆‰ŠŠłŽŇŒŒ´‚É‚¨‚Ż‚鉊FƒuƒhƒE‹…‹ŰŠO“Ĺ‘f‚ɑ΂ˇ‚é’†˜aR‘Ě‚Ě–đŠ„ iƒ[ƒNƒVƒ‡ƒbƒv|ƒAƒgƒs[Ť”畆‰Šj
ó“c@G•v@@“Ąˆä@Gs@@ŠŁ@dŽ÷@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć100‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2001.4.6-8
“Œ‹ž
@
‹‘ĺ‚ČŽîᎂđŒ`Ź‚ľ‚˝ cytophagic histiocytic panniculitis ‚Ě‚P—á
’†X@@ˆť@@ŠŁ@@dŽ÷@@’‡‘ş@‰ë˘@@ŽRŒű@—TŽj@@Ź—с@Ć–ž@@‹g—ǁ@ł_@@˛–ě@‰h‹I@@ó“c@G•v@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć100‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2001.4.6-8
“Œ‹ž
@
ƒCƒ“ƒ^[ƒlƒbƒg‚đ—˜—p‚ľ‚˝ŠŁáŠłŽŇ‰ď‚̉^‰c
“ŒŽR^—˘ i‘ĺă“úśj @@ź“cŒ’Ž÷@@˛–ě‰h‹I@@Źă@”Ž@@Ź—ŃĆ–ž@@ŠŁ@dŽ÷@@ŽO‰YG”V@@‹gě–M•F i‘ĺă‘ĺj @@‘ĺăŠŁá—F‚̉ď@@
‘ć100‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2001.4.6-8
“Œ‹ž
@
V‹KƒAƒ“ƒhƒƒQƒ“ƒŒƒZƒvƒ^[ƒRƒAƒNƒeƒBƒx[ƒ^[ ARA55‚ĚƒNƒ[ƒjƒ“ƒO‚Ć–Ń“ű“ލזE‚É‚¨‚Ż‚é‹@”\
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@•Ÿ—˘@—zŽq@@’†“‡@•”V@@‹gě@–M•F@@“Ą–{@’ź_
‘ć100‰ń“ú–{”畆‰ČŠw‰ď‘‰ď iƒ[ƒNƒVƒ‡ƒbƒvj
2001.4.6-8
“Œ‹ž
@
Keratinocytes ‚É”­Œť‚ľ‚˝ƒ‚ƒfƒ‹RŒ´‚ɑ΂ˇ‚é CD8+T×–E‚̐ś‘Ě“ŕ“Ž‘ԁFƒz[ƒ~ƒ“ƒO‚Ć‘gDZ
Ź“¤ŕVG–ž‚P@@Źă@@”Ž‚P@@Gao, Xing-Hua‚Q@@”ÂŒŠ@@’q‚P@@‹gě@–M•F‚P@i ‚P‘ĺă‘ĺ@@ ‚Q’†‘ˆă‰Č‘ĺj
“ú–{”畆‰ČŠw‰ď‘‰ď
2001.4.8.
“Œ‹ž
@
Stat3 Deficiency Leads to Increased Tyrosine Phosphorylation of p130cas and Focal Adhesion Abnormalities in Keratinocytes.
M Kira, S Sano, S Itami, S Takagi, J Takeda, and K Yoshikawa
62nd Annual Meeting of the Society for Investigative Dermatology
2001.5.11
Washinton, DC
@
Stat3 in Keratinocytes Plays a Crucial Role in Preventing Apoptosis Induced by UVB Irradiation.
S Sano, M Kira, S Takagi, M Tarutani, J Takeda, S Itami, K Yoshikawa, J Takeda
62nd Annual Meeting of the Society for Investigative Dermatology
2001.5.9-12
Washington DC
@
Keratinocyte-specific Ablation of Aryl Hydrocarbon Receptor Nuclear TranslocatoriARNTjExhibits Impaired Terminal Differentiation of the Epidermis.
S Takagi, M Hara, S Sano, S Tomita, Gonzalez FJ, G Kondoh, K Hosokawa, K Yoshikawa, S Inoue, S Itami, J Takeda
62nd Annual Meeting of the Society for Investigative Dermatology
2001.5.9-12
Washington,DC
@
DNA Damage and Melanin Production Induced by Ultraviolet Radiation in Human Skin within Various Racial/Etthnic groups
T Tadokoro. N Kobayashi, J Z Beer, B Z Zmudzka, K S Korossy, S Ito, K Wakamatsu, and V J Hearing
62nd Annual Meeting of the Society for Investigative Dermatology
2001.5.9-12
Washington DC
@
Androgen-inducible TGF-b1 Derived from Dermal Papilla Cells Mediates Hair Growth Suppression in Androgenetic Alopecia iAwardedj
S. Inui, Y. Fukuzato, T. Nakajima, K. Yoshikawa, S. Itami
Third intercontinental meeting of hair research
2001.6.13-15
“Œ‹ž
@
DNA DAMAGE INDUCED BY ULTRAVIOLET RADIATION AND MELANIN PRODUCTION IN HUMAN SKIN WITHIN VARIOUS RATTIAL/ETHNIC GROUPS
T.Tadokoro, N.Kobayashi, J.Z.Zmudzka, K.S.Korossy, S.Ito, K.Wakamatsu, V.J.Hering
‘ć10‰ńƒpƒ“ƒAƒƒŠƒJƒ“F‘f×–EŠw‰ď
2001.6.14-17
Minneapolis in USA
@
‘SgŤŒ`Žż×–E‘‘˝Ç‚Ě‚P—á
’ˇŕV@’q•F@@’†“‡@•”V@@ŠŁ@@dŽ÷@@ó“c@G•v@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺj
‘ć365‰ń@“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2001.6.16
“Ţ—Ç
@
Žá”N‚ĹƒPƒ‰ƒgƒAƒJƒ“ƒg[ƒ}‚𐜂ś‚˝Ž‰ü•ę”Á‚Ěˆę—á
ŹŕVŒ’‘ž˜Y@@ŽRŒű@—TŽj@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺŠwj
‘ć94‰ń‹ß‹E”畆‰ČW’k‰ď
2001.6.3
‘ĺă
@
‹š‘Bă”ç×–E‚Ě Stat3‚͐śŒăŠú‚É‚¨‚Ż‚é‹š‘BŠíŠŻ‚̍\‘˘ˆŰŽ‚Ć‹š‘B×–E‚̐ś‘śˆŰŽ‚É•K{‚Ĺ‚ ‚é
˛–ě@‰h‹I‚P@@‚•l@—m‰î‚Q@@Źă@@”Ž‚P@@‹{č@ƒˆę‚R@@W. van Ewijk‚S@@’|“c@“ń‚T i ‚P‘ĺă‘ĺE‰@ˆăE”畆‰ČŠw@@ ‚Q“ż“‡‘ĺEƒQƒmƒ€‹@”\Œ¤ƒZ@@‚R‰h—{Šw@@ ‚SErasmus U @@ ‚TCŽmŠÂ‹ŤˆăŠwj@@
‹ž“s‚s×–EƒJƒ“ƒtƒ@ƒŒƒ“ƒX iKTCCj
2001.6.30
‹ž“s
@
–ŃŽüŠúƒVƒOƒiƒ‹“`’BŒo˜H
˛–ě@‰h‹I
”畆ƒAƒŒƒ‹ƒM[Šw‰ďƒVƒ“ƒ|ƒWƒEƒ€
2001.7.13
•lź
@
’jŤŒ^’E–Ń‚É‚¨‚Ż‚é–Ń”Ż‚̐Ź’ˇ‚̓Aƒ“ƒhƒƒQƒ“‚É‚ć‚Á‚Ä—U“ą‚ł‚ę–Ń“ű“ލזE‚ŞŽYś‚ˇ‚éTGF-b1‚đ‰î‚ľ‚Ä—}§‚ł‚ę‚é
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@•Ÿ—˘@—zŽq@@’†“‡@•”V@@‹gě@–M•F
‘ć16‰ń‘ĺăƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX
2001.8.25
ŽOd
@
ƒŒƒbƒNƒŠƒ“ƒOƒnƒEƒ[ƒ“•a‚Ş‹^‚í‚ę‚˝Œ‹ßŤd‰ťÇ‚Ěˆę—á
‹ŕ“c@^—@@‹î’J@–ƒˆßŽq@@˛“Ą@Œ’“ń@@‹gě@–M•F
Œúś‰ČŠwŒ¤‹†”ď•â•‹ŕC “Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ć@_Œo”畆ÇŒóŒQ‚̐V‚ľ‚˘ŽĄ—Ă–@‚ĚŠJ”­‚ĆŽĄ—ĂŽwjěť‚ÉŠÖ‚ˇ‚錤‹†”ǁ@•˝Ź13”N‘ć‚P‰ń‘‰ď
2001.9
@
@
Œ‹ßŤd‰ťÇ‚É‚¨‚Ż‚é‚Q‚Â‚Ě×–EŽüŠú’˛ß‚ĚƒƒJƒjƒYƒ€
‹ŕ“c@^—@@‹ŕ“c@ˆŔŽj@@”ó–ě@‹ť•v@@‹gě@–M•F
‘ć26‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2001.9
@
@
…ávŤ—Ţ“VáváŒ‚đ‡•š‚ľ‚˝qíŤŠŁá‚Ě‚Q—á
‹g—ǁ@ł_@@’ˇ‘ň@’q•F@@”ÂŒŠ@@’q@@‹gě@–M•F i‘ĺă‘ĺŠwj @ŽR‘ş@’íˆę i‘ĺă‘Dˆő•ŰŒŻ•a‰@j @@
‘ć16‰ń“ú–{ŠŁáŠw‰ď
2001.9.1
ç—t
@
ƒPƒ‰ƒ`ƒmƒTƒCƒg‚Ě×–E“ŕƒVƒOƒiƒ‹
˛–ě@‰h‹I
‘ć16‰ń“ú–{ŠŁáŠw‰ďŠwp‘ĺ‰ďƒCƒuƒjƒ“ƒOƒZƒ~ƒi[
2001.9.1
ç—t
@
’jŤƒzƒ‹ƒ‚ƒ“Žó—e‘ĚƒRƒAƒNƒeƒBƒx[ƒ^[ ARA55‚̔畆‚É‚¨‚Ż‚é”­Œť‚Ć‹@”\‚ɂ‚˘‚Ä
ŠŁ@@dŽ÷
•˝Ź12”N“x“ú–{”畆‰ČŠw‰ďŠî‘bˆăŠwŒ¤‹†”ď•ń‰ď
2001.9.15
“Œ‹ž
@
ƒAƒ“ƒhƒƒQƒ“ƒŒƒZƒvƒ^[EƒRƒAƒNƒeƒBƒx[ƒ^[ ARA55‚đ‰î‚ľ‚˝$3002ጂ̕a‘Ôƒ‚ƒfƒ‹ |ƒƒLƒVƒXƒƒ}ƒCƒVƒ“‚̍RƒAƒ“ƒhƒƒQƒ“Ü‚Ć‚ľ‚Ẳ”\Ť|
ŠŁ@@dŽ÷
‘ć65‰ń“ú–{”畆‰ČŠw‰ď“Œ•”Žx•”‘‰ď iƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[j
2001.9.29-30
ŽD–y
@
Stat3 in epidermal keratinocytes functions as UV-sensor. iOral presentationj
M Kira, S Sano, S Takagi, M Tarutani, J Takeda, S Itami, K Yoshikawa.
‘ć26‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2001.9.7
źŽR
@
Establishment of keratinocyte-specific ceramide knockout mice. iPlenary Sessionj
S Sano, S Osuka, T Kobayashi, S Itami, K Yoshikawa, Y Hirabayashi, J Takeda.
‘ć26‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2001.9.7
źŽR
@
Analysis of keratinocyte-specific Bcl-xL Knock-out mouse in vivo and in vitro. iOral presentationj
J Umeda, S Sano, T Watanabe, K Yoshikawa, S Itami, J Takeda.
‘ć26‰ń@“ú–{Œ¤‹†”畆‰ČŠw‰ď
2001.9.7-8
ˆ¤•Q
@
Keratinocyte-specific ablation of aryl hydrocarbon receptor iAhRj nuclear translocator iARNTj exhibits impaired terminal differentiation of the epidermis. iOral presentationj
S Takagi, M Hara, H Tojo, S Sano, S Tomita, K Hosokawa, K Yoshikawa, S Inoue, S Itami, J Takeda.
‘ć26‰ń@“ú–{Œ¤‹†”畆‰ČŠw‰ď
2001.9.7-8
ˆ¤•Q
@
IEX-1‚ĚEGF Receptor ƒVƒOƒiƒ‹“`’B‚Ö‚ĚŠÖ—^‚ɂ‚˘‚Ä
Ź—с@Ć–ž
‘ć26‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2001.9.7-8
ˆ¤•Q
@
EB ƒEƒCƒ‹ƒXŠ´ő NK ×–E‘‘˝Ç‚É‚¨‚Ż‚é‰áƒAƒŒƒ‹ƒM[‚̖ƉuŠw“IŒŸ“˘
ó“c@G•v@@“Ąˆä@Gs@@ˆŔ“Œ@˜Đ”ü@@”ÂŒŠ@@’q@@ˆéƒmăł–ž@@ŒË‘q@VŽ÷@@‘şŽĺ@ß—Y@@‹gě@–M•F
‘ć26‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2001.9.7-8
ˆ¤•Q
@
Androgen-inducible TGF-b1 Derived from Dermal Papilla Cells Mediates Hair Growth Suppression in Androgenetic Alopecia
S. Inui, Y. Fukuzato, T. Nakajima, K. Yoshikawa, S. Itami
‘ć26‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2001.9.8
źŽR
@
•\”çŠp‰ť×–E Stat3‚ÍŽ‡ŠOüƒXƒgƒŒƒXƒZƒ“ƒT[‚Ć‚ľ‚Ä‹@”\‚ˇ‚é
‹g—ǁ@ł_@@˛–ě@‰h‹I@@‚–؁@˝Ži@@’M’J@Ÿm@@’|“c@“ń@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć26‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2001.9.8
źŽR
@
Targeted disruption of LIG-1 gene provides new insight into keratinocyte stem cells
”ÂŒŠ@@’q
Third Intercontinental meeting of Hair Research Societies
2001,6,13-15
“Œ‹ž
@
‘nŽĄ–ü‹@˜‚ÉŠî‚Ă‚­‰ş‘Ú’×ᇂ̎Ą—Ă–@
ŽRŒű@—TŽj@@ŹŕVŒ’‘ž˜Y@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć65‰ń“ú–{”畆‰ČŠw‰ď“Œ‹žŽx•”Šwp‘ĺ‰ď
2002
“Œ‹ž
@
ƒqƒgŒ‹ßŤd TSC1C TSC2‚Ě×–EŽüŠú’˛ß‚ĚƒƒJƒjƒYƒ€
‹ŕ“c@^—@@”ó–ě@‹ť•v@@‘Ť—§@_K@@‹gě@–M•F
Œúś‰ČŠwŒ¤‹†”ď•â•‹ŕC “Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ć@_Œo”畆ÇŒóŒQ‚̐V‚ľ‚˘ŽĄ—Ă–@‚ĚŠJ”­‚ĆŽĄ—ĂŽwjěť‚ÉŠÖ‚ˇ‚錤‹†”ǁ@‘ć‚Q‰ń‘‰ď
2002.1
@
@
ƒ‚ƒ“ƒh[ƒ‹•a‚ƍl‚Ś‚ç‚ę‚˝‚P—á
âˆä@_Žu@@źě@‘׏́@@’†X@@ˆť@@“ě@@G“T@@‹g—´@ŸŽq@@‰H”’@@˝
‘ć157‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
2002.1
‘ĺă
@
Wheatley–@‚É‚ć‚é•@ë•””畆Œ‡‘š‚ĚÄŒš
‚–؁@@ł@@‹g—´@ŸŽq
‘ć‚T‰ń˜a‰ĚŽRclinical dermaŒ¤‹†‰ď
2002.1
˜a‰ĚŽR
@
ƒAƒgƒs[Ť”畆‰ŠŠłŽŇ‚ĚƒXƒgƒŒƒX‚Ć‘~”j
‰H”’@@˝
‘ć‚V‰ńƒAƒgƒs[Ť”畆‰ŠŽĄ—ĂŒ¤‹†‰ď
2002.1
‹ž“s
@
ŠÖß•”‚âä\•”‚ÉŒŒáv‚â’×ᇂ𐶂ś‚˝‚P—á
Ä“Ą–ƒ”üŽq@@Ź—с@M•F@@”~ě@rŽ÷@@‘ĺ•“Ţ’ĂŽq@@•Ÿ–{@—˛–ç@@‹{ě@KŽq
”畆–ŹŠÇEäPŒ´•aŒ¤‹†‰ď
2002.1
Žwh
@
f’f—áFEpithelioid hemanngioendothelioma?
Šâˆä@ç‰Ř@@ˆî‹{@’m”ü@@ź–{@ç•ä@@‘ĺ˜a’JiŽq@@ˆÉ“Ą@—TŒ[
‘ć157‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
2002.1.10
‘ĺă
@
“Á•Ęu‰‰E–ѐŹ’ˇ‚Ćƒzƒ‹ƒ‚ƒ“
”ÂŒŠ@@’q
‘ć107‰ńŽ ‰ęŒ§”畆‰Čˆă‰ďŠwpu‰‰‰ď
2002.1.19
Ž ‰ę
@
‚˛Đ‰î’¸‚˘‚˝”畆ŽžŠłÇ—á
‰€“c@‘•c@@‰ŹŒ´@rŽĄ@@•—{@@M
’r“cŽsˆăŽt‰ď
2002.1.21
’r“c
@
ŹlŒ^ƒAƒgƒs[Ť”畆‰Š‚É‚¨‚Ż‚鍂ŒŒŸ÷Z“§ˆł‰ş‚Ĺ‚ĚR—˜”Aƒzƒ‹ƒ‚ƒ“ˆŮí‚’l
˛“Ą@Œ’“ń@@‹î’J–ƒˆßŽq@@‹´–{‹vm•F@@ŒĂ‰ę@łŽj
‘ć‚V‰ńƒAƒgƒs[Ť”畆‰ŠŽĄ—ĂŒ¤‹†‰ď
2002.1.26
‹ž“s
@
ƒAƒgƒs[Ť”畆‰ŠŠłŽŇ‚É’u‚Ż‚é‘~”j—}§‚Ě‚˝‚ß‚Ě‘•‹ď‚Ě—L—pŤ‚ɂ‚˘‚Ä
žwŕV@F”V@@‹g“c@’ź”ü@@Źă@@”Ž@@Šp@—˛”V@@•Đ‰Ş@—tŽq
‘ć‚V‰ńƒAƒgƒs[Ť”畆‰ŠŽĄ—ĂŒ¤‹†‰ď
2002.1.26
‹ž“s
@
ƒŒƒ`ƒmƒCƒh‚Ş’˜Œř‚ľ‚˝Œ‹ßŤáy]
‰€“c@‘•c
–L’†ŽsˆăŽt‰ď”畆‰Čˆă‰ď
2002.1.26
–L’†
@
”畆‰Š‚Ě‘ˆŤ‚É”ş‚˘’˜–ž‚Č’á‰h—{, ‘̏dŒ¸­, “d‰đŽżˆŮí‚đ‚Ť‚˝‚ľ‚˝“űŽ™ƒAƒgƒs[Ť”畆‰Š‚Ě‚S—á
žwŕV@F”V@@‹g“c@’ź”ü@@Ź—с@—˜ŽĄ@@Źă@@”Ž@@ Šp@—˛”V@@•Đ‰Ş@—tŽq i“Ż@ŹŽ™‰Čj@@źě@‰Ă‰p@@‹g“c@”V”́@@‹T“c@@˝@@‚ź@@—E@@“yˆä@@Œĺ
‹ß‹EƒAƒgƒs[”畆‰Š§˜b‰ď
2002.10
@
@
”畆‚ĚƒAƒŒƒ‹ƒM[ŽžŠł‚ƐSgˆăŠw
‰H”’@@˝
‘ĺă•{•ŰŒŻˆă‹Ś‰ď
2002.10
‘ĺă
@
ŠŁá‚Ěáy‚Ý‚Ě“Á’Ľ
“ŒŽR^—˘ i“úś•a‰@j @@Źă@”Ž i‰H‰g–ě•a‰@j @@Ź—ŃĆ–ž@@ŠŁ@dŽ÷@@‹g—ǐł_@@ź“cŒ’Ž÷@@‹gě–M•F i‘ĺă‘ĺŠwj @@
‘ć17‰ń“ú–{ŠŁáŠw‰ďŠwp‘ĺ‰ď
2002.10.11-13
Ž­Ž™“‡
@
”畆Žîᇁ|—ǐŤEˆŤŤ‚Ě‹ŤŠE|
’JŠ_@••F
“c•ÓE“ú‚ŒSEź–´˜KŒSˆăŽt‰ď‡“ŻŠwp‰ď
2002.10.18
˜a‰ĚŽR
@
ƒAƒgƒs[Ť”畆‰ŠŠłŽŇ––˝ŒŒ’PŠj‹…‚ĚƒOƒ‹ƒRƒRƒ‹ƒ`ƒRƒCƒhƒŒƒZƒvƒ^[a, b”­Œť—Ę‚ĚŒŸ“˘
ŠŁ@@dŽ÷@@Ÿě@–ő”V@@”ÂŒŠ@@’q@@‹gě@–M•F@@ó“c@G•v
‘ć23‰ń‹ß‹EƒAƒgƒs[Ť”畆‰Š’k˜b‰ď
2002.10.19
‘ĺă
@
ˆŮí‚ȍ‚ƒiƒgƒŠƒEƒ€ŒŒÇ‚đŽŚ‚ľ‚˝ƒAƒgƒs[Ť”畆‰Š‚Ě‚Q—á
˛“Ą@Œ’“ń i”畆j@@ŽOD@—mŽq@@‹ß“Ą@GŽ÷ iŹŽ™j@@Źź@—ĎŽq i•şŒÉˆă‘ĺ, ŹŽ™j@@‰ÄH@@—D i•şŒÉˆă‘ĺ, ”畆j
‘ć23‰ń‹ß‹EƒAƒgƒs[Ť”畆‰Š’k˜b‰ď
2002.10.19
‘ĺă
@
‹łˆçu‰‰F–Ń‚Ě•ŞŽqś•¨Šw‚ĆŠÖ˜AŽžŠł
”ÂŒŠ@@’q
•˝Ź14”N“x“Œ•”Žx•”Šé‰ćŒ¤CuK‰ď
2002.10.25
’}”g
@
LIG-1 is expressed in keratinocyte stem cells
A. Tanemura, K. Ozawa, S. Itami
4th international research workshop on alopecia Areata.
2002.10.31-11.2
Washington DC
@
•\”ç×–E“ÁˆŮ“I ARNT Œ‡Ž¸ƒ}ƒEƒX‚̉đÍ
‚–؁@˝Ži@@“Œé@”Ž‰ë@@•y“c@C•˝@@’|“c@“ń@@”ÂŒŠ@@’q@@‹gě@–M•F
•ŞŽq”畆‰ČƒtƒH[ƒ‰ƒ€
2002.10,18-19
źŽR
@
Ž—e“I‚ȐA”ç‚Ě‚˝‚ß‚ĚH•v
‹g—´@ŸŽq
‘ĺă•{ˆăŽt‰ďˆăŠw‰ď‘‰ď
2002.11
‘ĺă
@
‰şŠááىŽîᇐ؏œ‚̍H•v iKuhnt-Szymanowski•Ď–@j
‚–؁@@ł@@‘ĺ–ě@ł_@@ŒŠ–ځ@˜a’@@‹g—´@ŸŽq
‘ĺă•{ˆăŽt‰ďˆăŠw‰ď‘‰ď
2002.11
‘ĺă
@
Šááَ‰‘BŠŕ‚Ě‚R—á
‹g—´@ŸŽq@@‚–؁@@ł
‘ć20‰ń“ú–{—Տ°”畆ŠO‰ČŠw‰ďŠwp‘ĺ‰ď
2002.11
‹ŕ‘ň
@
Wheatley–@‚É‚ć‚é•@ë•”ÄŒš
‚–؁@@ł@@‘ĺ–ě@ł_@@ŒŠ–ځ@˜a’@@’J@@@Žç@@‹g—´@ŸŽq
‘ć20‰ń“ú–{—Տ°”畆ŠO‰ČŠw‰ďŠwp‘ĺ‰ď
2002.11
‹ŕ‘ň
@
SgˆăŠw‚Š‚猊‚˝”畆ƒAƒŒƒ‹ƒM[ŽžŠł
‰H”’@@˝
‘ć54‰ń“ú–{”畆‰ČŠw‰ďź•”Žx•”Šwp‘ĺ‰ďƒVƒ“ƒ|ƒWƒEƒ€ u”畆ƒAƒŒƒ‹ƒM[Šw‚̍Ą“ú“I—‰đv
2002.11
ź]
@
ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[E$3002ጂƒjŤƒzƒ‹ƒ‚ƒ“[’jŤƒzƒ‹ƒ‚ƒ“ƒŒƒZƒvƒ^[EƒRƒAƒNƒ`ƒx[ƒ^[‚ĚŠÖ—^‚ɂ‚˘‚Ä
”ÂŒŠ@@’q
‘ć54‰ń“ú–{”畆‰ČŠw‰ďź•Žx•”Šwp‘ĺ‰ď
2002.11.1
ź]
@
‘ĺă˜JĐ•a‰@‚É‚¨‚Ż‚éĺń጑΍ô‚ĚŒťó
“y‹@•q–ž@‘ź
‘ć26‰ń‘ĺă•{ˆăŽt‰ďˆăŠw‰ď‘‰ď
2002.11.10
‘ĺă
@
intravenous pyogenic granuloma‚Ě‚P—á
ŽR–{@ŽuD@@‘ĺ‘O‚ ‚ä‚݁@@ź–{@ç•ä@@­“c@‰ŔŽq@@ˆÉ“Ą@—TŒ[
‘ć162‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
2002.11.14
‘ĺă
@
Žs—§’r“c•a‰@”畆‰ČŠO—ˆE•a“‚ĚÇ—áĐ‰î‚¨‚ć‚Ń’r“cŽs“ŕŠeŽ{Ý‚Ĺ”­ś‚ľ‚˝ámᝊłŽŇ‘Ήž‚ɂ‚˘‚Ä
‰€“c@‘•c@@’‡‘ş@‰ë˘@@•—{@@M
‘ćˆę‰ń’r“cŽsˆăŽt‰ď”畆‰Čˆă‰ď
2002.11.22
•ó’Ë
@
Possible function of an androgen receptor coactivator ARA55 in dermal papilla cells
S Inui, S Itami, N Fujimoto, Y Fukuzato, T Nakajima, K Yoshikawa
6th Meeting of the German-Japanase Society of Dermatology
2002.11.3
Nara, Japan
@
–ě‹…‘IŽč‚ɐś‚śƒAƒgƒs[‘fˆö‚Ć“Š‹…“Žě‚É‚ć‚é–€ŽC‚ĚŠÖ—^‚ލl‚Ś‚ç‚ę‚˝‰Ý•źó”畆‰Š‚Ě‚P—á |Baseball pitcher's friction dermatitis| iƒ|ƒXƒ^[ÜŽóÜj
ŠŁ@@dŽ÷@@‹gě@–M•F
‘ć27‰ń“ú–{ÚG”畆‰ŠŠw‰ď‘‰ďEŠwp‘ĺ‰ď
2002.11.30-12.1
“Œ‹ž
@
ƒvƒƒNƒƒ‹ƒyƒ‰ƒWƒ“‚É‚ć‚éŒőü‰ß•qŒ^–ň]‚Ěˆę—á
‹g“c@’ź”ü@@žwŕV@F”V@@Źă@@”Ž@@Šp@—˛”V@@•Đ‰Ş@—tŽq
‘ć27‰ń“ú–{ÚG”畆‰ŠŠw‰ď‘‰ďĽŠwp‘ĺ‰ď
2002.11.30-12.1
“Œ‹ž
@
‘ĺă˜JĐ•a‰@‚É‚¨‚Ż‚éĺń጑΍ô‚ĚŒťó
“y‹@•q–ž
–{‰@ˆă‹Ç‰ď
2002.11.7
‰@“ŕ
@
”畆ŽžŠł‚É”ş‚¤—}‚¤‚Ǐó
‰H”’@@˝
ƒ‰ƒWƒI‚˝‚ń‚ρ@ƒƒfƒBƒJƒ‹ƒR[ƒi[
2002.12
‘ĺă
@
•\”ç×–E‚É”­Œť‚ˇ‚郂ƒfƒ‹äPŒ´‚É“ÁˆŮ“I‚Č×–EáŠQŤ‚s×–E‚Í‹š‘BŠO‚Ĺ•Ş‰ťŹn‚ľ, d“ĂȔ畆Çó‚đ—U“ą‚ˇ‚é
Ź“¤ŕVG–ž@@Źă@@”Ž@@˛–ě@‰h‹I@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć32‰ń“ú–{–ƉuŠw‰ď‘‰ď
2002.12
“Œ‹ž
@
üóIgA…ávÇ‚Ě‚P—á
b”ă—T”üŽq@@–î–ě“oŽuŒb@@ˆäăç’ĂŽq
‘ć374‰ń‘ĺă’n•ű‰ď
2002.12
‘ĺă
@
‘˝Œ^g”Á—l”ç]‚đ•š”­‚ľ‚˝Źl‚s×–E”’ŒŒ•a
’JŠ_@••F
‘ć374‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
2002.12.14
‘ĺă
@
ƒ}ƒ€ƒV™ů‚Ě‚S—á
ź–{@ç•ä@@‘ĺ‘O‚ ‚ä‚݁@@ŽR–{@ŽuD
‘ć374‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.12.14
‘ĺă
@
—Lž™×–EŠŕ‚đ•š”­‚ľ‚˝ć“VŤ•\”琅ávÇ‚Ěˆę—á
ź–ě@@—m@@ŕV“c@—R‰Ŕ@@‹{“‡@@i@@‰Ş“c“Ţ’ĂŽq
‘ć374‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.12.14
‘ĺă
@
‘˝Œ`g”Á—l”ç]‚đ•š”­‚ľ‚˝ŹlT×–E”’ŒŒ•a
’JŠ_@••F@@’r“c
‘ć374‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.12.14
‘ĺă
@
Spitz•ę”Á‚Ě‚Q—á
“cč@“TŽq@@ź“c@@Œ’@@Źă@@”Ž@@“y‹@•q–ž
‘ć374‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.12.14
‘ĺă
@
ƒAƒgƒs[Ť”畆‰Š‚Ɣ畆ŽžŠł
‰€“c@‘•c
–Ľ–ĘŽs–ňÜŽt‰ď
2002.12.18
–Ľ–Ę
@
‰–Ž_ƒsƒyƒŠƒfƒ“‚É‚ć‚éE‹ĆŤÚG”畆‰Š‚Ěˆę—á
’J@@@Žç@@“Ą–{@Œ\ˆę
‘ć374‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.12.4
‘ĺă
@
•\”ç×–E‚É”­Œť‚ˇ‚郂ƒfƒ‹RŒ´‚É“ÁˆŮ“I‚Č×–EáŠQŤT×–E‚Í‹š‘BŠO‚Ĺ•Ş‰ťŹn‚ľd“ĂȔ畆Çó‚đ—U“ą‚ˇ‚éB
H Azukizawa, H Kosaka, S Sano, S Itami and K Yoshikawa
“ú–{–ƉuŠw‰ď
2002.12.4
“Œ‹ž
@
Poroid (nodular) hidradenoma ‚Ě‚P—á
Œă“Ą@Í•v
‘ć31‰ń@“ňčˆÉ’O”畆‰Č•a‰@‹Î–ąˆăŒ¤‹†‰ď
2002.12.5
“ňč
@
Solitary fibrofolliculoma‚Ě‚P—á
ŽR–{@ˆŰl
‘ć31‰ń@“ňčˆÉ’O”畆‰Č•a‰@‹Î–ąˆăŒ¤‹†‰ď
2002.12.5
“ňč
@
A case of contact dermatitis due to Benzalkonium chloride in eye drops
Mika Terao, Kentaro Ozawa, Satoshi Itami, Kunihiko Yoshikawa
Japan-China joint meeting@
2002.12.6-8
LB i’†‘j
@
IFN-ƒż—Ă–@’†‚É‹}Œƒ‚É”ç]‚ޏoŒť‚ľ‚˝Šç–ĘˆŮ•¨’“ü—á‚ĚŒoŒą
‘ĺ‘O‚ ‚ä‚݁@@ŽR–{@ŽuD@@ź–{@ç•ä@@­“c@‰ŔŽq@@ˆÉ“Ą@—TŒ[
‘ć79‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”Šwp‘ĺ‰ď
2002.12.7
‘ĺă
@
“ŕ‰ČŽžŠł‚É‚¨‚Ż‚é”畆•a•Ď‚ĚŒŠ•ű
“y‹@•q–ž
”Ş”öˆăŽt‰ďŠwpu‰‰
2002.12.7
”Ş”ö
@
Ž‡ŠOüĆŽË‚É‚ć‚é DNA ‚Ć‘š‚Ćƒƒ‰ƒjƒ“—ʂ̐lŽíŠÔ‚ĚŒŸ“˘
“cŠ@äŽk@@Ź—с@M•F@@ˆÉ“Ą@Ë•ă@@Žáź@ˆę‰ë@@”ÂŒŠ@@’q@@‹gě@–M•F@@Zmudzka Barbara.B@@Beer Janusz.Z @@Hearing Vincent.J@
‘ć16‰ń“ú–{F‘f×–EŠw‰ď
2002.12.7-8
–źŒĂ‰Ž
@
Šáâ|“ŕŽîᇂ̌oŒą`Œo“ŞŠW“IƒAƒvƒ[ƒ`‚É‚Ä“Eo‚ľ‚˝‚R—á`
‹g—´@ŸŽq@@‚–؁@@ł
‘ć13‰ń‹`Šá°Œ¤‹†‰ď
2002.2
‘ĺă
@
Š×“ü’܂ɑ΂ˇ‚é’´’eŤƒƒCƒ„[‚É‚ć‚éŽg—pŒoŒą
–î–ě“oŽuŒb@@’ˇ’J•”MŹ@@ˆäăç’ĂŽq
‘ć369‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.2
‘ĺă
@
1.ƒCƒ\ƒWƒ“ƒXƒNƒ‰ƒu, 2.ƒXƒeƒŠƒNƒƒ“ƒXƒNƒ‰ƒu, 3.ƒrƒIƒŒ‚t, 4.‚a‚j…, 5.…“š…‚ž‚Ż‚ĚŽčô‚˘‚É‚¨‚Ż‚éŽčś‚̏œ‹ŰŒř‰Ę‚Ě”äŠr
‰Ş–ě@šŽ÷@@ó‘q@Gˆę@@“c’†@•q”Ž
‘ć18‰ń“ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ďEŠwp‘ĺ‰ď
2002.2.13-15
‰Ą•l
@
‘nŽĄ–ü‹@˜‚ÉŠî‚Ă‚­‘Ť‚¨‚ć‚щş‘Ú’×ᇂ̎Ą—Ă–@
ŽRŒű@—T“ń@@ŹŕVŒ’‘ž˜Y@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć65‰ń“ú–{”畆‰ČŠw‰ď“Œ‹žŽx•”Šwp‘ĺ‰ď
2002.2.16
“Œ‹ž
@
Cowden•a‚Ě‚P—á
’†‘ş@•q–ž@@‰Ź“°@—DŽq@@“ŒŽR@^—˘
‘ć369‰ń@“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.2.2
‘ĺă
@
WâƐŤ•B—ąŽî‚Ě‚P—á
‹g“c@’ź”ü@@žwŕV@F”V@@Źă@@”Ž@@Šp@—˛”V@@•Đ‰Ş@—tŽq
‘ć369‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.2.2
‘ĺă
@
Sweet•a—lÇó‚đ’ć‚ľ‚˝ƒx[ƒ`ƒFƒbƒg•a‚Ěˆę—á
ź–ě@@—m@@ˆÉ“Ą@—R‰Ŕ@@‹{“‡@@i@@‰Ş“c“Ţ’ĂŽq@@–k‘ş@@—m
‘ć369‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.2.2
‘ĺă
@
‹Í‚Š‚T•b‚̐…“š…‚ž‚Ż‚ĚŽčô‚˘‚Ĺ‚ŕ, ŽŔs‚ˇ‚ę‚Ή@“ੴő—\–h‚ɖ𗧂‚Ǝv‚¤B
‰Ş–ě@šŽ÷@@ó‘q@Gˆę@@“c’†@•q”Ž
‘ć17‰ń“ú–{ŠÂ‹ŤŠŁáŠw‰ď
2002.2.22-23
‘ĺă
@
ŹlŒ^ƒAƒgƒs[Ť”畆‰Š‚ĚŽĄ—Ă iu‰‰j
˛“Ą@Œ’“ń
ASIC10Žü”NƒVƒ“ƒ|ƒWƒEƒ€ uƒAƒgƒs[Ť”畆‰Š‚ĚŽĄ—Áv
2002.2.24
‘ĺă
@
DNA Damage and Melanin Content Induced by 1MED of Ultraviolet Radiation in Human Skin within Various Racial/Etthnic groups and Photo types
Taketsugu Tadokoro, Nobuhiko Kobayashi, Janusz Z.Beer, Barbara Z. Zmudzka,,and Vincent J.Hearing
Photobiology Interest Group Meeting
2002.2.27
WashingtonDC
@
ám᝗\–hƒ}ƒjƒ…ƒAƒ‹ěŹ‚ɂ‚˘‚Ä
‰€“c@‘•c
‘ĺă•{’r“cŽs•ŰŒ’Š
2002.2.28
’r“c
@
ƒAƒgƒs[Ť”畆‰Š‚Ě•ęe‹łŽş
‰€“c@‘•c
‘ĺă•{’r“cŽs•ŰŒ’Š
2002.2.28
’r“c
@
—DŤ‰h—{áŠQŒ^•\”琅ávÇ‚Ě‚P—á
‘ĺ•“Ţ’ĂŽq@@”óŒű@š‘Ľ@@”’ˆä@—˜•F@@‹{ě@KŽq
‘ć370‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.3
“V—
@
’PƒŒ^•\”琅ávÇ‚Ě‚P—á
”óŒű@š‘Ľ@@‘ĺ•“Ţ’ĂŽq@@”’ˆä@—˜•F@@‹{ě@KŽq
‘ć370‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.3
“V—
@
f’f—áFMycosis fungoides?
ˆî‹{@’m”ü@@ŕ_“c@ç‰Ř@@ź–{@ç•ä@@‘ĺ˜a’JiŽq@@ˆÉ“Ą@—TŒ[
‘ć158‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
2002.3.14
‘ĺă
@
ƒvƒƒgƒsƒbƒN“îpR‚ĚŽg—p‚Ĺ‹C‚É‚Č‚é”­ŠŕŤ‚ɂ‚˘‚āB ƒAƒgƒs[Ť”畆‰Š‚É–Ÿ‘R‚Ć‚ž‚ç‚ž‚çŽg‚Á‚Ä‘ĺä•v‚Č‚Ě‚Š‚Ç‚¤‚ŠB
‰Ş–ě@šŽ÷
‘ć383‰ń“ú–{”畆‰ČŠw‰ď‹žŽ ’n•ű‰ď-ăŒ´ł–¤‹łŽö‘ŢŠŻ‹L”O
2002.3.15
‘ĺ’Ă
@
‘˝Ę‚Č—Ő°Çó‚đ’ć‚ľ, ŽčŽw, ‘Ťćä‰óás‚ɊׂÁ‚˝DŽ_‹…‘‘˝ÇŒóŒQ‚Ěˆę—á
‹{“‡@@i@@ˆÉ“Ą@—R‰Ŕ@@‰Ş“c“Ţ’ĂŽq
‘ć14‰ń“ú–{ƒAƒŒƒ‹ƒM[Šw‰ďtŠú—Տ°‘ĺ‰ď
2002.3.21-23
ç—t
@
BCGÚŽí‚Ĺ•›”˝‰ž‚𐜂ś‚˝‚P—á
“cč@“TŽq@@ź“c@@Œ’@@‘q’m‹MŽu˜Y@@’JŠ_@••F
‘ć370‰ń“ú”ç‰ď‘ĺă’n•ű‰ď
2002.3.23
“Ţ—Ç
@
BCGÚŽí‚Ĺ•›”˝‰ž‚𐜂ś‚˝‚P—á
“cč@“TŽq@@ź“c@@Œ’@@‘q’m‹MŽu˜Y@@’JŠ_@••F i‘ĺă˜JĐj
‘ć370‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.3.23
“Ţ—Ç
@
‹}Ť• •”Çó‚Ĺ”­Ç‚ľ‚˝ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á‚Ě‚P—á
ŕ_“c@ç‰Ř@@ˆî‹{@’m”ü@@ź–{@ç•ä@@‘ĺ˜a’JiŽq
‘ć370‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.3.23
“Ţ—Ç
@
‹}Ť• •”Çó‚Ĺ”­Ç‚ľ‚˝ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á‚Ě‚P—á
ŕ_“c@ç‰Ř@@ˆî‹{@’m”ü@@ź–{@ç•ä@@‘ĺ˜a’JiŽq
‘ć370‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.3.23
“Ţ—Ç
@
MDS‚É”ş‚Á‚˝”ç]
‹î’J–ƒˆßŽq
‘ć28‰ń“ňčˆÉ’O”畆‰Č•a‰@‹Î–ąˆăŒ¤‹†‰ď
2002.3.7
“ňč
@
“–‰Č‚É‚¨‚Ż‚éŠáâ|“ŕŽîᇂ̌oŒą
‹g—´@ŸŽq@@‚–؁@@ł
‘ć45‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďŠwp‘ĺ‰ď
2002.4
’ˇč
@
“Á•Ęu‰‰E–Ń‚Ć’jŤƒzƒ‹ƒ‚ƒ“
”ÂŒŠ@@’q
‘ć39‰ń‰YˆŔ”畆‰Č—Տ°§˜b‰ď
2002.4.11
‰YˆŔ
@
ƒAƒgƒs[Ť”畆‰Š‚Ě‘~”j—}§—Ă–@
•Đ‰Ş@—tŽq
‘ć18‰ń“ú–{—Տ°”畆‰ČˆăŠw‰ď‘‰ďĽŠwp‘ĺ‰ď
2002.4.13-14
ĺ‘ä
@
“ŕ‘¤•Ç’P“Ć‚ĚŠáâ|ƒuƒ[ƒAƒEƒgœÜ‚É‚¨‚Ż‚é–â‘č“_
ź“c@@Œ’ iŒ`ŹŠO‰Čj@@Š_•Ł@ł’j@@‰Í‡Œšˆę˜Y i•şŒÉˆă‘厨•@‰Čj
‘ć45‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď
2002.4.17
’ˇč
@
ŒŒŠÇŽB‰e—Ěˆć‚É‚¨‚Ż‚é•úŽËü”畆áŠQ‚ĚŽŔó‚Ć‘Îô i‚Pj ”畆áŠQŽ–—á‚Ć‚ť‚ĚŽĄ—Ă‚É‚ ‚˝‚Á‚Ä
‘ĺ˜a’JiŽq
•úŽËü–hŒě•Ş‰Č‰ď‘ć58‰ń‘‰ďŠwp‘ĺ‰ď
2002.4.4
_ŒË
@
ŹlŒ^ƒAƒgƒs[Ť”畆‰Š‚ɂ‚˘‚Ä iu‰‰j
˛“Ą@Œ’“ń
ă_’n‹ć•a‰@Ef—ÏŠ‡“Ż•×‹­‰ď
2002.4.6
ˆÉ’O
@
ƒAƒgƒs[Ť”畆‰ŠŠłŽŇ‚̐SgˆăŠw“I‚Ȑf’fŠî€‚Ć•]‰żŽÚ“x‚̍쐬
ˆŔ“Ą@“N–ç@@‰H”’@@˝@@–ě“c@Œ[Žj@@Ž›”ö@@_@@Žu‘ş@@‰@@˛‹vŠÔłŠ°@@ŒĂ]@‘—˛@@‰Ą“c@‹ÓŽ™@@źŠÔ@ŽOŠ]@@Îě@r’j@@Ź–q@@Œł
‘ć43‰ń“ú–{SgˆăŠw‰ď‘‰ď
2002.5
“Œ‹ž
@
ƒAƒgƒs[Ť”畆‰Š‚¨‚ć‚Ń–Ťĺ@–ƒ]ŠłŽŇ‚̐EęEŠwZ•s“K‰ž‚ɂ‚˘‚Ä
‰H”’@@˝
‘ć43‰ń“ú–{SgˆăŠw‰ď‘‰ď
2002.5
“Œ‹ž
@
ŹlŒ^ƒAƒgƒs[Ť”畆‰ŠŠłŽŇ‚Ě‘~”js“Ž‚ɑ΂ˇ‚éƒZƒ‹ƒtƒ‚ƒjƒ^ƒŠƒ“ƒO‚ɂ‚˘‚Ä
Î“c@—LŠó@@‰H”’@@˝@@â–ě@—Y“ń
‘ć43‰ń“ú–{SgˆăŠw‰ď‘‰ď
2002.5
“Œ‹ž
@
–Ń“ű“ލזE‚É‚¨‚Ż‚éƒAƒ“ƒhƒƒQƒ“ƒŒƒZƒvƒ^[ƒRƒAƒNƒeƒBƒx[ƒ^[Hic-5/ARA55‚Ě”­Œť—Ę‚ĆŠˆŤ‚̉đÍ
ŠŁ@@dŽ÷@@•Ÿ—˘@—zŽq@@’†“‡@•”V@@‹gě@–M•F@@”ÂŒŠ@@’q
‘ć10‰ń–Ń”Ż‰ČŠwŒ¤‹†‰ď
2002.5.11
VŠƒ
@
“Á•Ęu‰‰E–ъ튯‚É‚¨‚Ż‚é×–E“ŕƒVƒOƒiƒ‹“`’B‹@\
”ÂŒŠ@@’q
‘ć10‰ń–Ń”Ż‰ČŠwŒ¤‹†‰ď
2002.5.11
VŠƒ
@
Induction of Generalized Skin Disease by Antigen-specific Cytotoxic T Lymphocytes That Develop Extrathymically
H Azukizawa, H Kosaka, S Sano, S Itami, and K Yoshikawa
63rd SID
2002.5.15
LA, U.S.A.
@
Ž„‚̏ˆ•ű|”畆‰ČŽžŠł‚Ě–ň•¨—Ă–@| iu‰‰j
˛“Ą@Œ’“ń
‘ć7‰ń—Տ°–ňŠwƒZƒ~ƒi[
2002.5.16
ˆÉ’O
@
Impact of Ras effectors RalGDS, Akt, and Raf on epidermal growth and differentiation.
M Tarutani, M Dajee, Q Lin, and P Khavari
63rd SID
2002.5.18
LA, U.S.A.
@
Regulated Ras function in transgenic skin demonstrates potent and reversible Ras effects on epidermal growth and differentiation.
M Tarutani, M Dajee, T Cai, and P Khavari
63rd SID
2002.5.18
LA, U.S.A.
@
Adiponectin, an adipose-specific cytokine, enhances keratinocyte proliferation and migration through the activation of extracellular signal-regulated kinase 1/2.
Nakatani Y, Yamaguchi Y, Nishida M, Kihara S, Shimomura I, Nishizawa H, Funahashi T, Matsuzawa Y, Itami S, Yoshikawa K.
‘ć63‰ń@The Society for Investigative Dermatology
2002.5.18
Los Angeles, California, USA
@
Rapid@Healing@of chronic foot and leg ulcers by the exposure of bone marrow cells and epidermal grafting.
Yamaguchi Y, Kubo T, Ozawa K, Asada H, Hakamada T, Murakami T, Takahashi M, Kobayashi E, Yoshikawa K, Itami S.
‘ć63‰ń@The Society for Investigative Dermatology
2002.5.18
Los Angeles, California, USA
@
ƒAƒgƒs[Ť”畆‰Š‚ĚŽĄ—Á@|“ű—cŽ™Šú‚Š‚çŠw—îŠú‚𒆐S‚É
•Đ‰Ş@—tŽq
‘ć19‰ń“ú–{ŹŽ™“šb‘§ĽƒAƒŒƒ‹ƒM[ŽžŠłŠw‰ď
2002.5.18-19
‘ĺă
@
qíŤ”^ጂ̂P—á
ŽR–{@—˛”V@@X“c@”ŽŽq@@”~“c@“ń˜Y@@’˛@@—TŽŸ
‘ć159‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
2002.5.9
‘ĺă
@
ƒqƒgŒ‹ßŤd TSC1C TSC2‚Ě×–EŽüŠú’˛ß‚ĚƒƒJƒjƒYƒ€
‹ŕ“c@^—@@”ó–ě@‹ť•v@@‘Ť—§@_K@@‹gě@–M•F
‘ć101‰ń“ú”ç‰ď‘‰ď
2002.6
@
@
—‘‘ƒ”t×–EŽîᇂɍ‡•š‚ľ‚˝”畆”ě–ž×–EÇ
‘ĺ•“Ţ’ĂŽq@@”óŒű@š‘Ľ@@‹{ě@KŽq@@–p@@‰i“Œ@@Žs“‡@š —Y
‘ć101‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2002.6
ŒF–{
@
Šááَ‰‘BŠŕ‚Ě‚R—á`Pitfall in diagnosis`
‹g—´@ŸŽq@@‚–؁@@ł
‘ć78‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖźŽx•”ŠwpW‰ď
2002.6
‘ĺă
@
—°Ž_“S‚É‚ć‚é–ň]‚Ěˆę—á
’J@@@Žç@@“Ą–{@Œ\ˆę
‘ć95‰đ‹ß‹E”畆‰ČW’k‰ď i‘ĺăj
2002.6
‘ĺă
@
Ž‰–b—Ţ‰óŽ€Ç‚É‚¨‚Ż‚éƒJƒ‹ƒ{ƒLƒVƒƒ`ƒ‹ƒŠƒWƒ“‚Ě’ž’…
ŠŁ@@dŽ÷@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć380‰ń@“ú–{”畆‰ČŠw‰ď‹žŽ ’n•ű‰ď
2002.6.1
‹ž“s
@
Clear Cell Acanthoma ‚Ě‚P—á
ŽR–{@ˆŰl
‘ć29‰ń@“ňčˆÉ’O”畆‰Č•a‰@‹Î–ąˆăŒ¤‹†‰ď
2002.6.13
“ňč
@
‘Ť‚ɐś‚¸‚éŒ{Šá, äEăń‚̐ł‘Ě‚Íánć҂Š‚Ç‚¤‚ŠB
‰Ş–ě@šŽ÷
‘ć95‰ń‹ß‹E”畆‰ČW’k‰ď
2002.6.2
‘ĺă
@
IgA“V•÷ጂ̈ę—á
‹g“c@’ź”ü@@žwŕV@F”V@@Źă@@”Ž@@Šp@—˛”V@@•Đ‰Ş@—tŽq
‘ć95‰ń‹ß‹E”畆‰ČW’k‰ď
2002.6.2
‘ĺă
@
ŽčŽw, ‘Ťćä‰óás‚ɊׂÁ‚˝DŽ_‹…‘‘˝ÇŒóŒQ, ŠŚ—â‹ĂW‘fÇ‡•š‚Ěˆę—á
‹{“‡@@i@@ź–ě@@—m@@ˆÉ“Ą@—R‰Ŕ@@‰Ş“c“Ţ’ĂŽq
‘ć95‰ń‹ß‹E”畆‰ČW’k‰ď
2002.6.2
‘ĺă
@
”畆NK cell lymphoma ‚Ě‚P—á
ŽR–{@ˆŰl@@‹î’J–ƒˆßŽq@@Œă“Ą@Í•v@@˛“Ą@Œ’“ń i”畆‰Čj@@—§ě@–LŽj i“ŕ‰Čj@‰Yě@W–ç i_ŒËŽsj
‘ć95‰ń‹ß‹E”畆‰ČW’k‰ď
2002.6.2
‘ĺă
@
Remitting Seronegative Symmetrical Synovitis with Pitting Edema(RS3PE)ÇŒóŒQ‚Ěˆę—á
ŽR–{@—˛”V@@X“c@”ŽŽq@@”~“c@“ń˜Y@@’˛@@—TŽŸ
‘ć95‰ń‹ß‹E”畆‰ČW’k‰ď
2002.6.2
‘ĺă
@
ƒGƒgƒŒƒ`ƒi[ƒg‚Ş‘tŒ÷‚ľ‚˝d‰ťŤˆŢˆŢkŤ‘Űᝂ̂P—á
ź‰Ş@@‰@@‰ĄŒŠ@–ž“T@@‘˝“c@łŒ›
‘ć95‰ń‹ß‹E”畆‰ČW’k‰ď
2002.6.2
‘ĺă
@
‰ş• •”‚ɐś‚ś‚˝–Iâ|D‰Š
‘ĺ‘O‚ ‚ä‚݁@@–î–ě“oŽuŒb@@ˆäăç’ĂŽq
‘ć95‰ń‹ß‹E”畆‰ČW’k‰ď
2002.6.2
‘ĺă
@
Langerhans cell histiocytosis‚Ě‚P—á
“ŒŽR@^—˘@@’†‘ş@•q–ž@@‰Ź“°@—DŽq@@ŽwŒ´@–ƒŽq@@’rŒ´çˆßŽq i“ŻŹŽ™‰Čj@Â–؁@•q”V i‘ĺăŽsj
‘ć95‰ń‹ß‹E”畆‰ČW’k‰ď
2002.6.2
‘ĺă
@
’jŤŒ^’E–ŃÇ‚ÉŠO—pR^‹ŰÜ‚ÍŒř‚­‚Ě‚Š‚Ç‚¤‚ŠB
‰Ş–ě@šŽ÷
‘ć8‰ń“ú–{EƒAƒWƒA—Տ°–Ń”ŻŠO‰ČŠw‰ď
2002.6.23
‘ĺă
@
“Á•Ęu‰‰E‘gDÄśF–Ń•ď‚đƒ‚ƒfƒ‹‚Ć‚ľ‚Ä
”ÂŒŠ@@’q
‘ć‚W‰ń“ú–{EƒAƒWƒA—Տ°–Ń”ŻŠO‰ČŠw‰ď
2002.6.23
‘ĺă
@
ä`‚̔畆•a‚R—á
‘Ť—§@@€@@ŽO‰Y@G”V@@Ż“c—T‹IŽq
‘ć58‰ń•şŒÉŒ§”畆‰Čˆă‰ď‘‰ď
2002.6.29
_ŒË
@
ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[E’jŤŒ^’E–Ń‚Ě”­ÇƒƒJƒjƒYƒ€
”ÂŒŠ@@’q
‘ć101‰ń“ú–{”畆‰ČŠw‰ď
2002.6.7
ŒF–{
@
ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[E“Ť”畆’×ᇂ̎Ą—Ă
”ÂŒŠ@@’q
‘ć101‰ń“ú–{”畆‰ČŠw‰ď
2002.6.7
ŒF–{
@
Źl‚Ě“`őŤg”Á
“ŒŽR@^—˘@@’†‘ş@•q–ž@@‰Ź“°@—DŽq
‘ć101‰ń@“ú–{”畆‰ČŠw‰ď‘‰ď
2002.6.7-9
ŒF–{
@
ƒAƒgƒs[Ť”畆‰ŠŠłŽŇ––˝ŒŒ’PŠj‹…‚ĚƒOƒ‹ƒRƒRƒ‹ƒ`ƒRƒCƒhƒŒƒZƒvƒ^[b”­Œť—Ę‚ĚŒŸ“˘
ŠŁ@@dŽ÷@@Ÿě@–ő”V@@ó“c@G•v@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć101‰ń@“ú–{”畆‰ČŠw‰ď‘‰ď@
2002.6.7-9
ŒF–{
@
PSS‚Ě‘Ť•”‚ɐś‚ś‚˝Šî’ę×–EŠŕ‚Ěˆę—á
ˆÉ“Ą@—R‰Ŕ@@ź–ě@@—m@@‹{“‡@@i@@‰Ş“c“Ţ’ĂŽq
‘ć101‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2002.6.7-9
ŒF–{
@
Œo‰ß’†’˜–ž‚Č“`“ąáŠQ‚đ‡•š‚ľ‚˝ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ěˆę—á
‹{“‡@@i@@ź–ě@@—m@@ˆÉ“Ą@—R‰Ŕ@@‰Ş“c“Ţ’ĂŽq
‘ć101‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2002.6.7-9
ŒF–{
@
“œ”A•aŤ’×á‡, ‰óás|‚ť‚Ě•a‘Ô‚Ć—Ő°|
‹{“‡@@i@@‰Ş“c“Ţ’ĂŽq
‘ć101‰ń“ú–{”畆‰ČŠw‰ď‘‰ď iƒCƒuƒjƒ“ƒOƒZƒ~ƒi[j
2002.6.7-9
ŒF–{
@
ƒAƒgƒs[Ť”畆‰Š‚Ě”ç]‚Ě•Ş•z‚É–{Ç‚̐ł‘Ě‚đ–\‚­ƒqƒ“ƒg‚Ş‚ ‚é‚Í‚¸B
‰Ş–ě@šŽ÷
‘ć101‰ń“ú–{”畆‰ČŠw‰ď‘‰ďEŠwp‘ĺ‰ď
2002.6.7-9
ŒF–{
@
ƒXƒeƒƒCƒhŠO—pÜ’ˇŠú“h•z‚É‚ć‚é”畆‚ւ̉e‹ż i‘ć‚Q•ńjB ƒAƒgƒs[‚Ć‚Ě•t‚Ť‡‚˘•ű‚Ě–ÍőB
‰Ş–ě@šŽ÷
‘ć101‰ń“ú–{”畆‰ČŠw‰ď‘‰ďEŠwp‘ĺ‰ď
2002.6.7-9
ŒF–{
@
ƒOƒŠƒNƒ‰ƒWƒh‚Épersistent light reaction‚ƍl‚Ś‚ç‚ę‚é‚P—á
ŽR–{@ŽuD@@ŠŁ@@dŽ÷@@ŹŕVŒ’‘ž˜Y@@’‡‘ş@‰ë˘@@’ră@—˛‘ž@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć101‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2002.6.9-9
ŒF–{
@
Cloning of a novel androgen receptor coactivator, ARA55/Hic-5, and analysis of its possible function in dermal papilla cells.
Inui S, Itami S, Fujimoto N, Fukuzato Y, Nakajima T, Yoshikawa K
20th World Congress of Dermatology
2002.7.1-5
Paris
@
Ž‡ŠOü‚É‚ć‚é‘˝lŽíŠÔ‚̔畆 DNA ‘š‚Ćƒƒ‰ƒjƒ“ŽYś‚ĚŒŸ“˘
“cŠ@äŽk
‘ć33‰ń‘ĺăŠŕŽĄ—ĂŒ¤‹†‰ď
2002.7.10
‘ĺă
@
• •”Žčp, ƒzƒ‹ƒ‚ƒ“—Ă–@Œă‚ɐś‚ś‚˝• •ÇƒfƒXƒ‚ƒCƒhŽîá‡
‰Ź“°@—DŽq@@’†‘ş@•q–ž@@“ŒŽR@^—˘
‘ć160‰ń@‘ĺă”畆‰ČÇ—ጟ“˘‰ď
2002.7.11
@
@
‚“x‚Ě•‚Žî‚𔺂Á‚˝g”çÇŒ^–ň]‚Ě‚P—áFINH‚É‚˝‚˘‚ˇ‚éDLST‚¨‚ć‚Ńƒpƒbƒ`ƒeƒXƒg‚É‚ć‚é”˝‰ž
Źă@@”Ž@@‹g“c@’ź”ü@@žwŕV@F”V@@Šp@—˛”V@@•Đ‰Ş@—tŽq
‘ć32‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď‘‰ďĽŠwp‘ĺ‰ď
2002.7.20-21
‘ĺă
@
“Á•Ęu‰‰E–Ń‚Ě×–Eś•¨Šw‚ĆŠÖ˜AŽžŠł
”ÂŒŠ@@’q
‹{é”畆ŽžŠłŠwpu‰‰‰ď
2002.7.24
ĺ‘ä
@
”űŠÔ‚̔牺Žîá‡
‘唨@ç‰Ŕ@@‰Ô“c@łl iŽs—§–L’†•a‰@•a—f’f‰Čj
‘ć18‰ń“ú–{•a—‘gDŠw‰ď
2002.7.27
“Œ‹ž
@
In vitro model system of androgenetic alopecia
”ÂŒŠ@@’q
‘ć20‰ń˘ŠE”畆‰ČŠw‰ď
2002.7.5
Paris
@
Extrathymic Maturation of Skin Antigen-specific Cytotoxic T Lymphocytes Results in Toxic Epidermal Necrolysis.
H Azukizawa, H Kosaka, S Sano, S Itami, and K Yoshikawa
JSID
2002.8.2
‹ž“s
@
BCL-XL AND THE PI3K-AKT PATHWAY FORM A COOPERATIVE AND INTERCOMPENSATORY AXIS, FAIL SAFE SYSTEM TO PREVENT APOPTOSIS OF KERATINOCYTES IN VIVO
J.Umeda, S.Sano, T.Watanabe, K Yoshikawa, S.Itami, G.Kondoh, J.Takeda
“ú–{Œ¤‹†”畆‰ČŠw‰ď‘ć27‰ń”NŽŸŠwp‘ĺ‰ďE‘‰ď
2002.8.2
‹ž“s
@
Inappropriate secretion of antidiuretic hormone under hypernaturemia in patients with adult-type atopic dermatitis
˛“Ą@Œ’“ń@@‹î’J–ƒˆßŽq@@‹´–{‹vm•F@@ŒĂ‰ę@łŽj
‘ć27‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ď
2002.8.2-3
‹ž“s
@
•\”çŠp‰ť×–E“ÁˆŮ“Ip38Œ‡Ž¸ƒ}ƒEƒX‚Í UVB ĆŽËƒAƒ|ƒg[ƒVƒX‚É’ďRŤ‚đŽŚ‚ˇ
Ź—с@Ć–ž@@˛–ě@‰h‹I@@”ÂŒŠ@@’q@@”~“c@“ń˜Y@@‹gě@–M•F@@{“Ą@—´•F@@ź“c@˜a•F@@‘ĺ’Á@‹Ó–ç@@’|“c@“ń
‘ć27‰ń“ú–{Œ¤‹†”畆‰ČŠw‰ďŠwp‘ĺ‰ď
2002.8.2-3
‹ž“s
@
Ú‡•”Œ^ć“VŤ•\”琅ávÇ‚Ě‚P—á
‰Ş–ě@šŽ÷
‘ć17‰ńŠp‰ťÇŒ¤‹†‰ď
2002.8.24
“Œ‹ž
@
”­Œť‚đ§Œä‚Ĺ‚Ť‚éƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚đ—p‚˘‚˝ Ras ’`”’Žż‚Ě•\”ç‚É‚¨‚Ż‚é–đŠ„‚ĚŒŸ“˘
’M’J@Ÿm@@”ÂŒŠ@@’q@@‹gě@–M•F@@P.A. Khavari
‘ć17‰ńŠp‰ťÇŒ¤‹†‰ď
2002.8.24
“Œ‹ž
@
“Á•Ęu‰‰F“Ť’×ᇁ[•\”çE^”ç‘ŠŒÝě—p‚̏d—vŤ‚ɂ‚˘‚Ä
”ÂŒŠ@@’q
‘ć63‰ńŠň•Œ”畆‰Čˆă‰ď
2002.8.25
Šň•Œ
@
’EF‘f”Á‚Ě—Ő°“IˆÓ‹`‚đÄ”FŽŻ‚ľ“ž‚˝double Paget's disease‚Ě‚P—á
‰Ąˆä@ËŽq@@Ź—с@M•F@@‘ĺ•“Ţ’ĂŽq@@ŽR‰Č@K•v@@‹{ě@KŽq@@ŒKŒ´@—[@@”g°@Œő’j
‘ć373‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.9
_ŒË
@
”ń’čŒ^R¸_•a–ň‚ŐSgˆăŠw“IŽĄ—Ă‚đs‚Á‚˝”畆Š´ŠoˆŮíÇ‚Ě‚R—á
‰H”’@@˝
‘ć53‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”Šwp‘ĺ‰ď
2002.9
Šň•Œ
@
f’f‚ɍ˘‚Á‚˝Žčś‚ɐś‚ś‚˝Œ‹ß
’‡‘ş@‰ë˘@@•—{@@M@@‰€“c@‘•c
‘ĺăÇ—ጟ“˘‰ď
2002.9.12
‘ĺă
@
IFN-ƒż—Ă–@’†, ‹}Œƒ‚ÉˆŮ•¨“÷‰čŽî‚𐜂ś‚˝‚P—á
‘ĺ‘O‚ ‚ä‚݁@@ŽR–{@ŽuD@@ź–{@ç•ä@@­“c@‰ŔŽq@@ˆÉ“Ą@—TŒ[
‘ć161‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď
2002.9.12
‘ĺă
@
1.ƒCƒ\ƒWƒ“ƒXƒNƒ‰ƒu, 2.ƒXƒeƒŠƒNƒƒ“ƒXƒNƒ‰ƒu, 3.ƒrƒIƒŒ‚t, 4.‚a‚j…, 5.…“š…‚ž‚Ż‚ĚŽčô‚˘‚É‚¨‚Ż‚éŽčś‚̏œ‹ŰŒř‰Ę‚Ě”äŠrB
‰Ş–ě@šŽ÷@@ó‘q@Gˆę@@“c’†@•q”Ž
‘ć53‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďEŠwp‘ĺ‰ď
2002.9.14-15
Šň•Œ
@
‘яó‚É‘˝”­‚ľ‚˝”íŠpŒŒŠÇŽî‚Ě‚P—á
ź‰Ş@@‰@@‰ĄŒŠ@–ž“T@@‘˝“c@łŒ›
‘ć53‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”Šwp‘ĺ‰ď
2002.9.15-16
Šň•Œ
@
d•ĄŠŕ‚ƍ‡•š‚ľ‚˝”畆‹Ř‰Š‚Ě‚P—á
ŽR–{@ŽuD@@ŹŕVŒ’‘ž˜Y@@ŸNŞ@ƒŽq@@–ě“c@˜HŽq@@’ră@—˛‘ž@@”ÂŒŠ@@’q@@‹gě@–M•F
‘ć53‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ď
2002.9.15-16
Šň•Œ
@
ƒ^ƒNƒƒŠƒ€ƒX“îpŠO—p‚Ćbath-PUVA —Ă–@‚Ş‘tŒ÷‚ľ‚˝Chronic G raft-vs-Host Disease‚Ě‚P—á
’†‘ş@•q–ž@@‰Ź“°@—DŽq@@“ŒŽR@^—˘ i”畆‰Čj@@’†ě@‰ëŽj@@––‘şłŽ÷ i‘ć3“ŕj
‘ć53‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ď
2002.9.15-16
Šň•Œ
@
‰E‰ş‘ڂɔ牺”^ᇂđŒ`Ź‚ľ‚˝Wegener“÷‰čŽîÇ
ŕV“c@—R‰Ŕ@@ź–ě@@—m@@‹{“‡@@i@@‰Ş“c“Ţ’ĂŽq
‘ć53‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ď
2002.9.15-16
Šň•Œ
@
ƒAƒ‹ƒR[ƒ‹ŤŠĚd•Ď‚É”ş‚¤’vŽ€“I‹Ř“÷ŒŒŽî‚Ěˆę—á
Źă@@”Ž@@‹g“c@’ź”ü@@žwŕV@F”V@@Šp@—˛”V@@•Đ‰Ş@—tŽq
‘ć53‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďĽŠwp‘ĺ‰ď
2002.9.15-16
Šň•Œ
@
Œo‰ß‚Ě‹}‚ČŠç–Ę‚Ě—Ţă”ç“÷‰čŽî
‘唨@ç‰Ŕ@@’ră@—˛‘ž@@‰Ž‹ň@_Žq
‘ć53‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďEŠwp‘ĺ‰ď
2002.9.15-16
Šň•Œ
@
Ž‡ŠOüĆŽË‚É‚ć‚é DNA ‘š•Ŕ‚Ń‚Éƒƒ‰ƒjƒ“ŽYś‚̐lŽíŠÔˇ‚ĚŒŸ“˘
“cŠ@äŽk@@Ź—с@M•F@@Beer Janusz.Z @@Zmudzka Barbara.B@@ˆÉ“Ą@Ë•ă@@Žáź@ˆę‰ë@@”ÂŒŠ@@’q@@‹gě@–M•F@@Hearing Vincent.J
‘ć53‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďEŠwp‘ĺ‰ď
2002.9.15-16
Šň•Œ
@
Œ´”­‘ƒ•s–ž‚Ĺ, • •”‘˝‘ŸŠí‚ɐZ‚ľŽ€–S‚ľ‚˝ˆŤŤ•FŽî‚Ěˆę—á
ź–ě@@—m@@‹{“‡@@i@@ŕV“c@—R‰Ŕ@@‰Ş“c“Ţ’ĂŽq@@‹g“c@N”V@@Ź—с@@ˆŔ
‘ć53‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ď
2002.9.15-16
Šň•Œ
@
‹łˆçu‰‰E–Ú‚ĹŒŠ‚é”畆‰ČŠwF“ŕ‰Čˆă‚Ş’m‚Á‚Ä‚¨‚Ť‚˝‚˘”畆•a•Ď
”ÂŒŠ@@’q
‘ć168‰ń“ú–{“ŕ‰ČŠw‰ď‹ß‹EŽx•”’n•ű‰ď
2002.9.21
‘ĺă
@
–ňÜ—U”­Ť‘яóáv]
Ž›”ö@”ü@@ŽR–{@—˛”V@@”~“c@“ń˜Y@@’˛@@—TŽŸ i‚m‚s‚sź“ú–{‘ĺă•a‰@j
‘ć373‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2002.9.21
_ŒË
@
Eccrine porocarcinoma (?) ‚Ě‚P—á
ŽR–{@ˆŰl
‘ć30‰ń@“ňčˆÉ’O”畆‰Č•a‰@‹Î–ąˆăŒ¤‹†‰ď
2002.9.26
“ňč
@
Eccrine poroma (?) ‚Ě‚P—á
Œă“Ą@Í•v
‘ć30‰ń@“ňčˆÉ’O”畆‰Č•a‰@‹Î–ąˆăŒ¤‹†‰ď
2002.9.26
“ňč
@
“Á•Ęu‰‰E–Ń‚Ě×–Eś•¨Šw‚ĆŠÖ˜AŽžŠł
”ÂŒŠ@@’q
H“cŒ§”畆‰Č’k˜b‰ď
2002.9.7
H“c
@
Šî‘b“I‚Č–Ę‚Š‚猊‚˝”畆‰Č‚Ěƒzƒ‹ƒ‚ƒ“Šw@|’jŤŒ^’E–сC $3002ጂŠ‚çƒAƒgƒs[Ť”畆‰Š‚܂Ł|
ŠŁ@@dŽ÷
‘ć145‰ń@ˆ¤’mŒ§”畆‰Čˆă‰ď
2002.9.7
–źŒĂ‰Ž
@
Ultraviolet radiation-induced DNA damage and melanogenesis in human skin of different racial/ethnic origin.
Y. Yamaguchi, T. Tadokoro, J.Z. Beer, B.Z. Zmudzka, S.A. Miller, V.J. Hearing
‘ć18‰ń@International Pigment Cell Conference
2002.9.9-13
Egmond aan Zee ƒIƒ‰ƒ“ƒ_
@
The Inhibitory Effect of Androgen and Sez Hormone-Binding Globulin on the Intracellular cAMP Level and Tyrosinase Activity of Normal Human Melanocytes
Taketsugu Tadokoro, Francois Rouzaud, Satoshi Itami, Kunihiko Yoshikawa and Vincent J Hearing
‘ć18‰ń‘ŰF‘f×–EŠw‰ď
2002.9.9-13
Egmond annZee
@
ƒAƒgƒs[Ť”畆‰Š‚̐SgÇ‚ÉŠÖ‚ˇ‚鎿–⎆‚ĆƒKƒCƒhƒ‰ƒCƒ“
‰H”’@@˝
ƒAƒgƒs[Ť”畆‰ŠŽĄ—ĂŒ¤‹†‰ď‘ć‚W‰ńƒVƒ“ƒ|ƒWƒEƒ€
2003.01
•Ÿ‰Ş
@
ƒAƒgƒs[Ť”畆‰Š (Atotpic dermatitis, AD) ‚̐SgÇ‚Ć‚ľ‚Ă̐f’fEŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“‚̍쐬
ˆŔ“Ą@“N–ç i‘—§¸__ŒoƒZƒ“ƒ^[¸_•ŰŒ’Œ¤‹†ŠSgˆăŠwŒ¤‹†•”j@@‰H”’@@˝ i‘—§‘ĺă•a‰@”畆‰Čj@@Œ´@Mˆę˜Y i‚–źĂ—{•a‰@j@@Îě@r’j i‘—§¸__ŒoƒZƒ“ƒ^[‘•{‘ä•a‰@S—Ă“ŕ‰Čj@@Ź–q@@Œł i‘—§¸__ŒoƒZƒ“ƒ^[¸_•ŰŒ’Œ¤‹†ŠSgˆăŠwŒ¤‹†•”j @@
‘ć‚V‰ń“ú–{S—Ă“ŕ‰ČŠw‰ďŠwp‘ĺ‰ďƒVƒ“ƒ|ƒWƒEƒ€
2003.01
VŠƒ
@
“Á•Ęu‰‰F”畆ÄśˆăŠw|•\”çE^”ç‘ŠŒÝě—p‚̏d—vŤ
”ÂŒŠ@’q
‘ć‚R‰ń‰ŞŽR”畆‰ČƒtƒH[ƒ‰ƒ€
2003.01.18
‰ŞŽR
@
“Á•Ęu‰‰F’jŤŒ^’E–Ń‚Ě”­ÇƒƒJƒjƒYƒ€
”ÂŒŠ@@’q
ˆç–ŃŒ¤‹†”­•\‰ď|‰Ô‰¤Š”ŽŽ‰ďŽĐŽĺĂ
2003.01.22
“Œ‹ž
@
ƒAƒgƒs[Ť”畆‰Š‚Ě‚p‚n‚k‚ĆEBM
•Đ‰Ş@—tŽq
‘ć‚W‰ńƒAƒgƒs[Ť”畆‰ŠŽĄ—ĂŒ¤‹†‰ď
2003.01.25
•Ÿ‰Ş
@
SgÇf’fEŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“‚ɂ‚˘‚Ä
‰H”’@@˝
‘ć17‰ń”畆‰ČSgˆăŠwŒ¤‹†‰ď
2003.02
“Œ‹ž
@
“–‰Č‚É‚¨‚Ż‚é‰ß‹Žˆę”NŠÔ‚̉şŽˆĂ–ŹáŽŽčp‚ɂ‚˘‚Ä
ˆéƒmăł–ž@@âˆä@_Žu@@‰H”’@@˝@@•Đ‰Ş@Ć‹M@@‘ĺ•“Ţ’ĂŽq@@“ě@@G“T@@‹g—´@ŸŽq@@
‘ć375‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.02
‘ĺă
@
“œ”A•aŤ‘Ť•a•ĎŽĄ—Ă‚ÉŠÖ‚ˇ‚éƒVƒXƒeƒ}ƒeƒCƒbƒNƒŒƒrƒ…[‚ĚŽŽ‚Ý
‹{“‡@@i@@‰Ş“c“Ţ’ĂŽq@@K–ě@@Œ’
‘ć17‰ń‹ß‹EMMCŒ¤‹†‰ď
2003.02.15
‘ĺă
@
”畆‰Č—Ěˆć‚É‚¨‚Ż‚éƒXƒeƒƒCƒhŤœ‘e頏Ç
‰Ş“c“Ţ’ĂŽq
‘ć66‰ń“ú–{”畆‰ČŠw‰ď“Œ‹žŽx•”Šwp‘ĺ‰ď iƒCƒuƒjƒ“ƒOƒZƒ~ƒi[j
2003.02.15-16
“Œ‹ž
@
ƒAƒgƒs[Ť”畆‰Š‚ĆƒXƒeƒƒCƒhˆË‘śŤ”畆Ç‚̍‡•š‚ɑ΂ˇ‚é’EƒXƒeƒƒCƒh’E•ŰŽź—Ă–@ iu‰‰j
˛“Ą@Œ’“ń
‘ć‚T‰ńƒAƒgƒs[Ť”畆‰Š‚ɑ΂ľƒXƒeƒƒCƒh‚đŽg‚í‚Č‚˘ŽĄ—Ă‚đl‚Ś‚é‰ď
2003.02.16
‘ĺăŽs iƒzƒeƒ‹ƒOƒ‰ƒ“ƒrƒA‘ĺăj
@
“Á•Ęu‰‰FŠŁá‚ĆŠ˛×–E
”ÂŒŠ@’q
‘ć‚P‰ńŠÖźŠŁá§˜b‰ď
2003.02.22
‘ĺă
@
ś‰şŽˆ[•”Ă–ŹŒŒđÇ‚đ•š”­‚ľ‚˝•s‘SŒ^ƒx[ƒ`ƒFƒbƒg•a‚Ě‚P—á
‰ĄŒŠ@–ž“T@@“c’†@‚Ü‚č@@ź‰Ş@@‰
‘ć375‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.02.9
‘ĺă
@
“œ”A•aŤ‘Ť•a•ĎŽĄ—Ă‚ÉŠÖ‚ˇ‚éƒVƒXƒeƒ}ƒeƒCƒbƒNƒŒƒrƒ†[‚ĚŽŽ‚Ý |”畆‰Čˆă‚É‚ć‚éƒKƒCƒhƒ‰ƒCƒ“ěŹ‚ÉŒü‚Ż‚ā|
‹{“‡@@i@@ź–ě@@—m@@ŕV“c@—R‰Ŕ@@‰Ş“c“Ţ’ĂŽq@K–ě@@Œ’
‘ć375‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.02.9
‘ĺă
@
ŹlŒ^ƒAƒgƒs[Ť”畆‰Š‚É‚¨‚Ż‚錌’†ƒŒƒjƒ“ŠˆŤ‚ĆƒAƒ‹ƒhƒXƒeƒƒ“’l
˛“Ą@Œ’“ń@@ŽR–{@ˆŰl@@Œă“Ą@Í•v
‘ć375‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.02.9
‘ĺăŽs i‘ĺă‘Ű‰ď‹cęj
@
ƒGƒgƒŒƒ`ƒi[ƒg‚Ş‘tŒř‚ľ‚˝‹Űó‘§“÷Ç‚Ě‚P—á
‘ĺ‘O‚ ‚ä‚݁@@ŽR–{@ŽuD@@ź–{@ç•ä
‘ć375‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.02.9
‘ĺă‘Ű‰ď‹cę
@
ƒGƒVŤ‹Ř–Œ‰Š‚Ě‚Q—á
’JŠ_@••F
‘ć375‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.02.9
‘ĺă@‘ĺă‘Ű‰ď‹cę
@
‰óŒŒ•a‚Ě‚P—á
’ră@—˛‘ž@@‘唨@ç‰Ŕ@@‰Ž‹ň@_Žq
‘ć375‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.02.9
‘ĺă@‘ĺă‘Ű‰ď‹cę
@
”ç]‚ސf’f‚Ě‚Ť‚Á‚Š‚Ż‚Ć‚Č‚Á‚˝‹}ŤŒ^‚`‚s‚k‚Ě‚P—á
”~“c@“ń˜Y@@Ž›”ö@”ü@@ŽR–{@—˛”V@@’˛@@—TŽŸ i‚m‚s‚sź“ú–{‘ĺă•a‰@j @“Ąě@ƒŽq@@‹ŕ@@‹`_ i“Ż“ŕ‰Čj
‘ć375‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.02.9
‘ĺă
@
Žčś‚̉ߊp‰ť‚đ‰”­Çó‚Ć‚ľ‚˝amyopathic dermatomyositis‚Ě‚P—á
ŒĂ—с@—˜ŽĄ@@‹g“c@’ź”ü@@žwŕV@F”V@@Šp@—˛”V@@•Đ‰Ş@—tŽq
‘ć375‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď@‹gě–M•F‹łŽö‘ŢŠŻ‹L”OŠw‰ď
2003.02.9
‘ĺă
@
“ú–{g”Á”M‚Ě‚P—á
‘ž“c@ƒŽq
‘ć375ŠK“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.02.9
‘ĺă
@
[ÝŤĂ–ŹŒŒđÇ i‚c‚u‚sj ‚Ěˆę—á
’‡‘ş@‰ë˘@@•—{@@M@@‰€“c@‘•c
“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.02.9
‘ĺă
@
dÇ‚̏ŹŽ™šb‘§‚Š‚çdÇ‚̐ŹlƒAƒgƒs[Ť”畆‰Š‚đœëŠł‚ľ, ‚ť‚ĚŒăŽŠsˆ×‚đ‚ˇ‚é‚悤‚É‚Č‚Á‚˝Ç—á
žwŕV@F”V@@‹g“c@’ź”ü@@ŒĂ—с@—˜ŽĄ@@X“c@”ŽŽq@@•Đ‰Ş@—tŽq
”畆SgÇˆăŠw—Ă–@Œ¤‹†‰ď
2003.03
@
@
‹łˆçu‰‰F’E–тɂ‚˘‚Ä
”ÂŒŠ@’q
‘ć‚Q‚O‰ń‰~Œ`’E–ŃÇ‚đl‚Ś‚é‰ď
2003.03.08
‘ĺă
@
“œ”A•aŤ‰óás, ’×á‡
‹{“‡@@i
‘ć163‰ń‘ĺă”畆‰ČÇ—ጟ“˘‰ď i“Á•Ęu‰‰j
2003.03.13
‘ĺă
@
Eccrine nivus‚Ě‚P—á
Ą’†@ˆ¤Žq
‘ć32‰ń@“ňčˆÉ’O”畆‰Č•a‰@‹Î–ąˆăŒ¤‹†‰ď
2003.03.20
“ňčŽs iŠÖź˜JĐ•a‰@, VŠO—ˆ“, 4ŠK‰ď‹cŽşj
@
ŒŔ‹ÇŤ‚Ěepidermolytic hyperkeratosis
˛“Ą@Œ’“ń
‘ć32‰ń@“ňčˆÉ’O”畆‰Č•a‰@‹Î–ąˆăŒ¤‹†‰ď
2003.03.20
“ňčŽs iŠÖź˜JĐ•a‰@, VŠO—ˆ“, 4ŠK‰ď‹cŽşj
@
Intravenous pyogenic granuloma‚Ě‚P—á
ŽR–{@ŽuD@@‘ĺ‘O‚ ‚ä‚݁@@ź–{@ç•ä@@­“c@‰ŔŽq@@ˆÉ“Ą@—TŒ[
‘ć376‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.03.29
•şŒÉŒ§–Ż‰ďŠŮ‚Ż‚ń‚Ý‚ńƒz[ƒ‹
@
‹‘ĺëŒ\ƒRƒ“ƒWƒ[ƒ}‚Ěˆę—á
Ž›”ö@”ü@@ŽR–{@—˛”V@@”~“c@“ń˜Y@@’˛@@—TŽŸ i‚m‚s‚sź“ú–{‘ĺă•a‰@j@@ŹŕVŒ’‘ž˜Y i‘ĺă‘ĺŠwj
‘ć376‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.03.29
_ŒË
@
ƒXƒeƒƒCƒh‘Sg“Š—^‚Ş’˜Œř‚ľ‚˝sclerosing panniculitis‚Ě‚P—á
ŒĂ—с@—˜ŽĄ@@‹g“c@’ź”ü@@žwŕV@F”V@@Šp@—˛”V@@•Đ‰Ş@—tŽq
‘ć376‰ń“ú–{”畆‰ČŠw‘ĺă’n•ű‰ď
2003.03.29
•şŒÉ
@
EBVŠ´ő‚É‚ć‚é‚f‚‰‚‚Ž‚‚”‚”‚‰ÇŒóŒQ‚Ěˆę—á
’‡‘ş@‰ë˘@@‰€“c@‘•c
–L’†ŽsˆăŽt‰ď”畆‰Čˆă‰ď
2003.03.29
–L’†
@
“Á•Ęu‰‰F–Ń‚ĚÄś
”ÂŒŠ@’q
‘ć‚P‚U‰ń“ě‘ĺăE˜a‰ĚŽR”畆‰Č§˜b‰ď
2003.04.17
‘ĺă
@
Involvement of adiponectin in the cutaneous wound healing process.
Y. Yamaguchi, H. Nishizawa, T. Funahashi, M. Nishida, Y. Nakatani, N. Maeda, I. Shimomura, S. Kihara, T. Kubo, G. Kondoh, J. Takeda, S. Itami, K. Yoshikawa and Y. Matsuzawa.
64th Annual Meeting of the Society for Investigative Dermatology
2003.04.30
Miami, Florida, USA
@
Ultraviolet radiation-induced melanogenesis in human skin of different racial/ethnic origin.
Y. Yamaguchi, T. Tadokoro, J. Beer, B. Zmudzka, S. Miller, V. Hearing.
64th Annual Meeting of the Society for Investigative Dermatology
2003.04.30
Miami, Florida, USA
@
Prevention of generalized autoimmune skin disease by transferring regulatory T cells
Hiroaki Azukizawa, Hiroshi Kosaka, Shigetoshi Sano,Satoshi Itam
IID
2003.04.30-05.04
ƒ}ƒCƒAƒ~
@
Ultraviolet radiation-induced melanogenesis in human skin of different racial/ethnic origin
Y Yamaguchi, T Tadokoro, JZ Beer, BZ Zmudzka, SA Miller and VJ Hearing
International Investigative Dermatology 2003
2003.04.30-05.04
Miami Beach, Florida in USA
@
Concurrent Minisymposium 9, Hair and Cutaneous Development, Co-chair with Marasso M, and Paus R.
Itami S
International Investigative Dermatology 2003
2003.05.01`05
Miami (USA)D
@
STAT3 is required for survival of epidermal keratinocytes against apoptotic stimuli and for skin cancer development despite its down-regulation by mutagens.
Sano S, Komazawa N, Kira M, Umeda J, Itami S, Tarutani M, Yoshikawa K, Takeda J
International Investigative Dermatology 2003
2003.05.01-05
Miami (USA)D
@
Ž•‰ČŽĄ—Ă‚É‚ć‚čÇó‚̉ü‘P‚đ‚Ý‚˝Melkersson-Rosenthal syndrome ‚Ě‚P—á
ˆÉ“Ą°NA“cŠäŽkAŹŕVŒ’‘ž˜YA’M’JŸmA‹g—ǐł_A•‘]—L”üA”ÂŒŠ@’qA‹gě–M•Fi‘ĺă‘ĺj
‘ć377‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.05.10
ź‹{Žs
@
ƒoƒUƒ“dŒ‹Ťg”Á‚ƍl‚Ś‚˝‰ş‘Ú‚ĚŽ‰–bD‰Š
X“cËŽqA‘哇‚ł‚â‚ŠAŽí‘ş“āAŹŕVŒ’‘ž˜YA‹g—ǐł_A’M’JŸmA“cŠäŽkA”ÂŒŠ@’qA‹gě–M•Fi‘ĺă‘ĺj
‘ć377‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.05.10
ź‹{Žs
@
ƒVƒ“ƒ|ƒWƒEƒ€F–ŃŽüŠú‚̐§Œä•ŞŽq
”ÂŒŠ@’q
‘ć‚P‚O‚Q‰ń“ú–{”畆‰ČŠw‰ď
2003.05.23
“Œ‹ž
@
Ž‡ŠOüĆŽË‚É‚ć‚éDNA‘š•Ŕ‚Ń‚Éƒƒ‰ƒjƒ“ŽYś‚̐lŽíŠÔˇ‚ĚŒŸ“˘
“cŠ@äŽkAŹ—с@M•FABeer Janusz. ZAZmudzka Barbara. BAˆÉ“Ą@Ë•ăAŽáź@ˆę‰ëA”ÂŒŠ@’qA‹gě@–M•FAHearing Vincent. J
‘ć102‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2003.05.23
‰YˆŔŽs
@
‰E‘OŠz•”‚̔牺ŽîáŽ(CPC)
‘唨ç‰ŔA‰H”’˝A‹g—´ŸŽqA“ěG“TA‰ÍŒ´–MŒő
‘ć102‰ń“ú–{”畆‰ČŠw‰ď‘‰ď
2003.05.23-25
‰YˆŔ
@
ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[F’jŤŒ^’E–Ń‚Ě”­ÇƒƒJƒjƒYƒ€
”ÂŒŠ@’q
‘ć‚P‚O‚Q‰ń“ú–{”畆‰ČŠw‰ď
2003.05.24
“Œ‹ž
@
“Á•Ęu‰‰F’E–яÇ
”ÂŒŠ@’q
‘ć‚P‚U‰ń‘ĺă”畆‰Čˆă‰ď
2003.06.07
‘ĺă
@
Spindle Cell Hemangioma: ‚˘‚í‚ä‚éSpindle Cell Hemangioendothelioma
‘唨ç‰ŔA‰Ô“cłl
‘ć19‰ń“ú–{”畆ˆŤŤŽîᇊw‰ď
2003.06.13-14
ŽD–y
@
Constitutive melanin, MED, and UV-induced DNA damage in different racial/ethnic groups
B. Zmudzka, J. Beer, H. Bushar, S. Coelho, V. Hearing, S. Miller, T. Tadokoro and Y. Yamaguchi
31st Annual Meeting of the American Society for Photobiology
2003.07.05-09
Baltimore, Maryland, USA. .
@
DNA damage and the dynamics of its removal in different racial/ethnic groups
J. Beer, V. Hearing, S. Miller, T. Tadokoro, Y. Yamaguchi and B. Zmudzka.
31st Annual Meeting of the American Society for Photobiology
2003.07.05-09
Baltimore, Maryland, USA. . . .
@
Effects of UV on melanocytes in human skin of various phototypes
Y. Yamaguchi, T. Tadokoro, J. Beer, B. Zmudzka, S. Miller and V. Hearing.
31st Annual Meeting of the American Society for Photobiology
2003.07.05-09
Baltimore, Maryland, USA. .
@
pŒăŒ¨‚ą‚č‚ŞÁŽ¸‚ľ‚˝€•”‹Ř“÷“ŕŽ‰–bŽî‚Ě‚P—á
‰ĄŒŠ–ž“TA“cŠäŽkA’ˇŕV’q•FAŹ“¤ŕVG–žAŠŁdŽ÷AŹŕVŒ’‘ž˜YA”ÂŒŠ’q
‘ć378‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.07.19
“Ţ—ÇŽs
@
“Á•Ęu‰‰F–ѕ‘B‚ĚŠî‘b‚Ć—Ő°
”ÂŒŠ@’q
ƒ‹ƒŠƒbƒhu‰‰‰ď
2003.07.24
Ź‘q
@
‰ş‘ڂ̔牺dŒ‹
‘唨ç‰ŔAŹŕVŒ’‘ž˜YA”ÂŒŠ’q
‘ć19‰ń“ú–{”畆•a—‘gDŠw‰ď
2003.07.26
“Œ‹ž
@
Ras’`”’Žż‚Ě•\”ç‚É‚¨‚Ż‚鑝B‘ŁiA•Ş‰ť—}§Œř‰Ę‚ÍRaf‚ĚƒVƒOƒiƒ‹“`’BŒo˜H‚đ‰î‚ľ‚Ä‚˘‚é
’M’JŸmA”ÂŒŠ’qA‹gě–M•FAPA Khavari
‘ć18‰ńŠp‰ťÇŒ¤‹†‰ď
2003.08.09
“Œ‹ž
@
Linear psoriasis‚Ě‚P—á
Ź“¤ŕVG–žA”ÂŒŠ@’q
“ú–{ŠŁáŠw‰ď
2003.09.12-13
‚ŽR
@
“Á•Ęu‰‰F‘gDÄś[–Ń•ď‚ÍĹ“K‚Čƒ‚ƒfƒ‹
”ÂŒŠ@’q
L“‡”畆‰Čˆă‰ď‚XŒŽ—á‰ď
2003.09.17
L“‡
@
ƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚đ—p‚˘‚˝Ras’`”’Žż‹y‚Ń‚ť‚̉ş—Ź‚ĚƒVƒOƒiƒ‹‚Ě•\”ç×–E‘B‹y‚Ń•Ş‰ť‚É‚¨‚Ż‚é–đŠ„‚ĚŒŸ“˘
’M’JŸmA”ÂŒŠ’qA‹gě–M•F
‘ć17‰ń•\”ç×–EŒ¤‹†‰ď
2003.10.18
H“c
@
“Á•Ęu‰‰F‘gDÄś[–Ń•ď‚ÍĹ“K‚Čƒ‚ƒfƒ‹
”ÂŒŠ@’q
ŽRŒ`”畆‰ČŠwpu‰‰‰ďiƒjƒ]ƒ‰[ƒ‹ƒ[ƒVƒ‡ƒ“”­”„‹L”Oj
2003.10.3
ŽRŒ`
@
ƒVƒ“ƒ|ƒWƒEƒ€F’jŤŒ^’E–Ń‚Ě”­ÇƒƒJƒjƒYƒ€‚ĆŽĄ—Ð헪
”ÂŒŠ@’q
‘ć‚Q‚S‰ń‰ŠÇEÄśŠw‰ď
2003.11.26
‹ž“s
@
THE MEMBRANE SIGNALING PATHWAY OF HUMAN NORMAL MELANOCYTES BY ANDROGEN-SEX HORMONE BINDING GLOGULIN
Taketsugu Tadokoro, Francois Rouzaud, Satoshi Itami, Vincent J. Hearing, Kunihiko Yoshikawa
‘ć17‰ń“ú–{F‘f×–EŠw‰ď
2003.11.29
“Œ‹ž
@
[’BŤ”畆’×ᇂ𐶂ś‚˝Churg-StraussÇŒóŒQ‚Ě‚P—á
–k‘şš‹IA’ˇŕV’q•FA“cŠäŽkA”ÂŒŠ@’q
‘ć380‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.12.06
‘ĺăŽs
@
Regulatory T cell‚ĚˆÚ“ü‚É‚ć‚鎊ŒČ–ƉuŤ”畆ŽžŠł‚̉ń”đ
Hiroaki Azukizawa, Hiroshi Kosaka, Shigetoshi Sano,Satoshi Itam
“ú–{–ƉuŠw‰ď
2003.12.08-10
”Ž‘˝
@
’jŤŒ^’E–Ń‚Ě”­ÇƒƒJƒjƒYƒ€
”ÂŒŠ@’q
‘ć‚P‚O‚Q‰ńFJƒZƒ~ƒi[
2003.12.19
“Œ‹ž
@
‰ß‹Ž‚T”NŠÔ‚Ě“–‰Č‚É‚¨‚Ż‚éPUVAbath—Ă–@‚É‚ć‚éqíŤŠŁá‚ĚŽĄ—ĂŒř‰Ę‚ĚŒŸ“˘
’†‘ş•q–ži‘ĺă‘ĺjA™Œ´^‹IA‰ĄŒŠ–ž“TA‰Ź“°—DŽqA“ŒŽR^—˘i“úśj
‘ć‚R‚W‚O‰ń“ú–{”畆‰ČŠw‰ď‘ĺă’n•ű‰ď
2003.12.6
‘ĺă
@
Self-monitoring for scratching behavior of adult atopic dermatitis
Yuki Ishida@@Makoto Hashiro@@Yuji Sakano
The 7th International Congress of Behavioral Medicine
August, 2002
Helsinki, Finland
@
A case of dysesthesia in Japan
Makoto Hashiro
The Association for Psychocutaneous Medicine of North America, Annual Meeting
February, 2002
New Orleans, U.S
@
Quality of life in atopic eczema and urticaria patients
Makoto Hashiro
Workshop: Quality of life issues and treatment compliance in dermatology, The 20th World Congress of Dermatology Paris 2002
July, 2002
Paris, France
@
A case of atopic dermatitis showed improvement of behavior and skin symptom by the intervention with behavior limitation and brief therapeutic technique
Makoto Hashiro
The association for psychocutaneous medicine of north america, annual meeting
San Francisco
2003.03
@